"companyid","keydevid","transcriptid","headline","mostimportantdateutc","keydeveventtypename","companyname","speakertypename","componenttextpreview","word_count","componenttext"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to Fourth Quarter 2015 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] As a reminder, today's conference call is being recorded. I will now turn the conference over to Mr. Brian Angeli, Vice Presid",49,"Good morning, and welcome to Fourth Quarter 2015 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] As a reminder, today's conference call is being recorded. 
I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning, everyone. Welcome to FMC Corporation's Fourth Quarter Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.",287,"Thank you, and good morning, everyone. Welcome to FMC Corporation's Fourth Quarter Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.
Pierre will begin the call with a review of FMC's fourth quarter and full year performance and then discuss the outlook for 2016. Paul will provide an overview of select financial results. 
As we have done for each of the past 2 quarters, we have published a slide presentation that accompanies our results. This slide presentation, along with our earnings release and 2016 outlook statement, is available on our website. The prepared remarks from today's discussion will be made available at the conclusion of the call.
After the prepared remarks, we will be joined by Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President FMC Health and Nutrition; and Tom Schneeberger, Vice President and Global Business Director, FMC Lithium, to address your questions.
Before we begin, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including but not limited to those factors identified in our release and in our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based on these risks and uncertainties. 
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms, as well as other non-GAAP financial terms, to which we may refer during today's conference call, are provided on our website.  
I will now turn the call over to Pierre."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian. Good morning, everyone. 2015 marked the completion of FMC's transformation to a technology-driven specialty company with leading market positions across agricultural, nutrition, pharmaceutical and specialty lithium applications. In Ag",2766,"Thank you, Brian. Good morning, everyone. 2015 marked the completion of FMC's transformation to a technology-driven specialty company with leading market positions across agricultural, nutrition, pharmaceutical and specialty lithium applications. 
In Ag solutions, the acquisition of Cheminova strengthened our technology pipeline, brought greater regional balance, broadened our market access and expanded our portfolio. The integration of Cheminova continues to go well. Our success to date reinforces our confidence in achieving the run rate cost savings of $140 million to $160 [ph] million by the middle of 2017. The acquisition and integration of Cheminova combines with the actions we have taken to restructure our Ag solutions operations in Brazil have positioned FMC to better address current market conditions. 
In Health and Nutrition, we focused on driving higher margin -- margins by capturing high-value commercial opportunities across our portfolio and by implementation of manufacturing actions program and process technology improvements. And in lithium, we continued to execute on our strategy of growing FMC's differentiated downstream specialty business to take advantage of favorable end market demand. 
2015, however, was also a year marked by significant foreign exchange headwinds and difficult conditions across the global agricultural market. We took decisive actions throughout the year to address these challenges, accelerating the integration of Cheminova, restructuring our Ag solutions operations in Brazil, exercising discipline on pricing and aggressively controlling costs across the company. As we enter 2016, we remain focused on the continued execution of our strategy to drive improved performance. Despite challenging macroeconomic and Ag market conditions, we believe the actions we have taken will enable FMC to deliver higher earnings growth across each of our business in 2016. 
I will provide further details regarding our 2016 outlook shortly. But first, I will review our fourth quarter and full year 2015 performance. 
Starting with FMC's full year results on Slide 1. FMC reported revenue of approximately $3.3 billion in 2015, roughly flat to reported revenue for 2014 and adjusted EPS of $2.47, a decline of 22% compared to last year.
For the fourth quarter, FMC reported revenue of $899 million, an increase of approximately 1% compared to the same period last year. Adjusted earnings per share for Q4 were $0.77, 9% below the fourth quarter of 2014.
Turning to Ag solutions on Slide 2. For the fourth quarter, Ag Solutions delivered revenue of $657 million and segment earnings of $101 million, a decline of 23% and 8% respectively from the pro forma results of the same period of 2014. The negative impact of foreign exchange and lower sales volume more than offset price increase and lower operating cost in the quarter. About 75% of the decline in sales volume during the fourth quarter was the results of deliberate actions to eliminate lower-margin, third-party product sales. Excluding these sales, volume declined by less than 5% compared to the fourth quarter of 2014 as we continued to see demand for FMC's proprietary products across all regions. 
In Europe, we saw healthy demand, as mild weather conditions allowed for a late application of cereal herbicides. During the fourth quarter, we were pleased to recall our first direct sales of FMC products into Western Europe as we transition to direct market access provided by the Cheminova acquisition. 
Across the Americas, however, market conditions were significantly more challenging. In North America, consecutive years with low pest pressure have resulted in elevated channel inventory levels, [indiscernible] the channel inventory issues is the deterioration in farmer income levels in the U.S., resulting in a more cautious mindset of distributors and growers. While we continue to see strong support for customers for our proprietary products, we expect challenging market conditions to persist through 2016.
In Brazil, we saw improving conditions in certain crop markets, including sugarcane and cotton, as well as niche crops such as coffee and citrus. However, channel inventories, especially in insecticide and unfavorable weather conditions, negatively impacted sales volume. As we have discussed previously, we expect channel inventory levels to remain elevated through 2016. 
In the rest of Latin America, we continue to see strong demand for FMC's product, including pre-emergent herbicides in Argentina and products for niche crops in Colombia and Mexico. Sales in Argentina, however, continues to be impacted by delay in receiving import licenses for formulated products.
In Asia, weather conditions in India, Pakistan, Australia and parts of Southeast Asia related to reduced demand and higher channel inventory.
The negative impact of foreign exchange was the single largest driver of our 2015 performance. In the quarter, the strengthening of the U.S. dollars -- of the U.S. dollar, reduced Ag Solutions segment earnings by about $60 [ph] million compared to last year. However, the combination of price increases and cost reductions more than offset the negative impact of foreign exchange.
In Brazil, we continued to implement significant price increases to maintain U.S. dollar-based pricing in that country. This price increases recovered more than 70% [ph] of the currency impact on segment earnings in the fourth quarter. In addition, FMC continued to aggressively reduce operating costs through the faster integration of Cheminova and further restructuring of Ag Solutions operations in Brazil.
As a result, and despite the challenging demand environment, segment earnings margin improved by 250 basis points to 15.4% in the quarter. I will provide further details regarding cost savings activities shortly.
But first, I will comment on the full year performance for Ag Solutions. As shown on Slide 3, Ag Solutions reported revenue of $2.6 billion [ph] for 2015 compared to pro forma revenue of $3.4 billion for 2014, a decline of 23%, as lower sales volume and foreign exchange headwinds more than offset price increases during the year. Lower sales volumes accounted for about 16% of the decline in revenue. However, more than half of these volume decline is the result of actions we took throughout the year to eliminate lower-margin, third-party product sales. Excluding this, sales volumes declined about 7% compared to 2014. 
In 2015, the strengthening of the U.S. dollar resulted in FX headwinds of about $300 million, erasing over 50% [ph] of Ag Solutions pro forma 2014 segment earnings. To be clear, these reduced reported sales by about $380 [ph] million and lowered our reported cost by about $80 [ph] million. We offset about 60% of the currency impact on sales in Brazil by raising prices throughout the year, and we expect to continue to offset future FX impacts in Brazil through price increases. 
Early in the year, we began to aggressively reduce operating costs. For the full year, operating costs were lower by about $100 million. This include savings from the Cheminova integration, lower spending on discretionary items and lower energy and material costs.
Despite the challenging market conditions in 2015, we continued to invest in innovation and our technology pipeline of new synthetic and biological active ingredients. Product introduced in 2015 were well received in the market and we expect further traction from new product introductions in 2016.
I will now turn to the 2016 cost savings we expect to realize from the Cheminova integration and related actions. As you can se eon Slide 4, in 2015, FMC realized about $40 million in cost savings as a direct result of the Cheminova integration and the restructuring of operations in Brazil.
For 2016, we expect to deliver additional cost savings over 2015 of between $60 million and $70 million, reflecting the full year benefit of previously announced headcount reduction and savings associated with various procurement and SAR cost-reduction for ramps.
As discussed, during our third quarter earnings call, FMC targeted total headcount reductions of 800 to 850 positions. As of December 31, 2015, over 700 positions have been eliminated, and we expect to implement the remaining reductions during the second half of 2016.
The success we have achieved to date in delivering these -- the headcount reduction plus the further cost reduction initiatives currently underway, gives us the high degree of confidence that we will deliver the 2016 cost savings target and achieve the $140 million to $160 million in run rate cost savings by the middle of 2017.
Turning now to Health and Nutrition on Slide 5. Q4 represented another quarter of solid earnings performance. As a result, the business delivered its 11th consecutive year of record earnings in 2015. Health and Nutrition reported revenue of $172 million, a decline of 10% compared to the fourth quarter of 2014 mainly due to lower sales volume and the weaker euro. We saw lower MCC banner and carrageenan sales in the quarter, partially offset by higher sales of MCC-based product for food application and increased sales of Omega-3 for the nutraceutical market.
Segment earnings for Health and Nutrition increased 5% compared to the fourth quarter of 2014 to $46 million. Lower operating cost more than offset the negative impact of lower sales volume. 
The benefits of ongoing Manufacturing Excellence and process technology improvements increased segment earnings margin in the quarter to 26.9%, an increase of almost 400 basis points compared to the fourth quarter of 2014.
As a result of the actions taken over the past year, Health and Nutrition is well-positioned to deliver continued earnings growth in 2016. 
Turning next to lithium on Slide 6. Lithium delivered a strong quarter. Revenue of $70 million was up slightly compared to the fourth quarter of 2014 as higher prices were partially offset by the impact of foreign exchange.
The fourth quarter of 2015 represents the fourth consecutive quarter in which FMC realized higher pricing in the Lithium business, as demand growth across end markets application, coupled with tight supply supported price increases, especially for FMC's carbonate and hydroxide products.
Sales volumes were essentially flat to last year as higher volumes for FMC's butyllithium and specialty organics were offset by lower volumes resulting from the scheduled maintenance downtime in our hydroxide unit and less third-party supply of carbonate.
Demand for FMC's downstream specialty lithium products remained strong. Hydroxide sales volume were up significantly on a full year basis, as demand for energy storage applications continue to grow at double-digit rates and as we continue to increase throughput from our existing assets.
Segment earnings increased 42% to $11 million in the quarter. The combination of higher pricing, improved sales mix and lower operating cost more than offset the impact of FX on FMC's reported results, pushing segment earnings margin to 15.9% [ph], an increase over 450 basis points compared to the fourth quarter of 2014. 
Now moving on to our 2016 outlook on Slide 7. Last night, we published our outlook statements for the first quarter and full year 2016. I will take a few minutes now to briefly discuss the outlook for each of FMC's business segments.
In Ag Solutions, full year segment revenue is expected to be approximately $2.3 billion to $2.5 billion and full year segment earnings are expected to be in the range of $380 million to $420 million, with first quarter segment earnings in the range of $70 million to $90 million. I will discuss Ag in more detail in a moment. 
In Health and Nutrition, we are anticipating full year segment revenue of $775 million to $825 million. We continue to see stable low to mid-single-digit demand growth in the majority of our end markets. Segment revenue growth is expected to be slightly below this level as we do not expect certain omega-3 sales to the pharmaceutical API market majoring the first quarter 2015 to happen in 2016. 
Excluding these sales, we expect underlying sales growth in the middle -- in the mid-single digit range driven by increased demand for health excipients and nutraceutical ingredients across emerging markets. 
Health and Nutrition segment earnings are expected to be in the range of $198 million to $208 million in 2016. The business made significant strides to improve its cost structure and operating efficiency over the past 12 months. We expect these efforts to drive further margin expansion in 2016 which will allow Health and Nutrition to grow earnings accordingly. 
We expect first quarter segment earnings for Health and Nutrition to be in the range of $46 million to $51 million. We have little similarity in this segment earnings for Health and Nutrition. However, as I mentioned previously, we do not expect certain omega-3 sales from the first quarter of 2015 to recur this year. As a result, reported first quarter segment earnings will be lower compared to 2015. 
In lithium, we see strong demand in a favorable pricing environment. We will continue to optimize our sales mix to drive higher volume of FMC's downstream specialty products.
As we enter 2016, FMC is sold out across most products. Higher pricing, improved mix and lower operating cost will drive earnings growth in 2016. In addition, the reduction in operating cost, as a result of the devaluation of the Argentine peso, will provide a tailwind for segment earnings over the next 12 to 18 months.
For the full year, we expect lithium segment revenue to be between $240 million and $260 million, and segment earnings to be in the range of $33 million and $43 million. We expect first quarter segment earnings of $8 million to $12 million. 
On a consolidated basis, we expect FMC's 2016 adjusted earnings per share to be between $2.50 and $2.80. We expect first quarter 2016 adjusted earnings to be between $0.48 and $0.60 per share.
I will now discuss the outlook for Ag Solutions business in more detail starting with a few comments regarding the market on Slide 8.
In Europe, we expect our key markets to be broadly flat compared to last year, although we expect to see higher growth across Eastern Europe. 
In North America, we expect the challenging market conditions will continue in 2016 given elevated channel inventory levels and projected lower farm incomes. As a result, we expect the market in North America to be down in 2016. 
Across Asia, we expect the market to be mixed depending on the countries, however, overall we expect region to be up slightly in 2016 assuming more normal past pressures and weather conditions. 
Turning to Latin America. Market conditions in Argentina, Mexico and Colombia are expected to remain favorable, with growth in weed resistant acres and increasing acreage for niche crops. We expect the market in Brazil to be down again in 2016. Channel inventory levels are expected to remain elevated in 2016. However, we expect to see an improvement in market fundamentals for sugarcane and cotton.
While the factors impacting market growth vary across growing regions, we are broadly seeing a more cautious approach to purchasing decision throughout the value chain as a result of the protracted downturn in the Ag cycle.
Based on the factors I just described, we expect the global crop protection chemical market to decline by a mid-to-high single digit percentage in 2016 under U.S. dollar basis. However, it is important to remember that these factors are dynamic and will change throughout the year. In particular, changes in planting decisions and past pressures, and of course weather conditions will significantly impact demand over the course of the growing season. We will get more clarity on these exceptional factors as the year progresses and we will update our views on market condition as some of these uncertainties become clear.
Turning next to Slide 9, where we summarize the critical earnings driver for 2016. A number of factors will contribute to the year-over-year increase in Ag Solutions segment earnings. First, we expect a positive $20 million impact from the full year of Cheminova. Next, we are targeting incremental cost savings of $90 million, including $60 million to $70 million from Cheminova related synergies. Third, we expect that our pricing actions in Brazil and overall mix improvement will contribute approximately $90 million.
New product introductions scheduled for 2016 and revenue synergies in Europe and North America from the Cheminova acquisition will positively impact our mix and volumes for the year. 
Continued FX headwinds, the broader market decline and our decision to exit certain low-margin third-party product sales will partially offset incremental earnings from the items I just described.
In Health and Nutrition, higher sales of excipient and nutritional products in emerging markets and the full year benefit of continued operational improvements are expected to deliver approximately $8 million in earnings growth.
Lithium is expected to contribute about $15 million to our growth in earnings in 2016, given primarily from higher pricing improved mix and lower operating costs.
I will now turn the call over to Paul who will discuss corporate expenses, the impact of foreign currencies on our results and cash flow."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Thanks, Pierre. Let me start with the income statement. Our corporate expense line represents both centrally held expenses that are not charged back to the businesses. 2015 came in lower than 2014 for the full year as we saw various items such as insuranc",885,"Thanks, Pierre. Let me start with the income statement. Our corporate expense line represents both centrally held expenses that are not charged back to the businesses. 2015 came in lower than 2014 for the full year as we saw various items such as insurance expenses, pension charges, year-end LIFO adjustments to inventory and various incidental FX-related expenses all come in below last year. We do not expect these to repeat in 2016 leading to our guidance for the corporate expense line of $70 million to $80 million. 
Looking at the tax rate, our full year rate benefited from the 2 drivers relative to our previous expectations. First, those legislative items passed after the end-of-the-year primarily related to R&D deductions resulted in a reduction in our overall rate. Second, the geographical mix of our earnings changed, away from the U.S. and Brazil and towards Europe and Asia. Since the latter regions typically have lower tax rates than the U.S. and Brazil, our overall tax rate benefited.
Together, these 2 items lowered our full year 2015 tax rate by approximately 300 basis points. Looking forward, we expect our adjusted tax rate to be in the 24% to 26% range. 
I'd like to spend a few moments on Slide 10 revisiting the impact of the strengthening U.S. dollar on our business during the year.
As Pierre has already described, our 2015 performance faced a significant challenge from the impact of the strengthening dollar in our earnings. Across all of FMC and before any pricing actions, the strengthening of the U.S. dollar would have reduced our 2014 operating earnings by approximately $310 million. Of this reduction, approximately $293 million would have directly impacted Agricultural Solutions. On Slide 10, you can see the drivers of this hit to the Ag Solutions segment earnings.
The cumulative effect of weakening local currencies on revenue was approximately $380 [ph] million average, of which the Brazilian real was easily the largest followed by the euro. Offsetting this revenue impact was the positive effect on our local cost base, again, maybe the real and the euro or euro-linked currencies, which reduced our cost in the U.S. dollar terms by $85 million. 
Our response to this was to raise prices. Pierre has already noted that for the full year in 2015, these price increases offset approximately 60% of the currency impact in Brazil. This was possible in large part because market practice in Brazil is to price in reais, but to do so relative to U.S. dollar impacts. In the rest of the work, pricing is generally not dollar indexed, creating a bigger challenge to raising prices, especially when market conditions are soft. 
In aggregate, globally, we recovered more than half of the $293 million earnings headwind through raising prices. Looking into 2016, we expect the FX headwinds to be more modest than in 2015. The forecast currency moves in major currency such as the euro are far smaller in 2016 than we saw a year ago. And while there remains uncertainty around various Asian and Eastern European currencies, movements in these currencies have a far smaller impact on our profitability. 
The key region that drives the guidance regarding both currency and pricing, as Pierre just described on Slide 9, is Brazil. First of all, our guidance assumes that there will be a less volatile depreciation of the Brazilian reais, with no rapid devaluation right in the middle of the key selling period as we saw in Q3 2015. Although we are not expecting stronger market conditions in Brazil, our guidance also assumes that local price actions already in place, plus additional price increases which will be introduced later in the year to reflect the actual depreciation of the Brazilian reais will largely offset the forecast year-over-year impact of currency depreciation.
Turning to the balance sheet and the cash flow on Slide 11. Our year-end net debt was approximately $2.1 billion, with the small increase over the Q3 net debt being entirely due to the final tax payment related to the Alkali sale. The fourth quarter is typically a flat to negative operating cash flow quarter for us given the seasonality of sales in Brazil. However, strong performance in Health and Nutrition and lithium, as well as continued cost in capital spending controls, ensured that we kept our net cash outflows to a minimum. 
For the full year, our adjusted cash from operations adjusted to remove the one-off impact of Cheminova and Alkali-related items, saw a 16% increase over 2014 despite a decline in EBITDA of around $100 million. We benefited from a positive year-on-year swing from working capital as all businesses improved their working capital performance compared to 2014. 
Our cost control programs included cash spending discipline. We saw lower cash outflows for capital expenditures, which was our third lower than in 2014, offset by slightly higher restructuring spending. 
In addition, our cash taxes related to ongoing operations was significantly lower than 2014, reflecting lower profitability in both the U.S. and Brazil.
Looking into 2016, we expect continued improvement in cash generation performance. In aggregate, we expect adjusted cash from operations to increase by approximately 25% in 2016 driven by higher earnings, continued working capital improvements and lower restructuring spending, offset by higher cash taxes.
With that, I will turn the call back to Pierre."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Thank you, Paul. Despite the Ag industry uncertainty, we believe that our 2016 plan is very achievable. It relies more on things we control than on expectations of positive external events. We expect to deliver earnings growth in all businesses in 2016. A",111,"Thank you, Paul. Despite the Ag industry uncertainty, we believe that our 2016 plan is very achievable. It relies more on things we control than on expectations of positive external events. We expect to deliver earnings growth in all businesses in 2016. And we'll continue to position FMC firmly on the path of growth by leveraging the company's unique business model that has defined our success. FMC remains a technology-driven company with low-cost, asset-light operation, a unique, high return [indiscernible] model for active ingredients innovation and strong regional formulation capabilities.
I want to thank you for your attention. And I will now turn the call back to the operator for questions."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] Your first question comes from the line of Frank Mitsch from Wells Fargo Securities.",16,"[Operator Instructions] Your first question comes from the line of Frank Mitsch from Wells Fargo Securities."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Pierre, kind of stepping back a second. obviously you guys are working hard on the Ag side. But we're dealing with these macro pressures that we continue to hear more and more about. And obviously the inventory situation is a bit worse. So if you think ov",76,"Pierre, kind of stepping back a second. obviously you guys are working hard on the Ag side. But we're dealing with these macro pressures that we continue to hear more and more about. And obviously the inventory situation is a bit worse. So if you think over the next couple of years how do you think the cycle plays out? And what needs to happen for things to really start to improve from a macro standpoint?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, from the cycle standpoint, I have to say that we are highly focused right now on 2016. We believe -- and the way we look at it today, as I said in my prepared remarks, is that we have a situation which is a little bit easier and more balanced in Euro",236,"Yes, from the cycle standpoint, I have to say that we are highly focused right now on 2016. We believe -- and the way we look at it today, as I said in my prepared remarks, is that we have a situation which is a little bit easier and more balanced in Europe and Asia. And for that matter, in Latin America outside of Brazil. But we have certainly still significant inventory level in Brazil and in North America. Actually in North America, for us, is as much of a concern as Brazil is. So we are highly focused on executing our strategy in a market we believe will be down mid-single to high single-digit in 2016. There is still the possibility of a cycle turn in 2017, but you have to see how 2016 will go. It is highly dependent upon how the industry behaves, making sure that we don't oversell, don't undersell. And there is a normal weather and pest pressure. That is going to be very critical. Any additional negative weather from an Ag industry standpoint or a no pest pressure would lead to resulting in less of primary inventory. So 2016 will be a difficult year. And as we go into 2016, we should be able to see if 2017 remained the year where you will have a turn of the cycle. Mark I don't know, if you have any additional comments."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","No. We're keeping a close watch on stock to use ratios, which shows very clearly where supply and demand is. We see some change in key crops for us, in sugarcane as sugar prices go up as suppliers reduce over the last few years. Those are the type of thin",73,"No. We're keeping a close watch on stock to use ratios, which shows very clearly where supply and demand is. We see some change in key crops for us, in sugarcane as sugar prices go up as suppliers reduce over the last few years. Those are the type of things that we look for to sense any changes in our key markets. But I think everything else you said, Pierre, is very valid."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","And from an FMC standpoint, obviously dealing with this, you guys have done a great job with the price increases and getting ahead of offsetting the pressures you're feeling. You alluded to more this year. Can you help me with the timing of it? And ultima",66,"And from an FMC standpoint, obviously dealing with this, you guys have done a great job with the price increases and getting ahead of offsetting the pressures you're feeling. You alluded to more this year. Can you help me with the timing of it? And ultimately, is 70% of recovery the right number to think about, or was it to go higher or lower from here?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","I think when we look at 2016, when we say we're going to pretty much cover the price increases for the FX impact for 2 reasons: First of all, because we expect the FX impact to be less in 2016 than it was in 2015. Remember that the biggest problem in 2015",158,"I think when we look at 2016, when we say we're going to pretty much cover the price increases for the FX impact for 2 reasons: First of all, because we expect the FX impact to be less in 2016 than it was in 2015. Remember that the biggest problem in 2015 was the high volatility and rapid devaluation of the reais in the third quarter. That was unprecedented, more than actually the overall devaluation of the reais. So we're not expecting that situation. In a less impact situation from currency, the price increase we need, going into 2016, is less than the last year because a big part is a recovery of currency issues from price increase which are already in place. So I would say we are entering 2016 with about 60% [ph]? 60% [ph] of the price actions already in place to recover the currency impact, and the rest is to happen during the year."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question comes from the line of Mike Sison from KeyBanc.",12,"Your next question comes from the line of Mike Sison from KeyBanc."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Pierre, I was wondering if you could -- there was a time when you thought for '16 maybe segment earnings for Ag could be in the mid-$600 millions. And clearly, a lot has changed since then. Foreign currency has taken a big hit. But if you can bridge the g",71,"Pierre, I was wondering if you could -- there was a time when you thought for '16 maybe segment earnings for Ag could be in the mid-$600 millions. And clearly, a lot has changed since then. Foreign currency has taken a big hit. But if you can bridge the gap or maybe talk about $400 million, '16 and where the opportunity is, what's the earnings power of Ag Solutions over time."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes. See, I don't think, from a business strength standpoint, anything has changed for FMC. I believe we remain one of the lowest cost manufacturer of active ingredients, and maybe the most flexible one with our asset-light model. We believe our technolog",260,"Yes. See, I don't think, from a business strength standpoint, anything has changed for FMC. I believe we remain one of the lowest cost manufacturer of active ingredients, and maybe the most flexible one with our asset-light model. We believe our technology strategy is even better today than it used to be. And our formulation strength has not changed. So it is, right now, the earnings potential of FMC Ag Solution has not changed. The problem is, we are in a situation where demand is very low. Decisions from growers are pushed to the last minute. And in a currency situation, which as you can see the biggest problem. So 2016 is going to be focused for us on earnings growth. There isn't much we can do around volume demand. We're also going to be highly, highly disciplined. We are not -- I can tell you one thing and we have not done that in 2015 and we're going to stick with that strategy in 2016. We are not going to run after market share. We are working our way from low profit sales and we are increasing price to recover the currency impact. That should position us as soon as the cycle turn to a very strong performance. So to expect the business going into the mid- to high-teens growth as soon as the market turn around, I have no doubt about it. The more we'll be seen intact. Right now, it is inventory. And what I would say, our worries are mostly placed in North America and Brazil."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, great. And your forecast for '16 look for volumes to be down a couple of percent, the minus 50 there in terms of impact to earnings -- or maybe that's an earnings impact. But it does sound like if the markets are down mid- to high-single digits, you",83,"Okay, great. And your forecast for '16 look for volumes to be down a couple of percent, the minus 50 there in terms of impact to earnings -- or maybe that's an earnings impact. But it does sound like if the markets are down mid- to high-single digits, you're going to do better than that. And I just wanted to get a better understanding why or why you feel that your volumes will be better than the market being down as it is?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","No, I think if you look at our overall performance from the business from the revenue standpoint, we are going to be about in line with the market if you remove the impact of third-party sales. So really, think about our business from a volume standpoint,",244,"No, I think if you look at our overall performance from the business from the revenue standpoint, we are going to be about in line with the market if you remove the impact of third-party sales. So really, think about our business from a volume standpoint, we're going to be in line with the market. So if it's a mid-to-high single digit, call it a 7%, few volume driven by market demand, that's where we are forecasting performance. Now our decline in sales are going to be higher because -- and I am talking about volume here, okay? Because we are working the way still from third party. The run rate from which we closed 2015 [ph] is leading to a number which is higher than in 2016 [ph] because we started process during the year. And I think it's about an incremental $100 million of third-party sales we are working our way in 2016, which make our performance from the revenue standpoint a bit worse than market. So -- 2 things, we've market from a demand standpoint, first third-party sales $100 million we'll work our way. Where we're going to outperform the market, as we've shown in one of the slide, I think it's Slide 9, the one where we have the earnings driver, is because of the work is done around integration, around the cost and also 2 drivers of growth, which are synergies from Cheminova and also the new product introduction."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from the line...",8,"Your next question is from the line..."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Actually, let me finish. Let me maybe more precise in the qualification. If you think about our sales we're going to be declining, just look at about 3 big buckets. Sales driven by market decline, about $150 million to $200 million. That's the market dema",92,"Actually, let me finish. Let me maybe more precise in the qualification. If you think about our sales we're going to be declining, just look at about 3 big buckets. Sales driven by market decline, about $150 million to $200 million. That's the market demand. Think about third party we are working away with no profit implication, about $100 million. And think about growth, which will be coming from synergies and no new technology, from $50 million to $100 million. Those are the 3 big buckets of our revenue drivers in 2016."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","We'll now go to your next question, which is from the line of Chris Parkinson with Credit Suisse.",19,"We'll now go to your next question, which is from the line of Chris Parkinson with Credit Suisse."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Can you give us an update on anything incremental on your potential cross-Europe specifically in the back of Cheminova? You mentioned some nice data points in fungicides, but how are you thinking about your now aggregated portfolio? And then also just in",61,"Can you give us an update on anything incremental on your potential cross-Europe specifically in the back of Cheminova? You mentioned some nice data points in fungicides, but how are you thinking about your now aggregated portfolio? And then also just in the near-term, quick question, do you believe the mild winter will benefit insecticide sales during the first half?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Chris, it's. We talked about Europe, talked about the direct market access on where the growth is going to come from. We're already seeing that, as Pierre alluded to, in the earlier part of this call. We're seeing now, primarily our herbicides from FMC ge",231,"Chris, it's. We talked about Europe, talked about the direct market access on where the growth is going to come from. We're already seeing that, as Pierre alluded to, in the earlier part of this call. We're seeing now, primarily our herbicides from FMC getting pushed through the Cheminova pipeline. So we've gone direct in the U.K. now, and we're also expanding into Spain. So we're seeing that geographic growth for herbicides that we wanted. Obviously, we're introducing new fungicides across the region. So everything we thought of in Europe is coming true. The country managers, the sales force from Cheminova have embraced the portfolio from FMC, and are now gearing up to put those products into the marketplace. So from my perspective, Europe is exactly where we thought it would be. And obviously, there's going to be growth for us, going forward. For the second part of your question on the insecticides, obviously we've had, especially North America, probably 3 years of extremely low pest pressures across the U.S. One could say that a warm winter would allow the pests to come back. But frankly, we don't know. We're not forecasting a strong pest season. We tend to forecast an average season and see where that takes us. But we'll know more about that as we get into end of Q1 into Q2. We'll get a better feel for that."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Good color. And also very quickly in Argentina. Is most of the potential here for your herbicide portfolio? And do you have any kind of new preliminary plans or initiatives for Southern [indiscernible] in particular? If so, how are you balancing that long",53,"Good color. And also very quickly in Argentina. Is most of the potential here for your herbicide portfolio? And do you have any kind of new preliminary plans or initiatives for Southern [indiscernible] in particular? If so, how are you balancing that long-term potential with FX credit volatility, length of terms, et cetera?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, Argentina has been a good market for us despite some difficult conditions in getting import licenses. Our predominant market down there is pre-herbicides for soy. We are a market leader. With the Cheminova acquisition, we bring along more fungicides",209,"Yes, Argentina has been a good market for us despite some difficult conditions in getting import licenses. Our predominant market down there is pre-herbicides for soy. We are a market leader. With the Cheminova acquisition, we bring along more fungicides and insecticides that we can put through the channel. We're actually doing a couple of things to expand our presence in Argentina at the moment. First of all is the consolidation of our market access with Cheminova. And then secondly, we're looking at expanding our supply chain in Argentina to more reflect what we do around the rest of the world in terms of tool manufacturing. We're actually going to be importing more active ingredients and formulating in country. That helps us two ways. First of all, it allows us to formulate projects for Argentina on the ground, gives us more flexibility. And then secondly, helps with our cost base, which is in local currency. So we do see Argentina growing. It has been a good market for us over the last couple of years. And we think our portfolio is ideally suited to where they're going. We are seeing weed resistant acres continue to increase, just like we do in the U.S  So I'm very bullish on Argentina."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question comes from Daniel Jester from Citi.",9,"Your next question comes from Daniel Jester from Citi."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Maybe just another one in pricing in Ag Solutions. I think you talked about the linkage between the reais and the U.S. dollar in Brazil and your ability to get pricing. But can you talk about how that is evolving in other parts of the world, which is ahea",92,"Maybe just another one in pricing in Ag Solutions. I think you talked about the linkage between the reais and the U.S. dollar in Brazil and your ability to get pricing. But can you talk about how that is evolving in other parts of the world, which is ahead other FX challenges? And specifically, are you seeing the competition also raise prices as aggressively as you? Or do you think there's a risk of that to get a maybe a little ahead of the market given how challenging how macro conditions are?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","I think the ability to increase price is very different in places like Brazil where the local pricing in Brazilian reais is indexed to a dollar currency, and there is a mechanism, usually, which is in place. Now it always ends up being in negotiation. And",201,"I think the ability to increase price is very different in places like Brazil where the local pricing in Brazilian reais is indexed to a dollar currency, and there is a mechanism, usually, which is in place. Now it always ends up being in negotiation. And I believe, yes, we have been the most aggressive increase in price because we believe our portfolio can afford that. And I also believe that today, protecting the profitability of the business is critical, especially when the cycle will turn because this cycle will turn and we believe we'll be in much stronger position at that time. It is more difficult to increase pricing in locations like Europe or even Asia where there is no indexation on the currency on the dollar, because there is clearly a supply, demand and negotiation. So I would say most of our pricing recovery comes from Brazil rather than the other region. And yes, you are correct. I don't think we are ahead of the market because as you can see, we only partially recovered the currency negative impact with price increase. But yes, we were and we believe it's the right strategy, the most aggressive on the front."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","And then maybe just quickly on lithium. You talked about $15 [ph] million of incremental growth and profit next year from price, mix, lower manufacturing. There's a lot of moving parts in the lithium story today, especially given the environment in Argent",79,"And then maybe just quickly on lithium. You talked about $15 [ph] million of incremental growth and profit next year from price, mix, lower manufacturing. There's a lot of moving parts in the lithium story today, especially given the environment in Argentina. So maybe a little bit color on what's driving that profit outlook? And also, any change in your willingness to do incremental investments in your capabilities in Argentina given what's happened for the last couple of months."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Sure. So the $15 million of earnings increase we are forecasting is driven by multiple factors. First of all, we know we've been working very hard in fixing operational issues, and we think we're there. Most of our plant, there are few somewhere, but most",317,"Sure. So the $15 million of earnings increase we are forecasting is driven by multiple factors. First of all, we know we've been working very hard in fixing operational issues, and we think we're there. Most of our plant, there are few somewhere, but most of our plant are operating much better than it used to. And also the currency, the peso in Argentina, has been helping us from a cost standpoint and is going to be the tailwind in 2016. Additionally, there is the price and mix. We have a very strong product line and technology for lithium hydroxide. We are one of the critical and leading supplier. And that market has increased in a tight supply situation, which allow us to right price the product. So all in all, pricing, mix, better operation and currency will be the driver in 2016. Around capacity, I think our capacity decisions will be in line with our strategy. First of all, we are working very hard at debottlenecking our plants special lithium hydroxide to make sure we can supply our customers with the growth they need. From a capital investment standpoint, we believe our key competitors today have made decisions to increase lithium carbonate in a significant way. So we do not believe volume of lithium carbonate from FMC will be required to serve the market. There will be plenty of products and we will be able to have supply agreement on lithium carbonate from other companies. So we do not believe -- even with an improving situation in Argentina, we do not believe we need going into 2017 to increase capacity in lithium carbonate, keep on debottlenecking the plant. Where we are looking at capital spending to improve our sales is in the downstream specialty business and mostly lithium hydroxide. This is where most of the capital spending will go in the next 2 or 3 years."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question comes from the line of Brian Maguire with Goldman Sachs.",13,"Your next question comes from the line of Brian Maguire with Goldman Sachs."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Pierre, I was wondering if you could comment on some of the consolidation that's been happening in the space lately? We've seen 2 pretty large deals kind of announced in the last, call it 3 or 4 months. Just kind of wondering competitively if you see that",75,"Pierre, I was wondering if you could comment on some of the consolidation that's been happening in the space lately? We've seen 2 pretty large deals kind of announced in the last, call it 3 or 4 months. Just kind of wondering competitively if you see that having any positive or negative impact on you, if consolidation could support better pricing, or competitively do you see the guys around you getting a little bit stronger?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Sure. Let me talk about the 2 deals. First of all, The one is now in DuPont. The consolidation of these 2 companies together will certainly create a very strong company with a very solid chemicals portfolio. But honestly, this is 2 years away. You first n",258,"Sure. Let me talk about the 2 deals. First of all, The one is now in DuPont. The consolidation of these 2 companies together will certainly create a very strong company with a very solid chemicals portfolio. But honestly, this is 2 years away. You first need to have the time to get the approval from Dao and DuPont to merge as a single company. And once that is done, they need integration. And then from integration they need to break up the company as they stated into 3 companies and merge together the Ag business. So I believe it's an interesting decision, which creates a very good company. But the impact on the market on the competitive landscape is still a couple of years away. So not a short-term concern for us. The Syngenta Cheminova, the [indiscernible] in China, my view is that it doesn't change much the competitive landscape. Because if I understand well, through what I've read and what I've heard, Syngenta will be operating as a stand-alone company instead of a publicly traded company. They will have a single shareholder, which is Chem China. So unless Chem China has a very fundamental push or very fundamentally different strategy, which I don't think so with Syngenta, we will be facing the same type of competition than we've been facing in the past. So my point of view at this stage, it's pretty much no change to the landscape for the next couple of years. And we'll see what will happen 2 years down the road."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","One more if I could. Just on the cadence of the Ag guidance to the year. I think historically 1Q has been strongest in the quarter segment earnings and Cheminova changes the profile a little bit. But the Outlook for '16 looks like it will be one of the be",94,"One more if I could. Just on the cadence of the Ag guidance to the year. I think historically 1Q has been strongest in the quarter segment earnings and Cheminova changes the profile a little bit. But the Outlook for '16 looks like it will be one of the below average quarter, if not the weakest quarter through the year. Just kind of wondering if you can help us understand why things will pick up sequentially from kind of a weaker 1Q, and what kind of needs to happen for that to play out?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Sure, our belief is this year will be different from what we've seen in the past for very specific reason. As I've said in the prepared remarks, we believe that North America market has maybe a higher level of inventory than it used to have in the previou",181,"Sure, our belief is this year will be different from what we've seen in the past for very specific reason. As I've said in the prepared remarks, we believe that North America market has maybe a higher level of inventory than it used to have in the previous years. And consequently, the decisions to purchase or fee up growers or inventory are going to be made in the last minute. So we are going to have sales in North America much more spread over a Q1, Q2 and Q3 period than we used to have where people who would really buy very strongly in advance in the fourth [ph] quarter. So the fact that we have a different profile in the first half of the year is purely due to North America. And North America being an important region for us from an earnings standpoint, that's why it spreads even more balanced the way earnings over the year. It is more that than the Cheminova impact. I would remind you that Cheminova is very small. It's fairly small in North America."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Brett Wong with Piper Jaffray.",10,"Your next question is from Brett Wong with Piper Jaffray."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","I'm just wondering, you talked about this elevated inventory that you're expecting through 2016. Can you just talk about what's going to improve that as we look out over the next couple of years?",35,"I'm just wondering, you talked about this elevated inventory that you're expecting through 2016. Can you just talk about what's going to improve that as we look out over the next couple of years?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes. I think what we are looking at is the demand that is very in a field in an enormous way. I think what will be resolving the issue is there is growth in demand, 2% to 3% every year, usually to resolve the end market demand. And then start-to-use ratio",190,"Yes. I think what we are looking at is the demand that is very in a field in an enormous way. I think what will be resolving the issue is there is growth in demand, 2% to 3% every year, usually to resolve the end market demand. And then start-to-use ratio should be decreasing in the next 2 years, which should start to show an increase in currency prices. Together with the fact that today all of the Ag chem companies, as you've seen in our performance, are selling less. So if you look, there is much more product on the ground, product which are put on the ground than product which are sold by the chemical industry into the market, and that differential is what is decreasing the level of inventory. You just need a strong weather or strong pest pressure combined with more product on the ground than industry selling, and you can see a turn in 2017. But we are not at all operating under the assumption that there will be any turn in 2016. I think that's where we are focused and we're not assuming anything."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, great. Just a quick one in Brazil. The early dry conditions impacted any fungicide application in that early part of the season?",23,"Okay, great. Just a quick one in Brazil. The early dry conditions impacted any fungicide application in that early part of the season?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, obviously, our dry conditions do not help fungicide use. We've seen a lot of variable conditions in Brazil. Fungicide for us is a smaller part of our portfolio, so we've not really been impacted that much. But you got to balance that with other parts",74,"Yes, obviously, our dry conditions do not help fungicide use. We've seen a lot of variable conditions in Brazil. Fungicide for us is a smaller part of our portfolio, so we've not really been impacted that much. But you got to balance that with other parts of Brazil being very wet. So you're going to get good pressure there. So I'm not so sure that fungicides will be off a significant amount in Brazil."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Don Carson with Susquehanna Financial.",10,"Your next question is from Don Carson with Susquehanna Financial."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","This is Ceely on for Don. I just wanted to ask about your outlook of the impact of the extended approval on authority volumes. And as a follow-up, the impact of INTACTA on Brazil insecticide volumes in '15 at your outlook in '16 as it impact acreage doubl",48,"This is Ceely on for Don. I just wanted to ask about your outlook of the impact of the extended approval on authority volumes. And as a follow-up, the impact of INTACTA on Brazil insecticide volumes in '15 at your outlook in '16 as it impact acreage doubles."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, taking the first one. obviously, Extend is an important platform. We don't expect much impact in '16, obviously, given where we are. But we do see that as a growth aspect for us in '17, '18, going into '19. So it's something we've invested a lot of t",162,"Yes, taking the first one. obviously, Extend is an important platform. We don't expect much impact in '16, obviously, given where we are. But we do see that as a growth aspect for us in '17, '18, going into '19. So it's something we've invested a lot of time and effort in. We are a market leader in the pre-herbicides section in North America. So yes, we do see that as a positive for as going forward. With INTACTA, INTACTA has had a lot of success in Brazil. Obviously, affect certain types of insecticides and not others. I think we've all been affected by lower spray amounts in Brazil. I expect that to continue. But we are seeing different types of pest pressure coming in Brazil. Certainly the piercing pest such as stink bugs. We're seeing much more activity in that area. So you got a different mix going on in insecticides. But overall, INTACTA has definitely reduced the amount of sprays."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Steve Byrne with Bank of America Merrill Lynch.",13,"Your next question is from Steve Byrne with Bank of America Merrill Lynch."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","This is Ian for Steve Byrne. Just following up on some of inventory issues. How much did FMC sell into North America in this fourth quarter? And what is the logic behind that if inventory levels are high?",38,"This is Ian for Steve Byrne. Just following up on some of inventory issues. How much did FMC sell into North America in this fourth quarter? And what is the logic behind that if inventory levels are high?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","We don't break up the sales by quarter, by region. But the inventory -- we believe North America actually has been less talked about from an inventory level compared to Brazil, because Brazil was -- had an underwhelming impact because it was combining hig",222,"We don't break up the sales by quarter, by region. But the inventory -- we believe North America actually has been less talked about from an inventory level compared to Brazil, because Brazil was -- had an underwhelming impact because it was combining higher inventory level and currencies. So when you put those 2 [ph] together, you have the dramatic situation from a business performance we've heard about. Obviously, North America doesn't have the piece which is the currency impact, so we talk less about it. But we come quickly to realize that purely from an inventory standpoint, about the same sentiment we've seen in Brazil is happening in North America. Community prices being low, growers were very cautious in terms of planting decisions and processing decision. As their colleague worry in Brazil. The crop protection industry kept on selling products. And there was a point where there was more product going into the channel than product going on the ground. And that created in Brazil a very elevated currency situation. Additionally, insect pressure was not great in the previous year, which has been creating even more of [indiscernible] So all of that has been compiling a situation, which from us from an inventory and supply chain standpoint, is very close to what we see in Brazil, less the currency effect."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And then just one follow-up on the Cheminova synergies from sales, moving some of that FMC product to Cheminova's distribution. Is that because FMC already has existing registrations in all these countries? And what is the outlook for further growth",55,"Okay. And then just one follow-up on the Cheminova synergies from sales, moving some of that FMC product to Cheminova's distribution. Is that because FMC already has existing registrations in all these countries? And what is the outlook for further growth as we move forward in time, either from active ingredients or for the registrations?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, I mean, a lot of the countries where Cheminova had market access where we didn't, predominantly in Europe and parts of Asia. We actually had registrations already. So it allows us to move forward pretty quickly. That's the reason we got cost synergie",184,"Yes, I mean, a lot of the countries where Cheminova had market access where we didn't, predominantly in Europe and parts of Asia. We actually had registrations already. So it allows us to move forward pretty quickly. That's the reason we got cost synergies in 2015 pretty quickly off the bat, and then in '16 as well. So from a registration standpoint, we think we're well-placed. And then you allay that to the fact that our innovation platform is still obviously delivering on our formulation capabilities. We probably have somewhere close to 60 products we're launching around the world in 2016. Obviously, you don't get a tremendous amount of revenue in the first year of the launch of a formulated product. But it goes to show that what we're doing on a formulation standpoint is continuing through these times in the Ag space. We believe that innovation is going to be supercritical for us as we go forward. So you see the growth not only from the synergies of FMC and Cheminova coming together, but the long-term view products as well in the marketplace."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Dmitry Silversteyn with Longbow Research.",10,"Your next question is from Dmitry Silversteyn with Longbow Research."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Most of my questions have been answered, but just a couple of follow-ups. First of all, what sort of debt level do you expect to have by the end of 2016? In other words, you talked about gas generation, how much of that is going to be deployed towards deb",51,"Most of my questions have been answered, but just a couple of follow-ups. First of all, what sort of debt level do you expect to have by the end of 2016? In other words, you talked about gas generation, how much of that is going to be deployed towards debt reduction."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","It's Paul.  We're clear where we want our leverage down to which is in the mid-2x to 3x range. We're not there right now. And so until we get to that point whether that's through expansion of EBITDA or pay down our debt, you should assume that surplus cas",58,"It's Paul.  We're clear where we want our leverage down to which is in the mid-2x to 3x range. We're not there right now. And so until we get to that point whether that's through expansion of EBITDA or pay down our debt, you should assume that surplus cash is going to be deployed in that direction."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","So pretty much free cash I calculate for the year, I'm safe to assume it was going toward the debt paydown.",21,"So pretty much free cash I calculate for the year, I'm safe to assume it was going toward the debt paydown."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Today, that's the safest assumption to make.",7,"Today, that's the safest assumption to make."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Look at the first quarter guidance for the Ag business, it looks like at the midpoint it's basically flat year-over-year versus last year, despite the fact that you have Cheminova profitability that didn't have last year. So is the offset to the acquisiti",75,"Look at the first quarter guidance for the Ag business, it looks like at the midpoint it's basically flat year-over-year versus last year, despite the fact that you have Cheminova profitability that didn't have last year. So is the offset to the acquisition benefit and the cost savings you're realizing from that, the deterioration in North America market is that going to be that bad in the first quarter? Is that basically the take away."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, it's the right way to look at it. It's -- I might not call that a deterioration, but the lack of improvement of the Ag market in North America and maybe a pushing of the decisions toward the [indiscernible] in the third [ph] quarter. But that's the r",93,"Yes, it's the right way to look at it. It's -- I might not call that a deterioration, but the lack of improvement of the Ag market in North America and maybe a pushing of the decisions toward the [indiscernible] in the third [ph] quarter. But that's the right way to look at it, which is the overall spread of business over 3 quarters, and the lack of growth -- not growth, we believe the business will be down in North America year-on-year, are erasing the benefit from Cheminova in the first quarter."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, Pierre. So maybe I can say this differently and see if it still makes sense. The sales that you typically get over the first couple of quarters of the year in North America and in European markets, you would expect those ssales to basically occur ov",81,"Okay, Pierre. So maybe I can say this differently and see if it still makes sense. The sales that you typically get over the first couple of quarters of the year in North America and in European markets, you would expect those ssales to basically occur over a 3 quarter period. But in terms of aggregate, not looking for significant down demand year in 2016 versus 2015, it's just that it's demand that can be spread over 3 quarters versus 2?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","So if you look at -- yes, part of your statement is correct. There is more of a spread over 3 quarters. That is correct. There is also, as I said, market we expect to be down in North America. So we're expecting the market in North America to be down 5% t",103,"So if you look at -- yes, part of your statement is correct. There is more of a spread over 3 quarters. That is correct. There is also, as I said, market we expect to be down in North America. So we're expecting the market in North America to be down 5% to 10%. That would be a range. The 2 biggest down market, that would be Brazil and North America. So you combine a spread of [indiscernible] over 3 quarters together with a down market in North America, not in Europe, in North America of mid-single-digit, that is what created the situation."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And if I can look forward to the second quarter and I know you guys provided guidance for it, but if I remember correctly most of Cheminova's European sales take place in April and maybe early May, which you sort of missed when you completed the acq",87,"Okay. And if I can look forward to the second quarter and I know you guys provided guidance for it, but if I remember correctly most of Cheminova's European sales take place in April and maybe early May, which you sort of missed when you completed the acquisition later in May in 2015. So we would expect to see more of a step up, if you will, in the profitability of the business on a year-over-year basis in the second quarter than we've seen in the first?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Not -- I think, think about the North America and European business more balanced over 3 quarters than it is over the similar [ph] quarter. So right now, we don't want to go into starting to guide Q2, Q3 because its starting to be a very difficult exercis",74,"Not -- I think, think about the North America and European business more balanced over 3 quarters than it is over the similar [ph] quarter. So right now, we don't want to go into starting to guide Q2, Q3 because its starting to be a very difficult exercise when you're in the Ag business. I think we'll have more of the development of the sales over 3 quarters than we had in the past."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Laurence Alexander with Jefferies.",9,"Your next question is from Laurence Alexander with Jefferies."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","This is Dan on for Lawrence. Just a question on a omega-3's. Are you seeing any signs of pricing in 2016 is part of the turn or is it going to be too much 2015 where you're subject to overcapacity and just some pricing pressures?",45,"This is Dan on for Lawrence. Just a question on a omega-3's. Are you seeing any signs of pricing in 2016 is part of the turn or is it going to be too much 2015 where you're subject to overcapacity and just some pricing pressures?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Laurence, this is Eric here. What we're seeing in a omega-3 is a mixed effect. We do expect to see in our mix in the nutraceutical market an improvement in products we're launching that are launched at a higher price. When you look at the core of the mark",101,"Laurence, this is Eric here. What we're seeing in a omega-3 is a mixed effect. We do expect to see in our mix in the nutraceutical market an improvement in products we're launching that are launched at a higher price. When you look at the core of the market, the middle part of concentration below part of concentration, we don't expect to see improvement in that market still remains in oversupplied market, where demand is not growing rapidly. And so we see similar set of pricing competitive dynamics in that part of the markets in '16 as we did in '15."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","I think in the last call if I'm wrong, but you said you strategically exiting a omega-3 market but it wasn't the right time. Is that kind of still the same outlook or the same thought process?",38,"I think in the last call if I'm wrong, but you said you strategically exiting a omega-3 market but it wasn't the right time. Is that kind of still the same outlook or the same thought process?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Here is what we believe. Our market strategy of policy bidding into the pharmaceutical and nutraceutical market has not changed. We are still going after all of these market, high concentration and mid-concentration product. What we are doing today is foc",104,"Here is what we believe. Our market strategy of policy bidding into the pharmaceutical and nutraceutical market has not changed. We are still going after all of these market, high concentration and mid-concentration product. What we are doing today is focusing more on supplying those markets from one of the assets we have rather than the high sales assets, which we do not believe is an asset, which is necessary for us to participate in the pharmaceutical market. So it is not a change in the market with intent to participate in. So it's a change in our manufacturing strategy to serve those markets."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","You're last question comes from the line of Rosemarie Morbelli from Gabelli and Company.",15,"You're last question comes from the line of Rosemarie Morbelli from Gabelli and Company."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","I have a couple of small ones. First of all, do you anticipate that the announcement of the additional capacity on the lithium carbonate will have a negative impact on overall pricing as those big plants come onstream?",38,"I have a couple of small ones. First of all, do you anticipate that the announcement of the additional capacity on the lithium carbonate will have a negative impact on overall pricing as those big plants come onstream?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Not in 2016. I think pricing will be pretty solid for lithium carbonate in 2016 as most of the capacity increase are already called for, from a demand standpoint. Will there be some pricing pressure in 2017? We'll have to see where the demand is. But I --",75,"Not in 2016. I think pricing will be pretty solid for lithium carbonate in 2016 as most of the capacity increase are already called for, from a demand standpoint. Will there be some pricing pressure in 2017? We'll have to see where the demand is. But I -- it is -- if it is a question, and I cannot answer that right now, but if it is a question around pricing, it's a 2017  question."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","And then are you successful in getting the receivables in Brazil? Are the farmers paying you in a timely -- well not a timely fashion, they don't, but in a way you would expect? Or the fact that you have done so much restructuring is creating the opportun",54,"And then are you successful in getting the receivables in Brazil? Are the farmers paying you in a timely -- well not a timely fashion, they don't, but in a way you would expect? Or the fact that you have done so much restructuring is creating the opportunity for someone to just not pay?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Hey Rosemary, it's Paul. I would answer as follows. The restructuring is not a factor in this. The way we restructure and what we restructured was done very carefully, so it does not at all impact our ability to collect. The factor that's driving our abil",265,"Hey Rosemary, it's Paul. I would answer as follows. The restructuring is not a factor in this. The way we restructure and what we restructured was done very carefully, so it does not at all impact our ability to collect. The factor that's driving our ability to collect are really driven more by market conditions. And I don't necessarily just mean Ag market conditions, but as much as the finance market conditions down in Brazil where we're seeing a continued cautiousness on the part of the Brazilian growr to hold on to its liquid resources. A lack of confidence that financing will be there for them in the next round of the growing season, is essentially across the board creating challenges to collection. Compounding on top of that of course, as we discussed the fact that most leverage you have is when you have -- when the grower have to buy new product, when you have pest pressures down and you have excess inventory in the channel. It just makes that collection process even more difficult for us. I would say 2016 and folded in the way we describe, we talked at length about it will be a multiyear program to reduce the receivables balance in Brazil. And '15 played out really exactly as we had expected. The next couple of quarters will be the next key benchmarks for us as we look at collection in the first half of the year. And the other at least, heading through the back end of '16 is the first time we measurable progress down there in Brazil."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","So you -- how much do you think you can reduce your receivables from Brazil in 2016 versus how much did you reduce it in 2015?",26,"So you -- how much do you think you can reduce your receivables from Brazil in 2016 versus how much did you reduce it in 2015?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","We will certainly reduce it more in '16 than we did in '15. We did reduce it in Brazil in 2015, but not by a huge amount. So we definitely expect to make more progress on that in '16.",39,"We will certainly reduce it more in '16 than we did in '15. We did reduce it in Brazil in 2015, but not by a huge amount. So we definitely expect to make more progress on that in '16."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","And one last one if I may. Could you talk about the protein demand in China? Are you seeing that improving or the decline when the price of milk and whey was really high has not recovered yet?",38,"And one last one if I may. Could you talk about the protein demand in China? Are you seeing that improving or the decline when the price of milk and whey was really high has not recovered yet?"
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Rosemary, it's Eric. We are seeing -- do see in China a very market that's fairly on the demand -- on a growth basis, flat to down. We saw big swing in our sales last year due to a correction in inventories for our colloidal products into that market and",91,"Rosemary, it's Eric. We are seeing -- do see in China a very market that's fairly on the demand -- on a growth basis, flat to down. We saw big swing in our sales last year due to a correction in inventories for our colloidal products into that market and some of the plant-based beverages, such as peanut milk. That's worked its way off. And the underlying demand is coming through, but that demand is fairly flat. We saw a modest growth ourselves. The overall market, however, is flat to down."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","That's all the time we have for the call today. I want to thank everyone for joining us. I'll be available to address any questions you may have. Thank you. Have a good day.",35,"That's all the time we have for the call today. I want to thank everyone for joining us. I'll be available to address any questions you may have. Thank you. Have a good day."
28606,321466580,931346,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","And again that is all the time we have for today. This concludes the FMC Corporation Fourth Quarter Earnings Release Conference Call. Thank you.",24,"And again that is all the time we have for today. This concludes the FMC Corporation Fourth Quarter Earnings Release Conference Call. Thank you."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the Fourth Quarter 2015 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] And as a reminder, today's conference call is being recorded. I will now turn the conference over to Mr. Brian Angeli, Vic",51,"Good morning, and welcome to the Fourth Quarter 2015 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] And as a reminder, today's conference call is being recorded. 
I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning, everyone. Welcome to FMC Corporation's fourth quarter earnings call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.",286,"Thank you, and good morning, everyone. Welcome to FMC Corporation's fourth quarter earnings call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.
Pierre will begin the call with a review of FMC's fourth quarter and full year performance and then discuss the outlook for 2016. Paul will provide an overview of select financial results. 
As we have done for each of the past 2 quarters, we have published a slide presentation that accompanies our results. This slide presentation, along with our earnings release and 2016 outlook statement, is available on our website. The prepared remarks from today's discussion will be made available at the conclusion of the call.
After the prepared remarks, we will be joined by Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, to address your questions.
Before we begin, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including, but not limited, to those factors identified in our release and in our filings with the Securities and Exchange Commission. Information presents our best judgment based on today's information. Actual results may vary based on these risks and uncertainties. 
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms as well as other non-GAAP financial terms, to which we may refer during today's conference call, are provided on our website.  
I will now turn the call over to Pierre."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian. Good morning, everyone. 2015 marked the completion of FMC's transformation to a technology-driven specialty company with leading market positions across agriculture, nutrition, pharmaceutical and specialty lithium applications. In Ag S",2746,"Thank you, Brian. Good morning, everyone. 2015 marked the completion of FMC's transformation to a technology-driven specialty company with leading market positions across agriculture, nutrition, pharmaceutical and specialty lithium applications. 
In Ag Solutions, the acquisition of Cheminova strengthened our technology pipeline, brought greater regional balance, broadened our market access and expanded our portfolio. The integration of Cheminova continues to go well. Our success to date reinforces our confidence in achieving the run rate cost savings of $140 million to $160 million by the middle of 2017. The acquisition and integration of Cheminova, combined with the actions we have taken to restructure our Ag Solutions operation in Brazil, have positioned FMC to better address current market conditions. 
In Health and Nutrition, we focused on driving higher margins by capturing high-value commercial opportunities across our portfolio and by implementation of manufacturing actions program and process technology improvements. And in lithium, we continued to execute on our strategy of growing FMC's differentiated downstream specialty business to take advantage of favorable end market demand. 
2015, however, was also a year marked by significant foreign exchange headwinds and difficult conditions across the global agricultural market. We took decisive actions throughout the year to address these challenges, accelerating the integration of Cheminova, restructuring our Ag Solutions operations in Brazil, exercising discipline on pricing and aggressively controlling costs across the company. As we enter 2016, we remain focused on the continued execution of our strategy to drive improved performance. Despite challenging macroeconomic and ag market conditions, we believe the actions we have taken will enable FMC to deliver higher earnings growth across each of our business in 2016. 
I will provide further details regarding our 2016 outlook shortly. But first, I will review our fourth quarter and full year 2015 performance. 
Starting with FMC's full year results on Slide 1. FMC reported revenue of approximately $3.3 billion in 2015, roughly flat to reported revenue for 2014 and adjusted EPS of $2.47, a decline of 22% compared to last year.
For the fourth quarter, FMC reported revenue of $899 million, an increase of approximately 1% compared to the same period last year. Adjusted earnings per share for Q4 were $0.77, 9% below the fourth quarter of 2014.
Turning to Ag Solutions on Slide 2. For the fourth quarter, Ag Solutions delivered revenue of $657 million and segment earnings of $101 million, a decline of 23% and 8%, respectively, from the pro forma results of the same period of 2014. The negative impact of foreign exchange and lower sales volume more than offset price increase and lower operating cost in the quarter. About 75% of the decline in sales volume during the fourth quarter was the result of deliberate actions to eliminate lower-margin, third-party product sales. Excluding these sales, volume declined by less than 5% compared to the fourth quarter of 2014, as we continue to see demand for FMC's proprietary products across all regions. 
In Europe, we saw healthy demand, as mild weather conditions allowed for late application of cereal herbicides. During the fourth quarter, we were pleased to recall our first direct sales of FMC products into Western Europe as we transition to direct market access provided by the Cheminova acquisition. 
Across the Americas, however, market conditions were significantly more challenging. In North America, consecutive years with low pest pressure have resulted in elevated channel inventory levels. Coupling the channel inventory issues is the deterioration in farmer income levels in the U.S., resulting in a more cautious mindset of distributors and growers. While we continue to see strong support for customers for our proprietary products, we expect challenging market conditions to persist through 2016.
In Brazil, we saw improving conditions in certain crop markets, including sugarcane and cotton, as well as niche crops such as coffee and citrus. However, channel inventories, especially in insecticide and unfavorable weather conditions, negatively impacted sales volume. As we have discussed previously, we expect channel inventory levels to remain elevated through 2016. 
In the rest of Latin America, we continue to see strong demand for FMC's product, including pre-emergent herbicides in Argentina and products for niche crops in Colombia and Mexico. Sales in Argentina, however, continues to be impacted by delay in receiving import licenses for formulated products.
In Asia, weather conditions in India, Pakistan, Australia and parts of Southeast Asia relate to reduce demand in higher channel inventories.
The negative impact of foreign exchange was the single largest driver of our 2015 performance. In the quarter, the strengthening of the U.S. dollar reduced Ag Solutions segment earnings by about $60 million compared to last year. However, the combination of price increases and cost reductions more than offset the negative impact of foreign exchange.
In Brazil, we continued to implement significant price increases to maintain U.S. dollar-based pricing in that country. This price increases recovered more than 70% of the currency impact on segment earnings in the fourth quarter. In addition, FMC continued to aggressively reduce operating costs through the faster integration of Cheminova and further restructuring of Ag Solutions operations in Brazil.
As a result, and despite the challenging demand environment, segment earnings margin improved by 250 basis points to 15.4% in the quarter. I will provide further details regarding cost savings activities shortly.
But first, I will comment on the full year performance for Ag Solution. As shown on Slide 3, Ag Solutions reported revenue of $2.6 billion for 2015 compared to pro forma revenue of $3.4 billion for 2014, a decline of 23%, as lower sales volume and foreign exchange headwind more than offset price increases during the year. Lower sales volumes accounted for about 16% of the decline in revenue. However, more than half of this volume decline is the result of actions we took throughout the year to eliminate lower-margin, third-party product sales. Excluding this, sales volumes declined about 7% compared to 2014. 
In 2015, the strengthening of the U.S. dollar resulted in FX headwind of about $300 million, erasing over 50% of Ag Solutions pro forma 2014 segment earnings. To be clear, this reduced reported sales by about $380 million and lowered our reported cost by about $80 million. We offset about 60% of the currency impact on sales in Brazil by raising prices throughout the year, and we expect to continue to offset future FX impacts in Brazil through price increases. 
Early in the year, we began to aggressively reduce operating costs. For the full year, operating costs were lower by about $100 million. This include savings from the Cheminova integration, lower spending on discretionary items and lower energy and raw material costs.
Despite the challenging market conditions in 2015, we continued to invest in innovation and our technology pipeline of new synthetic and biological active ingredients. Product introduced in 2015 were well received by the market, and we expect further traction from new product introductions in 2016.
I will now turn to the 2016 cost savings we expect to realize from the Cheminova integration and related actions. As you can see on Slide 4, in 2015, FMC realized about $40 million in cost savings as a direct result of the Cheminova integration and the restructuring of operations in Brazil.
For 2016, we expect to deliver additional cost savings over 2015 of between $60 million and $70 million, reflecting the full year benefit of previously announced headcount reduction and savings associated with various procurement and SAR cost-reduction programs.
As discussed, during our third quarter earnings call, FMC targeted total headcount reductions of 800 to 850 positions. As of December 31, 2015, over 700 positions have been eliminated, and we expect to implement the remaining reductions during the second half of 2016.
The success we have achieved to date in delivering the headcount reduction, plus the further cost reduction initiatives currently underway, gives us the high degree of confidence that we will deliver the 2016 cost savings target and achieve the $140 million to $160 million in run rate cost savings by the middle of 2017.
Turning now to Health and Nutrition on Slide 5. Q4 represented another quarter of solid earnings performance. As a result, the business delivered its 11th consecutive year of record earnings in 2015. Health and Nutrition reported revenue of $172 million, a decline of 10% compared to the fourth quarter of 2014, mainly due to lower sales volume and the weaker euro. We saw lower MCC banner and carrageenan sales in the quarter, partially offset by higher sales of MCC-based product for food application and increased sales of omega-3 for the nutraceutical market.
Segment earnings for Health and Nutrition increased 5% compared to the fourth quarter of 2014 to $46 million. Lower operating cost more than offset the negative impact of lower sales volume. 
The benefits of ongoing Manufacturing Excellence and process technology improvement increased segment earnings margin in the quarter to 26.9%, an increase of almost 400 basis points compared to the fourth quarter of 2014.
As a result of the actions taken over the past year, Health and Nutrition is well-positioned to deliver continued earnings growth in 2016. 
Turning next to Lithium on Slide 6. Lithium delivered a strong quarter. Revenue of $70 million was up slightly compared to the fourth quarter of 2014, as higher prices were partially offset by the impact of foreign exchange.
The fourth quarter of 2015 represents the fourth consecutive quarter in which FMC realized higher pricing in the Lithium business as demand growth across end markets application, coupled with tight supply, supported price increases, especially for FMC's carbonate and hydroxide products.
Sales volumes were essentially flat to last year as higher volumes for FMC's butyllithium and specialty organics were offset by lower volumes resulting from scheduled maintenance downtime in our hydroxide unit and less third-party supply of carbonate.
Demand for FMC's downstream specialty lithium products remains strong. Hydroxide sales volume were up significantly on a full year basis, as demand for energy storage applications continue to grow at double-digit rates and as we continue to increase throughput from our existing assets.
Segment earnings increased 42% to $11 million in the quarter. The combination of higher pricing, improved sales mix and lower operating cost more than offset the impact of FX on FMC's reported results, pushing segment earnings margin to 15.9%, an increase of 450 basis points compared to the fourth quarter of 2014. 
Now moving on to our 2016 outlook on Slide 7. Last night, we published our outlook statements for the first quarter and full year 2016. I will take a few minutes now to briefly discuss the outlook for each of FMC's business segments.
In Ag Solutions, full year segment revenue is expected to be approximately $2.3 billion to $2.5 billion. And full year segment earnings are expected to be in the range of $380 million to $420 million, with first quarter segment earnings in the range of $70 million to $90 million. I will discuss Ag in more detail in a moment. 
In Health and Nutrition, we are anticipating full year segment revenue of $775 million to $825 million. We continue to see stable low to mid-single-digit demand growth in the majority of our end markets. Segment revenue growth is expected to be slightly below this level, as we do not expect certain omega-3 sales to the pharmaceutical API market majoring the first quarter of 2015 to happen in 2016. 
Excluding these sales, we expect underlying sales growth in the middle -- in the mid-single-digit range driven by increased demand for health excipients and nutraceutical ingredients across emerging markets. 
Health and Nutrition segment earnings are expected to be in the range of $198 million to $208 million in 2016. The business made significant strides to improve its cost structure and operating efficiency over the past 12 months. We expect these efforts to drive further margin expansion in 2016, which will allow Health and Nutrition to grow earnings accordingly. 
We expect first quarter segment earnings for Health and Nutrition to be in the range of $46 million to $51 million. We have little similarity in this segment earnings for Health and Nutrition. However, as I mentioned previously, we do not expect certain omega-3 sales from the first quarter of 2015 to recur this year. As a result, reported first quarter segment earnings will be lower compared to 2015. 
In Lithium, we see strong demand in a favorable pricing environment. We will continue to optimize our sales mix to drive higher volume of FMC's downstream specialty products.
As we enter 2016, FMC is sold out across most products. Higher pricing, improved mix and lower operating cost will drive earnings growth in 2016. In addition, the reduction in operating cost as a result of the devaluation of the Argentine peso will provide a tailwind for segment earnings over the next 12 to 18 months.
For the full year, we expect Lithium segment revenue to be between $240 million and $260 million and segment earnings to be in the range of $33 million and $43 million. We expect first quarter segment earnings of $8 million to $12 million. 
On a consolidated basis, we expect FMC's 2016 adjusted earnings per share to be between $2.50 and $2.80. We expect first quarter 2016 adjusted earnings to be between $0.48 and $0.60 per share.
I will now discuss the outlook for Ag Solutions business in more detail starting with a few comments regarding the market on Slide 8.
In Europe, we expect our key markets to be broadly flat compared to last year, although we expect to see higher growth across Eastern Europe. 
In North America, we expect the challenging market conditions will continue in 2016 given elevated channel inventory levels and projected lower farm incomes. As a result, we expect the market in North America to be down in 2016. 
Across Asia, we expect the market to be mixed depending on the countries. However, overall, we expect the region to be up slightly in 2016 assuming more normal pest pressures and weather conditions. 
Turning to Latin America. Market conditions in Argentina, Mexico and Colombia are expected to remain favorable with growth in weed-resistant acres and increasing acreage for niche crops. We expect the market in Brazil to be down again in 2016. Channel inventory levels are expected to remain elevated in 2016. However, we expect to see an improvement in market fundamentals for sugarcane and cotton.
While the factors impacting market growth vary across growing regions, we are broadly seeing a more cautious approach to purchasing decision throughout the value chain as a result of the protracted downturn in the Ag cycle.
Based on the factors I just described, we expect the global crop protection chemical market to decline by a mid to-high-single-digit percentage in 2016 on a U.S. dollar basis. However, it is important to remember that these factors are dynamic and will change throughout the year. In particular, changes in planting decisions and pest pressures, and of course weather conditions, will significantly impact demand over the course of the growing season. We will get more clarity on these external factors as the year progresses, and we will update our views on market condition as some of these uncertainties become clear.
Turning next to Slide 9, where we summarize the critical earnings driver for 2016. A number of factors will contribute to the year-over-year increase in Ag Solutions segment earnings. First, we expect a positive $20 million impact from the full year of Cheminova. Next, we are targeting incremental cost savings of $90 million, including $60 million to $70 million from Cheminova-related synergies. Third, we expect that our pricing actions in Brazil and overall mix improvement will contribute approximately $90 million.
New product introductions scheduled for 2016 and revenue synergies in Europe and North America from the Cheminova acquisition will positively impact our mix and volumes for the year. 
Continued FX headwinds, the broader market decline and our decision to exit certain low-margin, third-party product sales will partially offset incremental earnings from the items I just described.
In Health and Nutrition, higher sales of excipient and nutritional products in emerging markets and the full year benefit of continued operational improvements are expected to deliver approximately $8 million in earnings growth.
Lithium is expected to contribute about $15 million to a growth in earnings in 2016, given primarily from higher pricing improved mix and lower operating costs.
I will now turn the call over to Paul, who will discuss corporate expenses, the impact of foreign currencies on our results and cash flow."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Thanks, Pierre. Let me start with the income statement. Our corporate expense line represents both centrally held expenses that are not charged back to the businesses. 2015 came in lower than 2014 for the full year, as we saw various items such as insuran",881,"Thanks, Pierre. Let me start with the income statement. Our corporate expense line represents both centrally held expenses that are not charged back to the businesses. 2015 came in lower than 2014 for the full year, as we saw various items such as insurance expenses, pension charges, year-end LIFO adjustments to inventory and various incidental FX-related expenses all come in below last year. We do not expect these to repeat in 2016 leading to our guidance for the corporate expense line of $70 million to $80 million. 
Looking at the tax rate, our full year rate benefited from 2 drivers relative to our previous expectations. First, those legislative items passed at the end of the year, primarily related to R&D deductions, resulted in a reduction in our overall rate. Second, the geographic mix of our earnings changed, away from the U.S. and Brazil and towards Europe and Asia. Since the latter regions typically have lower tax rates than the U.S. and Brazil, our overall tax rate benefited.
Together, these 2 items lowered our full year 2015 tax rate by approximately 300 basis points. Looking forward, we expect our adjusted tax rate to be in the 24% to 26% range. 
I'd like to spend a few moments on Slide 10 revisiting the impact of the strengthening U.S. dollar on our business during the year.
As Pierre has already described, our 2015 performance faced a significant challenge from the impact of the strengthening dollar in our earnings. Across all of FMC and before any pricing actions, the strengthening of the U.S. dollar would have reduced our 2014 operating earnings by approximately $310 million. Of this reduction, approximately $293 million would have directly impacted Agricultural Solutions. On Slide 10, you can see the drivers of this hit to the Ag Solutions segment earnings.
The cumulative effect of weakening local currencies on revenue was approximately $380 million, of which the Brazilian real was easily the largest followed by the euro. Offsetting this revenue impact was the positive effect on our local cost base, again, mainly the real and euro or euro-linked currencies, which reduced our costs in U.S. dollar terms by $85 million. 
Our response to this was to raise prices. Pierre has already noted that for the full year in 2015, these price increases offset approximately 60% of the currency impact in Brazil. This was possible in large part because market practice in Brazil is to price in real, but to do so relative to U.S. dollar impacts. In the rest of the world, pricing is generally not dollar-indexed, creating a bigger challenge to raising prices, especially when market conditions are soft. 
In aggregate, globally, we recovered more than half of the $293 million earnings headwind through raising prices. Looking into 2016, we expect the FX headwind to be more modest than in 2015. The forecast currency moves in major currency, such as the euro, are far smaller in 2016 than we saw a year ago. And while there remains uncertainty around various Asian and Eastern European currencies, movements in these currencies have a far smaller impact on our profitability. 
The key region that drives the guidance regarding both currency and pricing, as Pierre just described on Slide 9, is Brazil. First of all, our guidance assumes that there will be a less volatile depreciation of the real, with no rapid devaluation right in the middle of the key selling period, as we saw in Q3 2015. Although we are not expecting stronger market conditions in Brazil, our guidance also assumes that local price actions already in place, plus additional price increases, which will be introduced later in the year to reflect the actual depreciation of the real will, largely offset the forecast year-over-year impact of currency depreciation.
Turning to the balance sheet and the cash flow on Slide 11. Our year-end net debt was approximately $2.1 billion, with the small increase over the Q3 net debt being entirely due to the final tax payment related to the Alkali sale. The fourth quarter is typically a flat to negative operating cash flow quarter for us given the seasonality of sales in Brazil. However, strong performance in Health and Nutrition and Lithium, as well as continued cost and capital spending controls, ensured that we kept our net cash outflows to a minimum. 
For the full year, our adjusted cash from operations adjusted to remove the one-off impact of Cheminova and Alkali-related items saw a 16% increase over 2014 despite a decline in EBITDA of around $100 million. We benefited from a positive year-on-year swing from working capital, as all businesses improved their working capital performance compared to 2014. 
Our cost control programs included cash spending discipline. We saw lower cash outflows for capital expenditures, which was our third lower than in 2014, offset by slightly higher restructuring spending. 
In addition, our cash taxes related to ongoing operations was significantly lower than 2014, reflecting lower profitability in both the U.S. and Brazil.
Looking into 2016, we expect a continued improvement in cash generation performance. In aggregate, we expect adjusted cash from operations to increase by approximately 25% in 2016 driven by higher earnings, continued working capital improvements and lower restructuring spending, offset by higher cash taxes.
With that, I will turn the call back to Pierre."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Thank you, Paul. Despite the Ag industry uncertainty, we believe that our 2016 plan is very achievable. It relies more on things we control than on expectations of positive external events. We expect to deliver earnings growth in all businesses in 2016, a",111,"Thank you, Paul. Despite the Ag industry uncertainty, we believe that our 2016 plan is very achievable. It relies more on things we control than on expectations of positive external events. We expect to deliver earnings growth in all businesses in 2016, and we'll continue to position FMC firmly on the path of growth by leveraging the company's unique business model that has defined our success. FMC remains a technology-driven company with low-cost, asset-light operation, a unique, high return R&D model for active ingredients innovation and strong regional formulation capabilities.
I want to thank you for your attention, and I will now turn the call back to the operator for questions."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] Your first question comes from the line of Frank Mitsch from Wells Fargo Securities.",16,"[Operator Instructions] Your first question comes from the line of Frank Mitsch from Wells Fargo Securities."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Your view -- kind of stepping back a second. Obviously, you guys are working hard on the Ag side, but we're dealing with these macro pressures that we continue to hear more and more about. And obviously, the inventory situation is a bit worse. So if you t",80,"Your view -- kind of stepping back a second. Obviously, you guys are working hard on the Ag side, but we're dealing with these macro pressures that we continue to hear more and more about. And obviously, the inventory situation is a bit worse. So if you think about over the next couple of years, how ultimate do you think the cycle plays out? And what needs to happen for things to really start to improve from a macro standpoint?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes. From the cycle standpoint, I have to say that we are highly focused right now on 2016. We believe, and the way we look at it today, as I said in my prepared remarks, is that we have a situation which is a little bit easier and more balanced in Europe",239,"Yes. From the cycle standpoint, I have to say that we are highly focused right now on 2016. We believe, and the way we look at it today, as I said in my prepared remarks, is that we have a situation which is a little bit easier and more balanced in Europe and Asia. But -- and for that matter, in Latin America outside of Brazil. But we have certainly still significant inventory level in Brazil and in North America. Actually, in North America, for us, is as much of a concern as Brazil is. So we are highly focused on executing our strategy in a market we believe will be down mid-single to high-single digit in 2016. There is still the possibility of a cycle turn in 2017, but you have to see how 2016 will go. It is highly dependent upon how the industry behaves, making sure that we don't oversell, don't presell, and that there is a normal weather and pest pressure. That is going to be very critical. Any additional negative weather from an Ag industry standpoint or a no pest pressure would lead to -- resulting less the prime of inventory. So 2016 will be a difficult year. And as we go into 2016, we should be able to see if 2017 remained the year where you will have a turn of the cycle. Mark, I don't know, if you have any additional comments."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","No, I think the only thing I would add is we're keeping a close watch on stock-to-use ratios, which shows very clearly where supply and demand is. We're seeing some change in key crops for us, such as sugarcane, as sugar prices go up as supply has reduced",82,"No, I think the only thing I would add is we're keeping a close watch on stock-to-use ratios, which shows very clearly where supply and demand is. We're seeing some change in key crops for us, such as sugarcane, as sugar prices go up as supply has reduced over the last few years. Those are the type of things that we look for to sense any changes in our key markets. But I think everything else you said, Pierre, is very valid."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And then from an FMC standpoint, obviously dealing with this, you guys have done a great job with the price increases and getting ahead of kind of offsetting the pressures you're feeling. You alluded to more this year. Could you just help me with so",74,"Okay. And then from an FMC standpoint, obviously dealing with this, you guys have done a great job with the price increases and getting ahead of kind of offsetting the pressures you're feeling. You alluded to more this year. Could you just help me with some of the timing of it? And ultimately, is 70% of a recovery the right number to think about? Or does it to go higher or lower from here?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Well, I think when we look at 2016, as we said, we're going to pretty much cover with price increase the FX impact for 2 reasons. First of all, because we expect the FX impact to be less in 2016 than it was in 2015. Remember that the biggest problem in 20",155,"Well, I think when we look at 2016, as we said, we're going to pretty much cover with price increase the FX impact for 2 reasons. First of all, because we expect the FX impact to be less in 2016 than it was in 2015. Remember that the biggest problem in 2015 was the high volatility and rapid devaluation of the real in the third quarter. That was unprecedented, more than actually the overall devaluation of the real. So we're not expecting that situation. In a less impact situation from currency, the price increase we need going into 2016 is less than the last year because a big part is a recovery of currency issues from price increase, which are already in place. So I would say we are entering 2016 with about 60% of the price actions already in place to recover the currency impact. And the rest is to happen during the year."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question comes from the line of Mike Sison with KeyBanc.",12,"Your next question comes from the line of Mike Sison with KeyBanc."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Pierre, I was wondering if you could -- there was a time when you thought for '16 maybe segment earnings for Ag could be in the mid-$600 million. And clearly, a lot has changed since then. Foreign currency has taken a big hit. But if you can bridge the ga",72,"Pierre, I was wondering if you could -- there was a time when you thought for '16 maybe segment earnings for Ag could be in the mid-$600 million. And clearly, a lot has changed since then. Foreign currency has taken a big hit. But if you can bridge the gap or maybe talk about $400 million in '16 and where the opportunity is, what's the earnings power of Ag Solutions over time."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes. See, I don't think, from a business strength standpoint, anything has changed for FMC. I believe we remain one of the lowest-cost manufacturer of active ingredients and maybe the most flexible one. With our asset-light model, we believe our technolog",258,"Yes. See, I don't think, from a business strength standpoint, anything has changed for FMC. I believe we remain one of the lowest-cost manufacturer of active ingredients and maybe the most flexible one. With our asset-light model, we believe our technology strategy is even better today than it used to be and our formulation strength has not changed. So it is, right now, the earnings potential of FMC Ag Solution has not changed. The problem is we are in a situation where demand is very low. Decisions from growers are pushed to the last minute and in a currency situation, which has been, as you can see, the biggest problem. So 2016 is going to be focused for us on earnings growth. There isn't much we can do around volume demand. We're also going to be highly, highly disciplined. We are not -- I can tell you one thing and we have not done that in 2015, and we're going to stick with that strategy in 2016, we are not going to run after market share. We are working our way from low profit sales and we are increasing price to recover the currency impact. That should position us as soon as the cycle turn to a very strong performance. So to expect the business going into the mid- to high-teens growth as soon as the market turn around, I have no doubt about it, the [indiscernible] seem intact. Right now, it is inventory. And I would say, our worries are mostly placed in North America and Brazil."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, great. And then your forecast for '16 look for volumes to be down a couple of percent, the minus 50% there in terms of the impact for earnings -- or maybe that's an earnings impact. But it does sound like if the markets are down mid- to high single",85,"Okay, great. And then your forecast for '16 look for volumes to be down a couple of percent, the minus 50% there in terms of the impact for earnings -- or maybe that's an earnings impact. But it does sound like if the markets are down mid- to high single digits, you're going to do better than that. And just wanted to get a better understanding why or why you feel that your volumes will be better than the market being down as it is."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","No, I think if you look at our overall performance from the business from a revenue standpoint, we're going to be about in line with the market if you remove the impact of third-party sales. So really think about our business from a volume standpoint, we'",244,"No, I think if you look at our overall performance from the business from a revenue standpoint, we're going to be about in line with the market if you remove the impact of third-party sales. So really think about our business from a volume standpoint, we're going to be in line with the market. So if it's a mid- to high single digit, call it a 7%, few volume driven by market demand, that's where we are forecasting our performance. Now our decline in sales is going to be higher because we are -- and I'm talking about volume here, okay? Because we are working the way still from third party. The run rate at which we closed 2015 is leading to a number which is higher than 2015 because we started this process during the year. And I think it's about an incremental $100 million of third-party sales we are working our way in 2016, which make our performance from a revenue standpoint a bit worse than market. So 2 things, we market from a demand standpoint, first, third-party sales, $100 million, we'll work our way. Where we're going to outperform the market, as we show in one of the slides, I think it's Slide 9, the one where we have the earnings driver, is because of the work is done around integration, around the cost and also 2 drivers of growth, which are synergies from Cheminova and also the new product introduction."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from the line...",8,"Your next question is from the line..."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","No, let me finish. Let me maybe be more precise in the quantification. If you think about our sales, we're going to be declining, just look at about 3 big buckets: sales driven by market decline, about $150 million to $200 million, that's the market deman",94,"No, let me finish. Let me maybe be more precise in the quantification. If you think about our sales, we're going to be declining, just look at about 3 big buckets: sales driven by market decline, about $150 million to $200 million, that's the market demand; think about third party we are working our way with no profit implication, about $100 million; and think about growth, which will be coming from synergies and the new technology, from $50 million to $100 million. Those are the 3 big buckets of our revenue drivers in 2016."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","We'll now go to your next question, which is from the line of Chris Parkinson with Crdit Suisse.",19,"We'll now go to your next question, which is from the line of Chris Parkinson with Crdit Suisse."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Can you give us a quick update on anything incremental on your potential across Europe, specifically on the back of Cheminova? You mentioned some nice data points in fungicides. But how are you thinking about your now integrated aggregated portfolio? And",66,"Can you give us a quick update on anything incremental on your potential across Europe, specifically on the back of Cheminova? You mentioned some nice data points in fungicides. But how are you thinking about your now integrated aggregated portfolio? And then also just in the near term, a quick question, do you believe that the mild winter will benefit insecticide sales during the first half?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, Chris, it's Mark here. Talking about Europe, we've talked a lot about the direct market access and where the growth is going to come from. We're already seeing that, as Pierre alluded to, in the earlier part of this call. We're seeing now primarily o",237,"Yes, Chris, it's Mark here. Talking about Europe, we've talked a lot about the direct market access and where the growth is going to come from. We're already seeing that, as Pierre alluded to, in the earlier part of this call. We're seeing now primarily our herbicides from FMC getting pushed through the Cheminova pipeline. So we've gone direct in the U.K. now and we're also expanding into Spain. So we're seeing that geographic growth for herbicides that we wanted. Obviously, we're introducing new fungicides across the region. So everything we thought of in Europe is coming true. The country managers, the sales force from Cheminova have embraced the portfolio from FMC and are now gearing up to put those products into the marketplace. So from my perspective, Europe is exactly where we thought it would be. And obviously, there's going to be growth for us going forward. The second part of your question on the insecticides, obviously we've had, especially in North America, probably 3 years of extremely low pest pressures across the U.S. One could say that a warm winter would allow the pests to come back. But frankly, we don't know. We're not forecasting a strong pest season. We tend to forecast an average season and see where that takes us. But we'll know more about that as we get into the end of Q1 into Q2, we'll get a better feel for that."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Good color. And then just also very quickly in Argentina, is most of the potential here for your herbicide portfolio? And do you have any kind of new or preliminary plans or initiatives for Southern Lat Am in particular? And if so, how are you balancing t",58,"Good color. And then just also very quickly in Argentina, is most of the potential here for your herbicide portfolio? And do you have any kind of new or preliminary plans or initiatives for Southern Lat Am in particular? And if so, how are you balancing that long-term potential with FX, credit volatility, length of terms, et cetera?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, Argentina has been a good market for us despite some difficult conditions in getting import licenses. Our predominant market down there is pre-herbicides for soy. We are a market leader. With the Cheminova acquisition, we bring along more fungicides",208,"Yes, Argentina has been a good market for us despite some difficult conditions in getting import licenses. Our predominant market down there is pre-herbicides for soy. We are a market leader. With the Cheminova acquisition, we bring along more fungicides and insecticides that we can put through the channel. We're actually doing a couple of things to expand our presence in Argentina at the moment. First of all is the consolidation of our market access with Cheminova. And then secondly, we're looking at expanding our supply chain in Argentina to more reflect what we do around the rest of the world in terms of toll manufacturing. We're actually going to be importing more active ingredients and formulating in country. That helps us 2 ways. First of all, it allows us to formulate products for Argentina on the ground, gives us more flexibility. And secondly, it helps with our cost base, which is in local currency. So we do see Argentina growing. It has been a good market for us over the last couple of years. And we think our portfolio is ideally suited to where they're going. We are seeing weed-resistant acres continue to increase, just like we do in the U.S. So I'm very bullish on Argentina."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question comes from Daniel Jester with Citi.",9,"Your next question comes from Daniel Jester with Citi."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Maybe just another one on pricing in Ag Solutions. I think you talked about the linkage between the reais and the U.S. dollar in Brazil and your ability to get pricing. But can you talk about how that is evolving in other parts of the world, which has had",91,"Maybe just another one on pricing in Ag Solutions. I think you talked about the linkage between the reais and the U.S. dollar in Brazil and your ability to get pricing. But can you talk about how that is evolving in other parts of the world, which has had other FX challenges? And specifically, are you seeing the competition also raise prices as aggressively as you? Or do you think that there's a risk that you're getting maybe a little ahead of the market, given how challenging the macro conditions are?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","I think the ability to increase price is very different in places like Brazil, where the local pricing in real is indexed to a dollar currency. And there is a mechanism usually which is in place. Now it always ends up being a negotiation. And I believe, y",200,"I think the ability to increase price is very different in places like Brazil, where the local pricing in real is indexed to a dollar currency. And there is a mechanism usually which is in place. Now it always ends up being a negotiation. And I believe, yes, we have been the most aggressive at increasing price because we believe our portfolio can afford that. And I also believe that today, protecting the profitability of the business is critical, especially when the cycle will turn because this cycle will turn. And we believe we'll be in a much stronger position that time. It is more difficult to increase pricing in locations like Europe or even Asia, where there is no indexation on the currency on the dollar because there, it's purely a supply-demand and negotiations. So I would say most of our pricing recovery comes from Brazil rather than the other region. And yes, you are correct. I don't think we are ahead of the market because as you can see, we only partially recovered the currency negative impact with price increase. But yes, we were -- and we believe it's the right strategy, the most aggressive on that front."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And then maybe just quickly on lithium, you talked about $15 million of incremental growth in profit next year from price, mix, lower manufacturing. There's a lot of moving parts in the lithium story today, and certainly given the environment in Arg",83,"Okay. And then maybe just quickly on lithium, you talked about $15 million of incremental growth in profit next year from price, mix, lower manufacturing. There's a lot of moving parts in the lithium story today, and certainly given the environment in Argentina. So maybe just a little bit color on what's driving that profit outlook. And then also any change in your willingness to do incremental investments in your lithium capabilities in Argentina, given what's happened politically over the last couple months."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Sure. So the $15 million of earnings increase we are forecasting is driven by multiple factors. First of all, you know that we've been working very hard at fixing our operational issues, and I think we're there. Most of our plants, there are issues somewh",318,"Sure. So the $15 million of earnings increase we are forecasting is driven by multiple factors. First of all, you know that we've been working very hard at fixing our operational issues, and I think we're there. Most of our plants, there are issues somewhere, but most of our plants are operating much better than they used to. And also the currency, the peso in Argentina, has been helping us from a cost standpoint and is going to be a tailwind in 2016. Additionally, there is the price and mix. We have a very strong product line and technology for lithium hydroxide. We are one of the critical and leading suppliers. And that market has increased in a tight supply situation, which allow us to right-price the product. So all in all, pricing, mix, better operation and currency will be the drivers in 2016. Around capacity, I think our capacity decisions will be in line with our strategy. First of all, we are working very hard at debottlenecking our plants, especially lithium hydroxide, to make sure we can supply our customers with the growth they need. From a capital investment standpoint, we believe our key competitors today have made decisions to increase lithium carbonate in a significant way. So we do not believe volume of lithium carbonate from FMC will be required to serve the market. There will be plenty of products, and we will be able to have supply agreements on lithium carbonate from other companies. So we do not believe -- even with an improving situation in Argentina, we do not believe we need going into 2017 to increase capacity in lithium carbonate, keep on debottlenecking the plant. Where we are looking at capital spending to improve our sales is in the downstream specialty business and mostly lithium hydroxide. This is where most of the capital spending will go in the next 2 or 3 years."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question comes from the line of Brian Maguire with Goldman Sachs.",13,"Your next question comes from the line of Brian Maguire with Goldman Sachs."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Yes, Pierre, I was thinking if you could comment on some of the consolidation that's been happening in the space lately. We've seen 2 pretty large deals kind of announced in the last, call it, 3 or 4 months. Just kind of wondering competitively if you see",77,"Yes, Pierre, I was thinking if you could comment on some of the consolidation that's been happening in the space lately. We've seen 2 pretty large deals kind of announced in the last, call it, 3 or 4 months. Just kind of wondering competitively if you see that having any positive or negative impact on you or if consolidation could support better pricing. Or competitively, do you see the guys around you getting a little bit stronger?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Sure. Let me talk about the 2 deals. First of all, the one is Dow and DuPont. The consolidation of these 2 companies together will certainly create a very strong company with a very solid seed and chemicals portfolio. But honestly, this is 2 years away. Y",271,"Sure. Let me talk about the 2 deals. First of all, the one is Dow and DuPont. The consolidation of these 2 companies together will certainly create a very strong company with a very solid seed and chemicals portfolio. But honestly, this is 2 years away. You first need to have the time to get the approval from Dow and DuPont to merge as a single company. And once that is done, they need to do the integration. And then from the integration, they need to break up the company, as they stated, into 3 companies and merge together the 2 ag business. So I believe it's an interesting decision, which creates a very good company. But their impact on the market or the competitive landscape is still a couple of years away, so not a short-term concern for us. The Syngenta, Cheminova, my view -- or ChemChina. The Syngenta, ChemChina, my view is that it doesn't change much the competitive landscape because if I understand well, through what I've read and what I've heard, Syngenta will be operating as a stand-alone company. And instead of being a publicly traded company, they would have a single shareowner, which is ChemChina. So unless ChemChina has a very fundamental -- or push a very fundamentally different strategy, which I don't think so, into Syngenta, we would be facing the same type of competition that we've been facing in the past. So my point of view at this stage, it's pretty much no change to the landscape for the next couple of years. And we'll see what will happen 2 years down the road."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, great. And one more if I could, just on the cadence of the Ag guidance through the year. I think historically 1Q has been the strongest quarter for segment earnings. I know Cheminova changes the profile a little bit. But the outlook for '16 looks li",103,"Okay, great. And one more if I could, just on the cadence of the Ag guidance through the year. I think historically 1Q has been the strongest quarter for segment earnings. I know Cheminova changes the profile a little bit. But the outlook for '16 looks like it will be one of the -- or at least a below average quarter, if not the weakest quarter through the year. Just kind of wondering if you could help us understand why things will pick up sequentially from kind of a weaker 1Q. And what kind of needs to happen for that to play out?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Sure. Our belief is this year is going to be a bit different from what we've seen in the past for a very specific reason. As I said in the prepared remarks, we believe that North America market has maybe a higher level of inventory than it used to have in",187,"Sure. Our belief is this year is going to be a bit different from what we've seen in the past for a very specific reason. As I said in the prepared remarks, we believe that North America market has maybe a higher level of inventory than it used to have in the previous years. And consequently, the decisions to purchase or free up the growers for this year's inventory are going to be made at the last minute. So we're going to have sales in North America much more spread over a Q1, Q2 and Q3 period than we used to have, where people who would really buy very strongly in advance in the fourth quarter. So the fact that we have a different profile in the first half of the year is purely due to North America. And North America being an important region for us from an earnings standpoint, that's why it spreads in a more balanced way the earnings over the year. It is more that than the Cheminova impact. I remind you that Cheminova is very small, it's fairly small in North America."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Brett Wong with Piper Jaffray.",10,"Your next question is from Brett Wong with Piper Jaffray."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","I'm just wondering, you talked about this elevated inventory that you're expecting through 2016. Can you just talk about what's going to improve that as we look out over the next couple of years?",35,"I'm just wondering, you talked about this elevated inventory that you're expecting through 2016. Can you just talk about what's going to improve that as we look out over the next couple of years?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes. I think what we are looking at is the demand doesn't vary in a field in an enormous way. I think what will be resolving the issue is there is growth in demand, 2%, 3% every year, usually to resolve the end market demand. And then stock-to-use ratio s",190,"Yes. I think what we are looking at is the demand doesn't vary in a field in an enormous way. I think what will be resolving the issue is there is growth in demand, 2%, 3% every year, usually to resolve the end market demand. And then stock-to-use ratio should be decreasing in the next 2 years, which should start to show an increase in currency prices, together with the fact that today all of the ag chem companies, as you've seen in our performance, are selling less. So if you look, there is much more product on the ground, product which are put on the ground, than product which are sold by the chemical industry into the market. And that differential is what is decreasing the level of inventory. You just need strong weather or strong pest pressure, combined with more product on the ground than the industry is selling, and you could see a turn in 2017. But we are not at all operating under the assumption that there will be any turn in 2016. I think that's where we are focused and we are not assuming anything."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, great. And just a quick one in Brazil, wondering if the early dry conditions impacted any fungicide application in that early part of the season.",26,"Okay, great. And just a quick one in Brazil, wondering if the early dry conditions impacted any fungicide application in that early part of the season."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes. Obviously, dry conditions do not help fungicide use. We've seen a lot of variable conditions in Brazil. Fungicides for us is a smaller part of our portfolio. So we've not really been impacted that much. But you've got to balance that with other parts",74,"Yes. Obviously, dry conditions do not help fungicide use. We've seen a lot of variable conditions in Brazil. Fungicides for us is a smaller part of our portfolio. So we've not really been impacted that much. But you've got to balance that with other parts of Brazil are being very wet. So you're going to get good pressure there. So I'm not so sure that fungicides will be off a significant amount in Brazil."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Don Carson with Susquehanna Financial.",10,"Your next question is from Don Carson with Susquehanna Financial."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","This is [indiscernible] on for Don. Just wanted to ask about your outlook of the impact of the Xtend approval on Authority volumes. And as a follow-up, the impact of INTACTA on Brazilian insecticide volumes in '15 and your outlook in '16 as INTACTA acreag",46,"This is [indiscernible] on for Don. Just wanted to ask about your outlook of the impact of the Xtend approval on Authority volumes. And as a follow-up, the impact of INTACTA on Brazilian insecticide volumes in '15 and your outlook in '16 as INTACTA acreage doubles."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, taking the first one. obviously, Xtend is an important platform. We don't expect much impact in '16 obviously given where we are. But we do see that as a growth aspect for us in '17, '18 and going into '19. So it's something we've invested a lot of t",163,"Yes, taking the first one. obviously, Xtend is an important platform. We don't expect much impact in '16 obviously given where we are. But we do see that as a growth aspect for us in '17, '18 and going into '19. So it's something we've invested a lot of time and effort in. We are a market leader in the pre-herbicide section in North America. So yes, we do see that as a positive for us going forward. With INTACTA, INTACTA has had a lot of success in Brazil, obviously affect certain types of insecticides and not others. I think we've all been affected by lower spray amounts in Brazil. I expect that to continue. But we are seeing different types of pest pressure coming in Brazil. Certainly, the piercing pests, such as stink bugs, we're seeing much more activity in that area. So you've got a different mix going on in insecticides. But overall, INTACTA has definitely reduced the amount of sprays."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Steve Byrne with Bank of America Merrill Lynch.",13,"Your next question is from Steve Byrne with Bank of America Merrill Lynch."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","This is Ian for Steve Byrne. Just following up on some of the inventory issues, how much did FMC sell into North America in this fourth quarter? And what is the logic behind that if inventory levels are high?",39,"This is Ian for Steve Byrne. Just following up on some of the inventory issues, how much did FMC sell into North America in this fourth quarter? And what is the logic behind that if inventory levels are high?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","We don't break up the sales by quarter, by region. But the inventory, we believe North America actually has been less talked about from an inventory level compared to Brazil because Brazil was -- had an overwhelming impact because it was combining higher",221,"We don't break up the sales by quarter, by region. But the inventory, we believe North America actually has been less talked about from an inventory level compared to Brazil because Brazil was -- had an overwhelming impact because it was combining higher inventory level and currencies. So when you put those 2 together, you have the dramatic situation from a business performance we've heard about. Obviously, North America doesn't have the piece, which is the currency impact, so we've talked less about it. But we come quickly to realize that purely from an inventory standpoint, about the same phenomenon we've seen in Brazil is happening in North America, commodity prices being low, growers were very cautious in terms of planting decisions and processing decisions as their colleague were in Brazil. The crop protection industry kept on selling products. And there was a point where there was more product going into the channel than product going on the ground. And that created, as in Brazil, a very elevated situation. Additionally, insect pressure was not great in the previous year, which has been creating even more of a problem. So all of that has been compiling the situation, which for us from an inventory and supply chain standpoint is very close to what we see in Brazil, less the currency effect."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And then just one follow-up on the Cheminova synergies from sales, moving some of that FMC product to Cheminova's distribution, is that because FMC already has existing registrations in all these countries? And what is the outlook for further growth",55,"Okay. And then just one follow-up on the Cheminova synergies from sales, moving some of that FMC product to Cheminova's distribution, is that because FMC already has existing registrations in all these countries? And what is the outlook for further growth as we move forward in time, either from active ingredients or for the registrations?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, I mean, a lot of the countries where Cheminova have market access that we didn't, predominantly in Europe and parts of Asia, we actually had registrations already. So it allows us to move forward pretty quickly. That's the reason we got synergies in",185,"Yes, I mean, a lot of the countries where Cheminova have market access that we didn't, predominantly in Europe and parts of Asia, we actually had registrations already. So it allows us to move forward pretty quickly. That's the reason we got synergies in 2015 pretty quickly off the bat, and then in '16 as well. So from a registration standpoint, we think we're well placed. And then you ally that to the fact that our innovation platform is still obviously delivering on our formulation capabilities, we probably have somewhere close to 60 products we're launching around the world in 2016. Obviously, you don't get a tremendous amount of revenue in the first year of a launch of a formulated product. But it goes to show that what we're doing on a formulation standpoint is continuing through these times in the ag space. We believe that innovation is going to be supercritical for us as we go forward. So you see the growth not only from the synergies of FMC and Cheminova coming together, but the launch of new products as well into the marketplace."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Dmitry Silversteyn with Longbow Research.",10,"Your next question is from Dmitry Silversteyn with Longbow Research."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Most of my questions have been answered, but I have just a couple of follow-ups. First of all, what sort of debt level do you expect to have by the end of 2016? In other words, you talked about cash generation. How much of that is going to be deployed tow",53,"Most of my questions have been answered, but I have just a couple of follow-ups. First of all, what sort of debt level do you expect to have by the end of 2016? In other words, you talked about cash generation. How much of that is going to be deployed towards debt reduction?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Dmitry, it's Paul. I think we've been pretty clear where we want to get our leverage down to, which is in the mid-2 to 3x range. We're not there right now. And so until we get to that point, whether that's through expansion of EBITDA or pay-down in debt,",63,"Dmitry, it's Paul. I think we've been pretty clear where we want to get our leverage down to, which is in the mid-2 to 3x range. We're not there right now. And so until we get to that point, whether that's through expansion of EBITDA or pay-down in debt, you should assume that surplus cash is going to be deployed in that direction."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. So pretty much whatever free cash I calculate for you for the year, I'm safe in assuming it's going towards debt pay-down.",23,"Okay. So pretty much whatever free cash I calculate for you for the year, I'm safe in assuming it's going towards debt pay-down."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Today, that's the safest assumption to make there.",8,"Today, that's the safest assumption to make there."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, great. And then just looking at the first quarter guidance for the Ag business, it looks like at the midpoint, it's basically flat year-over-year versus last year, despite the fact that you're going to have Cheminova profitability that you didn't ha",83,"Okay, great. And then just looking at the first quarter guidance for the Ag business, it looks like at the midpoint, it's basically flat year-over-year versus last year, despite the fact that you're going to have Cheminova profitability that you didn't have last year. So is the offset to the acquisition benefit and the cost savings you're realizing from that, the deterioration of North American market, is that going to be really that bad in the first quarter? Is that basically the takeaway?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, I think it's the right way to look at it. I might not call that a deterioration but a lack of improvement of the Ag market in North America and maybe a pushing of the decisions toward the second and the third quarter. But that's the right way to look",91,"Yes, I think it's the right way to look at it. I might not call that a deterioration but a lack of improvement of the Ag market in North America and maybe a pushing of the decisions toward the second and the third quarter. But that's the right way to look at it, which is the overall spread of business over 3 quarters and the lack of growth -- not growth, we believe the business will be down in North America year-on-year are erasing the benefit from the Cheminova first quarter."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, Pierre. So maybe I can say this differently, and then see if it still makes sense. The sales that you typically get over the first couple of quarters of the year in North America and in European markets, you would expect those sales to basically occ",83,"Okay, Pierre. So maybe I can say this differently, and then see if it still makes sense. The sales that you typically get over the first couple of quarters of the year in North America and in European markets, you would expect those sales to basically occur over a 3-quarter period. But in terms of aggregate, you're not looking for a significantly down demand year in 2016 versus 2015. It's just that demand is going to be spread over 3 quarters versus 2."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","So if you look at -- yes, part of your statement is correct. There is more of a spread over 3 quarters. That is correct. There is also, as I said, market we expect to be down in North America. So we're expecting the market in North America to be down 5% t",105,"So if you look at -- yes, part of your statement is correct. There is more of a spread over 3 quarters. That is correct. There is also, as I said, market we expect to be down in North America. So we're expecting the market in North America to be down 5% to 10%. That would be a range. The 2 biggest down markets will be Brazil and North America. So you combine a spread of this year [indiscernible] over 3 quarters together with a down market in North America, not in Europe, in North America of mid-single digit, that is what created the situation."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And if I can look forward to the second quarter, and I know you guys can't provide a guidance for it. But if I remember it correctly, most of Cheminova's European sales sort of take place in April and maybe early May, which you sort of missed when y",91,"Okay. And if I can look forward to the second quarter, and I know you guys can't provide a guidance for it. But if I remember it correctly, most of Cheminova's European sales sort of take place in April and maybe early May, which you sort of missed when you completed the acquisition later in May in 2015. So we would expect to see more of a step-up, if you will, in the profitability of the business on a year-over-year basis in the second quarter than we've seen in the first?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Not -- I think, think about the North America, European business more balanced over 3 quarters than it is over the second quarter. So right now, we don't want to go into starting to guide Q2, Q3 because it starts to be a very difficult exercise, especiall",74,"Not -- I think, think about the North America, European business more balanced over 3 quarters than it is over the second quarter. So right now, we don't want to go into starting to guide Q2, Q3 because it starts to be a very difficult exercise, especially when you're in the Ag business. But I think we'll have more of the development of the sales over 3 quarters than we had in the past."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Laurence Alexander with Jefferies.",9,"Your next question is from Laurence Alexander with Jefferies."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","This is Dan Rizzo on for Lawrence. Just a question on omega-3s, are you seeing any signs of pricing in 2016 as part of the turn? Or is it going to be similar to 2015, where you're subject to overcapacity and just some pricing pressures?",45,"This is Dan Rizzo on for Lawrence. Just a question on omega-3s, are you seeing any signs of pricing in 2016 as part of the turn? Or is it going to be similar to 2015, where you're subject to overcapacity and just some pricing pressures?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Laurence, this is Eric here. What we're seeing on omega-3 is a mix effect. We do expect to see in our mix in the nutraceutical market an improvement in products we're launching that are launched at a higher price. If you look at the core of the market tho",113,"Laurence, this is Eric here. What we're seeing on omega-3 is a mix effect. We do expect to see in our mix in the nutraceutical market an improvement in products we're launching that are launched at a higher price. If you look at the core of the market though, the middle part of -- I'm going to talk about concentration, it's the middle low part of the concentration, we don't expect to see improvement in that. That market still remains an oversupplied market, where demand is not growing rapidly. And so we see a similar set of pricing competitive dynamics in that part of the market in '16 as we did in '15."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","I think on the last call, maybe I'm wrong, but you said that you potentially can see strategically exiting omega-3 market, but it wasn't the right time. Is that kind of still the same outlook or the same thought process?",40,"I think on the last call, maybe I'm wrong, but you said that you potentially can see strategically exiting omega-3 market, but it wasn't the right time. Is that kind of still the same outlook or the same thought process?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Here is what we believe. Our market strategy of participating into the pharmaceutical and nutraceutical market has not changed. We are still going after all of these market, high-concentration and mid-concentration product. What we are doing today is focu",103,"Here is what we believe. Our market strategy of participating into the pharmaceutical and nutraceutical market has not changed. We are still going after all of these market, high-concentration and mid-concentration product. What we are doing today is focusing more on supplying those markets from one of the assets we have rather than the high-concentration [indiscernible] assets, which we do not believe is an asset, which is necessary today for us to participate in the pharmaceutical market. So it is not a change in the market we intend to participate in. But it's a change in our manufacturing strategy to serve those markets."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","And your last question comes from the line of Rosemarie Morbelli with Gabelli & Company.",14,"And your last question comes from the line of Rosemarie Morbelli with Gabelli & Company."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","I have a couple of small ones. First of all, do you anticipate that the announcement of the additional capacity on the lithium carbonate will have a negative impact on overall pricing as those big plants come onstream?",38,"I have a couple of small ones. First of all, do you anticipate that the announcement of the additional capacity on the lithium carbonate will have a negative impact on overall pricing as those big plants come onstream?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Not in 2016. I think pricing will be pretty solid for lithium carbonate in 2016 as most of the capacity increase are already called for from a demand standpoint. Will there be some pricing pressure in 2017? We'll have to see where the demand is. But I --",72,"Not in 2016. I think pricing will be pretty solid for lithium carbonate in 2016 as most of the capacity increase are already called for from a demand standpoint. Will there be some pricing pressure in 2017? We'll have to see where the demand is. But I -- if it is a question, and I cannot answer that right now, but if it is a question around pricing, it's a 2017 question."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And then are you successful in getting your receivables in Brazil? Are the farmers paying you in a timely -- well not a timely fashion, they don't, but in the way you would expect? Or the fact that you have done so much restructuring is creating the",55,"Okay. And then are you successful in getting your receivables in Brazil? Are the farmers paying you in a timely -- well not a timely fashion, they don't, but in the way you would expect? Or the fact that you have done so much restructuring is creating the opportunity for someone to just not pay?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Rosemarie, it's Paul. I would answer as follows. The restructuring is not a factor in this. The way we restructure and what we restructured was done very carefully, so it does not at all impact our ability to collect. The factors that are driving our abil",276,"Rosemarie, it's Paul. I would answer as follows. The restructuring is not a factor in this. The way we restructure and what we restructured was done very carefully, so it does not at all impact our ability to collect. The factors that are driving our ability to collect are really driven more by market conditions. And I don't necessarily just mean Ag market conditions but as much as the financing market conditions down in Brazil, where we're seeing a continued cautiousness on the part of the Brazilian grower to hold on to its liquid resources. A lack of confidence that financing will be there for them as they head into the next growing season is essentially across the board creating challenges to collection. Compounding on top of that, of course, as we've discussed, is the fact that the most leverage you have is when you have to -- when the grower has to buy a new product, when you have pest pressures down and you have excess inventory in the channel, it just makes that collection process even more difficult for us. I would say 2015 unfolded very much in the way we described, and we've talked at length about it being a multiyear program to reduce the receivables balance in Brazil. And '15 played out really exactly as we had expected. The next couple of quarters will be the next key benchmarks for us as we look at collection in the first half of the year. And [indiscernible] at least, we think heading through the back end of '16 is the first time we'll be able to show real measurable progress down there in Brazil."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","So how much do you think you can reduce your receivables from Brazil in 2016 versus how much did you reduce it in 2015?",24,"So how much do you think you can reduce your receivables from Brazil in 2016 versus how much did you reduce it in 2015?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","We will certainly reduce it more in '16 than we did in '15. We did reduce it in Brazil in 2015 but not by a huge amount. So we definitely expect to make more progress on that in '16.",39,"We will certainly reduce it more in '16 than we did in '15. We did reduce it in Brazil in 2015 but not by a huge amount. So we definitely expect to make more progress on that in '16."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And one last one if I may, could you talk about the protein demand in China? Are you seeing that improving or the decline when the price of milk and whey was really high has not recovered yet?",39,"Okay. And one last one if I may, could you talk about the protein demand in China? Are you seeing that improving or the decline when the price of milk and whey was really high has not recovered yet?"
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Rosemarie, it's Eric. We are seeing -- continue to see in China a dairy market that's fairly, on a growth basis, flat to down. We saw a big swing in our sales last year due to a correction in inventories for our colloidal products into that market into so",89,"Rosemarie, it's Eric. We are seeing -- continue to see in China a dairy market that's fairly, on a growth basis, flat to down. We saw a big swing in our sales last year due to a correction in inventories for our colloidal products into that market into some of the plant-based beverages, such as peanut milk. That's worked its way off. And the underlying demand is coming through. But that demand is fairly flat. We saw a modest growth ourselves. The overall market, however, is flat to down."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","That's all the time we have for the call today. I want to thank everyone for joining us. I'll be available to address any additional questions you may have. Thank you. Have a good day.",36,"That's all the time we have for the call today. I want to thank everyone for joining us. I'll be available to address any additional questions you may have. Thank you. Have a good day."
28606,321466580,931572,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","And again, that is all the time we have for today. This concludes the FMC Corporation Fourth Quarter 2015 Earnings Release Conference Call. Thank you.",25,"And again, that is all the time we have for today. This concludes the FMC Corporation Fourth Quarter 2015 Earnings Release Conference Call. Thank you."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the Fourth Quarter 2015 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] And as a reminder, today's conference call is being recorded. I will now turn the conference over to Mr. Brian Angeli, Vic",51,"Good morning, and welcome to the Fourth Quarter 2015 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] And as a reminder, today's conference call is being recorded. 
I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning, everyone. Welcome to FMC Corporation's fourth quarter earnings call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.",286,"Thank you, and good morning, everyone. Welcome to FMC Corporation's fourth quarter earnings call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.
Pierre will begin the call with a review of FMC's fourth quarter and full year performance and then discuss the outlook for 2016. Paul will provide an overview of select financial results. 
As we have done for each of the past 2 quarters, we have published a slide presentation that accompanies our results. This slide presentation, along with our earnings release and 2016 outlook statement, is available on our website. The prepared remarks from today's discussion will be made available at the conclusion of the call.
After the prepared remarks, we will be joined by Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, to address your questions.
Before we begin, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including, but not limited to, those factors identified in our release and in our filings with the Securities and Exchange Commission. Information presents our best judgment based on today's information. Actual results may vary based on these risks and uncertainties. 
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms as well as other non-GAAP financial terms, to which we may refer during today's conference call, are provided on our website.  
I will now turn the call over to Pierre."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian. Good morning, everyone. 2015 marked the completion of FMC's transformation to a technology-driven specialty company with leading market positions across agriculture, nutrition, pharmaceutical and specialty lithium applications. In Ag S",2748,"Thank you, Brian. Good morning, everyone. 2015 marked the completion of FMC's transformation to a technology-driven specialty company with leading market positions across agriculture, nutrition, pharmaceutical and specialty lithium applications. 
In Ag Solutions, the acquisition of Cheminova strengthened our technology pipeline, brought greater regional balance, broadened our market access and expanded our portfolio. The integration of Cheminova continues to go well. Our success to date reinforces our confidence in achieving the run rate cost savings of $140 million to $160 million by the middle of 2017. The acquisition and integration of Cheminova, combined with the actions we have taken to restructure our Ag Solutions operation in Brazil, have positioned FMC to better address current market conditions. 
In Health and Nutrition, we focused on driving higher margins by capturing high-value commercial opportunities across our portfolio and by implementation of manufacturing actions program and process technology improvements. And in lithium, we continued to execute on our strategy of growing FMC's differentiated downstream specialty business to take advantage of favorable end market demand. 
2015, however, was also a year marked by significant foreign exchange headwinds and difficult conditions across the global agriculture market. We took decisive actions throughout the year to address these challenges, accelerating the integration of Cheminova, restructuring our Ag Solutions operations in Brazil, exercising discipline on pricing and aggressively controlling costs across the company. As we enter 2016, we remain focused on the continued execution of our strategy to drive improved performance. Despite challenging macroeconomic and ag market conditions, we believe the actions we have taken will enable FMC to deliver higher earnings growth across each of our business in 2016. 
I will provide further details regarding our 2016 outlook shortly. But first, I will review our fourth quarter and full year 2015 performance. 
Starting with FMC's full year results on Slide 1. FMC reported revenue of approximately $3.3 billion in 2015, roughly flat to reported revenue for 2014 and adjusted EPS of $2.47, a decline of 22% compared to last year.
For the fourth quarter, FMC reported revenue of $899 million, an increase of approximately 1% compared to the same period last year. Adjusted earnings per share for Q4 were $0.77, 9% below the fourth quarter of 2014.
Turning to Ag Solutions on Slide 2. For the fourth quarter, Ag Solutions delivered revenue of $657 million and segment earnings of $101 million, a decline of 23% and 8%, respectively, from the pro forma results of the same period of 2014. The negative impact of foreign exchange and lower sales volume more than offset price increase and lower operating cost in the quarter. About 75% of the decline in sales volume during the fourth quarter was the result of deliberate actions to eliminate lower-margin, third-party product sales. Excluding these sales, volume declined by less than 5% compared to the fourth quarter of 2014, as we continued to see demand for FMC's proprietary products across all regions. 
In Europe, we saw healthy demand, as mild weather conditions allowed for late application of cereal herbicides. During the fourth quarter, we were pleased to record our first direct sales of FMC products into Western Europe as we transitioned to direct market access provided by the Cheminova acquisition. 
Across the Americas, however, market conditions were significantly more challenging. In North America, consecutive years with low pest pressure have resulted in elevated channel inventory levels. Compounding the channel inventory issues is the deterioration in farmer income levels in the U.S., resulting in a more cautious mindset of distributors and growers. While we continued to see strong support for customers for our proprietary products, we expect challenging market conditions to persist through 2016.
In Brazil, we saw improving conditions in certain crop markets, including sugarcane and cotton, as well as niche crops such as coffee and citrus. However, channel inventories, especially in insecticide, and unfavorable weather conditions negatively impacted sales volume. As we have discussed previously, we expect channel inventory levels to remain elevated through 2016. 
In the rest of Latin America, we continue to see strong demand for FMC's product, including pre-emergent herbicides in Argentina and products for niche crops in Colombia and Mexico. Sales in Argentina, however, continues to be impacted by delay in receiving import licenses for formulated products.
In Asia, weather conditions in India, Pakistan, Australia and parts of Southeast Asia related to reduced demand and higher channel inventories.
The negative impact of foreign exchange was the single largest driver of our 2015 performance. In the quarter, the strengthening of the U.S. dollar reduced Ag Solutions segment earnings by about $60 million compared to last year. However, the combination of price increases and cost reductions more than offset the negative impact of foreign exchange.
In Brazil, we continued to implement significant price increases to maintain U.S. dollar-based pricing in that country. This price increases recovered more than 70% of the currency impact on segment earnings in the fourth quarter. In addition, FMC continued to aggressively reduce operating costs through the faster integration of Cheminova and further restructuring of Ag Solutions operations in Brazil.
As a result, and despite the challenging demand environment, segment earnings margin improved by 250 basis points to 15.4% in the quarter. I will provide further details regarding cost savings activities shortly.
But first, I will comment on the full year performance for Ag Solution. As shown on Slide 3, Ag Solutions reported revenue of $2.6 billion for 2015 compared to pro forma revenue of $3.4 billion for 2014, a decline of 23%, as lower sales volume and foreign exchange headwind more than offset price increases during the year. Lower sales volumes accounted for about 16% of the decline in revenue. However, more than half of this volume decline is the result of actions we took throughout the year to eliminate lower-margin, third-party product sales. Excluding this, sales volumes declined about 7% compared to 2014. 
In 2015, the strengthening of the U.S. dollar resulted in FX headwind of about $300 million, erasing over 50% of Ag Solutions pro forma 2014 segment earnings. To be clear, this reduced reported sales by about $380 million and lowered our reported cost by about $80 million. We offset about 60% of the currency impact on sales in Brazil by raising prices throughout the year, and we expect to continue to offset future FX impacts in Brazil through price increases. 
Early in the year, we began to aggressively reduce operating costs. For the full year, operating costs were lower by about $100 million. This include savings from the Cheminova integration, lower spending on discretionary items and lower energy and raw material costs.
Despite the challenging market conditions in 2015, we continued to invest in innovation and our technology pipeline of new synthetic and biological active ingredients. Product introduced in 2015 were well received by the market, and we expect further traction from new product introductions in 2016.
I will now turn to the 2016 cost savings we expect to realize from the Cheminova integration and related actions. As you can see on Slide 4, in 2015, FMC realized about $40 million in cost savings as a direct result of the Cheminova integration and the restructuring of operations in Brazil.
For 2016, we expect to deliver additional cost savings over 2015 of between $60 million and $70 million, reflecting the full year benefit of previously announced headcount reduction and savings associated with various procurement and SAR cost-reduction programs.
As discussed, during our third quarter earnings call, FMC targeted total headcount reductions of 800 to 850 positions. As of December 31, 2015, over 700 positions have been eliminated, and we expect to implement the remaining reductions during the second half of 2016.
The success we have achieved to date in delivering the headcount reduction, plus the further cost reduction initiatives currently underway, gives us a high degree of confidence that we will deliver the 2016 cost savings target and achieve the $140 million to $160 million in run rate cost savings by the middle of 2017.
Turning now to Health and Nutrition on Slide 5. Q4 represented another quarter of solid earnings performance. As a result, the business delivered its 11th consecutive year of record earnings in 2015. Health and Nutrition reported revenue of $172 million, a decline of 10% compared to the fourth quarter of 2014, mainly due to lower sales volume and the weaker euro. We saw lower MCC banner and carrageenan sales in the quarter, partially offset by higher sales of MCC-based product for food application and increased sales of omega-3 for the nutraceutical market.
Segment earnings for Health and Nutrition increased 5% compared to the fourth quarter of 2014 to $46 million. Lower operating cost more than offset the negative impact of lower sales volume. 
The benefits of ongoing Manufacturing Excellence and process technology improvement increased segment earnings margin in the quarter to 26.9%, an increase of almost 400 basis points compared to the fourth quarter of 2014.
As a result of the actions taken over the past year, Health and Nutrition is well positioned to deliver continued earnings growth in 2016. 
Turning next to Lithium on Slide 6. Lithium delivered a strong quarter. Revenue of $70 million was up slightly compared to the fourth quarter of 2014, as higher prices were partially offset by the impact of foreign exchange.
The fourth quarter of 2015 represents the fourth consecutive quarter in which FMC realized higher pricing in the Lithium business as demand growth across end markets application, coupled with tight supply, supported price increases, especially for FMC's carbonate and hydroxide products.
Sales volumes were essentially flat to last year as higher volumes for FMC's butyllithium and specialty organics were offset by lower volumes resulting from scheduled maintenance downtime in our hydroxide unit and less third-party supply of carbonate. 
Demand for FMC's downstream specialty lithium products remains strong. Hydroxide sales volume were up significantly on a full year basis, as demand for energy storage applications continued to grow at double-digit rates and as we continued to increase throughput from our existing assets.
Segment earnings increased 42% to $11 million in the quarter. The combination of higher pricing, improved sales mix and lower operating cost more than offset the impact of FX on FMC's reported results, pushing segment earnings margin to 15.9%, an increase of 450 basis points compared to the fourth quarter of 2014. 
Now moving on to our 2016 outlook on Slide 7. Last night, we published our outlook statements for the first quarter and full year 2016. I will take a few minutes now to briefly discuss the outlook for each of FMC's business segments.
In Ag Solutions, full year segment revenue is expected to be approximately $2.3 billion to $2.5 billion. And full year segment earnings are expected to be in the range of $380 million to $420 million, with first quarter segment earnings in the range of $70 million to $90 million. I will discuss Ag in more detail in a moment. 
In Health and Nutrition, we are anticipating full year segment revenue of $775 million to $825 million. We continue to see stable low to mid-single-digit demand growth in the majority of our end markets. Segment revenue growth is expected to be slightly below this level, as we do not expect certain omega-3 sales to the pharmaceutical API market made during the first quarter of 2015 to happen in 2016. 
Excluding these sales, we expect underlying sales growth in the middle -- in the mid-single-digit range driven by increased demand for health excipients and nutraceutical ingredients across emerging markets. 
Health and Nutrition segment earnings are expected to be in the range of $198 million to $208 million in 2016. The business made significant strides to improve its cost structure and operating efficiency over the past 12 months. We expect these efforts to drive further margin expansion in 2016, which will allow Health and Nutrition to grow earnings accordingly. 
We expect first quarter segment earnings for Health and Nutrition to be in the range of $46 million to $51 million. We have little similarity in this segment earnings for Health and Nutrition. However, as I mentioned previously, we do not expect certain omega-3 sales from the first quarter of 2015 to reoccur this year. As a result, reported first quarter segment earnings will be lower compared to 2015. 
In Lithium, we see strong demand and a favorable pricing environment. We will continue to optimize our sales mix to drive higher volume of FMC's downstream specialty products.
As we enter 2016, FMC is sold out across most products. Higher pricing, improved mix and lower operating cost will drive earnings growth in 2016. In addition, the reduction in operating cost as a result of the devaluation of the Argentine peso will provide a tailwind for segment earnings over the next 12 to 18 months.
For the full year, we expect Lithium segment revenue to be between $240 million and $260 million and segment earnings to be in the range of $33 million and $43 million. We expect first quarter segment earnings of $8 million to $12 million. 
On a consolidated basis, we expect FMC's 2016 adjusted earnings per share to be between $2.50 and $2.80. We expect first quarter 2016 adjusted earnings to be between $0.48 and $0.60 per share.
I will now discuss the outlook for Ag Solutions business in more detail starting with a few comments regarding the market on Slide 8.
In Europe, we expect our key markets to be broadly flat compared to last year, although we expect to see higher growth across Eastern Europe. 
In North America, we expect the challenging market conditions will continue in 2016 given elevated channel inventory levels and projected lower farm incomes. As a result, we expect the market in North America to be down in 2016. 
Across Asia, we expect the market to be mixed depending on the countries. However, overall, we expect the region to be up slightly in 2016 assuming more normal pest pressures and weather conditions. 
Turning to Latin America. Market conditions in Argentina, Mexico and Colombia are expected to remain favorable with growth in weed-resistant acres and increasing acreage for niche crops. We expect the market in Brazil to be down again in 2016. Channel inventory levels are expected to remain elevated in 2016. However, we expect to see an improvement in market fundamentals for sugarcane and cotton.
While the factors impacting market growth vary across growing regions, we are broadly seeing a more cautious approach to purchasing decision throughout the value chain as a result of the protracted downturn in the Ag cycle.
Based on the factors I just described, we expect the global crop protection chemical market to decline by a mid to high-single-digit percentage in 2016 on a U.S. dollar basis. However, it is important to remember that these factors are dynamic and will change throughout the year. In particular, changes in planting decisions and pest pressures, and of course weather conditions, will significantly impact demand over the course of the growing season. We will get more clarity on these external factors as the year progresses, and we will update our views on market condition as some of these uncertainties become clear.
Turning next to Slide 9, where we summarize the critical earnings driver for 2016. A number of factors will contribute to the year-over-year increase in Ag Solutions segment earnings. First, we expect a positive $20 million impact from the full year of Cheminova. Next, we are targeting incremental cost savings of $90 million, including $60 million to $70 million from Cheminova-related synergies. Third, we expect that our pricing actions in Brazil and overall mix improvement will contribute approximately $90 million.
New product introductions scheduled for 2016 and revenue synergies in Europe and North America from the Cheminova acquisition will positively impact our mix and volumes for the year. 
Continued FX headwinds, the broader market decline and our decision to exit certain low-margin, third-party product sales will partially offset incremental earnings from the items I just described.
In Health and Nutrition, higher sales of excipient and nutritional products in emerging markets and the full year benefit of continued operational improvements are expected to deliver approximately $8 million in earnings growth.
Lithium is expected to contribute about $15 million to growth in earnings in 2016, driven primarily from higher pricing, improved mix and lower operating costs.
I will now turn the call over to Paul, who will discuss corporate expenses, the impact of foreign currencies on our results and cash flow."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Thanks, Pierre. Let me start with the income statement. Our corporate expense line represents those centrally held expenses that are not charged back to the businesses. 2015 came in lower than 2014 for the full year, as we saw various items such as insura",881,"Thanks, Pierre. Let me start with the income statement. Our corporate expense line represents those centrally held expenses that are not charged back to the businesses. 2015 came in lower than 2014 for the full year, as we saw various items such as insurance expenses, pension charges, year-end LIFO adjustments to inventory and various incidental FX-related expenses all come in below last year. We do not expect these to repeat in 2016, leading to our guidance for the corporate expense line of $70 million to $80 million. 
Looking at the tax rate, our full year rate benefited from 2 drivers relative to our previous expectations. First, various legislative items passed at the end of the year, primarily related to R&D deductions, resulted in a reduction in our overall rate. Second, the geographic mix of our earnings changed, away from the U.S. and Brazil and towards Europe and Asia. Since the latter regions typically have lower tax rates than the U.S. and Brazil, our overall tax rate benefited.
Together, these 2 items lowered our full year 2015 tax rate by approximately 300 basis points. Looking forward, we expect our adjusted tax rate to be in the 24% to 26% range. 
I'd like to spend a few moments on Slide 10 revisiting the impact of the strengthening U.S. dollar on our business during the year.
As Pierre has already described, our 2015 performance faced a significant challenge from the impact of the strengthening dollar on our earnings. Across all of FMC and before any pricing actions, the strengthening of the U.S. dollar would have reduced our 2014 operating earnings by approximately $310 million. Of this reduction, approximately $293 million would have directly impacted Agricultural Solutions. On Slide 10, you can see the drivers of this hit to the Ag Solutions segment earnings.
The cumulative effect of weakening local currencies on revenue was approximately $380 million, of which the Brazilian real was easily the largest followed by the euro. Offsetting this revenue impact was the positive effect on our local cost base, again, mainly the real and euro or euro-linked currencies, which reduced our costs in U.S. dollar terms by $85 million. 
Our response to this was to raise prices. Pierre has already noted that for the full year in 2015, these price increases offset approximately 60% of the currency impact in Brazil. This was possible in large part because market practice in Brazil is to price in real, but to do so relative to a U.S. dollar index. In the rest of the world, pricing is generally not dollar-indexed, creating a bigger challenge to raising prices, especially when market conditions are soft. 
In aggregate, globally, we recovered more than half of the $293 million earnings headwind through raising prices. Looking into 2016, we expect the FX headwind to be more modest than in 2015. The forecast currency moves in major currencies, such as the euro, are far smaller in 2016 than we saw a year ago. And while there remains uncertainty around various Asian and Eastern European currencies, movements in these currencies have a far smaller impact on our profitability. 
The key region that drives the guidance regarding both currency and pricing, as Pierre just described on Slide 9, is Brazil. First of all, our guidance assumes that there will be a less volatile depreciation of the real, with no rapid devaluation right in the middle of the key selling period, as we saw in Q3 2015. Although we are not expecting stronger market conditions in Brazil, our guidance also assumes that local price actions already in place, plus additional price increases, which will be introduced later in the year to reflect the actual depreciation of the real, will largely offset the forecast year-over-year impact of currency depreciation.
Turning to the balance sheet and the cash flow on Slide 11. Our year-end net debt was approximately $2.1 billion, with the small increase over the Q3 net debt being entirely due to the final tax payment related to the Alkali sale. The fourth quarter is typically a flat to negative operating cash flow quarter for us, given the seasonality of sales in Brazil. However, strong performance in Health and Nutrition and Lithium, as well as continued cost and capital spending controls, ensured that we kept our net cash outflows to a minimum. 
For the full year, our adjusted cash from operations, adjusted to remove the one-off impact of Cheminova and Alkali-related items, saw a 16% increase over 2014 despite a decline in EBITDA of around $100 million. We benefited from a positive year-on-year swing from working capital, as all businesses improved their working capital performance compared to 2014. 
Our cost-control programs included cash spending discipline. We saw lower cash outflows for capital expenditures, which was a third lower than in 2014, offset by slightly higher restructuring spending. 
In addition, our cash taxes related to ongoing operations were significantly lower than 2014, reflecting lower profitability in both the U.S. and Brazil.
Looking into 2016, we expect a continued improvement in cash generation performance. In aggregate, we expect adjusted cash from operations to increase by approximately 25% in 2016, driven by higher earnings, continued working capital improvements and lower restructuring spending, offset by higher cash taxes.
With that, I will turn the call back to Pierre."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Thank you, Paul. Despite the Ag industry uncertainty, we believe that our 2016 plan is very achievable. It relies more on things we control than on expectations of positive external events. We expect to deliver earnings growth in all businesses in 2016, a",111,"Thank you, Paul. Despite the Ag industry uncertainty, we believe that our 2016 plan is very achievable. It relies more on things we control than on expectations of positive external events. We expect to deliver earnings growth in all businesses in 2016, and we'll continue to position FMC firmly on the path of growth by leveraging the company's unique business model that has defined our success. FMC remains a technology-driven company with low-cost, asset-light operation; a unique, high return R&D model for active ingredients innovation; and strong regional formulation capabilities.
I want to thank you for your attention, and I will now turn the call back to the operator for questions."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] Your first question comes from the line of Frank Mitsch from Wells Fargo Securities.",16,"[Operator Instructions] Your first question comes from the line of Frank Mitsch from Wells Fargo Securities."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Your view -- kind of stepping back a second. Obviously, you guys are working hard on the Ag side, but we're dealing with these macro pressures that we continue to hear more and more about. And obviously, the inventory situation is a bit worse. So if you t",80,"Your view -- kind of stepping back a second. Obviously, you guys are working hard on the Ag side, but we're dealing with these macro pressures that we continue to hear more and more about. And obviously, the inventory situation is a bit worse. So if you think about over the next couple of years, how ultimately do you think the cycle plays out? And what needs to happen for things to really start to improve from a macro standpoint?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes. From a cycle standpoint, I have to say that we are highly focused right now on 2016. We believe, and the way we look at it today, as I said in my prepared remarks, is that we have a situation which is a little bit easier and more balanced in Europe a",238,"Yes. From a cycle standpoint, I have to say that we are highly focused right now on 2016. We believe, and the way we look at it today, as I said in my prepared remarks, is that we have a situation which is a little bit easier and more balanced in Europe and Asia. But -- and for that matter, in Latin America outside of Brazil. But we have certainly still significant inventory level in Brazil and in North America. Actually, North America, for us, is as much of a concern as Brazil is. So we are highly focused on executing our strategy in a market we believe will be down mid-single to high-single digit in 2016. There is still the possibility of a cycle turn in 2017, but you have to see how 2016 will go. It is highly dependent upon how the industry behaves, making sure that we don't oversell, don't presell, and that there is a normal weather and pest pressure. That is going to be very critical. Any additional negative weather from an Ag industry standpoint or a no pest pressure would lead to -- resulting less the prime of inventory. So 2016 will be a difficult year. And as we go into 2016, we should be able to see if 2017 remained the year where you will have a turn of the cycle. Mark, I don't know if you have any additional comments."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","No, I think the only thing I would add is we're keeping a close watch on stock-to-use ratios, which shows very clearly where supply and demand is. We're seeing some change in key crops for us, such as sugarcane, as sugar prices go up as supply has reduced",82,"No, I think the only thing I would add is we're keeping a close watch on stock-to-use ratios, which shows very clearly where supply and demand is. We're seeing some change in key crops for us, such as sugarcane, as sugar prices go up as supply has reduced over the last few years. Those are the type of things that we look for to sense any changes in our key markets. But I think everything else you said, Pierre, is very valid."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And then just from an FMC standpoint, obviously dealing with this, you guys have done a great job with the price increases and getting ahead of kind of offsetting the pressures you're feeling. You alluded to more this year. Could you just help me un",72,"Okay. And then just from an FMC standpoint, obviously dealing with this, you guys have done a great job with the price increases and getting ahead of kind of offsetting the pressures you're feeling. You alluded to more this year. Could you just help me understand the timing of it? And ultimately, is 70% of a recovery the right number to think about? Or does it go higher or lower from here?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Well, I think when we look at 2016, as we said, we're going to pretty much cover with price increase the FX impact for 2 reasons. First of all, because we expect the FX impact to be less in 2016 than it was in 2015. Remember that the biggest problem in 20",155,"Well, I think when we look at 2016, as we said, we're going to pretty much cover with price increase the FX impact for 2 reasons. First of all, because we expect the FX impact to be less in 2016 than it was in 2015. Remember that the biggest problem in 2015 was the high volatility and rapid devaluation of the real in the third quarter. That was unprecedented, more than actually the overall devaluation of the real. So we're not expecting that situation. In a less impact situation from currency, the price increase we need going into 2016 is less than the last year because a big part is a recovery of currency issues from price increase, which are already in place. So I would say we are entering 2016 with about 60% of the price actions already in place to recover the currency impact. And the rest is to happen during the year."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question comes from the line of Mike Sison with KeyBanc.",12,"Your next question comes from the line of Mike Sison with KeyBanc."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Pierre, I was wondering if you could -- there was a time when you thought for '16 maybe segment earnings for Ag could be in the mid-$600 million. And clearly, a lot has changed since then. Foreign currency has taken a big hit. But if you can bridge the ga",72,"Pierre, I was wondering if you could -- there was a time when you thought for '16 maybe segment earnings for Ag could be in the mid-$600 million. And clearly, a lot has changed since then. Foreign currency has taken a big hit. But if you can bridge the gap or maybe talk about $400 million in '16 and where the opportunity is, what's the earnings power of Ag Solutions over time."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes. See, I don't think, from a business strength standpoint, anything has changed for FMC. I believe we remain one of the lowest-cost manufacturer of active ingredients and maybe the most flexible one. With our asset-light model, we believe our technolog",257,"Yes. See, I don't think, from a business strength standpoint, anything has changed for FMC. I believe we remain one of the lowest-cost manufacturer of active ingredients and maybe the most flexible one. With our asset-light model, we believe our technology strategy is even better today than it used to be and our formulation strength has not changed. So it is, right now, the earnings potential of FMC Ag Solution has not changed. The problem is we are in a situation where demand is very low. Decisions from growers are pushed to the last minute and in a currency situation, which has been, as you can see, the biggest problem. So 2016 is going to be focused for us on earnings growth. There isn't much we can do around volume demand. We're also going to be highly, highly disciplined. We are not -- I can tell you one thing and we have not done that in 2015, and we're going to stick with that strategy in 2016, we are not going to run after market share. We are walking away from low profit sales, and we are increasing price to recover the currency impact. That should position us as soon as the cycle turn to a very strong performance. So to expect the business going into the mid- to high-teens growth as soon as the market turn around, I have no doubt about it, the model seem intact. Right now, it is inventory. And I would say our worries are mostly placed in North America and Brazil."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, great. And then your forecast for '16 looks for volumes to be down a couple of percent, the minus 50 there in terms of the impact for earnings -- or maybe that's an earnings impact. But it does sound like if the markets are down mid- to high single",85,"Okay, great. And then your forecast for '16 looks for volumes to be down a couple of percent, the minus 50 there in terms of the impact for earnings -- or maybe that's an earnings impact. But it does sound like if the markets are down mid- to high single digits, you're going to do better than that. And just wanted to get a better understanding why or why you feel that your volumes will be better than the market being down as it is."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","No, I think if you look at our overall performance from the business from a revenue standpoint, we're going to be about in line with the market if you remove the impact of third-party sales. So really think about our business from a volume standpoint, we'",240,"No, I think if you look at our overall performance from the business from a revenue standpoint, we're going to be about in line with the market if you remove the impact of third-party sales. So really think about our business from a volume standpoint, we're going to be in line with the market. So if it's a mid- to high single digit, call it a 7%, pure volume driven by market demand, that's where we are forecasting our performance. Now our decline in sales is going to be higher because we are -- and I'm talking volume here, okay? Because we are walking away still from third party. The run rate at which we closed 2015 is leading to a number which is higher than 2015 because we started this process during the year. And I think it's about an incremental $100 million of third-party sales we are walking away in 2016, which make our performance from a revenue standpoint a bit worse than market. So 2 things, we market from a demand standpoint, plus third-party sales, $100 million, we walk away. Where we're going to outperform the market, as we show in one of the slides, I think it's Slide 9, the one where we have the earnings driver, is because of the work is done around integration, around the cost and also 2 drivers of growth, which are synergies from Cheminova and also the new product introduction."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from the line...",8,"Your next question is from the line..."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","No, let me finish. Let me maybe be more precise in the quantification. If you think about our sales, we're going to be declining, just look at about 3 big buckets: sales driven by market decline, about $150 million to $200 million, that's the market deman",93,"No, let me finish. Let me maybe be more precise in the quantification. If you think about our sales, we're going to be declining, just look at about 3 big buckets: sales driven by market decline, about $150 million to $200 million, that's the market demand; think about third party we are walking away with no profit implication, about $100 million; and think about growth, which will be coming from synergies and the new technology, from $50 million to $100 million. Those are the 3 big buckets of our revenue drivers in 2016."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","We'll now go to your next question, which is from the line of Chris Parkinson with Crdit Suisse.",19,"We'll now go to your next question, which is from the line of Chris Parkinson with Crdit Suisse."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Can you give us a quick update on anything incremental on your potential across Europe, specifically on the back of Cheminova? You mentioned some nice data points in fungicides. But how are you thinking about your now integrated aggregated portfolio? And",65,"Can you give us a quick update on anything incremental on your potential across Europe, specifically on the back of Cheminova? You mentioned some nice data points in fungicides. But how are you thinking about your now integrated aggregated portfolio? And then also just in the near term, a quick question, do you believe the mild winter will benefit insecticide sales during the first half?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, Chris, it's Mark here. Talking about Europe, we've talked a lot about the direct market access and where the growth is going to come from. We're already seeing that, as Pierre alluded to, in the earlier part of this call. We're seeing now primarily o",237,"Yes, Chris, it's Mark here. Talking about Europe, we've talked a lot about the direct market access and where the growth is going to come from. We're already seeing that, as Pierre alluded to, in the earlier part of this call. We're seeing now primarily our herbicides from FMC getting pushed through the Cheminova pipeline. So we've gone direct in the U.K. now and we're also expanding into Spain. So we're seeing that geographic growth for herbicides that we wanted. Obviously, we're introducing new fungicides across the region. So everything we thought of in Europe is coming true. The country managers, the sales force from Cheminova have embraced the portfolio from FMC and are now gearing up to put those products into the marketplace. So from my perspective, Europe is exactly where we thought it would be. And obviously, there's going to be growth for us going forward. The second part of your question on the insecticides, obviously we've had, especially in North America, probably 3 years of extremely low pest pressures across the U.S. One could say that a warm winter would allow the pests to come back. But frankly, we don't know. We're not forecasting a strong pest season. We tend to forecast an average season and see where that takes us. But we'll know more about that as we get into the end of Q1 into Q2; we'll get a better feel for that."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Good color. And then just also very quickly in Argentina, is most of the potential here for your herbicide portfolio? And do you have any kind of new or preliminary plans or initiatives for Southern Lat Am in particular? And if so, how are you balancing t",58,"Good color. And then just also very quickly in Argentina, is most of the potential here for your herbicide portfolio? And do you have any kind of new or preliminary plans or initiatives for Southern Lat Am in particular? And if so, how are you balancing that long-term potential with FX, credit volatility, length of terms, et cetera?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, Argentina has been a good market for us despite some difficult conditions in getting import licenses. Our predominant market down there is pre-herbicides for soy. We are a market leader. With the Cheminova acquisition, we bring along more fungicides",208,"Yes, Argentina has been a good market for us despite some difficult conditions in getting import licenses. Our predominant market down there is pre-herbicides for soy. We are a market leader. With the Cheminova acquisition, we bring along more fungicides and insecticides that we can put through the channel. We're actually doing a couple of things to expand our presence in Argentina at the moment. First of all is the consolidation of our market access with Cheminova. And then secondly, we're looking at expanding our supply chain in Argentina to more reflect what we do around the rest of the world in terms of toll manufacturing. We're actually going to be importing more active ingredients and formulating in country. That helps us 2 ways. First of all, it allows us to formulate products for Argentina on the ground, gives us more flexibility. And secondly, it helps with our cost base, which is in local currency. So we do see Argentina growing. It has been a good market for us over the last couple of years. And we think our portfolio is ideally suited to where they're going. We are seeing weed-resistant acres continue to increase, just like we do in the U.S. So I'm very bullish on Argentina."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question comes from Daniel Jester with Citi.",9,"Your next question comes from Daniel Jester with Citi."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Maybe just another one on pricing in Ag Solutions. I think you talked about the linkage between the real and the U.S. dollar in Brazil and your ability to get pricing. But can you talk about how that is evolving in other parts of the world, which has had",91,"Maybe just another one on pricing in Ag Solutions. I think you talked about the linkage between the real and the U.S. dollar in Brazil and your ability to get pricing. But can you talk about how that is evolving in other parts of the world, which has had other FX challenges? And specifically, are you seeing the competition also raise prices as aggressively as you? Or do you think that there's a risk that you're getting maybe a little ahead of the market, given how challenging the macro conditions are?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","I think the ability to increase price is very different in places like Brazil, where the local pricing in real is indexed to a dollar currency. And there is a mechanism usually which is in place. Now it always ends up being a negotiation. And I believe, y",200,"I think the ability to increase price is very different in places like Brazil, where the local pricing in real is indexed to a dollar currency. And there is a mechanism usually which is in place. Now it always ends up being a negotiation. And I believe, yes, we have been the most aggressive at increasing price because we believe our portfolio can afford that. And I also believe that today, protecting the profitability of the business is critical, especially when the cycle will turn because the cycle will turn. And we believe we'll be in a much stronger position that time. It is more difficult to increase pricing in locations like Europe or even Asia, where there is no indexation on the currency on the dollar because there, it's purely a supply-demand and negotiations. So I would say most of our pricing recovery comes from Brazil rather than the other region. And yes, you are correct. I don't think we are ahead of the market because as you can see, we only partially recovered the currency negative impact with price increase. But yes, we were -- and we believe it's the right strategy, the most aggressive on that front."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And then maybe just quickly on lithium, you talked about $15 million of incremental growth in profit next year from price, mix, lower manufacturing. There's a lot of moving parts in the lithium story today, and certainly given the environment in Arg",83,"Okay. And then maybe just quickly on lithium, you talked about $15 million of incremental growth in profit next year from price, mix, lower manufacturing. There's a lot of moving parts in the lithium story today, and certainly given the environment in Argentina. So maybe just a little bit color on what's driving that profit outlook. And then also any change in your willingness to do incremental investments in your lithium capabilities in Argentina, given what's happened politically over the last couple months."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Sure. So the $15 million of earnings increase we are forecasting is driven by multiple factors. First of all, you know that we've been working very hard at fixing our operational issues, and I think we're there. Most of our plants -- there is still some w",320,"Sure. So the $15 million of earnings increase we are forecasting is driven by multiple factors. First of all, you know that we've been working very hard at fixing our operational issues, and I think we're there. Most of our plants -- there is still some work, but most of our plants are operating much better than they used to. And also the currency, the peso in Argentina, has been helping us from a cost standpoint and is going to be a tailwind in 2016. Additionally, there is the price and mix. We have a very strong product line and technology for lithium hydroxide. We are one of the critical and leading suppliers. And that market has increased in a tight supply situation, which allow us to right-price the product. So all in all, pricing, mix, better operation and currency will be the drivers in 2016. Around capacity, I think our capacity decisions will be in line with our strategy. First of all, we are working very hard at debottlenecking our plants, especially lithium hydroxide, to make sure we can supply our customers with the growth they need. From a capital investment standpoint, we believe our key competitors today have made decisions to increase lithium carbonate in a significant way. So we do not believe volume of lithium carbonate from FMC will be required to serve the market. There will be plenty of products, and we will be able to have supply agreements on lithium carbonate from other companies. So we do not believe -- even with an improving situation in Argentina, we do not believe we need going into 2017 to increase capacity in lithium carbonate, keep on debottlenecking the plant. Where we are looking at capital spending to improve our sales is in the downstream specialty business and mostly lithium hydroxide. This is where most of our capital spending will go in the next 2 or 3 years."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question comes from the line of Brian Maguire with Goldman Sachs.",13,"Your next question comes from the line of Brian Maguire with Goldman Sachs."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Yes, Pierre, I was hoping you could comment on some of the consolidation that's been happening in the space lately. We've seen 2 pretty large deals kind of announced in the last, call it, 3 or 4 months. Just kind of wondering competitively if you see that",76,"Yes, Pierre, I was hoping you could comment on some of the consolidation that's been happening in the space lately. We've seen 2 pretty large deals kind of announced in the last, call it, 3 or 4 months. Just kind of wondering competitively if you see that having any positive or negative impact on you or if consolidation could support better pricing. Or competitively, do you see the guys around you getting a little bit stronger?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Sure. Let me talk about the 2 deals. First of all, the one is Dow and DuPont. The consolidation of these 2 companies together will certainly create a very strong company with a very solid seed and chemicals portfolio. But honestly, this is 2 years away. Y",273,"Sure. Let me talk about the 2 deals. First of all, the one is Dow and DuPont. The consolidation of these 2 companies together will certainly create a very strong company with a very solid seed and chemicals portfolio. But honestly, this is 2 years away. You first need to have the time to get the approval from Dow and DuPont to merge as a single company. And once that is done, they need to do the integration. And then from the integration, they need to break up the company, as they stated, into 3 companies and merge together the 2 ag business. So I believe it's an interesting decision, which creates a very good company. But their impact on the market or the competitive landscape is still a couple of years away, so not a short-term concern for us. The Syngenta, Cheminova, my view -- or ChemChina, sorry. The Syngenta, ChemChina, my view is that it doesn't change much to the competitive landscape because if I understand well, through what I've read and what I've heard, Syngenta will be operating as a stand-alone company. And instead of being a publicly traded company, they will have a single shareowner, which is ChemChina. So unless ChemChina has a very fundamental -- or push a very fundamentally different strategy, which I don't think so, into Syngenta, we would be facing the same type of competition that we've been facing in the past. So my point of view at this stage, it's pretty much no change to the landscape for the next couple of years. And we'll see what will happen 2 years down the road."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, great. And one more if I could, just on the cadence of the Ag guidance through the year. I think historically 1Q has been the strongest quarter for segment earnings. I know Cheminova changes the profile a little bit. But the outlook for '16 looks li",103,"Okay, great. And one more if I could, just on the cadence of the Ag guidance through the year. I think historically 1Q has been the strongest quarter for segment earnings. I know Cheminova changes the profile a little bit. But the outlook for '16 looks like it will be one of the -- or at least a below average quarter, if not the weakest quarter through the year. Just kind of wondering if you could help us understand why things will pick up sequentially from kind of a weaker 1Q. And what kind of needs to happen for that to play out?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Sure. Our belief is this year is going to be a bit different from what we've seen in the past for a very specific reason. As I said in the prepared remarks, we believe that North America market has maybe a higher level of inventory than it used to have in",186,"Sure. Our belief is this year is going to be a bit different from what we've seen in the past for a very specific reason. As I said in the prepared remarks, we believe that North America market has maybe a higher level of inventory than it used to have in the previous years. And consequently, the decisions to purchase or free up the growers' or distributors' inventory are going to be made at the last minute. So we're going to have sales in North America much more spread over a Q1, Q2 and Q3 period than we used to have, where people who would really buy very strongly in advance in the fourth quarter. So the fact that we have a different profile in the first half of the year is purely due to North America. And North America being an important region for us from an earnings standpoint, that's why it spreads in a more balanced way the earnings over the year. It is more that than the Cheminova impact. I remind you that Cheminova is fairly small, it's fairly small in North America."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Brett Wong with Piper Jaffray.",10,"Your next question is from Brett Wong with Piper Jaffray."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","I'm just wondering, you talked about this elevated inventory that you're expecting through 2016. Can you just talk about what's going to improve that as we look out over the next couple of years?",35,"I'm just wondering, you talked about this elevated inventory that you're expecting through 2016. Can you just talk about what's going to improve that as we look out over the next couple of years?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes. I think what we are looking at is the demand doesn't vary in our field in an enormous way. I think what will be resolving the issue is there is growth in demand, 2%, 3% every year, usually just to resolve the end market demand. And then stock-to-use",191,"Yes. I think what we are looking at is the demand doesn't vary in our field in an enormous way. I think what will be resolving the issue is there is growth in demand, 2%, 3% every year, usually just to resolve the end market demand. And then stock-to-use ratio should be decreasing in the next 2 years, which should start to show an increase in currency prices, together with the fact that today all of the ag chem companies, as you've seen in our performance, are selling less. So if you look, there is much more product on the ground, product which are put on the ground, than product which are sold by the chemical industry into the market. And that differential is what is decreasing the level of inventory. You just need strong weather or strong pest pressure, combined with more product on the ground than the industry is selling, and you could see a turn in 2017. But we are not at all operating under the assumption that there will be any turn in 2016. I think that's where we are focused, and we are not assuming anything."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, great. And just a quick one in Brazil, wondering if the early dry conditions impacted any fungicide applications in that early part of the season.",26,"Okay, great. And just a quick one in Brazil, wondering if the early dry conditions impacted any fungicide applications in that early part of the season."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes. Obviously, dry conditions do not help fungicide use. We've seen a lot of variable conditions in Brazil. Fungicides for us is a smaller part of our portfolio. So we've not really been impacted that much. But you've got to balance that with other parts",74,"Yes. Obviously, dry conditions do not help fungicide use. We've seen a lot of variable conditions in Brazil. Fungicides for us is a smaller part of our portfolio. So we've not really been impacted that much. But you've got to balance that with other parts of Brazil have been very wet. So you're going to get good pressure there. So I'm not so sure that fungicides will be off a significant amount in Brazil."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Don Carson with Susquehanna Financial.",10,"Your next question is from Don Carson with Susquehanna Financial."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","This is Suli [ph] on for Don. Just wanted to ask about your outlook of the impact of the Xtend approval on Authority volumes. And as a follow-up, the impact of INTACTA on Brazilian soy insecticide volumes in '15 and your outlook in '16 as INTACTA acreage",48,"This is Suli [ph] on for Don. Just wanted to ask about your outlook of the impact of the Xtend approval on Authority volumes. And as a follow-up, the impact of INTACTA on Brazilian soy insecticide volumes in '15 and your outlook in '16 as INTACTA acreage doubles."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, taking the first one. Obviously, Xtend is an important platform. We don't expect much impact in '16, obviously, given where we are. But we do see that as a growth aspect for us in '17, '18 and going into '19. So it's something we've invested a lot of",163,"Yes, taking the first one. Obviously, Xtend is an important platform. We don't expect much impact in '16, obviously, given where we are. But we do see that as a growth aspect for us in '17, '18 and going into '19. So it's something we've invested a lot of time and effort in. We are a market leader in the pre-herbicide section in North America. So yes, we do see that as a positive for us going forward. With INTACTA, INTACTA has had a lot of success in Brazil, obviously affect certain types of insecticides and not others. I think we've all been affected by lower spray amounts in Brazil. I expect that to continue. But we are seeing different types of pest pressure coming in Brazil. Certainly, the piercing pests, such as stink bugs, we're seeing much more activity in that area. So you've got a different mix going on in insecticides. But overall, INTACTA has definitely reduced the amount of sprays."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Steve Byrne with Bank of America Merrill Lynch.",13,"Your next question is from Steve Byrne with Bank of America Merrill Lynch."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","This is Ian for Steve Byrne. Just following up on some of the inventory issues, how much did FMC sell into North America in this fourth quarter? And what is the logic behind that if inventory levels are high?",39,"This is Ian for Steve Byrne. Just following up on some of the inventory issues, how much did FMC sell into North America in this fourth quarter? And what is the logic behind that if inventory levels are high?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","We don't break up the sales by quarter, by region. But the inventory, we believe North America actually has been less talked about from an inventory level compared to Brazil because Brazil was -- had an overwhelming impact because it was combining higher",222,"We don't break up the sales by quarter, by region. But the inventory, we believe North America actually has been less talked about from an inventory level compared to Brazil because Brazil was -- had an overwhelming impact because it was combining higher inventory level and currencies. So when you put those 2 together, you have the dramatic situation from a business performance we've heard about. Obviously, North America doesn't have the piece which is the currency impact, so we've talked less about it. But we've come quickly to realize that purely from an inventory standpoint, about the same phenomenon we've seen in Brazil is happening in North America, commodity prices being low, growers who are very cautious in terms of planting decisions and purchasing decisions as their colleague were in Brazil. The crop protection industry kept on selling products. And there was a point where there was more product going into the channel than product going on the ground. And that created, as in Brazil, a very elevated situation. Additionally, insect pressure was not great in the previous year, which has been creating even more of a problem. So all of that has been compiling the situation, which for us from an inventory and supply chain standpoint is very close to what we see in Brazil, less the currency effect."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And then just one follow-up on the Cheminova synergies from sales, moving some of that FMC product to Cheminova's distribution, is that because FMC already has existing registrations in all these countries? And what is the outlook for further growth",55,"Okay. And then just one follow-up on the Cheminova synergies from sales, moving some of that FMC product to Cheminova's distribution, is that because FMC already has existing registrations in all these countries? And what is the outlook for further growth as we move forward in time, either from active ingredients or for the registrations?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, I mean, a lot of the countries where Cheminova have market access that we didn't, predominantly in Europe and parts of Asia, we actually had registrations already. So it allows us to move forward pretty quickly. That's the reason we got synergies in",185,"Yes, I mean, a lot of the countries where Cheminova have market access that we didn't, predominantly in Europe and parts of Asia, we actually had registrations already. So it allows us to move forward pretty quickly. That's the reason we got synergies in 2015 pretty quickly off the bat, and then in '16 as well. So from a registration standpoint, we think we're well placed. And then you ally that to the fact that our innovation platform is still obviously delivering on our formulation capabilities, we probably have somewhere close to 60 products we're launching around the world in 2016. Obviously, you don't get a tremendous amount of revenue in the first year of a launch of a formulated product. But it goes to show that what we're doing on a formulation standpoint is continuing through these times in the ag space. We believe that innovation is going to be supercritical for us as we go forward. So you see the growth not only from the synergies of FMC and Cheminova coming together, but the launch of new products as well into the marketplace."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Dmitry Silversteyn with Longbow Research.",10,"Your next question is from Dmitry Silversteyn with Longbow Research."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Most of my questions have been answered, but I have just a couple of follow-ups. First of all, what sort of debt level do you expect to have by the end of 2016? In other words, you talked about cash generation. How much of that is going to be deployed tow",53,"Most of my questions have been answered, but I have just a couple of follow-ups. First of all, what sort of debt level do you expect to have by the end of 2016? In other words, you talked about cash generation. How much of that is going to be deployed towards debt reduction?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Dmitry, it's Paul. I think we've been pretty clear where we want to get our leverage down to, which is in the mid-2 to 3x range. We're not there right now. And so until we get to that point, whether that's through expansion of EBITDA or paydown in debt, y",63,"Dmitry, it's Paul. I think we've been pretty clear where we want to get our leverage down to, which is in the mid-2 to 3x range. We're not there right now. And so until we get to that point, whether that's through expansion of EBITDA or paydown in debt, you should assume that surplus cash is going to be deployed in that direction."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. So pretty much whatever free cash I calculate for you for the year, I'm safe in assuming that it's going to go towards debt paydown.",26,"Okay. So pretty much whatever free cash I calculate for you for the year, I'm safe in assuming that it's going to go towards debt paydown."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Today, that's the safest assumption to make there.",8,"Today, that's the safest assumption to make there."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, great. And then just looking at the first quarter guidance for the Ag business, it looks like at the midpoint, it's basically flat year-over-year versus last year, despite the fact that you're going to have Cheminova profitability that you didn't ha",83,"Okay, great. And then just looking at the first quarter guidance for the Ag business, it looks like at the midpoint, it's basically flat year-over-year versus last year, despite the fact that you're going to have Cheminova profitability that you didn't have last year. So is the offset to the acquisition benefit and the cost savings you're realizing from that, the deterioration of North American market, is that going to be really that bad in the first quarter? Is that basically the takeaway?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Yes, I think it's the right way to look at it. I might not call that a deterioration but a lack of improvement of the Ag market in North America and maybe a pushing of the decisions toward the second and the third quarter. But that's the right way to look",91,"Yes, I think it's the right way to look at it. I might not call that a deterioration but a lack of improvement of the Ag market in North America and maybe a pushing of the decisions toward the second and the third quarter. But that's the right way to look at it, which is the overall spread of business over 3 quarters and the lack of growth -- not growth, we believe the business will be down in North America year-on-year are erasing the benefit from the Cheminova first quarter."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay, Pierre. So maybe I can say this differently, and then see if it still makes sense. The sales that you typically get over the first couple of quarters of the year in North American and European markets, you would expect those sales to basically occur",82,"Okay, Pierre. So maybe I can say this differently, and then see if it still makes sense. The sales that you typically get over the first couple of quarters of the year in North American and European markets, you would expect those sales to basically occur over a 3-quarter period. But in terms of aggregate, you're not looking for a significantly down demand year in 2016 versus 2015. It's just that demand is going to be spread over 3 quarters versus 2."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","So if you look at -- yes, part of your statement is correct. There is more of a spread over 3 quarters. That is correct. There is also, as I said, a market we expect to be down in North America. So we're expecting the market in North America to be down 5%",106,"So if you look at -- yes, part of your statement is correct. There is more of a spread over 3 quarters. That is correct. There is also, as I said, a market we expect to be down in North America. So we're expecting the market in North America to be down 5% to 10%. That would be a range. The 2 biggest down markets will be Brazil and North America. So you combine a spread of this year-end purchasing over 3 quarters together with a down market in North America, not in Europe, in North America of mid-single digit, that is what created the situation."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And if I can look forward to the second quarter, and I know you guys haven't provided guidance for it. But if I remember correctly, most of Cheminova's European sales sort of take place in April and maybe early May, which you sort of missed when you",88,"Okay. And if I can look forward to the second quarter, and I know you guys haven't provided guidance for it. But if I remember correctly, most of Cheminova's European sales sort of take place in April and maybe early May, which you sort of missed when you completed the acquisition later in May in 2015. So we would expect to see more of a step-up, if you will, in profitability of the business on a year-over-year basis in the second quarter than we've seen in the first?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Not -- I think, think about the North America, European business more balanced over 3 quarters than it is over the second quarter. So right now, we don't want to go into starting to guide Q2, Q3 because it starts to be a very difficult exercise, especiall",74,"Not -- I think, think about the North America, European business more balanced over 3 quarters than it is over the second quarter. So right now, we don't want to go into starting to guide Q2, Q3 because it starts to be a very difficult exercise, especially when you're in the Ag business. But I think we'll have more of the development of the sales over 3 quarters than we had in the past."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","Your next question is from Laurence Alexander with Jefferies.",9,"Your next question is from Laurence Alexander with Jefferies."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","This is Dan Rizzo on for Laurence. Just a question on omega-3s, are you seeing any signs that pricing in 2016 has started to turn? Or is it going to be similar to 2015, where you're subject to overcapacity and just some pricing pressures?",44,"This is Dan Rizzo on for Laurence. Just a question on omega-3s, are you seeing any signs that pricing in 2016 has started to turn? Or is it going to be similar to 2015, where you're subject to overcapacity and just some pricing pressures?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Laurence, this is Eric here. What we're seeing on omega-3 is a mix effect. We do expect to see in our mix in the nutraceutical market an improvement in products we're launching that are launched at a higher price. If you look at the core of the market, th",111,"Laurence, this is Eric here. What we're seeing on omega-3 is a mix effect. We do expect to see in our mix in the nutraceutical market an improvement in products we're launching that are launched at a higher price. If you look at the core of the market, though, the middle part of -- when you talk about concentrations, the middle, low part of the concentration, we don't expect to see improvement in that. That market still remains an oversupplied market, where demand is not growing rapidly. And so we see a similar set of pricing competitive dynamics in that part of the market in '16 as we did in '15."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","I think on the last call, maybe I'm wrong, but you said that you potentially could see strategically exiting the omega-3 market, but it wasn't the right time. Is that kind of still the same outlook or same thought process?",40,"I think on the last call, maybe I'm wrong, but you said that you potentially could see strategically exiting the omega-3 market, but it wasn't the right time. Is that kind of still the same outlook or same thought process?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Here is what we believe. Our market strategy of participating into the pharmaceutical and nutraceutical market has not changed. We are still going after all of these market, high-concentration and mid-concentration product. What we are doing today is focu",103,"Here is what we believe. Our market strategy of participating into the pharmaceutical and nutraceutical market has not changed. We are still going after all of these market, high-concentration and mid-concentration product. What we are doing today is focusing more on supplying those markets from one of the assets we have rather than the high-concentration [indiscernible] asset, which we do not believe is an asset which is necessary today for us to participate in the pharmaceutical market. So it is not a change in the market we intend to participate in. But it's a change in our manufacturing strategy to serve those markets."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","And your last question comes from the line of Rosemarie Morbelli with Gabelli & Company.",14,"And your last question comes from the line of Rosemarie Morbelli with Gabelli & Company."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","I have a couple of small ones. First of all, do you anticipate that the announcement of the additional capacity on the lithium carbonate will have a negative impact on overall pricing as those big plants come onstream?",38,"I have a couple of small ones. First of all, do you anticipate that the announcement of the additional capacity on the lithium carbonate will have a negative impact on overall pricing as those big plants come onstream?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Not in 2016. I think pricing will be pretty solid for lithium carbonate in 2016 as most of the capacity increase are already called for from a demand standpoint. Will there be some pricing pressure in 2017? We'll have to see where the demand is. But I --",72,"Not in 2016. I think pricing will be pretty solid for lithium carbonate in 2016 as most of the capacity increase are already called for from a demand standpoint. Will there be some pricing pressure in 2017? We'll have to see where the demand is. But I -- if it is a question, and I cannot answer that right now, but if it is a question around pricing, it's a 2017 question."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And then are you successful in getting your receivables in Brazil? Are the farmers paying you in a timely -- well, not a timely fashion, they don't, but in the way you would expect? Or the fact that you have done so much restructuring is creating th",55,"Okay. And then are you successful in getting your receivables in Brazil? Are the farmers paying you in a timely -- well, not a timely fashion, they don't, but in the way you would expect? Or the fact that you have done so much restructuring is creating the opportunity for someone to just not pay?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Rosemarie, it's Paul. I would answer as follows. The restructuring is not a factor in this. The way we restructure and what we restructured was done very carefully so it does not at all impact on our ability to collect. The factors that are driving our ab",280,"Rosemarie, it's Paul. I would answer as follows. The restructuring is not a factor in this. The way we restructure and what we restructured was done very carefully so it does not at all impact on our ability to collect. The factors that are driving our ability to collect are really driven more by market conditions. And I don't necessarily just mean Ag market conditions but as much the financing market conditions down in Brazil, where we're seeing a continued cautiousness on the part of the Brazilian grower to hold on to his liquid resources. A lack of confidence that financing will be there for them as they head into the next growing season is essentially across the board creating challenges to collection. Compounding on top of that, of course, as we've discussed, is the fact that the most leverage you have is when you have to -- when the grower has to buy a new product, when you have pest pressures down and when you have excess inventory in the channel, it just makes that collection process even more difficult for us. I would say 2015 unfolded very much in the way we described. I think we talked at length about it being a multiyear program to reduce the receivables balance in Brazil. And '15 played out really exactly as we had expected. The next couple of quarters will be the next key benchmarks for us as we look at the collection in the first half of the year. And to us at least, we think heading through the back end of '16 is the first time we'll be able to show real measurable progress down there in Brazil."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","So how much do you think you can reduce your receivables from Brazil in 2016 versus how much did you reduce it in 2015?",24,"So how much do you think you can reduce your receivables from Brazil in 2016 versus how much did you reduce it in 2015?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","We will certainly reduce it more in '16 than we did in '15. We did reduce it in Brazil in 2015 but not by a huge amount. So we definitely expect to make more progress on that in '16.",39,"We will certainly reduce it more in '16 than we did in '15. We did reduce it in Brazil in 2015 but not by a huge amount. So we definitely expect to make more progress on that in '16."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Analysts","Okay. And one last one if I may, could you talk about the protein demand in China? Are you seeing that improving or the decline when the price of milk and whey was really high has not recovered yet?",39,"Okay. And one last one if I may, could you talk about the protein demand in China? Are you seeing that improving or the decline when the price of milk and whey was really high has not recovered yet?"
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","Rosemarie, it's Eric. We are seeing -- continue to see in China a dairy market that's fairly, on a growth basis, flat to down. We saw a big swing in our sales last year due to a correction in inventories for our colloidal products into that market, into s",89,"Rosemarie, it's Eric. We are seeing -- continue to see in China a dairy market that's fairly, on a growth basis, flat to down. We saw a big swing in our sales last year due to a correction in inventories for our colloidal products into that market, into some of the plant-based beverages, such as peanut milk. That's worked its way off. And the underlying demand is coming through. But that demand is fairly flat. We saw a modest growth ourselves. The overall market, however, is flat to down."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Executives","That's all the time we have for the call today. I want to thank everyone for joining us. I'll be available to address any additional questions you may have. Thank you. Have a good day.",36,"That's all the time we have for the call today. I want to thank everyone for joining us. I'll be available to address any additional questions you may have. Thank you. Have a good day."
28606,321466580,932243,"FMC Corp., Q4 2015 Earnings Call, Feb 11, 2016",2016-02-11,"Earnings Calls","FMC Corporation","Operator","And again, that is all the time we have for today. This concludes the FMC Corporation Fourth Quarter 2015 Earnings Release Conference Call. Thank you.",25,"And again, that is all the time we have for today. This concludes the FMC Corporation Fourth Quarter 2015 Earnings Release Conference Call. Thank you."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the First Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli,",41,"Good morning, and welcome to the First Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning everyone. Welcome to FMC Corporation's first quarter 2016 earnings call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Office",280,"Thank you, and good morning everyone. Welcome to FMC Corporation's first quarter 2016 earnings call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer. Pierre will begin the call with a review of FMC's first quarter performance and discuss the outlook for Q2 and the full year 2016. Paul will provide an overview of select financial results. 
The slide presentation that accompanies our results along with our earnings release and 2016 outlook statement are currently available on our website. The prepared remarks from today's discussion will be made available at the conclusion of the call. 
Following the prepared remarks, we will be joined by Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, to address your questions. 
Before I turn the call over to Pierre, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors including, but not limited to, those factors identified in our release and in our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based on these risks and uncertainties. 
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms as well as other non-GAAP financial terms, to which we may refer during today's conference call, are provided on our website. 
With that, I will now turn the call over to Pierre"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian, and good morning, everyone. 2016 marks the beginning of a new era for FMC. Today, FMC is a more focused and streamlined company. Our businesses operate in attractive end markets namely Agriculture, Nutrition, Pharmaceuticals and Lithium.",2757,"Thank you, Brian, and good morning, everyone. 2016 marks the beginning of a new era for FMC. Today, FMC is a more focused and streamlined company. Our businesses operate in attractive end markets namely Agriculture, Nutrition, Pharmaceuticals and Lithium. The actions we have taken over the past 18 months have aligned our operation with regional market demand and positioned each of our businesses to better capitalize on market opportunities. With our transformation complete, we are now solely focused on the execution of our strategy to drive pro forma in 2016 and beyond.
In Agricultural Solutions, we continue to see the benefits of the Cheminova acquisition. Prior to the acquisition, Ag Solutions was very much an American business. In 2014, more than 3 quarters of its revenues were generated in North and South America. Cheminova significantly increased the size of Ag Solutions operations in Europe and Asia, bringing greater scale and market access to Ag Solutions operations across our region. The increased global sale of operations, combined with actions we have taken in North and South America, will bring greater original bounds to Ag Solutions, aligning our operations with the global crop protection chemical market and limit Ag Solutions' reliance on any one region or market to drive performance.
For example, in 2014 almost 40% of Ag Solutions' revenue was generated in Brazil alone. In 2016, we expect Brazil to account for less than 20% of segment revenue and only 15% of total company revenue. 
Across the global ag market, conditions in the Americas remain the most challenging. With greater scale and regional balance, FMC is able to better manage our business in the Americas to address market conditions. Specifically, we researched an operation in Brazil to align the size of our business with market conditions and rationalize our product offering to increase our focus on higher margin, proprietary technology platforms and differentiated products. While these actions reduce our revenues in Brazil, they improved the quality of our operations and enhanced the potential to deliver higher earnings and return on capital.
In North America, we are supporting customer inventory draw downs to more closely match our sales with underlying grow our demand, an important step to further strengthen FMC's position from which to protect price and terms. Cheminova also expanded our product portfolio and technology pipeline and provided the opportunity to realize meaningful cost savings. We are already seeing the benefits of our expanded product portfolio in North America and Europe and the integration of Cheminova is progressing well. We remain on track to deliver the full run rate cost savings of $140 million to $160 million by the middle of 2017.
In Health and Nutrition, global demand for FMC's naturally derived ingredients product lines continue to be robust and we remain focused on maintaining the business' high margins through the implementation of manufacturing excellence program, process technology improvements and product differentiation.
In Lithium, we are seeing the benefits of our strategy to focus and grow FMC's business in the technology-driven specialty end market where demand continues to climb and pricing trends across FMC's portfolio remain favorable. I will discuss the performance of each of our businesses shortly and provide an update on our outlook for Q2 and the full year.
First, I will start with a brief review of FMC's consolidated reported results on Slide 2. FMC reported first quarter revenue of approximately $799 million. Adjusted EPS of $0.58 [ph] for the quarter was flat compared to the first quarter of 2015 but was towards the top end of our organic range as a solid performance in Ag Solutions and a very strong quarter for Lithium drove the results.
Turning now to Ag Solutions on Slide 3. Ag Solutions reported revenue of $546 million, a decline of 22% compared to pro forma results for the first quarter of 2015 has lower sales volume in North America and Brazil due to high channel inventories, planned product rationalization and currency headwinds more than offset the impact of price increases, revenue synergies and new product introductions in the quarter.
As I mentioned previously, we are focused on executing our strategy to drive improved performance. This includes completing the process of rationalizing the Ag Solutions product portfolio that began in 2014. The actions we took to eliminate certain products from our portfolio reduced revenue by approximately $30 million or 4% compared to pro forma revenue for Q1 2015.
However, as discussed in prior quarters, this product rationalization has a limited impact on segment earnings. We also remain focused on pricing discipline. At the operating earnings level, price increases implemented in Brazil more than offset the year-over-year impact of the weaker real. However, the broad-based strength of the U.S. dollar resulted in headwinds in Europe and Asia that are only partially offset by price increases.
Despite challenging market conditions, the Ag Solution business delivered segment earnings of $82 million, ahead of the midpoint of organic and maintain operating margins year-over-year on a pro forma basis. 
I will make a few additional comments regarding regional market conditions and Ag Solutions' performance now on Slide 4. Overall market conditions and our performance in the quarter were very much as expected. In North America, as we discussed on our Q4 earnings call back in February, the deterioration in farm incomes over the past year, combined with elevated channel inventory levels led distributors and growers to delay purchases of agricultural foods, including crop protection chemicals. We determined it was critical to maintain price and payment terms in North America this season. And as part of our strategy to achieve these, we believe it was important to allow the level of FMC product inventory in the sales channel to reduce. Our decision to allow FMC product inventory in the sales channel to be drawn down was the main factor behind the 35% decline in revenue in North America in the quarter compared to pro forma revenue for the first quarter 2015.
However, we anticipate full year revenue performance for Ag Solutions in North America will be largely in line with the broader North America crop protection market as the action we are taking today will facilitate increased sales in the second half of the year. In fact, the dollar we are seeing give us increased confidence that our approach to managing Ag Solutions business in North America will help protect price and terms in 2016.
Despite lower sales into the channel, FMC continues to gain market share when looking at growers' use of products. Based on independent data, application of FMC products or products on the ground rose 7% in the quarter compared to Q1 2015. In particular, we continue to see strength in FMC's authority brand pre-emergent herbicides, which address a growing number of soybean acres which exhibit glyphosate resistance. As a result, we are confident the reduction in revenue in Q1 is due more to a decision as went-to-sell than it is in any change in underlying demand for FMC products. And it is this strong good demand for FMC's portfolio of technical products which will ultimately provide the support of pricing and terms that we are focused on.
In addition, we continue to see demand by growers for new innovative and differentiated products that provide high-value end use. Recent product launches in FMC and the introduction of our expanded fungicide product offering as a result of the Cheminova acquisition received strong support from growers and distributors in the quarter. We also saw strong acceptance of our new biological and seed [ph] product combinations, including brand such as capturing VGR and [indiscernible]. 
In Latin America, revenue declined approximately 25% compared to the first quarter of 2015. Lower demand and planned product rationalizations in Brazil more than offset increased sales volume in the rest of Latin America.
Excluding this portfolio rationalization, sales in Latin America declined approximately 15% in line with the overall market. Market conditions in Brazil were a little changed from the fourth quarter of 2015. Channel inventory levels have improved but remain elevated, most notably in soybean insecticide in the northern states. However, we are seeing an increase in demand in the north for insecticide, such as FMC's Talisman [ph] to address pressure in soybean. 
In Southern Brazil, market conditions are improved, especially in sugarcane and certain niche crops such as coffee and [indiscernible]
We continue to remain disciplined on pricing in Brazil. As we have explained previously, greater stability in the Brazilian real to U.S. dollar exchange rate supports price increase to offset FX headwinds. Paul will comment further on the impact of foreign currencies later in the call. 
Outside of Brazil, we continue to see increasing demand for pre-emergent herbicides in Argentina and products for niche crops in Colombia and Mexico. In Argentina, we see improved conditions with far fewer restrictions on imports and with the leasing of export taxes for key crops. 
In Europe, sales declined approximately 11% as foreign exchange headwinds and lower market volume more than offset commercial synergies from the Cheminova transaction and new product launches in the quarter. A cold snap at the end of the winter impacted the season in certain Western European markets, and we have seen some tightening of demand by growers in an attempt to control costs in the face of persistently below grain prices. Strong demand in Central and Eastern Europe and FMC's transition to Cheminova's direct market access model in Europe partially offset the pullback in market activity in the quarter.
Sales volumes across Europe increased for FMC's legal portfolio, including herbicides and insecticides for [indiscernible]. With the benefits of a broader combined portfolio, we believe the business is well-positioned to address market demand in key crops, including [indiscernible] and all [indiscernible].
Profitability in the region improved meaningfully year-over-year as the move to direct market access, combined with other cost savings from the Cheminova integration, increased operating margins in Europe by about 200 basis points. 
In Asia, we saw increased demand in China and Australia. However, the stronger U.S. dollar combined with planned product rationalization and poor weather in India and Southeast Asia resulted in a 13% decline in pro forma revenue compared to the prior year quarter. Excluding the impact of currency and planned product rationalization, revenue decreased about 3% driven largely by lower sales volume in India.
Globally, we expect the challenging market conditions to persist for the remainder of the year. As previously stated, we believe the global crop protection chemicals market will decline by a mid- to high-single-digit percentage in 2016 on a U.S. dollar basis driven largely by market conditions in North America and Brazil.
We remain highly focused on decreasing FMC product inventory levels in the channel, holding on price in turn and increasing collections of accounts receivable. 
Our full year guidance for Ag Solutions remains unchanged. We continue to forecast full year revenue of between $2.3 billion and $2.5 billion and full year segment earnings in the range of $380 million to $420 million. In the second quarter, we expect to deliver segment earnings in the range of $90 million to $110 million, along with sequential margin improvement as we move toward the main selling season in North America and Europe. 
Turning next to Health and Nutrition on Slide 5. First quarter performance for Health and Nutrition was broadly in line with expectations. The business reported revenue of $192 million and segment earnings of $47 million. First quarter 2016 revenue declined approximately $19 million compared to the first quarter of last year. 
As discussed on our fourth quarter earnings call, last year's first quarter revenue included certain omega-3 sales which were not expected to occur in 2016. These sales relate principally to pharmaceutical API products and account for a decline in the revenue compared to the prior year period.
Excluding these sales volume and impact of currency, revenue was essentially flat compared to last year. 
Global demand for FMC's Health excipient products continues to grow, resulting in higher sales volume of minor and [indiscernible] products in the quarter. However, lower sales in functional health due to timing and a more competitive omega-3 pricing environment broadly offset the increase in health excipient revenue. 
For the first quarter 2016, Health and Nutrition reported segment earnings of $47 million while lower operating costs resulted in an increase in segment earnings margin to 24.6%. Looking forward, we continue to expect full year revenue in the range of $775 million and $825 million, and segment earnings of between $198 million and $208 million, driven principally by continued growth and demand for MCC-based health excipients and nutritional ingredients in North America and Asia and lower operating cost from ongoing manufacturing excellence program and process technology improvement. 
We expect Health and Nutrition second quarter segment earnings of between $49 million and $53 million with a sequential improvement in segment earnings margin in the quarter.
Turning to Lithium on Slide 6. Lithium delivered an outstanding quarter. Compared to the first quarter of 2015, revenue increased 8% to $60 [ph] million and segment earnings almost threefold to $14.9 million. Segment's operating margin climbed from under 10% last year in Q1 to almost 25% this quarter. These results reflect the impact of our strategy to focus on the downstream specialty markets. 
As a result of our advantaged process technology and ability to manage sales mix, FMC is uniquely positioned to serve the higher growth and higher-value specialty segments while maintaining the flexibility to take advantage of favorable market conditions in lithium carbonate and chloride.
Demand trends across specialty end markets remain strong. Demand for lithium hydroxide for energy storage and electric vehicle, or EV applications, continues to grow at double-digit rates. Our success in increasing throughput from our existing hydroxide asset allow FMC to deliver higher sales volume in the quarter. In addition, we managed our production mix in order to optimize our sales of butyllithium and high-purity lithium minerals. 
Favorable market conditions supported price increases across the FMC portfolio. We continue to realize price increases for lithium hydroxide while our approach to the carbonate and chloride markets is allowing us to achieve meaningful price increases from the limited sales volume. The extent to which carbonate and chloride prices remain elevated will depend on how quickly new supply comes online. We expect market supply of all product to remain tight in the near to midterm.
Lower operating cost coupled with higher specialty sales volume and price increases resulted in significant increases in segment earnings and margins in the quarter. Manufacturing efficiencies from ongoing process improvement initiatives and lower cost associated with the natural gas pipeline installed in 2015 reduced operating costs by more than $5 million year-over-year, helping to drive the increased operating margin in the quarter. 
We expect the second quarter to be another strong period for the Lithium business. We continue to shift our sales mix to grow our specialty product line, serving markets such as [indiscernible] and polymers while capitalizing on favorable market conditions in lithium carbonate. However, we expect to have slightly lower available carbonate volumes in Q2 compared to Q1, as a result of lower seasonal production in Argentina.
Consequently, we expect quarter segment earnings to be in the range of $10 million to $14 million and segment earnings margin in the range of 19% to 20%. Based on Lithium performance to date and our expectation for the remainder of 2016, we are raising our full year outlook for the Lithium business. We now expect full year revenue to be between $245 million and $265 [ph] million and segment earnings to be in the range of $43 million to $53 million, up $10 million from the prior range. 
Moving next to our outlook for the second quarter and full year 2016 on Slide 7. I previously commented on the outlook for each business for both Q2 and the full year. As I mentioned, we are maintaining segment earnings guidance for the full year for both Ag Solutions and Health and Nutrition. Segment earnings guidance for the second quarter reflect normal earnings level for these businesses based on our expectation for 2016. We are increasing the full year segment earnings guidance for Lithium as stated earlier. 
On a consolidated basis, we are increasing full year 2016 adjusted earnings per share by $0.05 versus previous guidance to a range of $2.55 to $2.85, and we expect second quarter 2016 adjusted earnings to be between $0.62 and $0.72 per share. 
I will now turn the call over to Paul to discuss select financial results, including taxes, foreign exchange and cash flow."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thank you very much, Pierre. As usual, I'll start with the income statement and specifically the tax rate. Our adjusted effective tax rate fell from 27.5% in the first quarter 2015 to 26% in Q1 '16. Part of this was the continued change in the mix of our",737,"Thank you very much, Pierre. As usual, I'll start with the income statement and specifically the tax rate. Our adjusted effective tax rate fell from 27.5% in the first quarter 2015 to 26% in Q1 '16. Part of this was the continued change in the mix of our earnings away from the U.S. and Brazil and towards Europe and Asia where rates are typically lowered. We continue to take steps to increase our tax efficiency and expect that the full year rate will come in somewhere in the 24% to 26% range. 
A theme in our earnings in recent quarters has been the impact of foreign currency movements, and the movement in the Brazilian real has been a particular area of focus. In the first quarter, the average rate of the reais the dollar was 3.9 [ph], significantly weaker than 2.87 [ph] average the same quarter a year ago. However, the total impact on our earnings was far less than we have seen in prior quarters for 2 main reasons. First, as you know, Q1 is not a large selling quarter for us in Brazil, reducing the impact of currency movement. Also, since we have not seen particularly volatile movements in the currency, our price list has been able to reflect the new currency levels for the entire quarter. As a result, the $13 million headwinds created by the weaker reais year-on-year was completely offset by price increases. In fact, the positive impact of the weaker real on our cost base and of the change in the real was actually enough positive driving constraint in Q1. 
Looking to the rest of the work, although a number of Asian currencies collectively reduced earnings, the only major currency we faced headwind in the quarter was the euro, which devalued by 2% versus the same period last year. The net hit for operating earnings from currency movements in the quarter was approximately $14 [ph] million. 
A second common theme of our earnings has also been the challenges of operating in Argentina, including areas such as import licenses restrictions, negative impacts of export duties and the headwind created by the disconnect between cost inflation and the pace of devaluation of peso against the dollar. Since the election of [indiscernible] as President, we have seen a rapid shift in all of these areas, to the benefits of our operations in Ag Solutions and especially Lithium. The devaluation of the peso had a relatively limited impact in our earnings in the quarter in Lithium since the lower cost of operations takes 1 to 2 quarters to work its way out of inventory and into the income statement. And our earnings guidance for 2016 reflect this lower cost of operations. We remain cautiously optimistic that the business environment in Argentina will remain positive and will continue to create opportunities for FMC. 
Turning to the balance sheet and cash flow on Slide 8. Q1 is historically the period in which we consumed the most cash given the seasonal nature of our Ag business. However, discipline around spending, the increased focus last year on sales terms, and of course the ongoing collection measures globally resulted in an improvement of operating cash flow of over $100 million compared to the same quarter last year. Cash flow was helped by higher EBITDA and a better performance around working capital, most notably from collection of receivables. This improvement was seen in all regions. 
With certain cash outflows, particularly capital spending and pension expenses also lower than last year, we were able to hold net debt flat during the quarter. As noted in our filing of March 28, we elected to amend the debt covenants for our term loan and revolver, defering the timing of step downs of our leverage ratios such that we retained the covenant limit of 4.5x for Q1. Our actual leverage ratio under the covenant calculation was 4.0x given the half turn of headwind that we considered to be prudent. 
Looking to the rest of the year, adjusted cash from operations is forecasted in the range of $450 million to $550 million, an improvement over last year of over a third at the midpoint of the range. This is driven by improvements in both EBITDA and working capital performance. Capital expenditure will remain broadly flat to 2015 in the $120 million to $140 million range.
And with that, I will turn the call back to Pierre."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Paul. To conclude, we continue to expect the challenging market in Ag Solutions, but we are managing the business to increase visibility and to protect both price and terms. As a result, we continue to expect full year earnings to be in line wi",105,"Thank you, Paul. To conclude, we continue to expect the challenging market in Ag Solutions, but we are managing the business to increase visibility and to protect both price and terms. As a result, we continue to expect full year earnings to be in line with prior guidance. 
The Health and Nutrition is performing largely in line with expectations and Lithium is well ahead over initial forecast. The portfolio transformation is done. We are now in execution mode, targeting year-over-year earnings growth for each of our 3 businesses. 
Thank you your attention. And I will now turn the call back to the operator for questions."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] And our first question comes from Christopher Parkinson from Crdit Suisse.",13,"[Operator Instructions] And our first question comes from Christopher Parkinson from Crdit Suisse."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","You mentioned in your presentation that Central and Eastern Europe were showing solid demands. But can you comment on the pricing landscape given the FX headwinds there as well, and whether or not you're going to offset that? And then also on the demand f",77,"You mentioned in your presentation that Central and Eastern Europe were showing solid demands. But can you comment on the pricing landscape given the FX headwinds there as well, and whether or not you're going to offset that? And then also on the demand front, do you believe the growth is simply driven by the market or do you believe there is any benefit from adding the FMC portfolio to the legacy Cheminova One in the region?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think on the Central and Eastern Europe, the pricing is pretty stable and it's not a very, very large market. Interesting for us because there is a strong possibility to increase volume. But pricing is quite stable. And I think, definitely, the growth i",98,"I think on the Central and Eastern Europe, the pricing is pretty stable and it's not a very, very large market. Interesting for us because there is a strong possibility to increase volume. But pricing is quite stable. And I think, definitely, the growth is one of the place where FMC had no structure in Central and Eastern Europe, where it was an area of focus for Cheminova. So definitely, a place where using the infrastructure and commercial organization from Cheminova and bringing in the product portfolio for FMC is going to create some significant opportunities for us."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Perfect. And just kind of a tangent question to that one. Given the progression of cost savings, with Cheminova clearly going well, can you just comment on the other geographies as far as intermediate to long-term and revenue synergies, inclusive of the U",53,"Perfect. And just kind of a tangent question to that one. Given the progression of cost savings, with Cheminova clearly going well, can you just comment on the other geographies as far as intermediate to long-term and revenue synergies, inclusive of the U.S. and then also in Latin America with Argentina in particular?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Chris, this is Mark. We've talked about North America in the past. In the U.S., we're seeing very good synergies with the fungicide portfolio from Cheminova going through our distribution network. In Latin America, obviously brazil in the South, we're see",120,"Chris, this is Mark. We've talked about North America in the past. In the U.S., we're seeing very good synergies with the fungicide portfolio from Cheminova going through our distribution network. In Latin America, obviously brazil in the South, we're seeing increased sales through co-ops where we've made decisions which co-ops and which distribution will go through. Argentina certainly very beneficial for us. Obviously we have a bigger footprint there now. We have the right products for the soy market, so we're expecting to see growth in Argentina. And then in other parts of Latin America, I would say obviously Mexico, Colombia are 2 countries that we're focused on and we're seeing very good synergies in Colombia on these crops."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think when we did the last earnings call as well as multiple discussions we all had, we've been talking about this year getting to $100 million -- $50 million to $100 million run rate in between the synergies and the new products and very much on track",79,"I think when we did the last earnings call as well as multiple discussions we all had, we've been talking about this year getting to $100 million -- $50 million to $100 million run rate in between the synergies and the new products and very much on track with that. So it is a place. I think, the opportunities created by Cheminova from a cost saving and the revenue synergies are very much in line with what we're expecting."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Your next question comes from the line of Frank Mitsch with Wells Fargo Securities.",14,"Your next question comes from the line of Frank Mitsch with Wells Fargo Securities."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, when you were talking about the ag business, you were talking about some positives with respect to the glyphosate resistance in terms of providing a boost. I was wondering if there was a way for you to kind of quantify it? And in terms of where yo",80,"Pierre, when you were talking about the ag business, you were talking about some positives with respect to the glyphosate resistance in terms of providing a boost. I was wondering if there was a way for you to kind of quantify it? And in terms of where you see that over the next 18 months or so? And then what sort of concerns may you have about some new technologies that Monsanto and others are rolling out in that area?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Frank, it's Mark. When you look at glyphosate resistance, we are really talking about the U.S., Argentina as the 2 big markets. I think you know that through our authority brands based upon sulfentrazone, we've had great success in the pre-emergent area i",123,"Frank, it's Mark. When you look at glyphosate resistance, we are really talking about the U.S., Argentina as the 2 big markets. I think you know that through our authority brands based upon sulfentrazone, we've had great success in the pre-emergent area in both of those countries. I expect that to continue. There will be some headwinds with new technologies coming in. But I think to offset that, we still see more ways to get in resistance in glyphosate and more acres and increasing especially in Argentina. It wouldn't surprise me if we don't start to see that in the next few years start to develop in Brazil as well and we're already positioning our brands in Brazil on soy for that area."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Okay. That's very helpful. And as you think about some of the combinations coming -- some of the major combinations in the ag chemical world coming over the next 12 months or less, how do you see yourselves perhaps participating and picking up some pieces",61,"Okay. That's very helpful. And as you think about some of the combinations coming -- some of the major combinations in the ag chemical world coming over the next 12 months or less, how do you see yourselves perhaps participating and picking up some pieces there? What's the interest level? Can you talk about your participation in the industry consolidation here?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Well, Frank, as you know, we made a move which was in line with what was our strategic intent by acquiring Cheminova. We have now a stable situation from a structural standpoint in Ag. We're finishing up on the integration. What we intend to do at this st",164,"Well, Frank, as you know, we made a move which was in line with what was our strategic intent by acquiring Cheminova. We have now a stable situation from a structural standpoint in Ag. We're finishing up on the integration. What we intend to do at this stage is watch what is happening specifically in places when 2 ag companies are coming together. So every time there will be consolidation of ag companies, if at any point during this process, there is -- because of [indiscernible] reasons, products which are made available, that is something we are very good in doing, which is taking a product and commercializing that with our own sales organization. So we're going to be opportunistic. But it's certainly something we will be able to afford to do and we'd be very interested in doing. Beyond that, do not expect us making any major move in acquiring any type of company. It will be an acquisition of technology and products."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Daniel Jester with Citigroup.",12,"Our next question comes from the line of Daniel Jester with Citigroup."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Maybe a couple of questions on Lithium. Price mix was a 4% benefit in the quarter. But by some kind of spot measures, looking at prices were much higher. So can you just kind of elaborate as how we should be thinking about pricing, kind of commodity and y",61,"Maybe a couple of questions on Lithium. Price mix was a 4% benefit in the quarter. But by some kind of spot measures, looking at prices were much higher. So can you just kind of elaborate as how we should be thinking about pricing, kind of commodity and your spot sales versus the contract market as we continue throughout the year?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes. If you think about our Lithium business, look at strategic price increase in place where we are technologically advantaged in grain markets where we have significant contract, which we revenue every year, like in lithium hydroxide. And then think abo",181,"Yes. If you think about our Lithium business, look at strategic price increase in place where we are technologically advantaged in grain markets where we have significant contract, which we revenue every year, like in lithium hydroxide. And then think about on the chloride and carbonate side for what is not used for internal purposes or sold in the contract, we are using the spot market to do one-off price increase. We believe that situation is going to carry on for the next few quarters. I think the market will remain tight, which will allow us to use the spot market in the more community businesses like chloride and carbonate to increase price on a spot basis. And where we are with opportunities, where people need our technology or products, we would be increasing price on contract and contract are being renewed. It is a situation which we see fairly, fairly stable for the future. If you look at our increase in guidance for the Lithium business, most of it is -- of the over performance will be due to pricing."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then just sticking with Lithium, you commented that you think the outlook is going to be tight in the near to medium term. Can you just flesh out a little bit about what's your expectations are for supply additions over the coming years?",45,"Okay. And then just sticking with Lithium, you commented that you think the outlook is going to be tight in the near to medium term. Can you just flesh out a little bit about what's your expectations are for supply additions over the coming years?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Well, I cannot comment too much beyond what all of you know on the lithium carbonate side because that's the decision of the people who have announced capacity increase. So I'm sure [indiscernible] when they talk on their earnings will be able to tell mor",111,"Well, I cannot comment too much beyond what all of you know on the lithium carbonate side because that's the decision of the people who have announced capacity increase. So I'm sure [indiscernible] when they talk on their earnings will be able to tell more about the timing. But we believe [indiscernible] will be [indiscernible] and we believe also some Chinese or Asian company will be bringing carbonate capacity in the next couple of years. We, ourselves, are focused more on the downstream and we will bring, in time, and we'll bring more detail in the weeks to come, but we'll be focusing more on increasing lithium hydroxide capacity as needed."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","And next, we'll go to Mike Harrison of Seaport Global.",10,"And next, we'll go to Mike Harrison of Seaport Global."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, if we could just continue on the Lithium front. I was, I guess I was just surprised to see that you put up $15 [ph] million a quarter in Lithium and your guidance was only calling for $43 million to $53 million for the full year. What's going to c",78,"Pierre, if we could just continue on the Lithium front. I was, I guess I was just surprised to see that you put up $15 [ph] million a quarter in Lithium and your guidance was only calling for $43 million to $53 million for the full year. What's going to change during the remainder of the year that would suggest that earnings could be lower than the Q1 level as we get through the rest of the year?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I'll ask Paul to comment with me. But as we said on the script, remember there are seasons in terms of manufacturing in Lithium and we are getting into a period where, which is the winter part of the season. And we're going to have more rain and more snow",160,"I'll ask Paul to comment with me. But as we said on the script, remember there are seasons in terms of manufacturing in Lithium and we are getting into a period where, which is the winter part of the season. And we're going to have more rain and more snow and conditions, which are going to limit more, to some extent, our production of carbonate. So what we're expecting in the next 3 quarters is less carbonate available because of our manufacturing, like most people operating in this part of the world in the next couple of quarters. On the quantitative side, our costs continue to be good and our pricing will be positive. So it's a differential between all of these which create maybe a little bit or less of a novel performance in the remaining 3 quarters than we had in the first quarter. I don't know if you want to add anything in terms of this."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think if you look historically at the earnings, the seasonality has been there. We're doing what we can to reduce volatility, but that seasonality is going to remain where the first and fourth quarter give us the most volume and flexibility on the mix w",48,"I think if you look historically at the earnings, the seasonality has been there. We're doing what we can to reduce volatility, but that seasonality is going to remain where the first and fourth quarter give us the most volume and flexibility on the mix we can sell."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","And then as I think about some of the lithium carbonate that you're actually purchasing to convert to hydroxide, are you experiencing higher raw material cost for that or do you have lower prices locked in for the year and you're actually getting a margin",55,"And then as I think about some of the lithium carbonate that you're actually purchasing to convert to hydroxide, are you experiencing higher raw material cost for that or do you have lower prices locked in for the year and you're actually getting a margin benefit for some of that raw material you're purchasing?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes, first, as you know, most of the carbonate by a long shot we use is produced by us. So what we are buying under contract today versus the overall usage is incremental and what we are buying is lost under a long-term supply agreement. So we are not fac",181,"Yes, first, as you know, most of the carbonate by a long shot we use is produced by us. So what we are buying under contract today versus the overall usage is incremental and what we are buying is lost under a long-term supply agreement. So we are not facing significant price increases. In fact if it plays the way we expect it to play and once again, is going to have to be confirmed, but the way we look at it is for now, we are producing enough carbonates and buying enough to run our strategy around chloride, butyllithium, metal and hydroxide. And as time will go, we're going to have to sell more hydroxide. We're going to have to increase our capacity in hydroxide and we'll have to buy more of carbonate on the Exxon [ph] market, which should be at a time when our peer company will be increasing capacity and making the product more available in the market. So it looks like all of this is falling in place quite well. Sam, you want to add something?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thanks for the question. Pierre has it down well. The other thing will look at always is the incremental things we can do in Argentina. And there are small opportunities for small capital to increase our throughput in Argentina, which gives us some flexib",48,"Thanks for the question. Pierre has it down well. The other thing will look at always is the incremental things we can do in Argentina. And there are small opportunities for small capital to increase our throughput in Argentina, which gives us some flexibility as we go forward."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","So right now, I would say there is no major issue around potential increase in the future of cost in terms of our ability to execute our strategy around carbonate and hydroxide.",32,"So right now, I would say there is no major issue around potential increase in the future of cost in terms of our ability to execute our strategy around carbonate and hydroxide."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Next, we'll go to the line of Mike Sison with KeyBanc.",11,"Next, we'll go to the line of Mike Sison with KeyBanc."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, when you think about -- you didn't change your outlook for crop protection markets this year. I understand, it's still difficult out there. But it does sound like you're feeling better about the integration and maybe the long-term potential. Can y",57,"Pierre, when you think about -- you didn't change your outlook for crop protection markets this year. I understand, it's still difficult out there. But it does sound like you're feeling better about the integration and maybe the long-term potential. Can you maybe map out where Ag Solutions income can go over time as hopefully things recover?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes, let me -- I'll tell you the way we look at Ag Solutions right now. First, let me talk about the ag market as we see it for this year. I think we are not changing our view for 2016. We still believe it's a mid-to-high single digit downmarket, mostly d",434,"Yes, let me -- I'll tell you the way we look at Ag Solutions right now. First, let me talk about the ag market as we see it for this year. I think we are not changing our view for 2016. We still believe it's a mid-to-high single digit downmarket, mostly driven by North America and Brazil in the high teens, and maybe Asia and Europe -- in the high single-digit, while Europe and Asia would be in the low to mid-single-digit decrease. So we are not changing our view. It could be maybe trending more toward the high single-digit overall global market. The way -- and why do I feel better about the way we are operating in the ag market? It is not because we are seeing a fundamental change in the market in the short-term. But what I think we are doing at FMC, I think the key difference is that we know better how to operate in this type of market. I can tell you, we see it on our number, we are not fighting to keep market share on sales of product. We are much more looking at 3 types of objectives. First, it's very important for us and focusing only on FMC project is to decrease FMC product in the channels. The second aspect is we want to be able by doing that to focus more on the quality of the sales, which is more term, price and collection. And then, looking at all of that, the objective is to align more sales with a normal demand pattern. You see that on the numbers in Q1 in North America. Sales down 35%, I think, on Slide 4, while product on the ground were up above market, 7%. So the way we are operating in the market today, I believe we have more control over our selling process than we might have had in the past when we got hit by the downturn. Beyond that, I would say -- I would not exclude the market to turnaround in 2017, but I have no indicators telling me that it will be the case. I think we are much more focused, Mike, on operating under the current conditions with very high control on term, price, managing very closely with -- in partnership with the customers, our inventory, to create much more predictability in our sales. So that's why the developed level of confidence for me is increasing at this stage. Market turnaround, I think we'll have to wait a little bit more to go into Q3, Q4 to have more visibility."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","I thought you said at current level where the real is at, is it going to be negative this year or is it a positive? I just want to make sure I understand your commentary around foreign currency there.",39,"I thought you said at current level where the real is at, is it going to be negative this year or is it a positive? I just want to make sure I understand your commentary around foreign currency there."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","You asked a million dollar question with the reais. The truth is the stability or the predictability of the movement of the real is really what matters. We talked about it in the past with regard to the timing of changes and the pace of changes. In Q1 and",244,"You asked a million dollar question with the reais. The truth is the stability or the predictability of the movement of the real is really what matters. We talked about it in the past with regard to the timing of changes and the pace of changes. In Q1 and Q2, just aren't periods in which we have a lot of commercial activity going on in Brazil. So it really is what it does in Q3. And again it isn't so much the level -- we've shown that in Q1 where with an average rate of 3.9 [ph] today is closer to 3.5 [ph] we were able to still capture pricing on a limited number of sales we have in Q1. The question will come in Q3, how stable, how predictable is the real? In the rest of the world when you look at the forward curve of the currency, it does not feel like a strengthening dollar is what the market is expecting. And so that, generally speaking, is what's factored into our numbers relative predictability, not a big strengthening of the dollar around the world. Q1 feels like when you look at where the dollar is today compared to a year ago, Q1 compared to the last of the quarters that we had those tough FX comps. So subject to any changes away from where the market expects today doesn't feel like currency will be quite the high-level that it was last year."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Joel Jackson with BMO.",12,"Our next question comes from the line of Joel Jackson with BMO."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","You have really guided up your operating cash flow projections for the year at $50 [ph] million but raised your EBIT projections by about $10 million. Can you give us a sense where the big delta is coming in the operating cash flow? Is extremely increment",48,"You have really guided up your operating cash flow projections for the year at $50 [ph] million but raised your EBIT projections by about $10 million. Can you give us a sense where the big delta is coming in the operating cash flow? Is extremely incremental working capital?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Sure. It's a pretty straightforward story. We clearly have an increased expectation around EBITDA. But the truth is it's largely around working capital. And you have to bear in mind, if you look over the last few years, 2 years ago, we had a terrible perf",173,"Sure. It's a pretty straightforward story. We clearly have an increased expectation around EBITDA. But the truth is it's largely around working capital. And you have to bear in mind, if you look over the last few years, 2 years ago, we had a terrible performance with working capital with largely cash outflow. Last year, we turned out the corner and sort of stopped the bleeding and improved it a bit slightly. But this year, we expect that trend to continue so the working capital becomes a positive generator of cash flows. Our biggest focus is always going to be the Brazil receivables balance and getting that receivable balance down. We will also be very, very focused on inventory levels, our own inventory levels, and making sure we are very efficient and very thoughtful about what inventory we will, where we hold it, how much of it we hold. So it's coming in multiple different areas, but you should look at working capital the primary driver of increase in cash flow for 2016."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","I'm sorry if this is asked already, but the synergies of Cheminova $60 million, $70 million for the year, do you still maintain that? And maybe give us how much you think you can still get in 2017 versus prior guidance?",42,"I'm sorry if this is asked already, but the synergies of Cheminova $60 million, $70 million for the year, do you still maintain that? And maybe give us how much you think you can still get in 2017 versus prior guidance?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","How much more are we [indiscernible] 60 [ph], 60 [ph], 70 [ph] still a guidance?",15,"How much more are we [indiscernible] 60 [ph], 60 [ph], 70 [ph] still a guidance?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes, we are not changing -- actually, we have the same number. So the numbers we've been talking about 60 [ph], 70 [ph], are very well in line. And a full run rate of 140 [ph] to 160 [ph] getting into the middle of next year are also still the target. So",61,"Yes, we are not changing -- actually, we have the same number. So the numbers we've been talking about 60 [ph], 70 [ph], are very well in line. And a full run rate of 140 [ph] to 160 [ph] getting into the middle of next year are also still the target. So there is no change in our numbers right now."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Steve Byrne with BOA.",12,"Our next question comes from the line of Steve Byrne with BOA."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","I think you -- in the U.S. crop protection market, are you seeing any increase discounting or bundling by your competitors? And do you see any risk of perhaps maybe losing some shelf space in the retail channel from allowing your product inventories to be",46,"I think you -- in the U.S. crop protection market, are you seeing any increase discounting or bundling by your competitors? And do you see any risk of perhaps maybe losing some shelf space in the retail channel from allowing your product inventories to be trimmed?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think whenever you talk about terms and pricing, we want to be highly cautious and solely comment about what we do. Our strategy today is quite simple. We are highly focused on maintaining our pricing at a healthy level. We are very vigilant in terms --",264,"I think whenever you talk about terms and pricing, we want to be highly cautious and solely comment about what we do. Our strategy today is quite simple. We are highly focused on maintaining our pricing at a healthy level. We are very vigilant in terms -- as you know, balance sheet is always a key challenge for a company like ours. And more than ever, we are highly disciplined on terms and not giving terms. What it means for us, and only talking for FMC, what it means for us is certainly, we are prepared to see timing change in ourselves. And that's what I've been talking about. We're not being willing to do anything to push product in the market if there is not a complete need for this product by the market. Specials is a word we use a lot. But when you have technical product to be sold, most production know they are needed and then you have commercial contract of customers. It is not a situation where because we are aligning ourselves with the market demand that we are taking an enormous risk to see somebody taking our shelf space by the end of the year and us not being able to sell our products. For example, Mark talked about our authority product line. It's a pre-emergent product. It's required needs to be bought in Q4 and Q1. We know this product will be sold. I think our strategy might be a big differentiator, but we are only focusing on ours along the line of what we discussed before."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","And Pierre, considering your comment about authority, would you say that the outlook for eventual penetration of the XTEND and the Enlist soybean products, does that -- is that a risk to your authority franchise in the Americas? Or could you see that as p",66,"And Pierre, considering your comment about authority, would you say that the outlook for eventual penetration of the XTEND and the Enlist soybean products, does that -- is that a risk to your authority franchise in the Americas? Or could you see that as potentially an opportunity where you might expand your franchise and move more over-the-top and bring in formulations with either 240 and ICAMPA."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes. Steve, this is Mark. I've got a question earlier about how we thought it would be a headwind or tailwind. I think in the initial stages I expect rates to be reduced. Good news is we know it with Enlist and XTEND there would still be recommended use o",187,"Yes. Steve, this is Mark. I've got a question earlier about how we thought it would be a headwind or tailwind. I think in the initial stages I expect rates to be reduced. Good news is we know it with Enlist and XTEND there would still be recommended use of a pre-emergent herbicides of which authority is one of the market leaders. So we know we're going to have a substantial market there. I would say weed-resistant acres continue to grow, so we're going to see that pre-emergent continuing, certainly in the U.S. And as I said, earlier, in Argentina. I think from an over-the-top perspective, I mean, we have some very god products that we're going to be promoting, such as our cadet herbicide, which we think will be a great tank mix partner for those products and will offer a broader spectrum of control. Don't expect to see us into 4D and Dicamba. That's not the sort of business were going to be in. We're going to be in the more differentiated products, more highly specialized where we can bring value to the growers distribution."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Next, we'll go to the line of Mark Connelly with CLSA.",11,"Next, we'll go to the line of Mark Connelly with CLSA."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, the trend among food companies to reformulate to simplify is clearly getting faster. How much is that reformulation trend actually helping do you think? And do. You think about it as a tailwind?",34,"Pierre, the trend among food companies to reformulate to simplify is clearly getting faster. How much is that reformulation trend actually helping do you think? And do. You think about it as a tailwind?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think the food market for us, there is an acceleration of -- the way we look at our markets in attrition and in health are interesting. In health, the good news is when the year with a customer, you're there for a while because are not being reformulate",151,"I think the food market for us, there is an acceleration of -- the way we look at our markets in attrition and in health are interesting. In health, the good news is when the year with a customer, you're there for a while because are not being reformulated out. The problem with that is it's not easy to gain new business. Well, the same applies to food but to the reverse. I think there is a trend to reformulate transformation. There's a very fast cycle, which gives opportunities for us. So the stronger we are with a product, the more opportunities. But by the same for new product and competitors. So I would say, today, it would be slightly a tailwind knowing that we are the largest market shareholder and more complete product line. But I don't see that as major change from the [indiscernible] do you have any commentary?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","This is Eric, Mark. Eric Norris. We see this as a trend that has come and go in the industry. The industry is broad-based to Pierre's point. Unlike the health markets where there's very little change over periods of time, there's a great deal of change fr",146,"This is Eric, Mark. Eric Norris. We see this as a trend that has come and go in the industry. The industry is broad-based to Pierre's point. Unlike the health markets where there's very little change over periods of time, there's a great deal of change from every 2 or 3 years, whether it's low fat Atkins and now this simplification clean label phenomenon. It really does come down to the product line where we have, well-suited being all-natural based and then having the application capability to respond to them I nthe right places around the world, having spread of knowledge in the right places to the customers. So we're well-positioned for it. Anytime there's a reformulation, there's a challenge, right? So it does create in our part to respond. Going forward, we see the tailwind given the rest of our part when an application capabilities."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Eric, in Pierre's comments you talked about product differentiation. Can you talk about how you think about product differentiation?",19,"Eric, in Pierre's comments you talked about product differentiation. Can you talk about how you think about product differentiation?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Specifically in the food market?",5,"Specifically in the food market?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Sure. Yes.",2,"Sure. Yes."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","It all comes down understanding very well not only what's going on with your direct customer, the large food or small food company but consumers and being able to put together a formulation that meets the needs. So product differentiation for us is less a",121,"It all comes down understanding very well not only what's going on with your direct customer, the large food or small food company but consumers and being able to put together a formulation that meets the needs. So product differentiation for us is less about proprietary technology intellectual property patent that might drive more what happens in our ag business. More about the know-how be able to put some of the ingredients together that a specific need an understanding either color, texture or taste issues that might impact the success of that brand. So it really comes down to the differentiation around the application and the ingredients we bring as opposed to a proprietary ingredient in the food products itself."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Brett Wong with Piper Jaffray.",13,"Our next question comes from the line of Brett Wong with Piper Jaffray."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, you are talking about can of the overall crop chemical market and the focus that FMC is going to have in terms of working inventory down and being disciplined around pricing in terms. I just want to get a clarification if others are competitors ar",76,"Pierre, you are talking about can of the overall crop chemical market and the focus that FMC is going to have in terms of working inventory down and being disciplined around pricing in terms. I just want to get a clarification if others are competitors are not acting rationally, pushing product in the market when the product is not needed as you were saying. FMC is not going to be participating in that kind of activity?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Listen, I don't know what strategy our competitors are operating around market product discount and our rational, they intent to be. I think we made a decision and decision we made globally. We believe we are in a situation where the markets are such and",254,"Listen, I don't know what strategy our competitors are operating around market product discount and our rational, they intent to be. I think we made a decision and decision we made globally. We believe we are in a situation where the markets are such and the level of inventory in the channel are such, that you can't guide your activity by what the others are doing. I think we have is we're working very, very closely in cooperation with our customers who understand our strategy. I'm not going to sell in Q1 or Q2 or Q3 a product which is needed in Q4. And in exchange, we maintain a healthy pricing in current situation. And that's what we're going to be focusing. I believe what we're going to do this downturn. And here these turns around, we are not going to work hoping that the overall level of inventory in the market channel is going to go down. I think it's too tall of an order and too impractical. So we're going to be focused solely on FMC product. I think the number is quite spectacular. I think I said that many times, 34% sales down in the first quarter, North America plus 7% products on the ground, that is millions of dollars of inventory, which are outside of our customers inventory in which they will need to replenish when the market needs it. And that's the way we are operating. Our competitors will have to use the strategy which is appropriate for them."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then just focusing again on inventory. Obviously, in the quarter your inventories were significantly elevated due to the strategy that you're speaking of. Can you just talk about the timing that you expect to be able to work through that invento",78,"Okay. And then just focusing again on inventory. Obviously, in the quarter your inventories were significantly elevated due to the strategy that you're speaking of. Can you just talk about the timing that you expect to be able to work through that inventory along with what the channels going to be doing? And then ultimately, I think you said you expect improvements in the second half in North America, can you just talk a little bit about that?"
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think the way we look at it -- and there was a question before, I think it's Michael who asked that question, level of confidence in the market. I think our strategy today will allow us to have a more visibility in terms of the timing and level of our s",162,"I think the way we look at it -- and there was a question before, I think it's Michael who asked that question, level of confidence in the market. I think our strategy today will allow us to have a more visibility in terms of the timing and level of our sales because we become less dependent upon what the market is doing and rushing to place sales to be safe and have those on the shelves. So what it does to us, it creates more predictability and increase the level of confidence of how the quarters ahead of us are going to be unfolding. We know, I mean, we know, which product will be required, usually which technology will be required depending upon the season in Q4 and Q1 and Q2. And that's a discussion we have with our customers and that's the way we're operating right now. So it's giving us a bit more certainty on how things will unfold."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our last question comes from the line of Aleksey Yefremov of Nomura Securities. That was our last question. Please go ahead.",21,"Our last question comes from the line of Aleksey Yefremov of Nomura Securities. That was our last question. Please go ahead."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","That's all the time we have on the call today. I want to thank everyone for joining. I'll be available for the rest of the day to go through any questions. Again, thank you. Have a good day.",39,"That's all the time we have on the call today. I want to thank everyone for joining. I'll be available for the rest of the day to go through any questions. Again, thank you. Have a good day."
28606,330161312,970480,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","That's all the time we have for today. This concludes FMC Corporation First Quarter 2016 Earnings Release Conference Call. Thank you.",22,"That's all the time we have for today. This concludes FMC Corporation First Quarter 2016 Earnings Release Conference Call. Thank you."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the First Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli,",41,"Good morning, and welcome to the First Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning everyone. Welcome to FMC Corporation's First Quarter 2016 Earnings Call. Joining me this morning is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial",282,"Thank you, and good morning everyone. Welcome to FMC Corporation's First Quarter 2016 Earnings Call. Joining me this morning is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer. Pierre will begin the call with a review of FMC's first quarter performance and discuss the outlook for Q2 and the full year 2016. Paul will provide an overview of select financial results. 
The slide presentation that accompanies our results, along with our earnings release and 2016 outlook statement are currently available on our website. The prepared remarks from today's discussion will be made available at the conclusion of the call. 
Following the prepared remarks, we will be joined by Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, to address your questions. 
Before I turn the call over to Pierre, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors including, but not limited to, those factors identified in our earnings release and in our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based upon these risks and uncertainties. 
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms, as well as other non-GAAP financial terms to which we may refer during today's conference call, are provided on our website. 
With that, I will now turn the call over to Pierre"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian, and good morning, everyone. 2016 marks the beginning of a new era for FMC. Today, FMC is a more focused and streamlined company. Our businesses operate in attractive end markets namely agriculture, nutrition, pharmaceuticals and lithium.",2763,"Thank you, Brian, and good morning, everyone. 2016 marks the beginning of a new era for FMC. Today, FMC is a more focused and streamlined company. Our businesses operate in attractive end markets namely agriculture, nutrition, pharmaceuticals and lithium. The actions we have taken over the past 18 months have aligned our operation with regional market demand and positioned each of our businesses to better capitalize on market opportunities. With our transformation complete, we are now solely focused on the execution of our strategy to drive performance in 2016 and beyond.
In Agricultural Solutions, we continue to see the benefits of the Cheminova acquisition. Prior to the acquisition, Ag Solutions was very much an American business. In 2014, more than 3 quarters of its revenues were generated in North and South America. Cheminova significantly increased the size of Ag Solutions operations in Europe and Asia, bringing greater scale and market access to Ag Solutions operations across our region. The increased global scale of operations, combined with actions we have taken in North and South America, will bring greater regional balance to Ag Solutions, aligning our operations with the global crop protection chemical market and limit Ag Solutions' reliance on any one region or market to drive performance.
For example, in 2014, almost 40% of Ag Solutions' revenue was generated in Brazil alone. In 2016, we expect Brazil to account for less than 20% of segment revenue and only 15% of total company revenue. 
Across the global ag market, conditions in the Americas remain the most challenging. With greater scale and regional balance, FMC is able to better manage our business in the Americas to address market conditions. Specifically, we restructured our operation in Brazil to align the size of our business with market conditions and rationalize our product offering to increase our focus on higher-margin, proprietary technology platforms and differentiated products. While these actions reduced our revenues in Brazil, they improved the quality of our operations and enhanced the potential to deliver higher earnings and return on capital.
In North America, we are supporting customer inventory drawdowns to more closely match our sales with underlying grower demand, an important step to further strengthen FMC's position from which to protect price and terms. Cheminova also expanded our product portfolio and technology pipeline and provided the opportunity to realize meaningful cost savings. We are already seeing the benefits of our expanded product portfolio in North America and Europe and the integration of Cheminova is progressing well. We remain on track to deliver the full run rate cost savings of $140 million to $160 million by the middle of 2017.
In Health and Nutrition, global demand for FMC's naturally derived ingredients product lines continue to be robust and we remain focused on maintaining the business' high margins through the implementation of manufacturing excellence program, process technology improvements and product differentiation.
In Lithium, we are seeing the benefits of our strategy to focus and grow FMC's business in the technology-driven specialty end market where demand continues to climb and pricing trends across FMC's portfolio remain favorable. I will discuss the performance of each of our businesses shortly and provide an update on our outlook for Q2 and the full year.
First, I will start with a brief review of FMC's consolidated reported results on Slide 2. FMC reported first quarter revenue of approximately $799 million. Adjusted EPS of $0.58 for the quarter was flat compared to the first quarter of 2015 but was towards the top end of our guidance range as a solid performance in Ag Solutions and a very strong quarter from Lithium drove the results.
Turning now to Ag Solutions on Slide 3. Ag Solutions reported revenue of $546 million, a decline of 22% compared to pro forma results for the first quarter of 2015 as lower sales volume in North America and Brazil due to high channel inventories, planned product rationalization and currency headwinds more than offset the impact of price increases, revenue synergies and new product introductions in the quarter.  
As I mentioned previously, we are focused on executing our strategy to drive improved performance. This includes completing the process of rationalizing the Ag Solutions product portfolio that began in 2014. The actions we took to eliminate certain products from our portfolio reduced revenue by approximately $30 million or 4% compared to pro forma revenue for Q1 2015.  However, as discussed in prior quarters, this product rationalization has a limited impact on segment earnings. 
We also remain focused on pricing discipline. At the operating earnings level, price increases implemented in Brazil more than offset the year-over-year impact of the weaker real. However, the broad-based strength of the U.S. dollar resulted in headwinds in Europe and Asia that were only partially offset by price increases.
Despite challenging market conditions, the Ag Solutions business delivered segment earnings of $82 million, ahead of the midpoint of our guidance, and maintained operating margins year-over-year on a pro forma basis. 
I will make a few additional comments regarding regional market condition and Ag Solutions performance now on Slide 4. 
Overall market conditions and our performance in the quarter were very much as expected. In North America, as we discussed on our Q4 earnings call back in February, the deterioration in farm incomes over the past year, combined with elevated channel inventory levels, led distributors and growers to delay purchases of agriculture in foods, including crop protection chemicals. We determined it was critical to maintain price and payment terms in North America this season. And as part of our strategy to achieve these, we believe it was important to allow the level of FMC product inventory in the sales channel to reduce. Our decision to allow FMC product inventory in the sales channel to be drawn down was the main factor behind the 35% decline in revenue in North America in the quarter compared to pro forma revenue for the first quarter 2015.
However, we anticipate full year revenue performance for Ag Solutions in North America will be largely in line with the broader North America crop protection market as the action we are taking today will facilitate increased sales in the second half of the year. In fact, the dollar we are seeing give us increased confidence that our approach to managing Ag Solutions business in North America will help protect price and terms in 2016.
Despite lower sales into the channel, FMC continues to gain market share when looking at growers' use of products. Based on independent data, application of FMC products or products on the ground rose 7% in the quarter compared to Q1 2015. In particular, we continue to see strength in FMC's Authority brand pre-emergent herbicide which address the growing number of soybean acres which exhibit glyphosate resistance. 
As a result, we are confident the reduction in revenue  in Q1 is due more to a decision as when to sell than it is to any change in underlying demand for FMC products. And it is this strong, good demand for FMC's portfolio of technical products which will ultimately provide the support for pricing and terms as we are -- that we are focused on.
In addition, we continue to see demand by growers for new innovative and differentiated products that provide high-value and use. Recent product launches in FMC in core herbicide and the introduction of our expanded fungicide product offering as a result of the Cheminova acquisition received strong support from growers and distributors in the quarter. We also saw strong acceptance of our new biological and [indiscernible] product combinations, including brand such as Capture, VGR and Ethos XB.
In Latin America, revenue declined approximately 25% compared to the first quarter of 2015. Lower demand and planned product rationalizations in Brazil more than offset increased sales volume in the rest of Latin America.  Excluding this portfolio rationalization, sales in Latin America declined approximately 15%, in line with the overall market. 
Market conditions in Brazil were a little changed from the fourth quarter of 2015. Channel inventory levels have improved but remain elevated, most notably in soybean insecticide in the northern states. However, we are seeing an increase in demand in the north for insecticide, such as FMC's Talisman to address secondary pest pressure in soybeans. 
In Southern Brazil, market conditions are improved, especially in sugarcane and certain niche crops such as coffee and citrus. We continue to remain disciplined on pricing in Brazil. As we have explained previously, greater stability in the Brazilian real to U.S. dollar exchange rate supports price increase to offset FX headwinds. Paul will comment further on the impact of foreign currencies later in the call. 
Outside of Brazil, we continue to see increasing demand for pre-emergent herbicides in Argentina and products for niche crops in Colombia and Mexico. In Argentina, we see improved conditions with far fewer restrictions on imports and with the leasing of export taxes for key crops. 
In Europe, sales declined approximately 11% as foreign exchange headwinds and lower market volume more than offset commercial synergies from the Cheminova transaction and new product launches in the quarter. A cold snap at the end of the winter impacted the season in certain Western European markets, and we have seen some tightening of demand by growers in an attempt to control costs in the face of persistently low grain prices. Strong demand in Central and Eastern Europe and FMC's transition to Cheminova's direct market access model in Europe partially offset the pullback in market activity in the quarter.
Sales volumes across Europe increased for FMC's legal portfolio, including herbicide and insecticide for cereals. With the benefit of a broader combined portfolio, we believe the business is well-positioned to address market demand in key crops, including cereals and all [indiscernible].
Profitability in the region improved meaningfully year-over-year as the move to direct market access, combined with other cost savings from the Cheminova integration, increased operating margins in Europe by about 200 basis points. 
In Asia, we saw increased demand in China and Australia. However, the stronger U.S. dollar, combined with planned product rationalization and poor weather in India and Southeast Asia resulted in a 13% decline in pro forma revenue compared to the prior year quarter. Excluding the impact of currency and planned product rationalization, revenue decreased about 3% driven largely by lower sales volume in India.
Globally, we expect the challenging market conditions to persist for the remainder of the year. As previously stated, we believe the global crop protection chemicals market will decline by a mid- to high-single-digit percentage in 2016 on a U.S. dollar basis, driven largely by market conditions in North America and Brazil.  We remain highly focused on decreasing FMC product inventory levels in the channel, holding on price and term and increasing collections of accounts receivable. 
Our full year guidance for Ag Solutions remains unchanged. We continue to forecast full year revenue of between $2.3 billion and $2.5 billion and full year segment earnings in the range of $380 million to $420 million. In the second quarter, we expect to deliver segment earnings in the range of $90 million to $110 million, along with sequential margin improvement as we move toward the main selling season in North America and Europe. 
Turning next to Health and Nutrition on Slide 5. First quarter performance for Health and Nutrition was broadly in line with expectation. The business reported revenue of $192 million and segment earnings of $47 million. First quarter 2016 revenue declined approximately $19 million compared to the first quarter of last year. 
As discussed on our fourth quarter earnings call, last year's first quarter revenue included certain omega-3 sales which were not expected to occur in 2016. These sales relate principally to pharmaceutical API products and account for a decline in the revenue compared to the prior year period.  Excluding these sales volume and the impact of currency, revenue was essentially flat compared to last year. 
Global demand for FMC's health excipient products continues to grow, resulting in higher sales volume of minor and [indiscernible] products in the quarter. However, lower sales in functional health due to timing and the more competitive omega-3 pricing environment broadly offset the increase in health excipient revenue. 
For the first quarter 2016, Health and Nutrition reported segment earnings of $47 million while lower operating costs resulted in an increase in segment earnings margin to 24.6%. 
Looking forward, we continue to expect full year revenue in the range of $775 million and $825 million, and segment earnings of between $198 million and $208 million, driven principally by continued growth and demand for MCC-based health excipients and nutritional ingredients in North America and Asia and lower operating cost from ongoing manufacturing excellence program and process technology improvement. 
We expect Health and Nutrition second quarter segment earnings of between $49 million and $53 million with a sequential improvement in segment earnings margin in the quarter.
Turning to Lithium on Slide 6. Lithium delivered an outstanding quarter. Compared to the first quarter of 2015, revenue increased 8% to $60 million and segment earnings almost threefold to $14.9 million. Segment's operating margin climbed from under 10% last year in Q1 to almost 25% this quarter. These results reflect the impact of our strategy to focus on the downstream specialty markets.  As a result of our advantaged process technology and ability to manage sales mix, FMC is uniquely positioned to serve the higher growth and higher-value specialty segments while maintaining the flexibility to take advantage of favorable market conditions in lithium carbonate and chloride.
Demand trends across specialty end markets remain strong. Demand for lithium hydroxide for energy storage and electric vehicle, or EV applications, continues to grow at double-digit rates. Our success in increasing throughput from our existing hydroxide asset allow FMC to deliver higher sales volume in the quarter. In addition, we managed our production mix in order to optimize our sales of butyllithium and high-purity lithium minerals. 
Favorable market conditions supported price increases across the FMC portfolio. We continue to realize price increases for lithium hydroxide, while our approach to the carbonate and chloride market is allowing us to achieve meaningful price increases from this limited sales volume. The extent to which carbonate and chloride prices remain elevated will depend on how quickly new supply comes online. We expect market supply of all product to remain tight in the near to midterm.
Lower operating cost, coupled with higher specialty sales volume and price increases, resulted in significant increases in segment earnings and margins in the quarter. Manufacturing efficiencies from ongoing process improvement initiatives and lower cost associated with the natural gas pipeline installed in 2015 reduced operating cost by more than $5 million year-over-year, helping to drive the increased operating margin in the quarter. 
We expect the second quarter to be another strong period for the Lithium business. We continue to shift our sales mix to grow our specialty product line, serving markets such as indiscernible] and polymers while capitalizing on favorable market conditions in lithium carbonate. However, we expect to have slightly lower available carbonate volumes in Q2 compared to Q1, as a result of lower seasonal production in Argentina.
Consequently, we expect quarter segment earnings to be in the range of $10 million to $14 million and segment earnings margin in the range of 19% to 20%. Based on Lithium performance to date and our expectation for the remainder of 2016, we are raising our full year outlook for the Lithium business. We now expect full year revenue to be between $245 million and $265 million and segment earnings to be in the range of $43 million to $53 million, up $10 million from the prior range. 
Moving next to our outlook for the second quarter and full year 2016 on Slide 7. I previously commented on the outlook for each business for both Q2 and the full year. As I mentioned, we are maintaining segment earnings guidance for the full year for both Ag Solutions and Health and Nutrition. Segment earnings guidance for the second quarter reflect normal earnings level for these businesses based on our expectation for 2016. We are increasing the full year segment earnings guidance for Lithium, as stated earlier. 
On a consolidated basis, we are increasing full year 2016 adjusted earnings per share by $0.05 versus previous guidance to a range of $2.55 to $2.85, and we expect second quarter 2016 adjusted earnings to be between $0.62 and $0.72 per share. 
I will now turn the call over to Paul to discuss select financial results, including taxes, foreign exchange and cash flow."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thank you very much, Pierre. As usual, I'll start with the income statement and specifically the tax rate. Our adjusted effective tax rate fell from 27.5% in the first quarter 2015 to 26% in Q1 '16. Part of this was the continued change in the mix of ou",743,"Thank you very much, Pierre. As usual, I'll start with the income statement and specifically the tax rate. 
Our adjusted effective tax rate fell from 27.5% in the first quarter 2015 to 26% in Q1 '16. Part of this was the continued change in the mix of our earnings, away from the U.S. and Brazil and towards Europe and Asia where rates are typically lower. We continue to take steps to increase our tax efficiency and expect that the full year rate will come in somewhere in the 24% to 26% range. 
A theme in our earnings in recent quarters has been the impact of foreign currency movements, and the movement in the Brazilian real has been a particular area of focus. In the first quarter, the average rate of the real to the dollar was 3.9, significantly weaker than the 2.87 average of the same quarter a year ago. However, the total impact on our earnings was far less than we have seen in prior quarters for 2 main reasons. First, as you know, Q1 is not a large selling quarter for us in Brazil, reducing the impact of currency move. Also, since we have not seen particularly volatile movements in the currency, our price list has been able to reflect the new currency levels for the entire quarter. As a result, the $13 million headwind created by the weaker real year-on-year was completely offset by price increases. In fact, the positive impact of the weaker real on our cost base and that the change in the real was actually a net positive to our income statement in Q1. 
Looking to the rest of the world, although a number of Asian currencies collectively reduced earnings, the only major currency in which we faced a headwind in the quarter was the euro, which devalued by 2% versus the same period last year. The net hit to operating earnings from currency movements in the quarter was approximately $14 million. 
A second common theme on our earnings has also been the challenges of operating in Argentina, including areas such as import license restrictions, negative impacts of export duties and the headwind created by the disconnect between cost inflation and the pace of devaluation of the peso against the dollar. Since the election of Macri as President, we've seen a rapid shift in all of these areas to the benefits of our operations in Ag Solutions and especially Lithium. The devaluation of the peso had a relatively limited impact on our earnings in the quarter in Lithium since the lower cost of operations takes 1 to 2 quarters to work its way out of inventory and into the income statement. And our earnings guidance for 2016 reflects this lower cost of operations. We remain cautiously optimistic that the business environment in Argentina will remain positive and will continue to create opportunities for FMC. 
Turning to the balance sheet and cash flow on Slide 8. Q1 is historically the period in which we consume the most cash given the seasonal nature of our Ag business. However, discipline around spending, the increased focus last year on sales terms, and of course the ongoing collection measures globally resulted in an improvement of operating cash flow of over $100 million compared to the same quarter last year. Cash flow was helped by higher EBITDA and a better performance around working capital, most notably from collection of receivables. This improvement was seen in all regions.  With certain cash outflows, particularly capital spending and pension expenses also lower than last year, we were able to hold net debt flat during the quarter. 
As noted in our filing of March 28, we elected to amend the debt covenants for our term loan and revolver, deferring the timing of step downs of our leverage ratios such that we retained the covenant limit of 4.5x for Q1. Our actual leverage ratio under the covenant calculation was 4.0x giving the half a turn of headwind that we consider to be prudent. 
Looking to the rest of the year, adjusted cash from operations is forecasted in the range of $450 million to $550 million, an improvement over last year of over 1/3 of the midpoint of the range. This is driven by improvements in both EBITDA and working capital performance. Capital expenditure will remain broadly flat to 2015 in the $120 million to $140 million range.
And with that, I will turn the call back to Pierre."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Paul. To conclude, we continue to expect the challenging market in Ag Solutions, but we are managing the business to increase visibility and to protect both price and term. As a result, we continue to expect full year earnings to be in line wit",106,"Thank you, Paul. To conclude, we continue to expect the challenging market in Ag Solutions, but we are managing the business to increase visibility and to protect both price and term. As a result, we continue to expect full year earnings to be in line with prior guidance. 
Health and Nutrition is performing largely in line with expectations, and Lithium is well ahead of our initial forecast. The portfolio transformation is done. We are now in execution mode, targeting year-over-year earnings growth for each of our 3 businesses. 
Thank you for your attention, and I will now turn the call back to the operator for questions."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] And the first question comes from Mr. Parkinson from Crdit Suisse.",13,"[Operator Instructions] And the first question comes from Mr. Parkinson from Crdit Suisse."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","You mentioned in your presentation that Central and Eastern Europe were showing solid demands. But can you comment on the pricing landscape given the FX headwinds there as well, and whether or not you're able to offset that? And then also on the demand fr",77,"You mentioned in your presentation that Central and Eastern Europe were showing solid demands. But can you comment on the pricing landscape given the FX headwinds there as well, and whether or not you're able to offset that? And then also on the demand front, do you believe the growth was simply driven by the market? Or do you believe there is any benefit from adding the FMC portfolio to the legacy Cheminova one in the region?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think on the Central and Eastern Europe, the pricing is pretty stable and it's not a very, very large market. Interesting for us because there is a strong possibility to increase volume. But pricing is quite stable. And I think, definitely, the growth i",98,"I think on the Central and Eastern Europe, the pricing is pretty stable and it's not a very, very large market. Interesting for us because there is a strong possibility to increase volume. But pricing is quite stable. And I think, definitely, the growth is one of the place where FMC had no structure in Central and Eastern Europe, where it was an area of focus for Cheminova. So definitely, a place where using the infrastructure and commercial organization from Cheminova and bringing in the product portfolio for FMC is going to create some significant opportunities for us."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Perfect. And just kind of a tangent question to that one. Given the progression of cost savings, with Cheminova clearly going well, can you just comment on the other geographies as far as intermediate to long-term revenue synergy opportunities inclusive o",53,"Perfect. And just kind of a tangent question to that one. Given the progression of cost savings, with Cheminova clearly going well, can you just comment on the other geographies as far as intermediate to long-term revenue synergy opportunities inclusive of the U.S., and then also in Latin America with Argentina in particular?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes. Chris, this is Mark. We've talked about North America in the past. And in the U.S., we're seeing very good synergies with the fungicide portfolio from Cheminova going through our distribution network. In Latin America, obviously, Brazil in the South,",123,"Yes. Chris, this is Mark. We've talked about North America in the past. And in the U.S., we're seeing very good synergies with the fungicide portfolio from Cheminova going through our distribution network. In Latin America, obviously, Brazil in the South, we're seeing increased sales through co-ops where we've made decisions which co-ops and which distribution network will go through. Argentina's certainly very beneficial for us. Obviously, we have a bigger footprint there now. We have the right products for the soy market, so we're expecting to see growth in Argentina. And then in other parts of Latin America, I would say, obviously, Mexico, Colombia are 2 countries that we're focused on and we're seeing very good synergies in Colombia on these crops."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think when we did the last earnings call, as well as multiple discussion we all had, we've been talking about this year getting to $100 million -- $50 million to $100 million run rate in between the synergies and the new products and very much on track",79,"I think when we did the last earnings call, as well as multiple discussion we all had, we've been talking about this year getting to $100 million -- $50 million to $100 million run rate in between the synergies and the new products and very much on track with that. So it is a place, I think, the opportunities created by Cheminova, from a cost saving and the revenue synergies, are very much in line with what we're expecting."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Your next question comes from the line of Frank Mitsch with Wells Fargo Securities.",14,"Your next question comes from the line of Frank Mitsch with Wells Fargo Securities."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, when you were talking about the ag business, you were talking about some positives with respect to the glyphosate resistance in terms of providing a boost. I was wondering if there was a way for you to kind of quantify it? And in terms of where yo",80,"Pierre, when you were talking about the ag business, you were talking about some positives with respect to the glyphosate resistance in terms of providing a boost. I was wondering if there was a way for you to kind of quantify it? And in terms of where you see that over the next 18 months or so? And then what sort of concerns may you have about some new technologies that Monsanto and others are rolling out in that area?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes, Frank, it's Mark. I think for us when we look at glyphosate resistance, we're really talking about the U.S., Argentina as the 2 big markets. I think you know that through our Authority brands based upon Sulfentrazone, we've had great success in the p",126,"Yes, Frank, it's Mark. I think for us when we look at glyphosate resistance, we're really talking about the U.S., Argentina as the 2 big markets. I think you know that through our Authority brands based upon Sulfentrazone, we've had great success in the pre-emergent area in both of those countries. I expect that to continue. There will be some headwinds with new technologies coming in. But I think to offset that, we still see more ways to get in resistance to glyphosate and more acres increasing, especially in Argentina. It wouldn't surprise me if we don't start to see that in the next few years, start to develop in Brazil as well, and we're already positioning our brands in Brazil on soy for that area."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Okay, that's very helpful. And as you think about some of the combinations coming -- some of the major combinations in the ag chem world coming over the next 12 months or less, how do you see yourselves perhaps participating and picking up some pieces the",58,"Okay, that's very helpful. And as you think about some of the combinations coming -- some of the major combinations in the ag chem world coming over the next 12 months or less, how do you see yourselves perhaps participating and picking up some pieces there? What's the interest level? Talk about your participation in industry consolidation here."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Well, Frank, as you know, we made a move, which was in line with what was our strategic intent by acquiring Cheminova. We have now a stable situation from a structural standpoint in Ag. We're finishing up on the integration. What we intend to do at this s",165,"Well, Frank, as you know, we made a move, which was in line with what was our strategic intent by acquiring Cheminova. We have now a stable situation from a structural standpoint in Ag. We're finishing up on the integration. What we intend to do at this stage is watch what is happening, specifically in places when 2 ag companies are coming together. So every time there will be consolidation of ag companies, if at any point during this process, there is -- because of antitrust reason, products which are made available, that is something we are usually very good at doing, which is taking a product and commercializing that with our own sales organization. So we're going to be opportunistic. But it's certainly something we will be able to afford to do and we'd be very interested in doing. Beyond that, do not expect us making any major move in acquiring any type of company. It will be an acquisition of technology and products."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Daniel Jester with Citigroup.",12,"Our next question comes from the line of Daniel Jester with Citigroup."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Maybe a couple of questions on Lithium. Price mix was a 4% benefit in the quarter. But by some kind of spot measures, lithium prices were much higher. So can you just kind of elaborate as to how we should be thinking about pricing, kind of commodity  and",60,"Maybe a couple of questions on Lithium. Price mix was a 4% benefit in the quarter. But by some kind of spot measures, lithium prices were much higher. So can you just kind of elaborate as to how we should be thinking about pricing, kind of commodity  and spot sales versus the contract market as we continue throughout the year?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes. If you think about our Lithium business, look at strategic price increase in place where we are technologically advantaged in grain  markets where we have significant contract, which are renewed every year, like in lithium hydroxide. And then think a",185,"Yes. If you think about our Lithium business, look at strategic price increase in place where we are technologically advantaged in grain  markets where we have significant contract, which are renewed every year, like in lithium hydroxide. And then think about on the chloride and carbonate side for what is not used for internal purpose or sold in the contract, we are using the spot market to do one-off price increase. We believe that situation is going to carry on for the next few quarters. I think the market will remain tight, which will allow us to use the spot market in the more commodity businesses like chloride and carbonate to increase price on a spot basis. And where we are with opportunities, where people need our technology or product, we would be increasing price on contract when contract are being renewed. So it is a situation which we see fairly, fairly stable for the future. If you look at our increase in guidance for the Lithium business, most of it is going to be -- of the over performance will be due to pricing."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then just sticking with Lithium, you commented that you think the outlook is going to be tight in the near to medium term. Can you just flesh out a little bit about what's your expectations are for supply additions over the coming years?",45,"Okay. And then just sticking with Lithium, you commented that you think the outlook is going to be tight in the near to medium term. Can you just flesh out a little bit about what's your expectations are for supply additions over the coming years?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Well, I cannot comment too much beyond what all of you know on the lithium carbonate side, because that's a decision of the people who have announced capacity increase. So I'm sure ADAMA, when they talk on their earnings, will be able to tell more about t",111,"Well, I cannot comment too much beyond what all of you know on the lithium carbonate side, because that's a decision of the people who have announced capacity increase. So I'm sure ADAMA, when they talk on their earnings, will be able to tell more about the timing. But we believe [indiscernible] and we believe also some Chinese or Australian company will be bringing carbonate capacity in the next couple of years. We, ourselves, are focused more on the downstream and we will bring -- in time, and we'll bring more detail in the weeks to come, but we'll be focusing more on increasing lithium hydroxide capacity as we need it."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","And next, we'll go to Mike Harrison of Seaport Global.",10,"And next, we'll go to Mike Harrison of Seaport Global."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, if we could just continue on the Lithium front. I was -- I guess I was just surprised to see that the -- you put up a $15 million quarter in Lithium and your guidance is only calling for $43 million to $53 million for the full year. What's going t",80,"Pierre, if we could just continue on the Lithium front. I was -- I guess I was just surprised to see that the -- you put up a $15 million quarter in Lithium and your guidance is only calling for $43 million to $53 million for the full year. What's going to change during the remainder of the year that would suggest that earnings could be lower than the Q1 level as we get through the rest of the year?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes, I'll ask for Tom to comment with me. But as we said on the script, remember, there is seasons in terms of manufacturing in Lithium, and we are getting into a period where -- which is the winter part of the season. And we're going to have more rain an",160,"Yes, I'll ask for Tom to comment with me. But as we said on the script, remember, there is seasons in terms of manufacturing in Lithium, and we are getting into a period where -- which is the winter part of the season. And we're going to have more rain and more snow and conditions which are going to limit more, to some extent, our production of carbonate. So what we're expecting in the next 3 quarters is less carbonate available because of our manufacturing, like most people operating in this part of the world, in the next couple of quarters. On the positive side, our costs continue to be good and our pricing will be positive. So it's a differential between all of these which create maybe a little bit of a -- less of a novel performance in the remaining 3 quarters than we have in the first quarter otherwise. You want to add anything, Tom, to this?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think if you look historically at the earnings, the seasonality has been there. We're doing what we can to reduce volatility, but that seasonality is going to remain where the first and fourth quarter give us the most volume and flexibility on the",49,"Yes. I think if you look historically at the earnings, the seasonality has been there. We're doing what we can to reduce volatility, but that seasonality is going to remain where the first and fourth quarter give us the most volume and flexibility on the mix we can sell."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","And then as I think about some of the lithium carbonate that you're actually purchasing to convert to hydroxide, are you experiencing higher raw material cost for that? Or do you have lower prices locked in for the year and you're actually getting a margi",55,"And then as I think about some of the lithium carbonate that you're actually purchasing to convert to hydroxide, are you experiencing higher raw material cost for that? Or do you have lower prices locked in for the year and you're actually getting a margin benefit for some of that raw material you're purchasing?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes. As we -- first, as you know, most of the carbonate, by a long shot, we use is produced by us. So what we are buying under contract today versus the overall usage is incremental, and what we are buying is locked under a long-term supply agreement. So",183,"Yes. As we -- first, as you know, most of the carbonate, by a long shot, we use is produced by us. So what we are buying under contract today versus the overall usage is incremental, and what we are buying is locked under a long-term supply agreement. So we are not facing significant price increase in carbonate. if it plays the way we expect it to play, and once again, it's going to have to be confirmed. But the way we look at it is, for now, we are producing enough carbonates and buying enough to run our strategy around chloride, butyllithium, metal and hydroxide. And as time will go, we're going to have to sell more hydroxide. We're going to have to increase our capacity in hydroxide. And we'll have to buy more of carbonate on the external  market, which should be at a time when our peer companies will be increasing capacity and making the product more available in the market. So it looks like all of this is falling in place quite well. Tom, you want to add something?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thanks for the question. Pierre has it down well. The other thing that we look at always is the incremental things we can do in Argentina. And there are small opportunities for small capital to increase our throughput in Argentina, which gives us some fle",49,"Thanks for the question. Pierre has it down well. The other thing that we look at always is the incremental things we can do in Argentina. And there are small opportunities for small capital to increase our throughput in Argentina, which gives us some flexibility as we go forward."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","So right now, I would say there is no major issue around potential increase in the future of cost in terms of our ability to execute our strategy around carbonate and hydroxide.",32,"So right now, I would say there is no major issue around potential increase in the future of cost in terms of our ability to execute our strategy around carbonate and hydroxide."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Next, we'll go to the line of Mike Sison with KeyBanc.",11,"Next, we'll go to the line of Mike Sison with KeyBanc."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, when you think about -- you didn't change your outlook for crop protection markets this year. I understand it's still difficult out there. But it does sound like you're feeling better about the integration and maybe the long-term potential. Can yo",58,"Pierre, when you think about -- you didn't change your outlook for crop protection markets this year. I understand it's still difficult out there. But it does sound like you're feeling better about the integration and maybe the long-term potential. Can you maybe map out where Ag Solutions op income can go over time as, hopefully, things recover?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes, let me -- I'll tell you the way we look at Ag Solutions right now. First, let me talk about the ag market as we see it for this year. I think we are not changing our view for 2016. We still believe it's a mid-to-high single digit downmarket, mostly d",445,"Yes, let me -- I'll tell you the way we look at Ag Solutions right now. First, let me talk about the ag market as we see it for this year. I think we are not changing our view for 2016. We still believe it's a mid-to-high single digit downmarket, mostly driven by North America and Brazil within -- in the high-teens, and maybe Asia and Europe to the low -- sorry, in the high-single digits, while Europe and Asia would be in the low- to mid-single-digit decrease. So we are not changing our view. It could be maybe trending more toward the high-single digit overall global market. The way -- and why do I feel better about the way we are operating in the ag market? It is not because we are seeing a fundamental change in the market in the short-term. But what I think we are doing at FMC, I think the key difference is that we know better how to operate in this type of market. I can tell you, you see it on our numbers, we are not fighting to keep market share on sales of product. We are much more looking at 3 types of objectives. First, it's very important for us and focusing only on FMC product is to decrease FMC product in the channels. The second aspect is we want to be able, by doing that, to focus more on the quality of the sales, which is more term, price and collection. And then, looking at all of that, the objective is to align more sales with a normal demand pattern. You see that on the numbers in Q1 in North America. Sales down 35%, I think, on page -- on Slide 4, while product on the ground were up above market, 7%. So the way we are operating in the market today, I believe we have more control over our selling process than we might have had in the past when we got hit by the downturn. Beyond that, I would say -- I would not exclude the market to turn around in 2017, but I have no indicators telling me that it will be the case. So I think we are much more focused, Mike, on operating under the current conditions with very high control on term, price, managing very closely with -- in partnership with the customers, our inventory, to create much more predictability in our sales. So that's where the level of confidence, for me, is increasing at this stage. Market turnaround, I think we'll have to wait a little bit more and certainly to go into Q3, Q4 to have more visibility."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then [indiscernible]. I thought you said at the current levels where the real is at, that it's -- is it going to be a negative this year or is it a positive? I just wanted to make sure I understood your commentary around foreign currency there.",48,"Okay. And then [indiscernible]. I thought you said at the current levels where the real is at, that it's -- is it going to be a negative this year or is it a positive? I just wanted to make sure I understood your commentary around foreign currency there."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","That's the million-dollar question with the real. I mean, the truth is that the stability or the predictability in the movement in the real is really what matters to us . We've talked about it in the past with regard to the timing of changes and the pace",250,"That's the million-dollar question with the real. I mean, the truth is that the stability or the predictability in the movement in the real is really what matters to us . We've talked about it in the past with regard to the timing of changes and the pace of changes. Q1 and Q2 just aren't really periods in which we have a lot of commercial activity going on in Brazil. So it's really what it does in Q3.  And again, it isn't so much the level -- we've shown that in Q1, where with an average rate of 3.9, today, it's closer to 3.5. We were able to still capture pricing on a limited number of sales that we have in Q1. The question will come in Q3, how stable, how predictable is the real? In the rest of the world, I mean, you look at the forward curves of the currency, it does not feel like a strengthening dollar is what the market is expecting. And so that, generally speaking, is what's factored into our numbers, relative predictability, not a big strengthening of the dollar around the world. Q1 feels like -- when you look at where the dollar is today compared to a year ago, Q1 feels like the last of the quarters that we had those tough FX comps. So subject to any changes away from where the market expects today doesn't feel like currency will be quite the high-level story that it was last year."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Joel Jackson with BMO.",12,"Our next question comes from the line of Joel Jackson with BMO."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","You have really guided up your operating cash flow projections for the year by $50 million, but raised your EBIT projections by about $10 million. Can you give us a sense where the big delta is coming in the operating cash flow? Is it really an improvemen",50,"You have really guided up your operating cash flow projections for the year by $50 million, but raised your EBIT projections by about $10 million. Can you give us a sense where the big delta is coming in the operating cash flow? Is it really an improvement an working capital?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Sure. It's a pretty straightforward story. We clearly have an increased expectation around EBITDA. But the truth is, it's largely around working capital. And you have to bear in mind that if you look over the last few years, 2 years ago, we had a terrible",178,"Sure. It's a pretty straightforward story. We clearly have an increased expectation around EBITDA. But the truth is, it's largely around working capital. And you have to bear in mind that if you look over the last few years, 2 years ago, we had a terrible performance with working capital with largely cash outflow. Last year, we turned that to corner and sort of stopped the bleeding and improved it a slightly. But this year, we expect that trend to continue so that working capital becomes a positive generator of cash flows. Our biggest focus is always going to be the Brazil receivables balance and getting that receivables balance down. But we're also be very, very focused on inventory levels, our own inventory levels, and making sure that we are very efficient and very thoughtful about what inventory we, where we hold it and how much of it we hold. So it's coming in multiple different areas, but you really should be looking at working capital as the primary driver of the increase in cash flow for 2016."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","I'm sorry if this is asked already's, but in terms of synergies from Cheminova, $60 million to $70 million for the year, do you still maintain that? And maybe give us how much more you think you can still get in 2017 versus prior guidance?",46,"I'm sorry if this is asked already's, but in terms of synergies from Cheminova, $60 million to $70 million for the year, do you still maintain that? And maybe give us how much more you think you can still get in 2017 versus prior guidance?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","[indiscernible]",1,"[indiscernible]"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Synergies in '16, $60 million to $70 million, still our guidance? And how much  more will we gain.",18,"Synergies in '16, $60 million to $70 million, still our guidance? And how much  more will we gain."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes, we are not changing the -- actually, we still have the same numbers. So the numbers we've been talking about $60 million to $70  million, are very well in line. And a full run rate of 140  to 160, getting into the middle of next year, are also still",62,"Yes, we are not changing the -- actually, we still have the same numbers. So the numbers we've been talking about $60 million to $70  million, are very well in line. And a full run rate of 140  to 160, getting into the middle of next year, are also still the target. So there is no change in our numbers right now."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Steve Byrne with BOA.",12,"Our next question comes from the line of Steve Byrne with BOA."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","In the U.S. crop protection market, are you seeing any increased discounting or bundling by your competitors? And do you see any risk of perhaps maybe losing some shelf space in the retail channel from allowing your product inventories to be trimmed?",43,"In the U.S. crop protection market, are you seeing any increased discounting or bundling by your competitors? And do you see any risk of perhaps maybe losing some shelf space in the retail channel from allowing your product inventories to be trimmed?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think whenever you talk about terms and pricing, we want to be highly cautious and slowly comment about what we do. Our strategy today is quite simple. We are highly focused on maintaining our  pricing at a healthy level. We are very vigilant on terms.",274,"I think whenever you talk about terms and pricing, we want to be highly cautious and slowly comment about what we do. Our strategy today is quite simple. We are highly focused on maintaining our  pricing at a healthy level. We are very vigilant on terms. As you know, balance sheet is always a key challenge for a company like us. And more than ever, we are highly disciplined on terms and not giving terms. What it means for us -- and I'm only talking for FMC. What it means for us is, certainly, we are prepared to see timing change in ourselves. And that's what I've been talking about. We're not being willing to do anything to push product in the market if there is not a complete need from this product -- for this product by the market. Space shelves is a word we use a lot. But when you have technical product to be sold, both production know they are needed, and then you have commercial contract with customers. So it is not a situation where because we are aligning ourselves with the market demand that we are taking an enormous risk to see somebody taking our shelf space by the end of the year and not -- us not being able to sell our product. For example, Mark talked about our Authority product line. It's a pre-emergent product. It's required. Needs to be bought in Q4 and Q1. We know this product will be sold. So I think our strategy might be a big differentiator, but we are only focusing on ours along the line of what we discussed before."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","And Pierre, considering your comment about Authority, would you say that the outlook for eventual penetration of the Xtend and the Enlist soybean products, does that -- is that a risk to your Authority franchise within the Americas? Or could you see that",69,"And Pierre, considering your comment about Authority, would you say that the outlook for eventual penetration of the Xtend and the Enlist soybean products, does that -- is that a risk to your Authority franchise within the Americas? Or could you see that as potentially an opportunity where you might expand your herbicide franchise and move more over the top and bring in formulations with either 2,4-D and Dicamba."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes. Steve, this is Mark. We talked about it earlier. I got a question earlier about whether we thought it would be a headwind or a tailwind. I think in the initial stages, I expect rates to be reduced. Good news is, we know with Enlist and Xtend that the",195,"Yes. Steve, this is Mark. We talked about it earlier. I got a question earlier about whether we thought it would be a headwind or a tailwind. I think in the initial stages, I expect rates to be reduced. Good news is, we know with Enlist and Xtend that they will still be recommending the use of pre-emergent herbicides, of which Authority is one of the market leaders. So we know we're going to have a substantial market there. I would say weed-resistant acres continue to grow, so we're going to see that pre-emergent continuing, certainly in the U.S,  and as I said earlier, in Argentina. I think from an over-the-top perspective, I mean, we have some very good products that we're going to be promoting, such as our Cadet herbicide, which we think will be a great tank mix partner for those products and really offer a broader spectrum of control. Don't expect to see us in 2,4-D and Dicamba. That's not just the sort of business were going to be in. We're going to be in the more differentiated products, more highly specialized where we can bring value to the growers and distribution."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Next, we'll go to the line of Mark Connelly with CLSA.",11,"Next, we'll go to the line of Mark Connelly with CLSA."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, the trend among food companies to reformulate to simplify is clearly getting faster. How much is that reformulation trend actually helping you, do you think? And do you think about it as a tailwind?",35,"Pierre, the trend among food companies to reformulate to simplify is clearly getting faster. How much is that reformulation trend actually helping you, do you think? And do you think about it as a tailwind?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think the food market, for us, there is an acceleration of -- the way we look at our market in attrition and in health are interesting. In health, the good news is when you're with a customer, you're there for a while, because you're not being reformula",163,"I think the food market, for us, there is an acceleration of -- the way we look at our market in attrition and in health are interesting. In health, the good news is when you're with a customer, you're there for a while, because you're not being reformulated out easily. The problem with that is it's not easy to gain new business. Well, the same apply to food, but the reverse. I think there is a trend to reformulate transformulation. There is a very fast cycle, which gives opportunities for us. So the stronger we are with a product, the more opportunities. But by the same token, also opens the door for new product and competitors. So I would say, today, it could be slightly a tailwind, knowing that we are maybe the largest market shareholder and maybe the more complete product line. But I don't see that as a major change from the past. Eric, you want to add some comments there?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I would say we see it as a trend. This is Eric, Mark. Eric Norris. I see it as a trend. We see it as a trend, like many others that have come and go in the industry. The industry is very fad-based, so to Pierre's point, unlike the health markets where the",180,"I would say we see it as a trend. This is Eric, Mark. Eric Norris. I see it as a trend. We see it as a trend, like many others that have come and go in the industry. The industry is very fad-based, so to Pierre's point, unlike the health markets where there's very little change over periods of time. There's a great deal of change from every 2 or 3 years, whether it's low-fat Atkins, and now, this simplification clean-label phenomenon. It really does come down to the breadth of product line we have. The fact that they're well-suited being all-naturally based. And then having the applications capability to respond to them at -- in the right places around the world, having a spread of knowledge in the right places and your customers. So we're well-positioned for it. Anytime there's a reformulation, there's a challenge, right? So it does create an effort in our part to respond. Going forward, we see it as a tailwind though, for us, given the breadth of our product line and our application capabilities."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Eric, in Pierre's comments you talked about product differentiation. Can you talk about how you think about product differentiation?",19,"Eric, in Pierre's comments you talked about product differentiation. Can you talk about how you think about product differentiation?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","In -- specifically in the food market?",7,"In -- specifically in the food market?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Sure. Yes.",2,"Sure. Yes."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","It comes down to understanding very well not only what's going on with your direct customer, the large food or small food company, but with consumers. And being able to put together a formulation that meets the needs. So product differentiation for us is",127,"It comes down to understanding very well not only what's going on with your direct customer, the large food or small food company, but with consumers. And being able to put together a formulation that meets the needs. So product differentiation for us is less about proprietary technology, intellectual property such as a patent that might drive more what happens in our Ag business. It's more about the know-how, being able to put a sum of ingredients together that meets a specific need and understanding either color, texture or taste issues that might impact the success of that brand. So it really comes down to the differentiation around the application and the ingredients we bring as opposed to a proprietary ingredient in the food product itself."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Brett Wong with Piper Jaffray.",13,"Our next question comes from the line of Brett Wong with Piper Jaffray."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, you were talking about kind of the overall crop chem market and the focus that FMC is going to have in terms of working inventory down and being disciplined on price and terms. So I just want to get a clarification. So if others are -- or the comp",82,"Pierre, you were talking about kind of the overall crop chem market and the focus that FMC is going to have in terms of working inventory down and being disciplined on price and terms. So I just want to get a clarification. So if others are -- or the competitors are not acting rationally and pushing product in the market when the product doesn't need it, as you were saying, FMC is not going to be participating in that kind of activity?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Listen, I don't know what strategy our competitors are operating around market push of product discount. In our rationale, they intend to be -- I think what we've made as a decision, and that's a decision we've made globally. We believe we are in a situat",266,"Listen, I don't know what strategy our competitors are operating around market push of product discount. In our rationale, they intend to be -- I think what we've made as a decision, and that's a decision we've made globally. We believe we are in a situation where the markets are such and the level of inventory in the channel are such, that you can't guide your activity by what the others are doing. I think we have a plan in place. We are working very, very closely in cooperation with our customers who understand our strategy. We are not going to try to sell in Q1 or Q2 or Q3 a product which is needed in Q4. And in exchange, we maintain a healthy pricing and terms situation. And that's what we're going to be focusing. I believe what we're going to do during this downturn. And until this turns around, we are not going to work, hoping that the overall level of inventory in the market channel is going to go down. I think it's too tall of an order and too impractical. So we're going to be focusing solely on FMC product. I think the numbers are quite spectacular. I said that many times, 34% sales down in the first quarter; North America, plus 7% growth on the ground. That is millions of dollars of inventory which are outside of our customers' inventory which they will need to replenish when the market need it. And that's the way we are operating. Our competitors will have to use the strategy which is appropriate for them."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then just focusing again on inventory. Obviously, in the quarter, your inventories were significantly elevated due to the strategy that you're speaking of. Can you just talk about the timing that you expect to be able to work through that invent",78,"Okay. And then just focusing again on inventory. Obviously, in the quarter, your inventories were significantly elevated due to the strategy that you're speaking of. Can you just talk about the timing that you expect to be able to work through that inventory along with what the channels going to be doing? And then ultimately, I think you said you expect improvements in the second half in North America. Can you just talk a little bit about that?"
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think the way we look at it -- and there was a question before. I think it's Michael who asked that question around the level of confidence in the market. I think our strategy today allow us to have more visibility in terms of the timing and level of ou",165,"I think the way we look at it -- and there was a question before. I think it's Michael who asked that question around the level of confidence in the market. I think our strategy today allow us to have more visibility in terms of the timing and level of our sales, because we become less dependent upon what the market is doing and rushing to place sales to be safe and have those on the shelves. So what it does to us, it creates more predictability and maybe increase the level of confidence of how the quarters ahead of us are going to be unfolding. We know -- I mean, we know, which product will be required, usually, which technology will be required depending upon the season in Q4 and Q1 and Q2. And that's a discussion we have with our customers and that's the way we're operating right now. So it's just giving us a bit more certainty on how things will unfold."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our last question comes from the line of Aleksey Yefremov of Nomura Securities. That was our last question. Please go ahead.",21,"Our last question comes from the line of Aleksey Yefremov of Nomura Securities. 
That was our last question. Please go ahead."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Okay. Well, that's all the time we have for the call today. I want to thank everyone for joining. I'll be available for the rest of the day to go through any additional questions. Again, thank you. Have a good day.",41,"Okay. Well, that's all the time we have for the call today. I want to thank everyone for joining. I'll be available for the rest of the day to go through any additional questions. Again, thank you. Have a good day."
28606,330161312,970834,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","And that's all the time we have for today. This concludes the FMC Corporation First Quarter 2016 Earnings Release Conference Call. Thank you.",24,"And that's all the time we have for today. This concludes the FMC Corporation First Quarter 2016 Earnings Release Conference Call. Thank you."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the First Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli,",41,"Good morning, and welcome to the First Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning everyone. Welcome to FMC Corporation's First Quarter 2016 Earnings Call. Joining me this morning is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial",282,"Thank you, and good morning everyone. Welcome to FMC Corporation's First Quarter 2016 Earnings Call. Joining me this morning is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer. Pierre will begin the call with a review of FMC's first quarter performance and discuss the outlook for Q2 and the full year 2016. Paul will provide an overview of select financial results. 
The slide presentation that accompanies our results, along with our earnings release and 2016 outlook statement are currently available on our website. The prepared remarks from today's discussion will be made available at the conclusion of the call. 
Following the prepared remarks, we will be joined by Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, to address your questions. 
Before I turn the call over to Pierre, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors including, but not limited to, those factors identified in our earnings release and in our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based upon these risks and uncertainties. 
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms, as well as other non-GAAP financial terms to which we may refer during today's conference call, are provided on our website. 
With that, I will now turn the call over to Pierre"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian, and good morning, everyone. 2016 marks the beginning of a new era for FMC. Today, FMC is a more focused and streamlined company. Our businesses operate in attractive end markets namely agriculture, nutrition, pharmaceuticals and lithium.",2765,"Thank you, Brian, and good morning, everyone. 2016 marks the beginning of a new era for FMC. Today, FMC is a more focused and streamlined company. Our businesses operate in attractive end markets namely agriculture, nutrition, pharmaceuticals and lithium. The actions we have taken over the past 18 months have aligned our operation with regional market demand and positioned each of our businesses to better capitalize on market opportunities. With our transformation complete, we are now solely focused on the execution of our strategy to drive performance in 2016 and beyond.
In Agricultural Solutions, we continue to see the benefits of the Cheminova acquisition. Prior to the acquisition, Ag Solutions was very much an American business. In 2014, more than 3 quarters of its revenues were generated in North and South America. Cheminova significantly increased the size of Ag Solutions operations in Europe and Asia, bringing greater scale and market access to Ag Solutions operations across our region. The increased global scale of operations, combined with actions we have taken in North and South America, will bring greater regional balance to Ag Solutions, aligning our operations with the global crop protection chemical market and limit Ag Solutions' reliance on any one region or market to drive performance.
For example, in 2014, almost 40% of Ag Solutions' revenue was generated in Brazil alone. In 2016, we expect Brazil to account for less than 20% of segment revenue and only 15% of total company revenue. 
Across the global ag market, conditions in the Americas remain the most challenging. With greater scale and regional balance, FMC is able to better manage our business in the Americas to address market conditions. Specifically, we restructured our operation in Brazil to align the size of our business with market conditions and rationalize our product offering to increase our focus on higher-margin, proprietary technology platforms and differentiated products. While these actions reduced our revenues in Brazil, they improved the quality of our operations and enhanced the potential to deliver higher earnings and return on capital.
In North America, we are supporting customer inventory drawdowns to more closely match our sales with underlying grower demand, an important step to further strengthen FMC's position from which to protect price and terms. Cheminova also expanded our product portfolio and technology pipeline and provided the opportunity to realize meaningful cost savings. We are already seeing the benefits of our expanded product portfolio in North America and Europe and the integration of Cheminova is progressing well. We remain on track to deliver the full run rate cost savings of $140 million to $160 million by the middle of 2017.
In Health and Nutrition, global demand for FMC's naturally derived ingredients product lines continue to be robust and we remain focused on maintaining the business' high margins through the implementation of manufacturing excellence program, process technology improvements and product differentiation.
In Lithium, we are seeing the benefits of our strategy to focus and grow FMC's business in the technology-driven specialty end market where demand continues to climb and pricing trends across FMC's portfolio remain favorable. I will discuss the performance of each of our businesses shortly and provide an update on our outlook for Q2 and the full year.
First, I will start with a brief review of FMC's consolidated reported results on Slide 2. FMC reported first quarter revenue of approximately $799 million. Adjusted EPS of $0.58 for the quarter was flat compared to the first quarter of 2015 but was towards the top end of our guidance range as a solid performance in Ag Solutions and a very strong quarter from Lithium drove the results.
Turning now to Ag Solutions on Slide 3. Ag Solutions reported revenue of $546 million, a decline of 22% compared to pro forma results for the first quarter of 2015 as lower sales volume in North America and Brazil due to high channel inventories, planned product rationalization and currency headwinds more than offset the impact of price increases, revenue synergies and new product introductions in the quarter.  
As I mentioned previously, we are focused on executing our strategy to drive improved performance. This includes completing the process of rationalizing the Ag Solutions product portfolio that began in 2014. The actions we took to eliminate certain products from our portfolio reduced revenue by approximately $30 million or 4% compared to pro forma revenue for Q1 2015.  However, as discussed in prior quarters, this product rationalization has a limited impact on segment earnings. 
We also remain focused on pricing discipline. At the operating earnings level, price increases implemented in Brazil more than offset the year-over-year impact of the weaker real. However, the broad-based strength of the U.S. dollar resulted in headwinds in Europe and Asia that were only partially offset by price increases.
Despite challenging market conditions, the Ag Solutions business delivered segment earnings of $82 million, ahead of the midpoint of our guidance, and maintained operating margins year-over-year on a pro forma basis. 
I will make a few additional comments regarding regional market condition and Ag Solutions performance now on Slide 4. 
Overall market conditions and our performance in the quarter were very much as expected. In North America, as we discussed on our Q4 earnings call back in February, the deterioration in farm incomes over the past year, combined with elevated channel inventory levels, led distributors and growers to delay purchases of agriculture in foods, including crop protection chemicals. We determined it was critical to maintain price and payment terms in North America this season. And as part of our strategy to achieve these, we believe it was important to allow the level of FMC product inventory in the sales channel to reduce. Our decision to allow FMC product inventory in the sales channel to be drawn down was the main factor behind the 35% decline in revenue in North America in the quarter compared to pro forma revenue for the first quarter 2015.
However, we anticipate full year revenue performance for Ag Solutions in North America will be largely in line with the broader North America crop protection market as the action we are taking today will facilitate increased sales in the second half of the year. In fact, the dollar we are seeing give us increased confidence that our approach to managing Ag Solutions business in North America will help protect price and terms in 2016.
Despite lower sales into the channel, FMC continues to gain market share when looking at growers' use of products. Based on independent data, application of FMC products or products on the ground rose 7% in the quarter compared to Q1 2015. In particular, we continue to see strength in FMC's Authority brand pre-emergent herbicide which address the growing number of soybean acres which exhibit glyphosate resistance. 
As a result, we are confident the reduction in revenue  in Q1 is due more to a decision as when to sell than it is to any change in underlying demand for FMC products. And it is this strong, grower demand for FMC's portfolio of technical products which will ultimately provide the support for pricing and terms as we are -- that we are focused on.
In addition, we continue to see demand by growers for new innovative and differentiated products that provide high-value end use. Recent product launches in FMC in core herbicide and the introduction of our expanded fungicide product offering as a result of the Cheminova acquisition received strong support from growers and distributors in the quarter. We also saw strong acceptance of our new biological and [indiscernible] product combinations, including brand such as Capture, VGR and Ethos XB.
In Latin America, revenue declined approximately 25% compared to the first quarter of 2015. Lower demand and planned product rationalizations in Brazil more than offset increased sales volume in the rest of Latin America.  Excluding this portfolio rationalization, sales in Latin America declined approximately 15%, in line with the overall market. 
Market conditions in Brazil were a little changed from the fourth quarter of 2015. Channel inventory levels have improved but remain elevated, most notably in soybean insecticide in the northern states. However, we are seeing an increase in demand in the north for insecticide, such as FMC's Talisman to address secondary pest pressure in soybeans. 
In Southern Brazil, market conditions are improved, especially in sugarcane and certain niche crops such as coffee and citrus. We continue to remain disciplined on pricing in Brazil. As we have explained previously, greater stability in the Brazilian real to U.S. dollar exchange rate supports price increase to offset FX headwinds. Paul will comment further on the impact of foreign currencies later in the call. 
Outside of Brazil, we continue to see increasing demand for pre-emergent herbicides in Argentina and products for niche crops in Colombia and Mexico. In Argentina, we see improved conditions with far fewer restrictions on imports and with the leasing of export taxes for key crops. 
In Europe, sales declined approximately 11% as foreign exchange headwinds and lower market volume more than offset commercial synergies from the Cheminova transaction and new product launches in the quarter. A cold snap at the end of the winter impacted the season in certain Western European markets, and we have seen some tightening of demand by growers in an attempt to control costs in the face of persistently low grain prices. Strong demand in Central and Eastern Europe and FMC's transition to Cheminova's direct market access model in Europe partially offset the pullback in market activity in the quarter.
Sales volumes across Europe increased for FMC's legal portfolio, including herbicide and insecticide for cereals. With the benefit of a broader combined portfolio, we believe the business is well-positioned to address market demand in key crops, including cereals and all alginate [ph]. 
Profitability in the region improved meaningfully year-over-year as the move to direct market access, combined with other cost savings from the Cheminova integration, increased operating margins in Europe by about 200 basis points. 
In Asia, we saw increased demand in China and Australia. However, the stronger U.S. dollar, combined with planned product rationalization and poor weather in India and Southeast Asia resulted in a 13% decline in pro forma revenue compared to the prior year quarter. Excluding the impact of currency and planned product rationalization, revenue decreased about 3% driven largely by lower sales volume in India.
Globally, we expect the challenging market conditions to persist for the remainder of the year. As previously stated, we believe the global crop protection chemicals market will decline by a mid- to high-single-digit percentage in 2016 on a U.S. dollar basis, driven largely by market conditions in North America and Brazil.  We remain highly focused on decreasing FMC product inventory levels in the channel, holding on price and term and increasing collections of accounts receivable. 
Our full year guidance for Ag Solutions remains unchanged. We continue to forecast full year revenue of between $2.3 billion and $2.5 billion and full year segment earnings in the range of $380 million to $420 million. In the second quarter, we expect to deliver segment earnings in the range of $90 million to $110 million, along with sequential margin improvement as we move toward the main selling season in North America and Europe. 
Turning next to Health and Nutrition on Slide 5. First quarter performance for Health and Nutrition was broadly in line with expectation. The business reported revenue of $192 million and segment earnings of $47 million. First quarter 2016 revenue declined approximately $19 million compared to the first quarter of last year. 
As discussed on our fourth quarter earnings call, last year's first quarter revenue included certain omega-3 sales which were not expected to occur in 2016. These sales relate principally to pharmaceutical API products and account for a decline in the revenue compared to the prior year period.  Excluding these sales volume and the impact of currency, revenue was essentially flat compared to last year. 
Global demand for FMC's health excipient products continues to grow, resulting in higher sales volume of minor and [indiscernible] products in the quarter. However, lower sales in functional health due to timing and the more competitive omega-3 pricing environment broadly offset the increase in health excipient revenue. 
For the first quarter 2016, Health and Nutrition reported segment earnings of $47 million while lower operating costs resulted in an increase in segment earnings margin to 24.6%. 
Looking forward, we continue to expect full year revenue in the range of $775 million and $825 million, and segment earnings of between $198 million and $208 million, driven principally by continued growth in demand for MCC-based health excipients and nutritional ingredients in North America and Asia and lower operating cost from ongoing manufacturing excellence program and process technology improvement. 
We expect Health and Nutrition second quarter segment earnings of between $49 million and $53 million with a sequential improvement in segment earnings margin in the quarter.
Turning to Lithium on Slide 6. Lithium delivered an outstanding quarter. Compared to the first quarter of 2015, revenue increased 8% to $60 million and segment earnings almost threefold to $14.9 million. Segment's operating margin climbed from under 10% last year in Q1 to almost 25% this quarter. These results reflect the impact of our strategy to focus on the downstream specialty markets.  As a result of our advantaged process technology and ability to manage sales mix, FMC is uniquely positioned to serve the higher growth and higher-value specialty segments while maintaining the flexibility to take advantage of favorable market conditions in lithium carbonate and chloride.
Demand trends across specialty end markets remain strong. Demand for lithium hydroxide for energy storage and electric vehicle, or EV applications, continues to grow at double-digit rates. Our success in increasing throughput from our existing hydroxide asset allow FMC to deliver higher sales volume in the quarter. In addition, we managed our production mix in order to optimize our sales of butyllithium and high-purity lithium minerals. 
Favorable market conditions supported price increases across the FMC portfolio. We continue to realize price increases for lithium hydroxide, while our approach to the carbonate and chloride market is allowing us to achieve meaningful price increases from this limited sales volume. The extent to which carbonate and chloride prices remain elevated will depend on how quickly new supply comes online. We expect market supply of all product to remain tight in the near to midterm.
Lower operating cost, coupled with higher specialty sales volume and price increases, resulted in significant increases in segment earnings and margins in the quarter. Manufacturing efficiencies from ongoing process improvement initiatives and lower cost associated with the natural gas pipeline installed in 2015 reduced operating cost by more than $5 million year-over-year, helping to drive the increased operating margin in the quarter. 
We expect the second quarter to be another strong period for the Lithium business. We continue to shift our sales mix to grow our specialty product line, serving markets such as UVs [ph] and polymers while capitalizing on favorable market conditions in lithium carbonate. However, we expect to have slightly lower available carbonate volumes in Q2 compared to Q1, as a result of lower seasonal production in Argentina.
Consequently, we expect quarter segment earnings to be in the range of $10 million to $14 million and segment earnings margin in the range of 19% to 20%. Based on Lithium performance to date and our expectation for the remainder of 2016, we are raising our full year outlook for the Lithium business. We now expect full year revenue to be between $245 million and $265 million and segment earnings to be in the range of $43 million to $53 million, up $10 million from the prior range. 
Moving next to our outlook for the second quarter and full year 2016 on Slide 7. I previously commented on the outlook for each business for both Q2 and the full year. As I mentioned, we are maintaining segment earnings guidance for the full year for both Ag Solutions and Health and Nutrition. Segment earnings guidance for the second quarter reflect normal earnings level for these businesses based on our expectation for 2016. We are increasing the full year segment earnings guidance for Lithium, as stated earlier. 
On a consolidated basis, we are increasing full year 2016 adjusted earnings per share by $0.05 versus previous guidance to a range of $2.55 to $2.85, and we expect second quarter 2016 adjusted earnings to be between $0.62 and $0.72 per share. 
I will now turn the call over to Paul to discuss select financial results, including taxes, foreign exchange and cash flow."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thank you very much, Pierre. As usual, I'll start with the income statement and specifically the tax rate. Our adjusted effective tax rate fell from 27.5% in the first quarter 2015 to 26% in Q1 '16. Part of this was the continued change in the mix of ou",742,"Thank you very much, Pierre. As usual, I'll start with the income statement and specifically the tax rate. 
Our adjusted effective tax rate fell from 27.5% in the first quarter 2015 to 26% in Q1 '16. Part of this was the continued change in the mix of our earnings, away from the U.S. and Brazil and towards Europe and Asia where rates are typically lower. We continue to take steps to increase our tax efficiency and expect that the full year rate will come in somewhere in the 24% to 26% range. 
A theme in our earnings in recent quarters has been the impact of foreign currency movements, and the movement in the Brazilian real has been a particular area of focus. In the first quarter, the average rate of the real to the dollar was 3.9, significantly weaker than the 2.87 average of the same quarter a year ago. However, the total impact on our earnings was far less than we have seen in prior quarters for 2 main reasons. First, as you know, Q1 is not a large selling quarter for us in Brazil, reducing the impact of currency move. Also, since we have not seen particularly volatile movements in the currency, our price list has been able to reflect the new currency levels for the entire quarter. As a result, the $13 million headwind created by the weaker real year-on-year was completely offset by price increases. In fact, the positive impact of the weaker real on our cost base meant the change in the real was actually a net positive to our income statement in Q1. 
Looking to the rest of the world, although a number of Asian currencies collectively reduced earnings, the only major currency in which we faced a headwind in the quarter was the euro, which devalued by 2% versus the same period last year. The net hit to operating earnings from currency movements in the quarter was approximately $14 million. 
A second common theme on our earnings has also been the challenges of operating in Argentina, including areas such as import license restrictions, negative impacts of export duties and the headwind created by the disconnect between cost inflation and the pace of devaluation of the peso against the dollar. Since the election of Macri as President, we've seen a rapid shift in all of these areas to the benefits of our operations in Ag Solutions and especially Lithium. The devaluation of the peso had a relatively limited impact on our earnings in the quarter in Lithium since the lower cost of operations takes 1 to 2 quarters to work its way out of inventory and into the income statement. And our earnings guidance for 2016 reflects this lower cost of operations. We remain cautiously optimistic that the business environment in Argentina will remain positive and will continue to create opportunities for FMC. 
Turning to the balance sheet and cash flow on Slide 8. Q1 is historically the period in which we consume the most cash given the seasonal nature of our Ag business. However, discipline around spending, the increased focus last year on sales terms, and of course the ongoing collection measures globally resulted in an improvement of operating cash flow of over $100 million compared to the same quarter last year. Cash flow was helped by higher EBITDA and a better performance around working capital, most notably from collection of receivables. This improvement was seen in all regions.  With certain cash outflows, particularly capital spending and pension expenses also lower than last year, we were able to hold net debt flat during the quarter. 
As noted in our filing of March 28, we elected to amend the debt covenants for our term loan and revolver, deferring the timing of step downs of our leverage ratios such that we retained the covenant limit of 4.5x for Q1. Our actual leverage ratio under the covenant calculation was 4.0x giving the half a turn of headwind that we consider to be prudent. 
Looking to the rest of the year, adjusted cash from operations is forecasted in the range of $450 million to $550 million, an improvement over last year of over 1/3 of the midpoint of the range. This is driven by improvements in both EBITDA and working capital performance. Capital expenditure will remain broadly flat to 2015 in the $120 million to $140 million range.
And with that, I will turn the call back to Pierre."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Paul. To conclude, we continue to expect the challenging market in Ag Solutions, but we are managing the business to increase visibility and to protect both price and term. As a result, we continue to expect full year earnings to be in line wit",106,"Thank you, Paul. To conclude, we continue to expect the challenging market in Ag Solutions, but we are managing the business to increase visibility and to protect both price and term. As a result, we continue to expect full year earnings to be in line with prior guidance. 
Health and Nutrition is performing largely in line with expectations, and Lithium is well ahead of our initial forecast. The portfolio transformation is done. We are now in execution mode, targeting year-over-year earnings growth for each of our 3 businesses. 
Thank you for your attention, and I will now turn the call back to the operator for questions."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] And the first question comes from Mr. Parkinson from Crdit Suisse.",13,"[Operator Instructions] And the first question comes from Mr. Parkinson from Crdit Suisse."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","You mentioned in your presentation that Central and Eastern Europe were showing solid demands. But can you comment on the pricing landscape given the FX headwinds there as well, and whether or not you're able to offset that? And then also on the demand fr",77,"You mentioned in your presentation that Central and Eastern Europe were showing solid demands. But can you comment on the pricing landscape given the FX headwinds there as well, and whether or not you're able to offset that? And then also on the demand front, do you believe the growth was simply driven by the market? Or do you believe there is any benefit from adding the FMC portfolio to the legacy Cheminova one in the region?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think on the Central and Eastern Europe, the pricing is pretty stable and it's not a very, very large market. Interesting for us because there is a strong possibility to increase volume. But pricing is quite stable. And I think, definitely, the growth i",98,"I think on the Central and Eastern Europe, the pricing is pretty stable and it's not a very, very large market. Interesting for us because there is a strong possibility to increase volume. But pricing is quite stable. And I think, definitely, the growth is one of the place where FMC had no structure in Central and Eastern Europe, where it was an area of focus for Cheminova. So definitely, a place where using the infrastructure and commercial organization from Cheminova and bringing in the product portfolio for FMC is going to create some significant opportunities for us."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Perfect. And just kind of a tangent question to that one. Given the progression of cost savings, with Cheminova clearly going well, can you just comment on the other geographies as far as intermediate to long-term revenue synergy opportunities inclusive o",53,"Perfect. And just kind of a tangent question to that one. Given the progression of cost savings, with Cheminova clearly going well, can you just comment on the other geographies as far as intermediate to long-term revenue synergy opportunities inclusive of the U.S., and then also in Latin America with Argentina in particular?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes. Chris, this is Mark. We've talked about North America in the past. And in the U.S., we're seeing very good synergies with the fungicide portfolio from Cheminova going through our distribution network. In Latin America, obviously, Brazil in the South,",123,"Yes. Chris, this is Mark. We've talked about North America in the past. And in the U.S., we're seeing very good synergies with the fungicide portfolio from Cheminova going through our distribution network. In Latin America, obviously, Brazil in the South, we're seeing increased sales through co-ops where we've made decisions which co-ops and which distribution network we'll go through. Argentina's certainly very beneficial for us. Obviously, we have a bigger footprint there now. We have the right products for the soy market, so we're expecting to see growth in Argentina. And then in other parts of Latin America, I would say, obviously, Mexico, Colombia are 2 countries that we're focused on and we're seeing very good synergies in Colombia on these crops."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think when we did the last earnings call, as well as multiple discussion we all had, we've been talking about this year getting to $100 million -- $50 million to $100 million run rate in between the synergies and the new products and very much on track",79,"I think when we did the last earnings call, as well as multiple discussion we all had, we've been talking about this year getting to $100 million -- $50 million to $100 million run rate in between the synergies and the new products and very much on track with that. So it is a place, I think, the opportunities created by Cheminova, from a cost saving and the revenue synergies, are very much in line with what we're expecting."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Your next question comes from the line of Frank Mitsch with Wells Fargo Securities.",14,"Your next question comes from the line of Frank Mitsch with Wells Fargo Securities."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, when you were talking about the ag business, you were talking about some positives with respect to the glyphosate resistance in terms of providing a boost. I was wondering if there was a way for you to kind of quantify it? And in terms of where yo",80,"Pierre, when you were talking about the ag business, you were talking about some positives with respect to the glyphosate resistance in terms of providing a boost. I was wondering if there was a way for you to kind of quantify it? And in terms of where you see that over the next 18 months or so? And then what sort of concerns may you have about some new technologies that Monsanto and others are rolling out in that area?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes, Frank, it's Mark. I think for us when we look at glyphosate resistance, we're really talking about the U.S., Argentina as the 2 big markets. I think you know that through our Authority brands based upon Sulfentrazone, we've had great success in the p",126,"Yes, Frank, it's Mark. I think for us when we look at glyphosate resistance, we're really talking about the U.S., Argentina as the 2 big markets. I think you know that through our Authority brands based upon Sulfentrazone, we've had great success in the pre-emergent area in both of those countries. I expect that to continue. There will be some headwinds with new technologies coming in. But I think to offset that, we still see more ways to get in resistance to glyphosate and more acres increasing, especially in Argentina. It wouldn't surprise me if we don't start to see that in the next few years, start to develop in Brazil as well, and we're already positioning our brands in Brazil on soy for that area."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Okay, that's very helpful. And as you think about some of the combinations coming -- some of the major combinations in the ag chem world coming over the next 12 months or less, how do you see yourselves perhaps participating and picking up some pieces the",58,"Okay, that's very helpful. And as you think about some of the combinations coming -- some of the major combinations in the ag chem world coming over the next 12 months or less, how do you see yourselves perhaps participating and picking up some pieces there? What's the interest level? Talk about your participation in industry consolidation here."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Well, Frank, as you know, we made a move, which was in line with what was our strategic intent by acquiring Cheminova. We have now a stable situation from a structural standpoint in Ag. We're finishing up on the integration. What we intend to do at this s",165,"Well, Frank, as you know, we made a move, which was in line with what was our strategic intent by acquiring Cheminova. We have now a stable situation from a structural standpoint in Ag. We're finishing up on the integration. What we intend to do at this stage is watch what is happening, specifically in places when 2 ag companies are coming together. So every time there will be consolidation of ag companies, if at any point during this process, there is -- because of antitrust reason, products which are made available, that is something we are usually very good at doing, which is taking a product and commercializing that with our own sales organization. So we're going to be opportunistic. But it's certainly something we will be able to afford to do and we'd be very interested in doing. Beyond that, do not expect us making any major move in acquiring any type of company. It will be an acquisition of technology and products."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Daniel Jester with Citigroup.",12,"Our next question comes from the line of Daniel Jester with Citigroup."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Maybe a couple of questions on Lithium. Price mix was a 4% benefit in the quarter. But by some kind of spot measures, lithium prices were much higher. So can you just kind of elaborate as to how we should be thinking about pricing, kind of commodity  and",60,"Maybe a couple of questions on Lithium. Price mix was a 4% benefit in the quarter. But by some kind of spot measures, lithium prices were much higher. So can you just kind of elaborate as to how we should be thinking about pricing, kind of commodity  and spot sales versus the contract market as we continue throughout the year?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes. If you think about our Lithium business, look at strategic price increase in place where we are technologically advantaged in grain  markets where we have significant contract, which are renewed every year, like in lithium hydroxide. And then think a",185,"Yes. If you think about our Lithium business, look at strategic price increase in place where we are technologically advantaged in grain  markets where we have significant contract, which are renewed every year, like in lithium hydroxide. And then think about on the chloride and carbonate side for what is not used for internal purpose or sold in the contract, we are using the spot market to do one-off price increase. We believe that situation is going to carry on for the next few quarters. I think the market will remain tight, which will allow us to use the spot market in the more commodity businesses like chloride and carbonate to increase price on a spot basis. And where we are with opportunities, where people need our technology or product, we would be increasing price on contract when contract are being renewed. So it is a situation which we see fairly, fairly stable for the future. If you look at our increase in guidance for the Lithium business, most of it is going to be -- of the over performance will be due to pricing."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then just sticking with Lithium, you commented that you think the outlook is going to be tight in the near to medium term. Can you just flesh out a little bit about what's your expectations are for supply additions over the coming years?",45,"Okay. And then just sticking with Lithium, you commented that you think the outlook is going to be tight in the near to medium term. Can you just flesh out a little bit about what's your expectations are for supply additions over the coming years?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Well, I cannot comment too much beyond what all of you know on the lithium carbonate side, because that's a decision of the people who have announced capacity increase. So I'm sure ADAMA, when they talk on their earnings, will be able to tell more about t",111,"Well, I cannot comment too much beyond what all of you know on the lithium carbonate side, because that's a decision of the people who have announced capacity increase. So I'm sure ADAMA, when they talk on their earnings, will be able to tell more about the timing. But we believe [indiscernible] and we believe also some Chinese or Australian company will be bringing carbonate capacity in the next couple of years. We, ourselves, are focused more on the downstream and we will bring -- in time, and we'll bring more detail in the weeks to come, but we'll be focusing more on increasing lithium hydroxide capacity as we need it."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","And next, we'll go to Mike Harrison of Seaport Global.",10,"And next, we'll go to Mike Harrison of Seaport Global."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, if we could just continue on the Lithium front. I was -- I guess I was just surprised to see that the -- you put up a $15 million quarter in Lithium and your guidance is only calling for $43 million to $53 million for the full year. What's going t",80,"Pierre, if we could just continue on the Lithium front. I was -- I guess I was just surprised to see that the -- you put up a $15 million quarter in Lithium and your guidance is only calling for $43 million to $53 million for the full year. What's going to change during the remainder of the year that would suggest that earnings could be lower than the Q1 level as we get through the rest of the year?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes, I'll ask for Tom to comment with me. But as we said on the script, remember, there is seasons in terms of manufacturing in Lithium, and we are getting into a period where -- which is the winter part of the season. And we're going to have more rain an",160,"Yes, I'll ask for Tom to comment with me. But as we said on the script, remember, there is seasons in terms of manufacturing in Lithium, and we are getting into a period where -- which is the winter part of the season. And we're going to have more rain and more snow and conditions which are going to limit more, to some extent, our production of carbonate. So what we're expecting in the next 3 quarters is less carbonate available because of our manufacturing, like most people operating in this part of the world, in the next couple of quarters. On the positive side, our costs continue to be good and our pricing will be positive. So it's a differential between all of these which create maybe a little bit of a -- less of a novel performance in the remaining 3 quarters than we have in the first quarter otherwise. You want to add anything, Tom, to this?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think if you look historically at the earnings, the seasonality has been there. We're doing what we can to reduce volatility, but that seasonality is going to remain where the first and fourth quarter give us the most volume and flexibility on the",49,"Yes. I think if you look historically at the earnings, the seasonality has been there. We're doing what we can to reduce volatility, but that seasonality is going to remain where the first and fourth quarter give us the most volume and flexibility on the mix we can sell."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","And then as I think about some of the lithium carbonate that you're actually purchasing to convert to hydroxide, are you experiencing higher raw material cost for that? Or do you have lower prices locked in for the year and you're actually getting a margi",55,"And then as I think about some of the lithium carbonate that you're actually purchasing to convert to hydroxide, are you experiencing higher raw material cost for that? Or do you have lower prices locked in for the year and you're actually getting a margin benefit for some of that raw material you're purchasing?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes. As we -- first, as you know, most of the carbonate, by a long shot, we use is produced by us. So what we are buying under contract today versus the overall usage is incremental, and what we are buying is locked under a long-term supply agreement. So",183,"Yes. As we -- first, as you know, most of the carbonate, by a long shot, we use is produced by us. So what we are buying under contract today versus the overall usage is incremental, and what we are buying is locked under a long-term supply agreement. So we are not facing significant price increase in carbonate. If it plays the way we expect it to play, and once again, it's going to have to be confirmed. But the way we look at it is, for now, we are producing enough carbonates and buying enough to run our strategy around chloride, butyllithium, metal and hydroxide. And as time will go, we're going to have to sell more hydroxide. We're going to have to increase our capacity in hydroxide. And we'll have to buy more of carbonate on the external  market, which should be at a time when our peer companies will be increasing capacity and making the product more available in the market. So it looks like all of this is falling in place quite well. Tom, you want to add something?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Thanks for the question. Pierre has it down well. The other thing that we look at always is the incremental things we can do in Argentina. And there are small opportunities for small capital to increase our throughput in Argentina, which gives us some fle",49,"Thanks for the question. Pierre has it down well. The other thing that we look at always is the incremental things we can do in Argentina. And there are small opportunities for small capital to increase our throughput in Argentina, which gives us some flexibility as we go forward."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","So right now, I would say there is no major issue around potential increase in the future of cost in terms of our ability to execute our strategy around carbonate and hydroxide.",32,"So right now, I would say there is no major issue around potential increase in the future of cost in terms of our ability to execute our strategy around carbonate and hydroxide."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Next, we'll go to the line of Mike Sison with KeyBanc.",11,"Next, we'll go to the line of Mike Sison with KeyBanc."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, when you think about -- you didn't change your outlook for crop protection markets this year. I understand it's still difficult out there. But it does sound like you're feeling better about the integration and maybe the long-term potential. Can yo",58,"Pierre, when you think about -- you didn't change your outlook for crop protection markets this year. I understand it's still difficult out there. But it does sound like you're feeling better about the integration and maybe the long-term potential. Can you maybe map out where Ag Solutions op income can go over time as, hopefully, things recover?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes, let me -- I'll tell you the way we look at Ag Solutions right now. First, let me talk about the ag market as we see it for this year. I think we are not changing our view for 2016. We still believe it's a mid-to-high single digit downmarket, mostly d",445,"Yes, let me -- I'll tell you the way we look at Ag Solutions right now. First, let me talk about the ag market as we see it for this year. I think we are not changing our view for 2016. We still believe it's a mid-to-high single digit downmarket, mostly driven by North America and Brazil within -- in the high-teens, and maybe Asia and Europe to the low -- sorry, in the high-single digits, while Europe and Asia would be in the low- to mid-single-digit decrease. So we are not changing our view. It could be maybe trending more toward the high-single digit overall global market. The way -- and why do I feel better about the way we are operating in the ag market? It is not because we are seeing a fundamental change in the market in the short-term. But what I think we are doing at FMC, I think the key difference is that we know better how to operate in this type of market. I can tell you, you see it on our numbers, we are not fighting to keep market share on sales of product. We are much more looking at 3 types of objectives. First, it's very important for us and focusing only on FMC product is to decrease FMC product in the channels. The second aspect is we want to be able, by doing that, to focus more on the quality of the sales, which is more term, price and collection. And then, looking at all of that, the objective is to align more sales with a normal demand pattern. You see that on the numbers in Q1 in North America. Sales down 35%, I think, on page -- on Slide 4, while product on the ground were up above market, 7%. So the way we are operating in the market today, I believe we have more control over our selling process than we might have had in the past when we got hit by the downturn. Beyond that, I would say -- I would not exclude the market to turn around in 2017, but I have no indicators telling me that it will be the case. So I think we are much more focused, Mike, on operating under the current conditions with very high control on term, price, managing very closely with -- in partnership with the customers, our inventory, to create much more predictability in our sales. So that's where the level of confidence, for me, is increasing at this stage. Market turnaround, I think we'll have to wait a little bit more and certainly to go into Q3, Q4 to have more visibility."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then Paul I thought you said at the current levels where the real is at, that it's -- is it going to be a negative this year or is it a positive? I just wanted to make sure I understood your commentary around foreign currency there.",48,"Okay. And then Paul I thought you said at the current levels where the real is at, that it's -- is it going to be a negative this year or is it a positive? I just wanted to make sure I understood your commentary around foreign currency there."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","That's the million-dollar question with the real. I mean, the truth is that the stability or the predictability in the movement in the real is really what matters to us . We've talked about it in the past with regard to the timing of changes and the pace",250,"That's the million-dollar question with the real. I mean, the truth is that the stability or the predictability in the movement in the real is really what matters to us . We've talked about it in the past with regard to the timing of changes and the pace of changes. Q1 and Q2 just aren't really periods in which we have a lot of commercial activity going on in Brazil. So it's really what it does in Q3.  And again, it isn't so much the level -- we've shown that in Q1, where with an average rate of 3.9, today, it's closer to 3.5. We were able to still capture pricing on a limited number of sales that we have in Q1. The question will come in Q3, how stable, how predictable is the real? In the rest of the world, I mean, you look at the forward curves of the currency, it does not feel like a strengthening dollar is what the market is expecting. And so that, generally speaking, is what's factored into our numbers, relative predictability, not a big strengthening of the dollar around the world. Q1 feels like -- when you look at where the dollar is today compared to a year ago, Q1 feels like the last of the quarters that we had those tough FX comps. So subject to any changes away from where the market expects today doesn't feel like currency will be quite the high-level story that it was last year."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Joel Jackson with BMO.",12,"Our next question comes from the line of Joel Jackson with BMO."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","You have really guided up your operating cash flow projections for the year by $50 million, but raised your EBIT projections by about $10 million. Can you give us a sense where the big delta is coming in the operating cash flow? Is it really an improvemen",50,"You have really guided up your operating cash flow projections for the year by $50 million, but raised your EBIT projections by about $10 million. Can you give us a sense where the big delta is coming in the operating cash flow? Is it really an improvement in working capital?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Sure. It's a pretty straightforward story. We clearly have an increased expectation around EBITDA. But the truth is, it's largely around working capital. And you have to bear in mind that if you look over the last few years, 2 years ago, we had a terrible",178,"Sure. It's a pretty straightforward story. We clearly have an increased expectation around EBITDA. But the truth is, it's largely around working capital. And you have to bear in mind that if you look over the last few years, 2 years ago, we had a terrible performance with working capital with largely cash outflow. Last year, we turned the corner and sort of stopped the bleeding and improved it a slightly. But this year, we expect that trend to continue so that working capital becomes a positive generator of cash flows. Our biggest focus is always going to be the Brazil receivables balance and getting that receivables balance down. But we're also be very, very focused on inventory levels, our own inventory levels, and making sure that we are very efficient and very thoughtful about what inventory we hold, where we hold it and how much of it we hold. So it's coming in multiple different areas, but you really should be looking at working capital as the primary driver of the increase in cash flow for 2016."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","I'm sorry if this is asked already's, but in terms of synergies from Cheminova, $60 million to $70 million for the year, do you still maintain that? And maybe give us how much more you think you can still get in 2017 versus prior guidance?",46,"I'm sorry if this is asked already's, but in terms of synergies from Cheminova, $60 million to $70 million for the year, do you still maintain that? And maybe give us how much more you think you can still get in 2017 versus prior guidance?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","[indiscernible]",1,"[indiscernible]"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Synergies in '16, $60 million to $70 million, still our guidance? And how much  more will we gain.",18,"Synergies in '16, $60 million to $70 million, still our guidance? And how much  more will we gain."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes, we are not changing the -- actually, we still have the same numbers. So the numbers we've been talking about $60 million to $70  million, are very well in line. And a full run rate of 140  to 160, getting into the middle of next year, are also still",62,"Yes, we are not changing the -- actually, we still have the same numbers. So the numbers we've been talking about $60 million to $70  million, are very well in line. And a full run rate of 140  to 160, getting into the middle of next year, are also still the target. So there is no change in our numbers right now."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Steve Byrne with BOA.",12,"Our next question comes from the line of Steve Byrne with BOA."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","In the U.S. crop protection market, are you seeing any increased discounting or bundling by your competitors? And do you see any risk of perhaps maybe losing some shelf space in the retail channel from allowing your product inventories to be trimmed?",43,"In the U.S. crop protection market, are you seeing any increased discounting or bundling by your competitors? And do you see any risk of perhaps maybe losing some shelf space in the retail channel from allowing your product inventories to be trimmed?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think whenever you talk about terms and pricing, we want to be highly cautious and slowly comment about what we do. Our strategy today is quite simple. We are highly focused on maintaining our  pricing at a healthy level. We are very vigilant on terms.",274,"I think whenever you talk about terms and pricing, we want to be highly cautious and slowly comment about what we do. Our strategy today is quite simple. We are highly focused on maintaining our  pricing at a healthy level. We are very vigilant on terms. As you know, balance sheet is always a key challenge for a company like us. And more than ever, we are highly disciplined on terms and not giving terms. What it means for us -- and I'm only talking for FMC. What it means for us is, certainly, we are prepared to see timing change in ourselves. And that's what I've been talking about. We're not being willing to do anything to push product in the market if there is not a complete need from this product -- for this product by the market. Space shelves is a word we use a lot. But when you have technical product to be sold, both production know they are needed, and then you have commercial contract with customers. So it is not a situation where because we are aligning ourselves with the market demand that we are taking an enormous risk to see somebody taking our shelf space by the end of the year and not -- us not being able to sell our product. For example, Mark talked about our Authority product line. It's a pre-emergent product. It's required. Needs to be bought in Q4 and Q1. We know this product will be sold. So I think our strategy might be a big differentiator, but we are only focusing on ours along the line of what we discussed before."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","And Pierre, considering your comment about Authority, would you say that the outlook for eventual penetration of the Xtend and the Enlist soybean products, does that -- is that a risk to your Authority franchise within the Americas? Or could you see that",69,"And Pierre, considering your comment about Authority, would you say that the outlook for eventual penetration of the Xtend and the Enlist soybean products, does that -- is that a risk to your Authority franchise within the Americas? Or could you see that as potentially an opportunity where you might expand your herbicide franchise and move more over the top and bring in formulations with either 2,4-D and Dicamba."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Yes. Steve, this is Mark. We talked about it earlier. I got a question earlier about whether we thought it would be a headwind or a tailwind. I think in the initial stages, I expect rates to be reduced. Good news is, we know with Enlist and Xtend that the",195,"Yes. Steve, this is Mark. We talked about it earlier. I got a question earlier about whether we thought it would be a headwind or a tailwind. I think in the initial stages, I expect rates to be reduced. Good news is, we know with Enlist and Xtend that they will still be recommending the use of pre-emergent herbicides, of which Authority is one of the market leaders. So we know we're going to have a substantial market there. I would say weed-resistant acres continue to grow, so we're going to see that pre-emergent continuing, certainly in the U.S,  and as I said earlier, in Argentina. I think from an over-the-top perspective, I mean, we have some very good products that we're going to be promoting, such as our Cadet herbicide, which we think will be a great tank mix partner for those products and really offer a broader spectrum of control. Don't expect to see us in 2,4-D and Dicamba. That's not just the sort of business we're going to be in. We're going to be in the more differentiated products, more highly specialized where we can bring value to the growers and distribution."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Next, we'll go to the line of Mark Connelly with CLSA.",11,"Next, we'll go to the line of Mark Connelly with CLSA."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, the trend among food companies to reformulate to simplify is clearly getting faster. How much is that reformulation trend actually helping you, do you think? And do you think about it as a tailwind?",35,"Pierre, the trend among food companies to reformulate to simplify is clearly getting faster. How much is that reformulation trend actually helping you, do you think? And do you think about it as a tailwind?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think the food market, for us, there is an acceleration of -- the way we look at our market in nutrition and in health are interesting. In health, the good news is when you're with a customer, you're there for a while, because you're not being reformula",163,"I think the food market, for us, there is an acceleration of -- the way we look at our market in nutrition and in health are interesting. In health, the good news is when you're with a customer, you're there for a while, because you're not being reformulated out easily. The problem with that is it's not easy to gain new business. Well, the same apply to food, but the reverse. I think there is a trend to reformulate transformulation. There is a very fast cycle, which gives opportunities for us. So the stronger we are with a product, the more opportunities. But by the same token, also opens the door for new product and competitors. So I would say, today, it could be slightly a tailwind, knowing that we are maybe the largest market shareholder and maybe the more complete product line. But I don't see that as a major change from the past. Eric, you want to add some comments there?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I would say we see it as a trend. This is Eric, Mark. Eric Norris. I see it as a trend. We see it as a trend, like many others that have come and go in the industry. The industry is very fad-based, so to Pierre's point, unlike the health markets where the",180,"I would say we see it as a trend. This is Eric, Mark. Eric Norris. I see it as a trend. We see it as a trend, like many others that have come and go in the industry. The industry is very fad-based, so to Pierre's point, unlike the health markets where there's very little change over periods of time. There's a great deal of change from every 2 or 3 years, whether it's low-fat Atkins, and now, this simplification clean-label phenomenon. It really does come down to the breadth of product line we have. The fact that they're well-suited being all-naturally based. And then having the applications capability to respond to them at -- in the right places around the world, having a spread of knowledge in the right places and your customers. So we're well-positioned for it. Anytime there's a reformulation, there's a challenge, right? So it does create an effort in our part to respond. Going forward, we see it as a tailwind though, for us, given the breadth of our product line and our application capabilities."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Eric, in Pierre's comments you talked about product differentiation. Can you talk about how you think about product differentiation?",19,"Eric, in Pierre's comments you talked about product differentiation. Can you talk about how you think about product differentiation?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","In -- specifically in the food market?",7,"In -- specifically in the food market?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Sure. Yes.",2,"Sure. Yes."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","It comes down to understanding very well not only what's going on with your direct customer, the large food or small food company, but with consumers. And being able to put together a formulation that meets the needs. So product differentiation for us is",127,"It comes down to understanding very well not only what's going on with your direct customer, the large food or small food company, but with consumers. And being able to put together a formulation that meets the needs. So product differentiation for us is less about proprietary technology, intellectual property such as a patent that might drive more what happens in our Ag business. It's more about the know-how, being able to put a sum of ingredients together that meets a specific need and understanding either color, texture or taste issues that might impact the success of that brand. So it really comes down to the differentiation around the application and the ingredients we bring as opposed to a proprietary ingredient in the food product itself."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Brett Wong with Piper Jaffray.",13,"Our next question comes from the line of Brett Wong with Piper Jaffray."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, you were talking about kind of the overall crop chem market and the focus that FMC is going to have in terms of working inventory down and being disciplined on price and terms. So I just want to get a clarification. So if others are -- or the comp",82,"Pierre, you were talking about kind of the overall crop chem market and the focus that FMC is going to have in terms of working inventory down and being disciplined on price and terms. So I just want to get a clarification. So if others are -- or the competitors are not acting rationally and pushing product in the market when the product doesn't need it, as you were saying, FMC is not going to be participating in that kind of activity?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Listen, I don't know what strategy our competitors are operating around market push of product discount. In our rationale, they intend to be -- I think what we've made as a decision, and that's a decision we've made globally. We believe we are in a situat",266,"Listen, I don't know what strategy our competitors are operating around market push of product discount. In our rationale, they intend to be -- I think what we've made as a decision, and that's a decision we've made globally. We believe we are in a situation where the markets are such and the level of inventory in the channel are such, that you can't guide your activity by what the others are doing. I think we have a plan in place. We are working very, very closely in cooperation with our customers who understand our strategy. We are not going to try to sell in Q1 or Q2 or Q3 a product which is needed in Q4. And in exchange, we maintain a healthy pricing and terms situation. And that's what we're going to be focusing. I believe what we're going to do during this downturn. And until this turns around, we are not going to work, hoping that the overall level of inventory in the market channel is going to go down. I think it's too tall of an order and too impractical. So we're going to be focusing solely on FMC product. I think the numbers are quite spectacular. I said that many times, 34% sales down in the first quarter; North America, plus 7% growth on the ground. That is millions of dollars of inventory which are outside of our customers' inventory which they will need to replenish when the market need it. And that's the way we are operating. Our competitors will have to use the strategy which is appropriate for them."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then just focusing again on inventory. Obviously, in the quarter, your inventories were significantly elevated due to the strategy that you're speaking of. Can you just talk about the timing that you expect to be able to work through that invent",78,"Okay. And then just focusing again on inventory. Obviously, in the quarter, your inventories were significantly elevated due to the strategy that you're speaking of. Can you just talk about the timing that you expect to be able to work through that inventory along with what the channels going to be doing? And then ultimately, I think you said you expect improvements in the second half in North America. Can you just talk a little bit about that?"
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","I think the way we look at it -- and there was a question before. I think it's Michael who asked that question around the level of confidence in the market. I think our strategy today allow us to have more visibility in terms of the timing and level of ou",165,"I think the way we look at it -- and there was a question before. I think it's Michael who asked that question around the level of confidence in the market. I think our strategy today allow us to have more visibility in terms of the timing and level of our sales, because we become less dependent upon what the market is doing and rushing to place sales to be safe and have those on the shelves. So what it does to us, it creates more predictability and maybe increase the level of confidence of how the quarters ahead of us are going to be unfolding. We know -- I mean, we know, which product will be required, usually, which technology will be required depending upon the season in Q4 and Q1 and Q2. And that's a discussion we have with our customers and that's the way we're operating right now. So it's just giving us a bit more certainty on how things will unfold."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","Our last question comes from the line of Aleksey Yefremov of Nomura Securities. That was our last question. Please go ahead.",21,"Our last question comes from the line of Aleksey Yefremov of Nomura Securities. 
That was our last question. Please go ahead."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Executives","Okay. Well, that's all the time we have for the call today. I want to thank everyone for joining. I'll be available for the rest of the day to go through any additional questions. Again, thank you. Have a good day.",41,"Okay. Well, that's all the time we have for the call today. I want to thank everyone for joining. I'll be available for the rest of the day to go through any additional questions. Again, thank you. Have a good day."
28606,330161312,971397,"FMC Corp., Q1 2016 Earnings Call, May 03, 2016",2016-05-03,"Earnings Calls","FMC Corporation","Operator","And that's all the time we have for today. This concludes the FMC Corporation First Quarter 2016 Earnings Release Conference Call. Thank you.",24,"And that's all the time we have for today. This concludes the FMC Corporation First Quarter 2016 Earnings Release Conference Call. Thank you."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the Second Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] As a reminder, today's conference is being recorded. And I would now turn the conference over to Brian Angeli, Vice Presiden",50,"Good morning, and welcome to the Second Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] As a reminder, today's conference is being recorded. And I would now turn the conference over to Brian Angeli, Vice President of Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning. Welcome to FMC Corporation's Second Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.Pier",275,"Thank you, and good morning. Welcome to FMC Corporation's Second Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.
Pierre will begin the call with a review of FMC second quarter performance and discuss the outlook for Q3 and the full year 2016. Paul will provide an overview of select financial results. The slide presentation that accompanies our results, along with our earnings release and 2016 outlook statements, are currently available on our website and the prepared remarks from today's discussion will be made available at the conclusion of the call.
As with our prior calls, Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, will join to address questions.
Before we begin, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including but not limited to, those factors and they divide in our earnings release and then our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based on these risks and uncertainties.
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms, as well as other non-GAAP financial terms to which we may refer during today's conference call, are provided on our website.
With that, I will now turn the call over to Pierre."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian, and good morning, everyone. As you can see on the first slide, for the second quarter of 2016, FMC reported revenue of $810 million and adjusted operating profit of $143 million. Adjusted EPS of $0.69 was $0.01 below the second quarter o",2107,"Thank you, Brian, and good morning, everyone. As you can see on the first slide, for the second quarter of 2016, FMC reported revenue of $810 million and adjusted operating profit of $143 million. Adjusted EPS of $0.69 was $0.01 below the second quarter of 2015, but above the mid-point of our guidance range. 
Ag Solutions delivered another solid quarter and it continues to realize the benefits of the Cheminova acquisition. Lithium outperformed on higher sales volumes and higher realized prices across the portfolio with lower operating cost from ongoing Manufacturing Excellence program.
Earnings in Health and Nutrition were below expectations as results in omega-3 were significantly weaker than anticipated. Based on our performance to date and the outlook for the back half of the year, we are increasing full year adjusted EPS guidance by $0.05 to $2.60 to $2.90 per share. I will provide more detail on how that breaks down across each of the businesses shortly. But first, I will discuss second quarter results for each of our 3 segments, starting with Ag Solutions on Slide 2.
Overall, market conditions and our performance in the quarter were in line with our prior expectations. We remained focus on reducing the level of FMC product inventory in the channel and on maintaining discipline on price and terms. We also took actions needed to complete the product rationalization that began in late 2014. 
For the second quarter, Ag Solutions reported revenue of $515 million and segment earnings of $101 million, slightly ahead of the mid-point of our guidance range. Revenue declined 19% compared to the second quarter of 2015, largely due to lower sales volume, unfavorable weather conditions in Europe and Asia, the drawdown of channel inventory by customers in most regions and planned product rationalization all contributed to the decline in volume in the quarter.
Excluding planned product rationalization, revenue declined broadly in line with the crop protection market as a whole. Segment earnings declined 14% compared to 2015, as the impact of lower sales volumes, less favorable product mix in Asia and North America and the stronger U.S. dollar were partially offset by lower operating cost. Compared to pro forma results from Q2 last year, operating margin increased 100 basis points, reflecting pricing discipline, the elimination of sales of low-margin products due to portfolio rationalization and cost savings from the Cheminova integration.
As we move to Slide 3, I will first need a few comments on the global crop protection market, then I will move to review FMC's performance by region and discuss the outlook for Q3 and the full year. So first, the market.
Overall, conditions in the global crop protection market were as expected and it will change from Q1. In North America, soft commodity prices continue to put pressure on some incomes resulting in more cautious bang behavior by growers and elevated inventory levels across the channel. 
In Europe, unfavorable weather conditions early in the quarter, most notably in Central and Western Europe, reduced market demand, leading to lower volumes and increased channel inventory in certain countries. In Brazil, channel inventory across the market remained elevated, especially for insecticide. And while foreign exchange rate have been more stable, growers continue to be negatively impacted by a lack of credit availability.
In Asia, weather conditions were poor across most of the region resulting in weaker market demand. We believe these challenging market conditions will persist for the remainder of the year and we still forecast that the global crop protection chemical market will decline by mid to high single-digit percent in 2016 on a U.S. dollar basis. I will now discuss FMC's performance in light of these market conditions.
First, let me address the lower-than-expected revenue for the quarter. Market in Asia and Europe were weaker than expected, but the main driver of the lower revenue is a more successful and aggressive product rationalization. 
We continue to manage the quality of our sales in order to protect margins, earnings and working capital. In North America, our strategy remained one of the standing price and terms, allowing the level of FMC product inventory in the sales channel to reduce. Although we see point of view that inventory of FMC products in the channel is declining. Reflecting the benefits of the actions we took early in the season to reduce inventory of FMC product in the channel, sales in Q2 increased 5%. We saw strong demand for FMC's authority brand of pre-emergent soybean herbicide and independent data show that the authority brand has taken market share this year. We also saw grower support for the extended fungicide products we can now offer as a result of the Cheminova acquisition.
In Europe, revenue declined by 19%, driven largely by poor weather conditions and reduced volume due to the planned product rationalization, as well as the impact of transitioning to a direct market access model. However, the product rationalization and move to direct market access have resulted in improved operating margins in the region.
In Latin America, revenue declined 43%, primarily as a result of steps we took to reduce the level of FMC product inventory in the South channel in Brazil. We were great by our ability to recover U.S. dollar pricing in the quarter. While not matching to overall segment performance, given the seasonally lower sales volume, realized price increased in Brazil more than offset the negative impact of FX on a reported revenue.
In Asia, the combination of poor weather condition, further portfolio rationalization and the stronger U.S. dollar caused revenue to decline 22% compared to the second quarter last year. Moving on to the outlook for Ag Solutions. 
Our full year segment earnings guidance remains unchanged at $380 million to $420 million. For the third quarter, we expect segment earnings of between $80 million and $90 million. At the mid-point of guidance, second half segment earnings will increase by approximately 35% compared to 2015, driven by improved performance in Brazil and Latin America and additional cost savings from the Cheminova integration. The steps we have already taken to rationalize our product portfolio and reduce the level of FMC inventory in the channel, in the sales channel, leave us well-positioned as we enter the 2016, 2017 crop season in the Americas.
The relative stability of the Brazilian real over the past few months gives us increased confidence in our ability to recapture price despite tightening credit condition from growers and weak market demand as channel inventory levels decline. We expect full year segment earnings margin to be between 17% and 18%, which at the mid-point, represents more than 250 basis points of improvement compared to 2015 driven by more favorable mix, improved pricing in Brazil and realization of cost savings. We remain on track to deliver the incremental cost savings target of $60 million to $70 million in 2016 and the full run rate cost saving of $140 million to $160 million by the middle of next year.
Moving on to Health and Nutrition on Slide 4. The business reported second quarter segment revenue of $195 million and segment earnings of $45 million. Revenue declined approximately 6% and earnings declined approximately 11% compared to the second quarter of 2015. 
Results for the quarter were negatively impacted by worse-than-expected performance of omega-3. The headwinds we saw in omega-3 over the past year increased in the second quarter. Specifically, prices and volumes were much lower than anticipated. There is significant overcapacity in the industry, which, combined with lower demand for higher products, acceptance even greater pressure on prices than we saw earlier in the year. 
We have seen new entrants with business at prices that are close to cash cost of production, resulting in considerably lower volume for our products in several key area. We have aggressively taken costs out of this business with 6 cost falling by almost 40%. We continue to pursue new opportunities for high-end cost alteration products, but do not expect to recover these lost volumes this year and do not anticipate the change in pricing levels any time soon.
Excluding omega-3, results were in line with expectations. In nutritional ingredients, volumes in the quarter were slightly below Q2 2015, largely due to timing as orders shifted to the second half of the year. In health excipients, sales volumes increased in all key pharmaceutical market.
Given performance to date in omega-3 and our expectations for the rest of the year, we are lowering our guidance for Health and Nutrition. We now expect full year segment earnings to be in the range of $190 million to $196 million, roughly flat with 2015, and third quarter segment earnings to be in the range of $44 million to $48 million. We continue to expect operating margins of approximately 25% for the full year. helped by lower operating cost and improved production yields.
Turning next to retail on Slide 5.  Lithium delivered another outstanding quarter. Revenue increased 15% year-over-year to $63 million and segment earnings more than tripled to $16.5 million. Lithium's performance reflect a success of FMC strategy of constructing lithium carbonate into higher value downstream specialty product supported by strong pressure performance especially in Argentina in our hydroxide facility.
Higher sales volume, higher average prices in all major product categories, improved mix and lower operating costs, all contributed to deliver segment earnings above the top end of our prior guidance range and push segment earnings margin to over 26% in the quarter.
We expect supply/demand conditions to remain tight for the remainder of the year as previously announced capacity expansions across industry have been slow to come online. This reinforces our confidence in favorable pricing conditions to the remainder of 2016. 
For the full year, we expect segment earnings to be in the range of $58 million to $66 million, an increase at the mid-point of approximately 30% compared to prior guidance and nearly 3x segment earnings in 2015. Higher prices and lower operating costs compared to last year will support operating margins in the range of 24% to 25% for the year.
We expect third quarter segment earnings to be in the range of $13 million to $17 million as the benefit of higher prices will be partially offset by seasonally lower production at our operations in Argentina. FMC's Lithium business is positioned to deliver significant earnings growth in 2016 and beyond. In May, we announced plans to triple our production capacity of lithium hydroxide to 30,000 metric tons by 2019 in order to meet growing demand from our customers starting with a 4,000 metric ton expansion scheduled to come online in 2017.
Last week, we announced we will accelerate that capacity expansion and we now expect 8,000 metric tons to come online by the middle of 2017. We continue to evaluate the turning or further capacity expansion and expect the entire 20,000 metric ton of additional capacity to be online by 2017. We believe we will more than double the revenue and earnings of our Lithium business between 2016 and 2020, resulting in over 20% per year growth through the rest of this decade.
We recognize that our hydroxide investment plans require us to have cost-effective access to sufficient lithium carbonate. Our current carbonate capacity is sufficient to support the expansion in FMC's hydroxide production to at least 2018. 
Beyond this, we are actively pursuing multiple task to ensure we are not carbonate constrained. First, we have several low options to debottleneck our Argentina operations, potentially adding 20% capacity. Second, we are in ongoing discussions with multiple carbonate producers. We have announced plans to add capacity in the coming years and are exploring mutually beneficial long-term supply agreement or trouble partnerships. And of course, we retained the option to add significant capacity at our operation, our existing operation in Argentina beyond the debottlenecking I just mentioned. Consequently, we are highly confident that access to lithium carbonate will not be a constrain in our ability to extend our hydroxide business in the coming years.
Before I turn the call over to Paul, I will comment briefly on the outlook for the third quarter and full year 2016 on Slide 6. As I mentioned, we are maintaining full year segment earnings for Ag Solutions and adjusting our full year earnings expectation for both Health and Nutrition and lithium. As a result, on a consolidated basis, we are increasing full year adjusted EPS guidance by $0.05 at the mid-point to $2.60 to $2.90 per share. For the third quarter, we expect adjusted EPS to be in the range of $0.53 to $0.63. I will now turn the call over to Paul to discuss select financial results."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Pierre. As usual, I'll start with the income statement and specifically, the tax rate. Our adjusted effective tax rate for the full year is now expected to be in the range of 24% to 25%, giving us a small benefit this quarter compared to Q2 las",611,"Thank you, Pierre. As usual, I'll start with the income statement and specifically, the tax rate. Our adjusted effective tax rate for the full year is now expected to be in the range of 24% to 25%, giving us a small benefit this quarter compared to Q2 last year.
This lowered late is largely due to the continued change in the mix of our earnings away from high tax jurisdictions, such as the U.S, towards regions were tax rates are lower. Foreign exchange was not a major factor in our results this quarter with the stronger dollar mainly impacting the Ag Solutions segment. 
Various Asian currencies,  plus the Mexican peso, was due the drivers of the FX headwinds in the quarter. The second quarter is not a period of significant activity in Brazil. And therefore, the recent strengthening of the year are have a limited impact in our financials in the quarter. However, with an FX rate in the quarter that was weaker than the same period of last year and with the price list that largely reflective of current spot rate, the combined effect of price and currency in Brazil was a net positive to our second quarter earnings.
Looking into the second half of the year. The recent stability in the real U.S. dollar exchange rate means that the assumptions regarding the future exchange rate that has underpinned our guidance is unchanged. To remind you, our guidance has assumed that we have a real to U.S. the dollar rate that is relatively stable with no major short-term swings in the FX rate, combined with a price list that largely reflects the prevailing spots exchange rate. 
Sitting here today, both of those assumptions remain unchanged. And therefore, we do not expect is very positive or negative impact on our second half performance from the real-FX rate compared to our previous guidance provided these conditions hold.
Turning to the balance sheet and cash flow on Slide 7. We continue to make progress in increasing our cash generation while maintaining discipline on capital spending. For the first half of the year, our adjusted cash from operations was 40% higher than the first half of last year, driven primarily by stronger working capital performance. 
We remain on target to meet our outlook for the full year of $450 million to $550 million of adjusted cash from operations. Net debt fell by $90 million compared to the first quarter and by over $120 million since the start of the year. 
The second quarter is important period for us in terms of cash collections in Brazil. We remain very focused on the credit capacity of our customers, particularly given the constrained access to third-party financing for Brazilian growers. This has an impact on both our ability to collect cash from customers and our willingness to continue to extend credit in the form of new sales. 
On the first point, we were pleased with our performance in collecting in Brazil, with net cash collections slightly ahead of our expectations and particularly good progress in collecting from our past due balances. As a result, we saw meaningful reduction in our Brazil receivables balance. However, it is still significantly higher than we would like and we will remain focused on reducing our exposure in the coming quarters.
The credit tightness in Brazil has been an important factor for us for several quarters now, but our willingness to extend credit to certain segments of the market reduced. As we head into the key second half selling season in Brazil, our guidance reflects the disciplined approach to credit exposure. 
And with that, I will turn the call back to Pierre."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Paul. And before I continue with my remarks, let me correct a statement I made. The 20,000 ton of additional lithium hydroxide capacity is to be online by 2019, not as I say 2017.So to continue and to conclude. I am very pleased with the over",370,"Thank you, Paul. And before I continue with my remarks, let me correct a statement I made. The 20,000 ton of additional lithium hydroxide capacity is to be online by 2019, not as I say 2017.
So to continue and to conclude. I am very pleased with the overall execution of our strategy and improved outlook for the year. Despite ongoing challenges facing the agricultural industry, our strategy and the actions we have taken in the back half of 2015 and the first half of 2016 give us strong confidence in the performance for the remainder of the year. 
We have remained focused on reducing the level of FMC product inventory in the channel, maintain discipline on price and term, aggressively manage our mix by rationalizing our product line leading to stronger margins. This strategy, combined with a successful integration of Cheminova and the more benign FX situation, have increased the predictability of our business and will drive the second half performance of Ag Solutions with earnings up 35% compared to pro forma results for 2015.
We are investing in our technology roadmap in order to offer unique value-added solutions to our customers. We see higher acceptance rates for our new products launches, including our theological platform, and remain on track to introduce our new active ingredients pipeline starting in 2017.
Lithium continues to deliver strong performance altering its product mix and increasing output to meet growing market demand. FMC's focused strategy has enabled the business to take advantage of favorable market conditions to rely significant earnings growth in 2016. Our announced capacity expansion strengthens FMC's leadership position in lithium hydroxide and specialty lithium application and will deliver further growth in the years to come.
Health and Nutrition had a weaker-than-expected quarter. However, the business continues to generate high margins and return and demand across key nutritional and pharmaceutical market will support growth over the second half of the year.
Finally, we are generating increased operating cash flow to improve our balance sheet. We are on track to increase adjusted cash from operations by approximately 40% in 2016. 
I thank you for your attention this morning. And with that, I will turn the call back to the operator for questions."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] And your first question comes from the line of Christopher Parkinson with Credit Suisse.",16,"[Operator Instructions] And your first question comes from the line of Christopher Parkinson with Credit Suisse."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Can you just comment a little more on your longer-term expectations for your European business, given your shifts or I'd say rather evolution of your good market strategy? And then also, parse out your views for Northwest here versus CIS. And then also, y",57,"Can you just comment a little more on your longer-term expectations for your European business, given your shifts or I'd say rather evolution of your good market strategy? And then also, parse out your views for Northwest here versus CIS. And then also, you mentioned product rationalization as well. Just any additional detail would be helpful."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Chris, this is Mark. Well, first of all, for Europe. Obviously, we now have a very different business model with the acquisition of Cheminova. I think you're going to expect just to see, over the long haul, outperformance in the marketplace. And it kind o",166,"Chris, this is Mark. Well, first of all, for Europe. Obviously, we now have a very different business model with the acquisition of Cheminova. I think you're going to expect just to see, over the long haul, outperformance in the marketplace. And it kind of fits with your second question around the CIS in Western Europe. We obviously had a bigger exposure in Western Europe with the Cheminova acquisition, but we see a lot of opportunity in the CIS countries, other parts of Eastern Europe in terms of Poland and Hungary, Czech, Slovakia, as well as the Ukraine. Introduction of new technologies is important for us in Europe. The portfolio is strong. But without pipeline, we have new products that will benefit both niche crops and especially cereals, where Cheminova have exposure that FMC did not have. So if you think of outperformance versus the market, it's really going to be cereals and the niche crops, especially in the South, and then accelerated growth in these."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Perfect. And then just a quick follow-up. Just can you just comment a little bit more about the working capital for me you saw there in the quarter. And then also on a go-forward basis. Specifically, how do you typically evaluate growth versus credit risk",81,"Perfect. And then just a quick follow-up. Just can you just comment a little bit more about the working capital for me you saw there in the quarter. And then also on a go-forward basis. Specifically, how do you typically evaluate growth versus credit risk as we head into the third quarter with Brazil? And is it becoming more dependent on crop types, farm size or even region within Brazil? Just any comments on the puts and takes will be helpful."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Sure, let me touch on that. The working capital progress we made really, if you look at the cash flow improvement we had over last year in the first half of the year, you can put almost all of that into embedded collections in Brazil. So we made significa",196,"Sure, let me touch on that. The working capital progress we made really, if you look at the cash flow improvement we had over last year in the first half of the year, you can put almost all of that into embedded collections in Brazil. So we made significant progress over there. We've talked many times about the steps we're taking a company to any one thing that's changed that, it's about getting some momentum behind those collection conversations. Now in terms of growth versus credit. Actually, we really think about it that way. We think about that in terms of credit. We think about the ability of the customer to repairs, the stability of the customer and their access to finance.  There are all natural differences by crop and by region in Brazil. And we obviously, factual that in the way that we go-to-market. But we have the same questions that we ask and the same standards that we set regardless of region or crop, essentially, based on our competence that we will recover the payments from our customers on the terms that we sell them to. That's the single largest factor that we consider."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, the only thing I would add, Chris, you know Brazil very well. Given where the exposure is, I would say the North, the Toronto regions are where it is probably the most stressed. The South with the pull ups and the distribution is in better shape, and",84,"Yes, the only thing I would add, Chris, you know Brazil very well. Given where the exposure is, I would say the North, the Toronto regions are where it is probably the most stressed. The South with the pull ups and the distribution is in better shape, and then sugarcane as well. Sugar industries come through challenges. But with the price of sugar today, they are in better shape as they go forward into 2017. But it's definitely the North where the stress is."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And your next question comes from the line of Joel Jackson with BMO Capital Markets.",15,"And your next question comes from the line of Joel Jackson with BMO Capital Markets."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Just staying in Brazil. You commented that you had a good destock of your own FMC product. Are you -- can you talk about where you're seeing your competitors for their -- in the channel for inventories? I think we've seen commentary before that you heard",52,"Just staying in Brazil. You commented that you had a good destock of your own FMC product. Are you -- can you talk about where you're seeing your competitors for their -- in the channel for inventories? I think we've seen commentary before that you heard over your products from your competitors."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you. No, we can't and we don't want to comment on competitors. It's sometimes quite difficult to understand the overall inventory in the chalice. So really what's we've been doing. That's the change we started to make in the fourth quarter is truly",77,"Thank you. No, we can't and we don't want to comment on competitors. It's sometimes quite difficult to understand the overall inventory in the chalice. So really what's we've been doing. That's the change we started to make in the fourth quarter is truly focusing on tuning down our own inventory of product. There is product in the channel but really to comment specifically about our competitors, that would not make sense for us to do so."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","If I look at your guidance, you seem to be maybe implying a 300 or 400 basis points improvement in Ag Solution margin in the fourth quarter. Can you talk about that, where you see the big margin pick up in Q4 and how it's going to play out?",49,"If I look at your guidance, you seem to be maybe implying a 300 or 400 basis points improvement in Ag Solution margin in the fourth quarter. Can you talk about that, where you see the big margin pick up in Q4 and how it's going to play out?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes. Certainly, and I think this -- the comment I would make are valid for the entire second half. We are getting now into a position. If you look compared to the backhand of 2015, where there is no of improvement. First of all, our product mix is getting",205,"Yes. Certainly, and I think this -- the comment I would make are valid for the entire second half. We are getting now into a position. If you look compared to the backhand of 2015, where there is no of improvement. First of all, our product mix is getting much stronger than what it was. We -- our actions to work with from low margin third-party more generic products is working very well. So we are increasing the margins of our products through mix. Second of all, we have been pretty successful over the last 3 or 4 quarters in moving our price. So we're and looking at the importance of Brazil and Latin America in Q3 and Q4 and taking into account the pricing versus FX situation, we are in a stronger position. So blend of stronger volume full we're going to see in the second half of the year, a better mix because we are moving away from third-party products and the pricing FX situation will lead to, first of all, to more predictable business. We have a much better visibility going in the second half of the year than we had in a long time and with stronger margins for the business."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our next question comes from the line of Mike Harrison with Seaport Global securities.",15,"And our next question comes from the line of Mike Harrison with Seaport Global securities."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, you mentioned last call that Q2 were in the Lithium business was when you were expecting some seasonal production weakness there, yet you were able to deliver well ahead of your guidance. Can you talk about what drove that upside during the quarte",62,"Pierre, you mentioned last call that Q2 were in the Lithium business was when you were expecting some seasonal production weakness there, yet you were able to deliver well ahead of your guidance. Can you talk about what drove that upside during the quarter and whether there can be some potential upside as we look at your guidance for Q3 and Q4?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Certainly. I think the seasonal weakness is not only in Q2. It's in the back end of Q2 through Q3. So we've seen part of it and we're going to keep on seeing it. It's usually due to the fact that it is winter. There is more rainy season right now in Argen",332,"Certainly. I think the seasonal weakness is not only in Q2. It's in the back end of Q2 through Q3. So we've seen part of it and we're going to keep on seeing it. It's usually due to the fact that it is winter. There is more rainy season right now in Argentina where we're operating. So it's not only a Q2 phenomenon, it's a back of Q2, early Q3. I think the visibility we have today due to our production is quite, quite correct that the earnings level. Mainly, there is multiple reasons, which have been leading the improve of earnings. First of all, the mix. We are moving more business to all of lithium hydroxide, where we've been able to operate our plants quite, quite well and where there is a healthy demand and pricing situation. Second of all, our plants have been operating also very well for carbonate production and we have been -- and we are continuing to do that for the second half, selling more product made within the company than third-party product we would resell. And then there is some volume. So if I look at the second half of the year, I think our earnings is quite in line with our expectation. I don't think there is a light of upside. Most likely what you will see is we decided not to change the revenue range because we are a little bit below the middle point of the range initially. Looking to demand for back half of the year, it's most likely to lead us to where they higher range from a revenue standpoint. But I believe we have forecasted in lithium for Q3, Q4 are correct, unless, less, I'd say the only place where I could see upside but it is not possible for us to predict that today is pricing. Pricing is always something, depending upon demand, and how capacity, come on stream. So that one, we've made some assumption, you never know."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","And then a question just on the product rationalization that you did in Ag Solutions. Is that mostly legacy FMC products or are there some Cheminova products? And is there any more to come? Just trying to get a sense of whether we could see some additiona",77,"And then a question just on the product rationalization that you did in Ag Solutions. Is that mostly legacy FMC products or are there some Cheminova products? And is there any more to come? Just trying to get a sense of whether we could see some additional pressure there. And at some point, do you hit a point where you see some negative leverage as a result of scaling back on the number of products you're selling?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think the product rationalization is very well advanced today. I think it's a mix. It's as much from Cheminova legacy products than it is from FMC products. Both company used to resale third-party product as a service to customers. And that seems you ca",187,"I think the product rationalization is very well advanced today. I think it's a mix. It's as much from Cheminova legacy products than it is from FMC products. Both company used to resale third-party product as a service to customers. And that seems you can afford to do it at a given time with a very healthy market, you cannot do in the market is more intense. So it was a normal thing for us to move away. We had very precisely defined what those product could be. I'm very pleased with the speed at which the organization responded to that. I think more than half of the shortfall in our sales today in the second quarter is coming from product rationalization, but that's pretty much where it is. So you will not see numbers going beyond what we've talked about, which was total run rate, adding this year of $350 million, which is $100 million more than we did last year, we did $250 million last year. And this is it. There will be no further as far as we can see actions to be taken."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And your next question comes from the line of Frank Mitsch with Wells Fargo.",14,"And your next question comes from the line of Frank Mitsch with Wells Fargo."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, I was struck by the comment that the inventory levels of insecticides are rather high in Brazil. And I guess, is I was thinking about together. Does that offer any opportunity for you in that marketplace?",37,"Pierre, I was struck by the comment that the inventory levels of insecticides are rather high in Brazil. And I guess, is I was thinking about together. Does that offer any opportunity for you in that marketplace?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, Frank, this is Mark. Yes, we have seen increased sales of specific insecticides that we're providing for that effect to control market. It's not huge, though. Let's put it in perspective. It's not going to move the Ag business. It's a nice business t",93,"Yes, Frank, this is Mark. Yes, we have seen increased sales of specific insecticides that we're providing for that effect to control market. It's not huge, though. Let's put it in perspective. It's not going to move the Ag business. It's a nice business that. We have a leading position in Brazil. And we've seen that business grow over the last 18 months. And we expect it to continue with a way to seek a is progressing through the region. But it's not going to be significant enough to really move the needle."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","All right, interesting. I mean, as the geography of concerns spreads, one would think that, that would be an opportunity. I guess, just simplistically, how would you describe your market share in that application?",34,"All right, interesting. I mean, as the geography of concerns spreads, one would think that, that would be an opportunity. I guess, just simplistically, how would you describe your market share in that application?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","It's pretty good. Let's -- why don't we just put it in perspective. The global public health market is about $700 million, and that's within the total Ag space crop protection chemicals of over $51 billion. So really, for mosquito control, the market worl",128,"It's pretty good. Let's -- why don't we just put it in perspective. The global public health market is about $700 million, and that's within the total Ag space crop protection chemicals of over $51 billion. So really, for mosquito control, the market worldwide is about $325 million to $340 million and the U.S. is about $90 million of that. So you can get a sense of the scale of that business. In particular applications, we have a very good market share. But only with our [indiscernible] but with a product called malathion that we bought from Cheminova. So just keep it in perspective. Then if you want to talk about it a lot, but the U.S. market is only $90 million out of that $700 million."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Mark, I appreciate you throwing a wet blanket on that thesis. And then, lastly, Paul, you sounded more sanguined with respect to the FX impact for 2016. Do you have a size as to what you think the negative effect will be when all is said and done on the y",51,"Mark, I appreciate you throwing a wet blanket on that thesis. And then, lastly, Paul, you sounded more sanguined with respect to the FX impact for 2016. Do you have a size as to what you think the negative effect will be when all is said and done on the year?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I wish I could predict FX markets that well, Frank. I mean, I wouldn't be in this job. I'm pretty confident around that. I think the key is that we see a more predictable. You see the peso has been a surprising area for us. We didn't -- I mean, we never s",128,"I wish I could predict FX markets that well, Frank. I mean, I wouldn't be in this job. I'm pretty confident around that. I think the key is that we see a more predictable. You see the peso has been a surprising area for us. We didn't -- I mean, we never see him coming. And the Brazil has been -- the real has been some kind of a bright spot, not because of the absolute rate, but as I mentioned about the stability around the rate. And I think that's sort of the keepers as we look forward, that's the ability of the rates and a lack of surprise is more important to us on most of our business than the actual movement in the exchange rates."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our next question comes from line of Daniel Jester with Citibank.",12,"And our next question comes from line of Daniel Jester with Citibank."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","What kind of visibility do you have in Health and Nutrition in the second half of this year? Your guidance seems to imply an acceleration and profits, which seems seasonally maybe a little bit different than the past few years. So given sort of the commen",67,"What kind of visibility do you have in Health and Nutrition in the second half of this year? Your guidance seems to imply an acceleration and profits, which seems seasonally maybe a little bit different than the past few years. So given sort of the comments that you called out about omega-3, can you just walk us through some of the key drivers for the second half?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Certainly. I think we do have pretty good visibility on our 3 segments today from a demand standpoint. But it is important to understand that the earnings growth, especially in the fourth quarter, is maybe more predictable because it is June  to a cost si",159,"Certainly. I think we do have pretty good visibility on our 3 segments today from a demand standpoint. But it is important to understand that the earnings growth, especially in the fourth quarter, is maybe more predictable because it is June  to a cost situation. We always work our cost and decrease of cost. But the way costs flows into operations depend upon the speak that we should turn your product. And I think we call that capitalized variance. But the main reason for the bump in earnings in the backhand of the year is due to the fact that we will be operating at a lower cost than moving operating via the quarters in previous year. That is why you will see such a turn. So it is not due to a major turn in demand for any of our products, but it's much more the benefit of prior activity we've done on operational costs and manufacturing excellence."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Okay, that's helpful. And then of this $60 million to $70 million of full year cost synergies from Cheminova, can you quantify how much of that you realized in this first half? And then maybe just holistically, beyond just cost synergies, where do you see",51,"Okay, that's helpful. And then of this $60 million to $70 million of full year cost synergies from Cheminova, can you quantify how much of that you realized in this first half? And then maybe just holistically, beyond just cost synergies, where do you see the integration process for Cheminova today?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, thanks. I think at a run rate basis, we want to close the past here on our rate basis in the $30 million to $40 million range for the first half of the year on the Cheminova.",38,"Yes, thanks. I think at a run rate basis, we want to close the past here on our rate basis in the $30 million to $40 million range for the first half of the year on the Cheminova."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Talk a little bit about the integration side. From an integration perspective, we are very much done on the commercial side, that's all in place. A lot of the functional groups are also fully integrated and operating. We have some systems that we're still",139,"Talk a little bit about the integration side. From an integration perspective, we are very much done on the commercial side, that's all in place. A lot of the functional groups are also fully integrated and operating. We have some systems that we're still working through as a Dean in Europe, as an example, which will be completed early in the fourth quarter. And then the long lead time item is how we bring together the different manufacturing units, the total manufacturing units and the formulating units. We are well progressed with that. We still have some to go, but that will occur over time. And the basic need there is to make sure we have registrations as we move products around the world. So that's the right limited set, but everything of this pretty much done right now."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think from a Cheminova integration, we're going to start reporting. I mean, we'll answer any questions you guys might have. But we can almost declare success. Everything is in place to reach, as we discussed by the middle of next year, the $140 million",102,"I think from a Cheminova integration, we're going to start reporting. I mean, we'll answer any questions you guys might have. But we can almost declare success. Everything is in place to reach, as we discussed by the middle of next year, the $140 million to $160 million run rate, the 800  to 900  positions being eliminated. So we are very much more than on track ahead of initial schedule. And I think lots of the remaining activities are more under impulse shop around IT, SAP, science integration. So much more back-office integration than anything during the front end of the business."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And we do have a question from the line of Rosemarie Morbelli with Gabelli & Company.",15,"And we do have a question from the line of Rosemarie Morbelli with Gabelli & Company."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","I was wondering if you can talk about the expected lithium capacity, lithium carbonate capacity increase in 2017 based on what you see in here in the marketplace. Is that coming on stream, a lot of it in the first half of 2017 and therefore, would have a",52,"I was wondering if you can talk about the expected lithium capacity, lithium carbonate capacity increase in 2017 based on what you see in here in the marketplace. Is that coming on stream, a lot of it in the first half of 2017 and therefore, would have a negative impact on pricing?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Rosemarie. Yes, we're starting to see some exchange of volumes coming on even in the back half of 2016, mostly out of the new exciting capacity that's coming online in Australia. As you know, there's also some capacity in Chile, and it there ha",110,"Thank you, Rosemarie. Yes, we're starting to see some exchange of volumes coming on even in the back half of 2016, mostly out of the new exciting capacity that's coming online in Australia. As you know, there's also some capacity in Chile, and it there has been capacity ramping up in Argentina targeting back end of 2016 and early 2017. So these were the volumes that we're watching. And I characterize it, could be anywhere between 50,000 to 75,000 tons by early 2017. So as Eric comment earlier, this is where we make pricing assumption, and we're monitoring the conditions as we interact with customers in terms of pricing expectations."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","And that particular capacity addition is going to be smaller than the demand increase, is in it? And therefore pricing is going to come down across the Board including lithium hydroxide or you don't think so?",36,"And that particular capacity addition is going to be smaller than the demand increase, is in it? And therefore pricing is going to come down across the Board including lithium hydroxide or you don't think so?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","No, first, yes, there will be -- we are expecting, as time goes, starting in '17 and into '18, we're expecting carbonate pricing to grew more toward normal pricing, which mean a lower pricing we are currently seeing when they will be more or they balance",128,"No, first, yes, there will be -- we are expecting, as time goes, starting in '17 and into '18, we're expecting carbonate pricing to grew more toward normal pricing, which mean a lower pricing we are currently seeing when they will be more or they balance between in the carbonate demand and the supply. It will not impact the hydroxide pricing. If you look right now and if you put together all of the hydroxide capacity increase, which actually we are leading, they are very much in line with the demand increase. So from a pricing standpoint, we my night see hydroxide rising tremendously the year to come. But I think one of want to be in a healthy pricing situation for the next 3 to 4 years."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","And just to add a little bit to that, Rosemarie. In our hydroxide business, we're targeting specific sequence of that demand, where high quality hydroxide, where they're willing to pay for the quality we bring to the markets. So when we look at supply/dem",62,"And just to add a little bit to that, Rosemarie. In our hydroxide business, we're targeting specific sequence of that demand, where high quality hydroxide, where they're willing to pay for the quality we bring to the markets. So when we look at supply/demand, we're looking even specifically at that customer mix versus one that might trade-off to carbonate or other supply."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","And my second question. Also inventory, overall inventory in the Ag sector. You said that you have loyalty FMC product inventories. But without talking about any specific competitors, what do you see in terms of the overall inventory channel? Is it declin",58,"And my second question. Also inventory, overall inventory in the Ag sector. You said that you have loyalty FMC product inventories. But without talking about any specific competitors, what do you see in terms of the overall inventory channel? Is it declining? Or is it still growing? Or more or less sort of flat -- has it plateaued?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think from a -- as I said, I want to repeat, we're mostly focusing on our inventory. But overall, if I would have or if we would have an overall statement, we believe overall inventory in the channel is declining. We do not believe right now we are at a",132,"I think from a -- as I said, I want to repeat, we're mostly focusing on our inventory. But overall, if I would have or if we would have an overall statement, we believe overall inventory in the channel is declining. We do not believe right now we are at a turning point from a market standpoint. But we can see we are at a place where the dialogue with the customers is changing. There is more certainty. There's more productivity. Still means that the inventory in the channel is pretty heavy. We are not yet at a situation where it's not -- but the dialogue is changing. And I believe -- really [indiscernible] to decrease their inventory. We believe we most likely aggressive. But overall, I think the situation is improving."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our next question comes from line of Mark Connelly with CLSA.",12,"And our next question comes from line of Mark Connelly with CLSA."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Two things. Paul, you talked about the longer timeline for rationalization of the manufacturing in Europe. Is that sort of a 2020 time goal in your mind? Or is there a specific target in your mind? And then second question to Latin America again. As we th",104,"Two things. Paul, you talked about the longer timeline for rationalization of the manufacturing in Europe. Is that sort of a 2020 time goal in your mind? Or is there a specific target in your mind? And then second question to Latin America again. As we think about the working capital cycles in cotton and sugarcane, is your penetration in that market permanently shifting your working capital cycle in a material way? My understanding is Cheminova manage working capital much differently than you did using more receivables, for example. And I'm curious whether that has all shifted over to your way of doing things."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Well, let me address first the question on the manufacturing rationalization. Right now, we are at a place where we have a stable manufacturing network for Ag business. We are always looking at improving. But any improvement, any decisions today is always",153,"Well, let me address first the question on the manufacturing rationalization. Right now, we are at a place where we have a stable manufacturing network for Ag business. We are always looking at improving. But any improvement, any decisions today is always a mid-to long-term decisions because there is some product registrations, which are changing when you do a change of manufacturing. So I have to say that right now, as any company would do, we are keeping our options open. But we are in what I would call a stable manufacturing network. And we will see as time goes what are the best decisions to be taken for our business in terms of network. But today, we're not penalized by the structure we have and it's a matter of doing continuous improvement and being able to supply what will be requests of the market at a time when the market turns around."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","So you're comfortable then not being quite as asset light as you have been sort of in the medium term?",21,"So you're comfortable then not being quite as asset light as you have been sort of in the medium term?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","We are asset light. I think if you think about FMC prior to the acquisition of Cheminova, our manufacturing cost was 95% asset light. I would say today, maybe we're at 90%. We should not believe that the fact that we have a plant in India in panel income",115,"We are asset light. I think if you think about FMC prior to the acquisition of Cheminova, our manufacturing cost was 95% asset light. I would say today, maybe we're at 90%. We should not believe that the fact that we have a plant in India in panel income and a plant they have in London are fundamentally changing the mix of product we shall made until manufacturers versus what is being made today. Those are big plans. But you know in the big scheme of things, the production capacity versus what we do with total network is fairly small. So it is our fundamental departure to what we used to be in the past."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Working capital question down there in Brazil. Sugarcane and cotton can have very, very different terms, part tends to be longer-term sugarcane tend to be short term although that's very depending on the nature of the planting cycles and on the financial",238,"Working capital question down there in Brazil. Sugarcane and cotton can have very, very different terms, part tends to be longer-term sugarcane tend to be short term although that's very depending on the nature of the planting cycles and on the financial health of the sugarcane guidance. But as a rule, as we shifted away from cotton, would we expect to see our working capital terms common and to what sugarcane also does the same thing. I would not though expect that you go to TrackBack to our working capital balance as you look at it. It's definitely fact that helps but it's not so much that you're going to see a major movement in our numbers. In terms of how Cheminova approach it. Cheminova, this is segment to a different difference. Cheminova did not have a different approach to working capital than anybody else in the industry. They did have a different approach to heavily finance that working capital. And to be blunt, as a weak balance sheet company with very unsophisticated treasury operations, they used to be some very, very expensive local financing a result, which can you the present are there to reducing the working capital. And with appropriate for non-U.S. GAAP reported, it was appropriate for some investment grade company, it was incredibly expensive and we'll recently factor in why their overall profitability was so low and it's not something we intend to do."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And we do have a question from the line of Aleksey Yefrenov with Nomura Securities.",15,"And we do have a question from the line of Aleksey Yefrenov with Nomura Securities."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","What is the current competitive environment in Latin America and North America? Do you see your competitors generally be more disappointed up our production prices?",25,"What is the current competitive environment in Latin America and North America? Do you see your competitors generally be more disappointed up our production prices?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Well, we're not going to talk about what competition is doing on price. Tell you where we are. As Pierre said earlier, we're doing everything we can to make sure we manage price in terms across North America. And secondly, in Brazil while we have reduced",129,"Well, we're not going to talk about what competition is doing on price. Tell you where we are. As Pierre said earlier, we're doing everything we can to make sure we manage price in terms across North America. And secondly, in Brazil while we have reduced our exposure to the Brazil market by taking out through product rationalization, significant amount of volume and revenue. But we're very focused on making sure that we maximize price, not only terms of pricing, sort of across the portfolio on what we're selling. I think you're going to see all sorts of different activities as we go through the next year. But for us, it's very much around protecting the margins, protecting the value of the business and certainly, looking after working capital."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think in term of pricing, just to get back to one of the comment Paul made around the balance of FX and pricing. As you know, we tend to have a rule in Brazil where we index price on currency. Last year, we were with a pricing running after the currency",173,"I think in term of pricing, just to get back to one of the comment Paul made around the balance of FX and pricing. As you know, we tend to have a rule in Brazil where we index price on currency. Last year, we were with a pricing running after the currency and trying to move up our price. This year, the same process of adjusting pricing to currency is going the other way, which mean it is not any longer us asking the customer to take higher price, but the customer asking us to lower the price more toward the currency. So needless to say that for all of us, regardless of what behavior, individual companies would take, it is a major conversation from the profitability of the pricing. And this FX situation give us a much better position to talk about pricing, more control in term of understanding pricing in the next 2 quarters. And I think it's got to apply to every company. It is just an FX price situation."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","And turning to Europe and crop protection. You had some revenue declines there. How much of that was your move to direct market? And was it a one-time impact or is there any way to improve that next year?",39,"And turning to Europe and crop protection. You had some revenue declines there. How much of that was your move to direct market? And was it a one-time impact or is there any way to improve that next year?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, the direct market situation is a one-time impact. It is just a capital of situation, which happened all the time when you do this kind of a transfer. First of all, you work with your distribution network, which are moving away from. Those guys have i",169,"Yes, the direct market situation is a one-time impact. It is just a capital of situation, which happened all the time when you do this kind of a transfer. First of all, you work with your distribution network, which are moving away from. Those guys have inventory. They have start -- they are feeling it when you're replenishing your own now where to sell. So there is still a time where you have 2 networks, which have to roll up for a little while. And you have to give the time to your distributors to sell the product they weren't supposed to sell the product by contract. Second of all, you are [indiscernible] so where your distributors are not replenishing their inventory in advance. So by the time we get into -- this is happening at the transition now. I believe by the time we get into European season Q1, Q2 next year, we should be in a very normalized situation and it will be stable for the future."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And we do have a question from the line of Mike Sison with KeyBanc.",14,"And we do have a question from the line of Mike Sison with KeyBanc."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Just curious. You maintained your outlook for crop protection markets this year down mid to high single-digit. What was it down in the first half? And just trying to gauge what the expectation is for the second half in terms of demand.",42,"Just curious. You maintained your outlook for crop protection markets this year down mid to high single-digit. What was it down in the first half? And just trying to gauge what the expectation is for the second half in terms of demand."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","So I think in the first half, the way I would look at it, Mike, is when we gave the range, we said mid single-digit to high single-digit. Maybe we were thinking about more toward when we started this process, the lower end of the range, maybe 5%, 6%, 7%.",248,"So I think in the first half, the way I would look at it, Mike, is when we gave the range, we said mid single-digit to high single-digit. Maybe we were thinking about more toward when we started this process, the lower end of the range, maybe 5%, 6%, 7%. We are more today on a 7%, 8% more toward the higher end of the range. And that is due, maybe less due to channel inventory than it was to specific reasons in Asia and Europe, mostly driven by weather. So for us, when we look at the market, if you remember, we were thinking about North America and Latin America in the higher end of the range, and this being helped by flattish to slightly down market in Europe and Asia. We don't see that any longer. I mean, we still see North America and Latin America on the higher end of the range, but we see Asia and Europe being down in the 5%, 6% for this year. That is why today, we are looking at maybe more the higher end of our range. For us, what we've been doing is we've been able, no matter what, to protect our earnings by being even more drastic on pricing, more drastic on product rationalization. So we'll be slightly lower on sales. But we believe we are going to be -- we're going to have very solid performance in the second half and productivity on the earning side."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then so the fourth quarter for Ag Solutions, you talked about better visibility than in the past. But just curious, what sort of gets you to the high end of the range? I mean, it's pretty wide in terms of the top end, given your guidance for Ag",67,"Okay. And then so the fourth quarter for Ag Solutions, you talked about better visibility than in the past. But just curious, what sort of gets you to the high end of the range? I mean, it's pretty wide in terms of the top end, given your guidance for Ag Solutions from the third quarter and the low end. What sort of gets you to the top?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I would say always the same answer. When we give the middle of the range, it under normal circumstances from a demand and weather standpoint. And those -- there is always a range. You just need, you just very strong insect pressure or other pressure. And",103,"I would say always the same answer. When we give the middle of the range, it under normal circumstances from a demand and weather standpoint. And those -- there is always a range. You just need, you just very strong insect pressure or other pressure. And you drive that either to the lower or either to the [indiscernible]. Today, we believe we are very comfortable with the middle of the range to see anything going up or down would be due to external events not linked to channel inventory or anything that kind, but much more to specific agricultural seasonal situation, mostly weather."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our last question comes from the line of Peter Butler with Glen Hill Investment.",15,"And our last question comes from the line of Peter Butler with Glen Hill Investment."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, early on regarding lithium, you folks had a conservative outlook on shorter-term of lithium growth, but you saw good possibilities longer-term. I knew this outlook has been proven correct. What do you see now for the longer-term growth of lithium?",78,"Pierre, early on regarding lithium, you folks had a conservative outlook on shorter-term of lithium growth, but you saw good possibilities longer-term. I knew this outlook has been proven correct. What do you see now for the longer-term growth of lithium? And how do you -- how does your research pipeline on lithium derivatives look compared to what you're seeing from competitors and how does this change your future position on earnings and cash flow growth, et cetera?"
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Peter. Yes, so lithium, I have to say, we do have increased confidence in the future. Today, we believe this market is getting more and more solid. I have to say that we are prudent. But the big breakthrough for us is technology, we're able to",288,"Thank you, Peter. Yes, so lithium, I have to say, we do have increased confidence in the future. Today, we believe this market is getting more and more solid. I have to say that we are prudent. But the big breakthrough for us is technology, we're able to develop from a manufacturing standpoint allowing us to add very low capital spend and division cost of operations, ability to create 4,000 to 8,000 tons mutuals for lithium hydroxide instead of having to build in one shot, a 20,000 or 30,000 tons. So today, we have an improved view and more certain view of what lithium hydroxide is doing. But on the work we've done in the last 2 years was to develop a manufacturing process allowing us to follow the demand growth. Which means that if the growth is not as we're expecting, we can stop 1 or 2 of these modules manufacturing and slowdown the capacity increase we have planned. If the demand becomes more aggressive, very easy for us to speed up the building of those modules. So first, your question, yes, we have increased confidence. Our strategy we're highly focused on the downstream product, where we have the highest profitability. Third, we have a safety net around demand by these manufacturing process we have in place allowing to match the demand. Where are we on our forecast? We are taking a much middle of the range. We are far in the process and but its ability for the numbers I gave to you to take the highest prediction from AV companies. So that could be upside, but you know, we are prepared also for the downside. And maybe I'll ask Tom to comment on the technology."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, and thanks for the question. On the technology, we've got a technology roadmap. And I'd say that with the strategy that we've been undertaken on the high-value products, the biggest shift is the increased collaboration and formalized collaboration wi",87,"Yes, and thanks for the question. On the technology, we've got a technology roadmap. And I'd say that with the strategy that we've been undertaken on the high-value products, the biggest shift is the increased collaboration and formalized collaboration with our customers. So we do have a number of exciting opportunities that are being discussed with customers and being trialed with customers, and we're looking forward to that. It will continue to add to high-quality sales of new lithium derivatives and new applications with existing lithium derivatives."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","So as it was the last question, let me close with a couple of words before I hand the closing comments to Brian. I think we went through those 2 quarters very highly focused on delivering what we promised to do. Everything we've done in the 2 quarters hav",187,"So as it was the last question, let me close with a couple of words before I hand the closing comments to Brian. I think we went through those 2 quarters very highly focused on delivering what we promised to do. Everything we've done in the 2 quarters have done a few things for us. First of all, I believe from an Ag standpoint, even if the market are not yet returning to the level of growth this kind of market could expect to see one day, we have improved highly controlled visibility and productivity of our own business. I think from a lithium standpoint, it is a bright spot for us. We have refined our strategy. And I have to say the breakthrough we had in technology about lithium hydroxide manufacturing are already enormous win for us looking for the future. Our penetration, the business is solid. The business is highly profitable. But we also understand the challenges we have on omega-3 and its something we'll be focusing on in the quarters to come. So with this, I'm going to turn the call back to Brian."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Pierre. As always, appreciate the time and the questions. I'll be available for the call to address any further questions that you may have. So with that, thank you and have a good day.",36,"Thank you, Pierre. As always, appreciate the time and the questions. I'll be available for the call to address any further questions that you may have. So with that, thank you and have a good day."
28606,341073936,1022892,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And ladies and gentlemen, today's conference will be available for replay after 10:00 a.m. today through September 3 at midnight. You may access the AT&T teleconference replay system at any time by dialing 1 (800) 475-6701 and entering the access code 378",72,"And ladies and gentlemen, today's conference will be available for replay after 10:00 a.m. today through September 3 at midnight. You may access the AT&T teleconference replay system at any time by dialing 1 (800) 475-6701 and entering the access code 378964. International participants may dial (320) 365-3844. That does conclude your conference for today. Thank you for your participation and for using the AT&T executive teleconference service. You may now disconnect."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the Second Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] As a reminder, today's conference is being recorded.And I would now turn the conference over to Brian Angeli, Vice Preside",50,"Good morning, and welcome to the Second Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] As a reminder, today's conference is being recorded.
And I would now turn the conference over to Brian Angeli, Vice President of Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning. Welcome to FMC Corporation's Second Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.Pier",273,"Thank you, and good morning. Welcome to FMC Corporation's Second Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.
Pierre will begin the call with a review of FMC second quarter performance and discuss the outlook for Q3 and the full year 2016. Paul will provide an overview of select financial results. The slide presentation that accompanies our results, along with our earnings release and 2016 outlook statements, are currently available on our website and the prepared remarks from today's discussion will be made available at the conclusion of the call.
As with our prior calls, Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President, FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, will join to address questions.
Before we begin, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including but not limited to, those factors identified in our earnings release and then our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based on these risks and uncertainties.
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms as well as other non-GAAP financial terms to which we may refer during today's conference call are provided on our website.
With that, I will now turn the call over to Pierre."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian, and good morning, everyone. As you can see on the first slide for the second quarter of 2016, FMC reported revenue of $810 million and adjusted operating profit of $143 million. Adjusted EPS of $0.69 was $0.01 below the second quarter of",2115,"Thank you, Brian, and good morning, everyone. As you can see on the first slide for the second quarter of 2016, FMC reported revenue of $810 million and adjusted operating profit of $143 million. Adjusted EPS of $0.69 was $0.01 below the second quarter of 2015, but above the midpoint of our guidance range.
Ag Solutions delivered another solid quarter and it continues to realize the benefits of the Cheminova acquisition. Lithium outperformed on higher sales and volumes, and higher realized prices across the portfolio with lower operating cost from ongoing manufacturing excellence program.
Earnings in Health and Nutrition were below expectation as results in omega-3 were significantly weaker than anticipated. Based on our performance to date and the outlook for the back half of the year, we are increasing full year adjusted EPS guidance by $0.05 to $2.60 to $2.90 per share. I will provide more details on how that breaks down across each of the businesses shortly. But first, I will discuss second quarter results for each of our 3 segments, starting with Ag Solutions on Slide 2.
Overall, market condition and our performance in the quarter were in line with our prior expectations. We remained focused on reducing the level of FMC product inventory in the channel and on maintaining discipline on price and terms. We also took actions needed to complete the product rationalization that began in late 2014.
For the second quarter, Ag Solutions reported revenue of $515 million and segment earnings of $101 million, slightly ahead of the midpoint of our guidance range. Revenue declined 19% compared to the second quarter of 2015, largely due to lower sales volume, unfavorable weather conditions in Europe and Asia, the drawdown of channel inventory by customers in most regions and planned product rationalization all contributed to the decline in volume in the quarter.
Excluding planned product rationalization, revenue declined broadly in line with the crop protection market as a whole. Segment earnings declined 14% compared to 2015 as the impact of lower sales volumes, less favorable product mix in Asia and North America and the stronger U.S. dollar were partially offset by lower operating cost. Compared to pro forma results from Q2 last year, operating margin increased 100 basis points, reflecting pricing discipline, the elimination of sales of low-margin products due to portfolio rationalization and cost savings from the Cheminova integration.
As we move to Slide 3, I will first give a few comments on the global crop protection market then I will move on to review FMC's performance by region and discuss the outlook for Q3 and the full year. So first, the market.
Overall, conditions in the global crop protection market were as expected little changed from Q1. In North America, soft commodity prices continue to put pressure on some incomes resulting in more cautious buying behavior by growers and elevated inventory levels across the channel.
In Europe, unfavorable weather conditions early in the quarter, most notably in Central and Western Europe, reduced market demand, leading to lower volumes and increased channel inventory in certain countries. In Brazil, channel inventory across the market remained elevated, especially for insecticides. And while foreign exchange rates have been more stable, growers continue to be negatively impacted by a lack of credit availability.
In Asia, weather conditions were poor across most of the region resulting in weaker market demand. We believe these challenging market conditions will persist for the remainder of the year and we still forecast that the global crop protection chemical market will decline by mid- to high single-digit percent in 2016 on a U.S. dollar basis. I will now discuss FMC's performance in light of these market conditions.
First, let me address the lower-than-expected revenue for the quarter. Markets in Asia and Europe were weaker than expected, but the main driver of the lower revenue is a more successful and aggressive product rationalization.
We continue to manage the quality of our sales in order to protect margins, earnings and working capital. In North America, our strategy remained one of the standing price and terms, allowing the level of FMC product inventory in the sales channel to reduce. All the data we see support our view that inventory of FMC products in the channel is declining. Reflecting the benefits of the actions we took early in the season, to reduce inventory of FMC product in the channel, sales in Q2 increased 5%. We saw strong demand for FMC's Authority brand of pre-emergent soybean herbicide and independent data show that the Authority brand has taken market share this year. We also saw grower support for the extended fungicide products we can now offer as a result of the Cheminova acquisition.
In Europe, revenue declined by 19%, driven largely by poor weather conditions and reduced volume due to the planned product rationalization as well as the impact of transitioning to a direct market access model. However, the product rationalization and move to direct market access have resulted in improved operating margins in the region.
In Latin America, revenue declined 43%, primarily as a result of steps we took to reduce the level of FMC product inventory in the south channel in Brazil. We were encouraged by our ability to recover U.S. dollar pricing in the quarter. While not matching to overall segment performance, given the seasonally lower sales volume, realized price increase in Brazil more than offset the negative impact of FX on a reported revenue.
In Asia, the combination of poor weather condition, further portfolio rationalization and a stronger U.S. dollar caused revenue to decline 22% compared to the second quarter last year. Moving on to the outlook for Ag Solutions.
Our full year segment earnings guidance remains unchanged at $380 million to $420 million. For the third quarter, we expect segment earnings of between $80 million and $90 million. At the midpoint of guidance, second half segment earnings will increase by approximately 35% compared to 2015, driven by improved performance in Brazil and Latin America and additional cost savings from the Cheminova integration. The steps we have already taken to rationalize our product portfolio and reduce the level of FMC inventory in the channel, in the sales channel, leave us well positioned as we enter the 2016, 2017 crop season in the Americas.
The relative stability of the Brazilian real over the past few months gives us increased confidence in our ability to recapture price despite tightening credit condition from growers and weak market demand as channel inventory levels decline. We expect full year segment earnings margin to be between 17% and 18%, which at the midpoint represents more than 250 basis points of improvement compared to 2015 driven by more favorable mix, improved pricing in Brazil and realization of cost savings. We remain on track to deliver the incremental cost savings target of $60 million to $70 million in 2016 and the full run rate cost saving of $140 million to $160 million by the middle of next year.
Moving on to Health and Nutrition on Slide 4. The business reported second quarter segment revenue of $195 million and segment earnings of $45 million. Revenue declined approximately 6% and earnings declined approximately 11% compared to the second quarter of 2015.
Results for the quarter were negatively impacted by worse-than-expected performance of omega-3. The headwinds we saw in omega-3 over the past year increased in the second quarter. Specifically, prices and volumes were much lower than anticipated. There is significant overcapacity in the industry, which, combined with lower demand for higher concentration products has exerted even greater pressure on prices than we saw earlier in the year. 
We have seen new entrants with business at prices that are close to cash cost of production, resulting in considerably lower volume for our products in certain key areas. We have aggressively taken costs out of this business with fixed cost falling by almost 40%. We continue to pursue new opportunities for high-end cost alteration products, but do not expect to recover these lost volumes this year and do not anticipate the change in pricing levels any time soon.
Excluding omega-3, results were in line with expectations. In nutritional ingredients, volumes in the quarter were slightly below Q2 2015, largely due to timing as orders shifted to the second half of the year. In health excipients, sales volumes increased in all key pharmaceutical markets.
Given performance to date in omega-3 and our expectations for the rest of the year, we are lowering our guidance for Health and Nutrition. We now expect full year segment earnings to be in the range of $190 million to $196 million, roughly flat with 2015, and third quarter segment earnings to be in the range of $44 million to $48 million. We continue to expect operating margins of approximately 25% for the full year helped by lower operating cost and improved production yields.
Turning next to retail on Slide 5.  Lithium delivered another outstanding quarter. Revenue increased 15% year-over-year to $63 million and segment earnings more than tripled to $16.5 million. Lithium's performance reflect a success of FMC strategy of converting lithium carbonate into higher value downstream specialty product supported by strong manufacturing performance, especially in Argentina in our Bessemer City Hydroxide Facility.
Higher sales volume, higher average prices in all major product categories, improved mix and lower operating costs, all contributed to deliver segment earnings above the top end of our prior guidance range and push segment earnings margin to over 26% in the quarter.
We expect supply/demand conditions to remain tight for the remainder of the year as previously announced capacity expansions across industry have been slow to come online. This reinforces our confidence in favorable pricing conditions through the remainder of 2016.
For the full year, we expect segment earnings to be in the range of $58 million to $66 million, an increase at the midpoint of approximately 30% compared to prior guidance and nearly 3x segment earnings in 2015. Higher prices and lower operating costs compared to last year will support operating margins in the range of 24% to 25% for the year.
We expect third quarter segment earnings to be in the range of $13 million to $17 million as the benefit of higher prices will be partially offset by seasonally lower production at our operations in Argentina. 
FMC's Lithium business is positioned to deliver significant earnings growth in 2016 and beyond. In May, we announced plans to triple our production capacity of lithium hydroxide to 30,000 metric tons by 2019 in order to meet growing demand from our customers starting with a 4,000 metric ton expansion scheduled to come online in 2017.
Last week, we announced we will accelerate that capacity expansion and we now expect 8,000 metric tons to come online by the middle of 2017. We continue to evaluate the turning or further capacity expansion and expect the entire 20,000 metric ton of additional capacity to be online by 2017. We believe, we will more than double the revenue and earnings of our Lithium business between 2016 and 2020, resulting in over 20% per year growth through the rest of this decade.
We recognize that our hydroxide investment plans require us to have cost-effective access to sufficient lithium carbonate. Our current carbonate capacity is sufficient to support the expansion in FMC's hydroxide production to at least 2018.
Beyond this, we are actively pursuing multiple tasks to ensure we are not carbonate constrained. First, we have several low capital options to debottleneck our Argentina operations, potentially adding 20% capacity. Second, we are in ongoing discussions with multiple carbonate producers. We have announced plans to add capacity in the coming years and are exploring mutually beneficial long-term supply agreement or strategic partnerships. And of course, we retained the option to add significant capacity at our operation, our existing operation in Argentina beyond the debottlenecking I just mentioned. Consequently, we are highly confident that access to lithium carbonate will not be a constrain in our ability to extend our hydroxide business in the coming years.
Before I turn the call over to Paul, I will comment briefly on the outlook for the third quarter and full year 2016 on Slide 6. As I mentioned, we are maintaining full year segment earnings for Ag Solutions and adjusting our full year earnings expectation for both Health and Nutrition and lithium. As a result, on a consolidated basis, we are increasing full year adjusted EPS guidance by $0.05 at the midpoint to $2.60 to $2.90 per share. For the third quarter, we expect adjusted EPS to be in the range of $0.53 to $0.63. 
I will now turn the call over to Paul to discuss select financial results."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Pierre. As usual, I'll start with the income statement and specifically of the tax rate. Our adjusted effective tax rate for the full year is now expected to be in the range of 24% to 25%, giving us a small benefit this quarter compared to Q2 l",611,"Thank you, Pierre. As usual, I'll start with the income statement and specifically of the tax rate. Our adjusted effective tax rate for the full year is now expected to be in the range of 24% to 25%, giving us a small benefit this quarter compared to Q2 last year.
This lowered rate is largely due to the continued change in the mix of our earnings away from high tax jurisdictions, such as the U.S., towards regions where tax rates are lower. Foreign exchange was not a major factor in our results this quarter with the stronger dollar, mainly impacting the Ag Solutions segment.
Various Asian currencies plus the Mexican peso were the drivers of the FX headwind in the quarter. The second quarter is not a period of significant activity in Brazil. And therefore, the recent strengthening of the reais had a limited impact on our financials in the quarter. However, with an FX rate in the quarter that was weaker than the same period of last year, and with the price list that largely reflect to the current spot rate, the combined effect of price and currency in Brazil was a net positive to our second quarter earnings.
Looking into the second half of the year. The recent stability in the reais-U.S. dollar exchange rate means that the assumptions regarding the future exchange rate that has underpinned our guidance is unchanged. To remind you, our guidance has assumed that we have a reais to U.S. dollar rate that is relatively stable with no major short-term swings in the FX rate, combined with a price list that largely reflects the prevailing spot exchange rate.
Sitting here today, both of those assumptions remain unchanged. And therefore, we do not expect either a positive or negative impact on our second half performance from the reais-FX rate compared to our previous guidance, provided these conditions hold.
Turning to the balance sheet and cash flow on Slide 7. We continue to make progress in increasing our cash generation while maintaining discipline on capital spending. For the first half of the year, our adjusted cash from operations was 40% higher than the first half of last year, driven primarily by stronger working capital performance.
We remain on target to meet our outlook for the full year of $450 million to $550 million of adjusted cash from operations. Net debt fell by $90 million compared to the first quarter and by over $120 million since the start of the year.
The second quarter is an important period for us in terms of cash collections in Brazil. We remain very focused on the credit capacity of our customers, particularly given the constrained access to third-party financing for Brazilian growers. This has an impact on both our ability to collect cash from customers and our willingness to continue to extend credit in the form of new sales. 
On the first point, we were pleased with our performance in collecting in Brazil. With net cash collections slightly ahead of our expectations and particularly good progress in collecting from our past due balances. As a result, we saw a meaningful reduction in our Brazil receivables balance. However, it is still significantly higher than we would like and we will remain focused on reducing our exposure in the coming quarters.
The credit tightness in Brazil has been an important factor for us for several quarters now, but our willingness to extend credit to certain segments of the market reduced. As we head into the key second half selling season in Brazil, our guidance reflects the disciplined approach to credit exposure.
And with that, I will turn the call back to Pierre."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Paul. And before I continue with my remarks, let me correct a statement I made. The 20,000 ton of additional lithium hydroxide capacity is to be online by 2019, not as I said 2017.So to continue and to conclude. I am very pleased with the ove",373,"Thank you, Paul. And before I continue with my remarks, let me correct a statement I made. The 20,000 ton of additional lithium hydroxide capacity is to be online by 2019, not as I said 2017.
So to continue and to conclude. I am very pleased with the overall execution of our strategies and improved outlook for the year. Despite ongoing challenges facing the agricultural industry, our strategy and the actions we have taken in the back end of 2015 and the first half of 2016 give us strong confidence in our performance for the remainder of the year.
We have remained focused on reducing the level of FMC product inventory in the channel, maintain discipline on price and term, aggressively manage our mix by rationalizing our product line, leading to stronger margins. This strategy, combined with a successful integration of Cheminova and the more benign FX situation in Brazil have increased the credit abilities of our business and will drive the second half performance of Ag Solutions with earnings up 35% compared to pro forma results for 2015
We are investing in our technology roadmap in order to offer unique, value-added solutions to our customers. We see high acceptance rates for our new products launches, including our biological platform, and remain on track to introduce our new active ingredients pipeline starting in 2017.
Lithium continues to deliver strong performance altering its product mix and increasing output to meet growing market demand. FMC's focused strategy has enabled the business to take advantage of favorable market conditions to rely significant earnings growth in 2016. Our announced capacity expansion strengthens FMC's leadership position in lithium hydroxide and specialty lithium application and will deliver further growth in the years to come.
Health and Nutrition had a weaker-than-expected quarter. However, the business continues to generate high margins and return and demand across key nutritional and pharmaceutical markets will support growth over the second half of the year.
Finally, we are generating increased operating cash flow to improve our balance sheet. We are on track to increase adjusted cash from operations by approximately 40% in 2016. 
I thank you for your attention this morning. And with that, I will turn the call back to the operator for questions."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] And your first question comes from the line of Christopher Parkinson with Crdit Suisse.",16,"[Operator Instructions] And your first question comes from the line of Christopher Parkinson with Crdit Suisse."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Can you just comment a little more on your longer-term expectations for your European business, given your shift or I'd say rather evolution of your good market strategy? And then also parse out your views for Northwest here versus CIS. And then also, you",58,"Can you just comment a little more on your longer-term expectations for your European business, given your shift or I'd say rather evolution of your good market strategy? And then also parse out your views for Northwest here versus CIS. And then also, you mentioned a product rationalization as well. Just any additional detail would be helpful."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Chris, this is Mark. Well, first of all, for Europe, obviously, we now have a very different business model with the acquisition of Cheminova. I think you're going to expect just to see, over the long haul, outperformance in the marketplace. And it kind o",168,"Chris, this is Mark. Well, first of all, for Europe, obviously, we now have a very different business model with the acquisition of Cheminova. I think you're going to expect just to see, over the long haul, outperformance in the marketplace. And it kind of fits in with your second question around the CIS in Western Europe. We obviously had a bigger exposure in Western Europe with the Cheminova acquisition, but we see a lot of opportunity in the CIS countries, other parts of Eastern Europe in terms of Poland and Hungary, Czech, Slovakia, as well as the Ukraine. Introduction of new technologies is important for us in Europe. The portfolio is strong. But without pipeline, we have new products that will benefit, both niche crops and especially cereals, where Cheminova have exposure that FMC did not have. So if you think of the outperformance versus the market, it's really going to be cereals and the niche crops, especially in the South, and then accelerated growth in these."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Perfect. And then just a quick follow-up. Just can you just comment a little bit more about the working capital for me you saw there in the quarter. And then also on a go-forward basis, specifically, how do you typically evaluate growth versus credit risk",81,"Perfect. And then just a quick follow-up. Just can you just comment a little bit more about the working capital for me you saw there in the quarter. And then also on a go-forward basis, specifically, how do you typically evaluate growth versus credit risk as we head into the third quarter with Brazil? And is it becoming more dependent on crop types, farm size or even region within Brazil? Just any comments on the puts and takes would be helpful."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Sure, let me touch on that. The working capital progress we made really, if you look at the cash flow improvement we had over last year in the first half of the year, you can literally put almost all of that antibiotic collections in Brazil. So we've made",198,"Sure, let me touch on that. The working capital progress we made really, if you look at the cash flow improvement we had over last year in the first half of the year, you can literally put almost all of that antibiotic collections in Brazil. So we've made significant progress over there. We've talked many times about the steps we're taking. I can't point to any one thing that's changed that. It's about getting some momentum behind those collection conversations. Now in terms of growth versus credit. Sure, we really think about it that way. We think about credit in terms of credit. We think about the ability of the customer to repay us, the stability of the customer and their access to finance.  There are natural differences by crop and by region in Brazil. And we obviously factual of that in the way that we go-to-market. But we have the same questions that we ask and the same standards that we set regardless of region or crop, essentially, based on our competence that we will recover the payments from our customers on the terms that we sell them to. That's the single largest factor that we consider."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, the only thing I would add, Chris is you know Brazil very well. Given where the exposure is, I would say the North, the serato regions are where it is probably the most stressed. The South with the co-ops and the distribution channel is in better sha",90,"Yes, the only thing I would add, Chris is you know Brazil very well. Given where the exposure is, I would say the North, the serato regions are where it is probably the most stressed. The South with the co-ops and the distribution channel is in better shape, and then sugarcane as well. Sugar industries have gone through a lot of challenges. But with the price of sugar today, they are in a better shape as they go forward into 2017. But it's definitely the North where the stress is."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And your next question comes from the line of Joel Jackson with BMO Capital Markets.",15,"And your next question comes from the line of Joel Jackson with BMO Capital Markets."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Just staying in Brazil. You commented that you had a good destock of your own FMC product. Are you -- can you talk about where you're seeing your competitors for their -- in the channel for inventories? I think we've seen commentary before that there had",55,"Just staying in Brazil. You commented that you had a good destock of your own FMC product. Are you -- can you talk about where you're seeing your competitors for their -- in the channel for inventories? I think we've seen commentary before that there had been over a year of products from your competitors."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you. No, we can't and we don't want to comment on competitors. It's sometimes quite difficult to understand the overall inventory in the channel. So really what's we've been doing and that's the change we started to make in the fourth quarter is tru",78,"Thank you. No, we can't and we don't want to comment on competitors. It's sometimes quite difficult to understand the overall inventory in the channel. So really what's we've been doing and that's the change we started to make in the fourth quarter is truly focusing on tuning down our own inventory of product. There is product in the channel, but really to comment specifically about our competitors, that would not make sense for us to do so."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Okay. If I look at your guidance, you seem to be implying a 300 or 400 basis points improvement in Ag Solution margin in the fourth quarter. Can you talk about that, where you see the big margin pick up in Q4 and how it's going to play out?",49,"Okay. If I look at your guidance, you seem to be implying a 300 or 400 basis points improvement in Ag Solution margin in the fourth quarter. Can you talk about that, where you see the big margin pick up in Q4 and how it's going to play out?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes. Certainly, and I think this -- the comment I would make are valid for the entire second half. We are getting now into a position. If you look compared to the backend of 2015, where there is multiple area of improvement. First of all, our product mix",207,"Yes. Certainly, and I think this -- the comment I would make are valid for the entire second half. We are getting now into a position. If you look compared to the backend of 2015, where there is multiple area of improvement. First of all, our product mix is getting much stronger than what it was. We -- our actions to work away from low margin, third party more generic products is working very well. So we are increasing the margins of our products through mix. Second of all, we have been pretty successful over the last 3 or 4 quarters in moving a price. So with a situation looking at the importance of Brazil and Latin America in Q3 and Q4 and taking into account the pricing versus FX situation, we are in a stronger position. So blend of stronger volume we're going to see in the second half of the year, a better mix because we are moving away from third-party products and the pricing FX situation will lead to, first of all, to more predictable business. We have a much better visibility going in the second half of the year than we had in a long time and with stronger margins for the business."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our next question comes from the line of Mike Harrison with Seaport Global securities.",15,"And our next question comes from the line of Mike Harrison with Seaport Global securities."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, you mentioned in the last call that Q2 or in the Lithium business was when you were expecting some seasonal production weakness there, yet you were able to deliver well ahead of your guidance. Can you talk about what drove that upside during the q",64,"Pierre, you mentioned in the last call that Q2 or in the Lithium business was when you were expecting some seasonal production weakness there, yet you were able to deliver well ahead of your guidance. Can you talk about what drove that upside during the quarter and whether there could be some potential upside as we look at your guidance for Q3 and Q4?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Certainly. I think the seasonal weakness is not only in Q2. It's in the back end of Q2 and through Q3. So we've seen part of it and we're going to keep on seeing it. It's usually due to the fact that it is winter. There is more rainy season right now in A",341,"Certainly. I think the seasonal weakness is not only in Q2. It's in the back end of Q2 and through Q3. So we've seen part of it and we're going to keep on seeing it. It's usually due to the fact that it is winter. There is more rainy season right now in Argentina, where we're operating. So it's not only a Q2 phenomenon, it's a back of Q2, early Q3. I think the visibility we have today due to our production is quite, quite correct at the earnings level. Mainly, there is multiple reasons, which have been leading to the improved earnings. First of all, the mix. We are moving more business to all of lithium hydroxide, where we've been able to operate our plants quite, quite well and where there is a healthy demand and pricing situation. Second of all, our plants have been operating also very well for carbonate production and we have been -- and we are continuing to do that for the second half, selling more products made within the company than third-party products we would resell. And then there is some volume. So if I look at the second half of the year, I think our earnings is quite in line with our expectation. I don't think there is a lot of upside. Most likely what you will see is, we decided not to change the revenue range because we are a little bit below the middle point of the range initially. Looking at the demand for the back end of the year, it's most likely going to lend us to where the higher end of the range from a revenue standpoint. But I believe, the earnings we have forecasted in lithium for Q3, Q4 are correct, unless. Unless, I'd say the only place where I could see upside, but it is not possible for us to predict that today is pricing. Pricing is always something, depending upon demand, and how capacity come on stream. So that one, we've made some assumptions, you never know."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","And then a question just on the product rationalization that you did in Ag Solutions. Is that mostly legacy FMC products or are there some Cheminova products? And is there any more to come? Just trying to get a sense of whether we could see some additiona",78,"And then a question just on the product rationalization that you did in Ag Solutions. Is that mostly legacy FMC products or are there some Cheminova products? And is there any more to come? Just trying to get a sense of whether we could see some additional pressure there. And at some point, do you hit a point where you could see some negative leverage as a result of scaling back on the number of products you're selling?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think the product rationalization is very well advanced today. I think it's a mix. It's as much from Cheminova legacy products than it is from FMC products. Both company use to resale third-party products as a service to customers. And the things you ca",189,"I think the product rationalization is very well advanced today. I think it's a mix. It's as much from Cheminova legacy products than it is from FMC products. Both company use to resale third-party products as a service to customers. And the things you can afford to do it at a given time with a very healthy market, you cannot do when the market is more tense. So it was a normal thing for us to move the way. We had very precisely defined what those products could be. I'm very pleased with the speed at which the organization responded to it. I think more than half of the shortfall in our sales today in the second quarter is coming from product rationalization, but that's pretty much where it is. So you will not see numbers going beyond what we've talked about, which was total run rate, adding of this year of $350 million, which is $100 million more than we did last year. We did $250 million last year. And this is it. There will be no further as far as we can see actions to be taken."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And your next question comes from the line of Frank Mitsch with Wells Fargo.",14,"And your next question comes from the line of Frank Mitsch with Wells Fargo."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, I was struck by the comment that the inventory levels of insecticides are rather high in Brazil. And I guess, I was thinking about Zika there. Does that offer any opportunity for you in that marketplace?",37,"Pierre, I was struck by the comment that the inventory levels of insecticides are rather high in Brazil. And I guess, I was thinking about Zika there. Does that offer any opportunity for you in that marketplace?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, Frank, this is Mark. Yes, we have seen increased sales of specific insecticides that we're providing for that effect to control market. It's not huge, though. Let's put it in perspective. It's not going to move the Ag business. It's nice business to",91,"Yes, Frank, this is Mark. Yes, we have seen increased sales of specific insecticides that we're providing for that effect to control market. It's not huge, though. Let's put it in perspective. It's not going to move the Ag business. It's nice business to have. We have a leading position in Brazil. And we've seen that business grow over the last 18 months. And we expect it to continue with the way Zika is progressing through the region. But it's not going to be significant enough to really move the needle."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Interesting. I mean, as the geography of concern spreads, one would think that, that would be an opportunity. I guess, just simplistically, how would you describe your market share in that application?",32,"Interesting. I mean, as the geography of concern spreads, one would think that, that would be an opportunity. I guess, just simplistically, how would you describe your market share in that application?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","It's pretty good. Let's -- why don't we just put it in perspective. The global public health market is about $700 million, and that's within the total Ag space crop protection chemicals of over $51 billion. So really, for mosquito control, the market worl",129,"It's pretty good. Let's -- why don't we just put it in perspective. The global public health market is about $700 million, and that's within the total Ag space crop protection chemicals of over $51 billion. So really, for mosquito control, the market worldwide is about $325 million to $340 million and the U.S. is about $90 million of that. So you can get a sense of the scale of that business. In particular applications, we have a very good market share. But only with our pyrethroids, but with a product called malathion that we bought from Cheminova. So just keep it in perspective. And if you are able to talk about it a lot, but the U.S. market is only $90 million out of that $700 million."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Mark, I appreciate you throwing a wet blanket on that thesis. And then, lastly, Paul, you sounded more sanguined with respect to the FX impact for 2016. Do you have a size as to what you think the negative effect will be when all is said and done on the y",51,"Mark, I appreciate you throwing a wet blanket on that thesis. And then, lastly, Paul, you sounded more sanguined with respect to the FX impact for 2016. Do you have a size as to what you think the negative effect will be when all is said and done on the year?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I wish I could predict FX markets that well, Frank. I mean, I wouldn't be in this job. I'm pretty confident around that. I think the key is that we seem to have more predictability around that. You see the peso has been a surprising area for us. We didn't",130,"I wish I could predict FX markets that well, Frank. I mean, I wouldn't be in this job. I'm pretty confident around that. I think the key is that we seem to have more predictability around that. You see the peso has been a surprising area for us. We didn't -- I mean, we never see him coming. And the Brazil has been -- the reais has been some kind of a bright spot, not because of the absolute rate, but as I mentioned about the stability around the rates. And I think that's sort of the keepers as we look forward, that stability of the rates and a lack of surprise is more important to us on most of our business than the actual movement in the exchange rates."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our next question comes from line of Daniel Jester with Citibank.",12,"And our next question comes from line of Daniel Jester with Citibank."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","What kind of visibility do you have in Health and Nutrition in the second half of this year? Your guidance seems to imply an acceleration in profits, which seems seasonally maybe a little bit different than the past few years. So given sort of the comment",67,"What kind of visibility do you have in Health and Nutrition in the second half of this year? Your guidance seems to imply an acceleration in profits, which seems seasonally maybe a little bit different than the past few years. So given sort of the comments that you called out about omega-3, can you just walk us through some of the key drivers for the second half?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Certainly, I think we do have a pretty good visibility on our 3 segments today from a demand standpoint. But it is important to understand that the earnings growth, especially in the fourth quarter, is maybe more predictable because it is due to a cost si",162,"Certainly, I think we do have a pretty good visibility on our 3 segments today from a demand standpoint. But it is important to understand that the earnings growth, especially in the fourth quarter, is maybe more predictable because it is due to a cost situation. We always work our cost and decrease our cost. But the way costs flows into operations depend upon the speed at which you turn your product. And I think, we call that capitalized variance. But the main reason for the bump in earnings in the backend of the year is due to the fact that we would be operating at a lower cost than we have been operating via the quarters in previous year. That is why you will see such a jump. So it is not due to a major turn in demand for any of our products, but it's much more the benefit of prior activity we've done on operational costs and manufacturing excellence."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Okay, that's helpful. And then of this $60 million to $70 million of full year cost synergies from Cheminova, can you quantify how much of that you realized in the first half? And then maybe just holistically, beyond just cost synergies, where do you see",51,"Okay, that's helpful. And then of this $60 million to $70 million of full year cost synergies from Cheminova, can you quantify how much of that you realized in the first half? And then maybe just holistically, beyond just cost synergies, where do you see the integration process for Cheminova today?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, thanks. I think at a run rate basis, we want to close the [indiscernible] on the run rate basis in the $30 million to $40 million range for the first half of the year on the Cheminova. Do you want, Mark?",42,"Yes, thanks. I think at a run rate basis, we want to close the [indiscernible] on the run rate basis in the $30 million to $40 million range for the first half of the year on the Cheminova. Do you want, Mark?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","You want me to talk a little bit about the integration side. From an integration perspective, we are very much done on the commercial side, that's all in place. A lot of the functional groups are also fully integrated and operating. We have some systems t",142,"You want me to talk a little bit about the integration side. From an integration perspective, we are very much done on the commercial side, that's all in place. A lot of the functional groups are also fully integrated and operating. We have some systems that we're still working through SAP in Europe, as an example, which will be completed early in the fourth quarter. And then the long lead time item is how we bring together the different manufacturing units, the total manufacturing units and the formulating units. We are well progressed with that. We still have some to go, but that will occur over time. And the basic need there is to make sure that we have registrations as we move products around the world. So that's the rate limiting step, but everything else is pretty much done by now."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think from the Cheminova integration, we're going to stop reporting. I mean, we'll answer any questions you guys might have. But we can almost declare success. Everything is in place to reach, as we discussed by the middle of next year, the $140 million",105,"I think from the Cheminova integration, we're going to stop reporting. I mean, we'll answer any questions you guys might have. But we can almost declare success. Everything is in place to reach, as we discussed by the middle of next year, the $140 million to $160 million run rate, the 800 to 900 positions being eliminated. So we are very much more than on track ahead of the initial schedule. And I think the lots of the remaining activities are more under impulse shop around IT, SAP, science integration. So much more back-office integration than anything during with the front end of the business."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And we do have a question from the line of Rosemarie Morbelli with Gabelli & Company.",15,"And we do have a question from the line of Rosemarie Morbelli with Gabelli & Company."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","I was wondering if you could talk about the expected lithium capacity, lithium carbonate capacity increase in 2017. Based on what you see in here in the marketplace, is that coming on stream, a lot of it in the first half of 2017 and therefore, would have",52,"I was wondering if you could talk about the expected lithium capacity, lithium carbonate capacity increase in 2017. Based on what you see in here in the marketplace, is that coming on stream, a lot of it in the first half of 2017 and therefore, would have a negative impact on pricing?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Rosemarie. Yes, we're starting to see some exchange of volumes coming on even in the back half of 2016, mostly out of the new spodumene capacity that's coming online in Australia. As you know, there's also some capacity in Chile, and there has",110,"Thank you, Rosemarie. Yes, we're starting to see some exchange of volumes coming on even in the back half of 2016, mostly out of the new spodumene capacity that's coming online in Australia. As you know, there's also some capacity in Chile, and there has been capacity ramping up in Argentina, targeting back end of 2016 and early 2017. So these were the volumes that we're watching. And I characterize it, could be anywhere between 50,000 to 75,000 tons by early 2017. So as Eric commented earlier, this is where we make a pricing assumption, and we're monitoring the conditions as we interact with customers in terms of pricing expectations."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","And that particular capacity addition is going to be smaller than the demand increase, is in it? And therefore pricing is going to come down across the board, including lithium hydroxide or you don't think so?",36,"And that particular capacity addition is going to be smaller than the demand increase, is in it? And therefore pricing is going to come down across the board, including lithium hydroxide or you don't think so?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","No. First, yes. There will be -- we are expecting, as time goes, starting in '17 and into '18, we're expecting carbonate pricing to grew more towards normal pricing, which mean a lower pricing we are currently seeing when they will be more or they balance",126,"No. First, yes. There will be -- we are expecting, as time goes, starting in '17 and into '18, we're expecting carbonate pricing to grew more towards normal pricing, which mean a lower pricing we are currently seeing when they will be more or they balance between the carbonate demand and the supply. It will not impact the hydroxide pricing. If you look right now and if you put together all of the hydroxide capacity increase, which actually we are leading, they are very much in line with the demand increase. So from a pricing standpoint, we might not see hydroxide rising tremendously in the year to come. But I think wanted to be in a healthy pricing situation for the next 3 to 4 years."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","And just to add a little bit to that, Rosemarie. In our hydroxide business, we're targeting specific segments of that demand, where it's high quality hydroxide, where they're willing to pay for the quality we bring to the markets. So when we look at suppl",63,"And just to add a little bit to that, Rosemarie. In our hydroxide business, we're targeting specific segments of that demand, where it's high quality hydroxide, where they're willing to pay for the quality we bring to the markets. So when we look at supply/demand, we're looking even specifically at that customer mix versus one that might trade-off to carbonate or other supply."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And my second question deals with the inventory, overall inventory in the Ag sector. You said that you have loyalty FMC product inventories. But without talking about any specific competitors, what do you see in terms of the overall inventory channe",60,"Okay. And my second question deals with the inventory, overall inventory in the Ag sector. You said that you have loyalty FMC product inventories. But without talking about any specific competitors, what do you see in terms of the overall inventory channel? Is it declining? Or is it still growing? Or more as sort of flat -- has it plateaued?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think from a -- as I said, I want to repeat, we're mostly focusing on our inventory. But overall, if I would have or if we would have to make an overall statement, we believe overall inventory in the channel is declining. We do not believe right now we",142,"I think from a -- as I said, I want to repeat, we're mostly focusing on our inventory. But overall, if I would have or if we would have to make an overall statement, we believe overall inventory in the channel is declining. We do not believe right now we are at a turning point from a market standpoint. But we can see we are at a place where the dialogue with the customers is changing. There is more certainty. There is more productivity. Still means that the inventory in the channel is pretty heavy. We are not yet at a situation where it's not -- but the dialogue is changing. And I believe, everybody is trying to do the upbeat to decrease their inventory. We believe, we most likely have been most aggressive. But overall, I think the situation is improving."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our next question comes from line of Mark Connelly with CLSA.",12,"And our next question comes from line of Mark Connelly with CLSA."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Two things. Paul, you talked about the longer time line for rationalization of the manufacturing in Europe. Is that sort of a 2020 time goal in your mind? Or is there a specific target in your mind? And then the second question to Latin America again. As",106,"Two things. Paul, you talked about the longer time line for rationalization of the manufacturing in Europe. Is that sort of a 2020 time goal in your mind? Or is there a specific target in your mind? And then the second question to Latin America again. As we think about the working capital cycles in cotton and sugarcane, is your penetration in that market permanently shifting your working capital cycle in a material way? My understanding is Cheminova manage working capital much differently than you did using more receivables, for example. And I'm curious whether that has all shifted over to your way of doing things."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Well, let me address first the question on the manufacturing rationalization. Right now, we are at a place where we have a stable manufacturing network for Ag business. We are always looking at improving. But any improvement, any decision today is always",154,"Well, let me address first the question on the manufacturing rationalization. Right now, we are at a place where we have a stable manufacturing network for Ag business. We are always looking at improving. But any improvement, any decision today is always a mid- to long-term decisions because there is some product registrations, which are changing when you do a change of manufacturing. So I have to say that right now, as any company would do, we are keeping our options open. But we are in what I would call a stable manufacturing network. And we will see as time goes what are the best decisions to be taken for our business in terms of network. But today, we're not penalized by the structure we have and it's a matter of doing continuous improvement and being able to supply what will be requested by the market at the time when the market turns around."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","So you're comfortable than not being quite as asset light as you had been sort of in the medium term?",21,"So you're comfortable than not being quite as asset light as you had been sort of in the medium term?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","We are asset light. I think if you think about FMC prior to the acquisition of Cheminova, our manufacturing cost was 95% asset light. I would say today, maybe we're at 90%. We should not believe that the fact that we have a plant in India in Panoli and a",114,"We are asset light. I think if you think about FMC prior to the acquisition of Cheminova, our manufacturing cost was 95% asset light. I would say today, maybe we're at 90%. We should not believe that the fact that we have a plant in India in Panoli and a plant we have in Ronland are fundamentally changing the mix of product we shall made until manufacturers versus what is being made today. Those are big plans. But you know in the big scheme of things, the production capacity versus what we do with total network is fairly small. So it is our fundamental departure to what we used to be in the past."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Let me touch on the working capital question down there in Brazil. Sugarcane and cotton can have very, very different terms, cotton tends to be longer term, sugarcane tends to be much short term although that does vary depending on the nature of the plant",253,"Let me touch on the working capital question down there in Brazil. Sugarcane and cotton can have very, very different terms, cotton tends to be longer term, sugarcane tends to be much short term although that does vary depending on the nature of the planting cycles and on the financial health of the sugarcane guidance. But as a rule, as we shifted away from cotton, we'll expect to see our working capital terms come in and to what sugarcane also does the same thing. I would not though expect that you're going about to track that to our working capital balance as you look at it. It's definitely a factor that helps, but it's not so large that you're going to really see a major move in our numbers. In terms of how Cheminova approached it. Cheminova, this is to separate the two important differences. Cheminova did not have a different approach to working capital than anybody else in the industry. They did have a different approach to have the finance that working capital. And to be blunt, as a weak balance sheet company with very unsophisticated treasury operations, they used to use some very, very expensive local financing in Brazil, which can give the impression that they are reducing their working capital. It was appropriate for non-U.S. GAAP reporting, it was appropriate for a sub-investment grade company, it was incredibly expensive and we'll certainly factor in why their overall profitability was so low and it's certainly not something we intend to do."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And we do have a question from the line of Aleksey Yefremov with Nomura Securities.",15,"And we do have a question from the line of Aleksey Yefremov with Nomura Securities."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","What is the current competitive environment in Latin America and North America? Do you see your competitors generally being more disappointed on crop reduction prices?",25,"What is the current competitive environment in Latin America and North America? Do you see your competitors generally being more disappointed on crop reduction prices?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Well, obviously, I'm not going to talk about what competition is doing on price. I'll tell you where we are. As Pierre said earlier, we're doing everything we can to make sure we manage price in terms across North America. And certainly in Brazil, where w",131,"Well, obviously, I'm not going to talk about what competition is doing on price. I'll tell you where we are. As Pierre said earlier, we're doing everything we can to make sure we manage price in terms across North America. And certainly in Brazil, where we have reduced our exposure to the Brazilian market by taking out through product rationalization, significant amount of volume and revenue. But we're very focused on making sure that we maximize price, not only in terms of pricing, but across the portfolio of what we're selling. I think you're going to see all sorts of different activities as we go through the next year. But for us, it's very much around protecting the margins, protecting the value of the business and certainly, looking after working capital."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think in term of pricing, just to get back to one of the comment Paul made around the balance of FX and pricing. As you know, we tend to have a rule in Brazil, where we index price on currency. Last year, we were with a pricing running after the currenc",173,"I think in term of pricing, just to get back to one of the comment Paul made around the balance of FX and pricing. As you know, we tend to have a rule in Brazil, where we index price on currency. Last year, we were with a pricing running after the currency and trying to move up our price. This year, the same process of adjusting pricing to currency is going the other way, which mean it is not any longer us asking the customers to take higher price, but the customer asking us to lower the price more towards the currency. So needless to say that for all of us, regardless of what behavior individual companies would take, it is an easier conversation from the predictability of the pricing. And this FX situation give us a much better position to talk about pricing, more control in term of understanding pricing in the next 2 quarters. And I think, it's got to apply to every company. It is just an FX price situation."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Very helpful. And turning to Europe and crop protection. You had some revenue declines there. How much of that was your move to direct market? And was it a onetime impact or is there any way to improve that next year?",41,"Very helpful. And turning to Europe and crop protection. You had some revenue declines there. How much of that was your move to direct market? And was it a onetime impact or is there any way to improve that next year?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes. The direct market situation is a onetime impact. It is just a couple of situation, which happen all the time when you do this kind of a transfer. First of all, you work with your distribution network, which we're moving away from. Those guys have inv",172,"Yes. The direct market situation is a onetime impact. It is just a couple of situation, which happen all the time when you do this kind of a transfer. First of all, you work with your distribution network, which we're moving away from. Those guys have inventory. They have stocked -- they are filling it while you replenishing your own now warehouses to sell. So there is steal of time, where you have 2 networks, which have to roll out for a little while. And you have to give the time to your distributors to sell the product they were supposed to sell the product by contract. Second of all, you are at a stage also, where your distributors are not replenishing their inventory in advance. So by the time we get into -- this is happening at the transition now. I believe if by the time we get into European season Q1, Q2 next year, we should be in a very normalized situation and it will be stable for the future."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And we do have a question from the line of Mike Sison with KeyBanc.",14,"And we do have a question from the line of Mike Sison with KeyBanc."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Just curious that you maintained your outlook for the crop protection markets this year down mid- to high single digit. What was it down in the first half? And just trying to gauge what the expectation is for the second half in terms of demand.",45,"Just curious that you maintained your outlook for the crop protection markets this year down mid- to high single digit. What was it down in the first half? And just trying to gauge what the expectation is for the second half in terms of demand."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","So I think in the first half, the way I would look at it, Mike, is when we gave the range, we said mid-  single digit to high single digit. Maybe we were thinking about more toward when we started this process, the lower end of the range, maybe 5%, 6%, 7%",250,"So I think in the first half, the way I would look at it, Mike, is when we gave the range, we said mid-  single digit to high single digit. Maybe we were thinking about more toward when we started this process, the lower end of the range, maybe 5%, 6%, 7%. We are more today on a 7%, 8% more toward the higher end of the range. And that is due, maybe less due to channel inventory than it was to specific reasons in Asia and Europe, mostly driven by weather. So for us, when we look at the market, if you remember, we were thinking about North America and Latin America in the higher end of the range, and these being helped by flattish to slightly down market in Europe and Asia. We don't see that any longer. I mean, we still see North America and Latin America on the higher end of the range, but we see Asia and Europe being down in the 5%, 6% from this year. That is why today, we are looking at maybe more the higher end of our range. For us, what we've been doing is we've been able, no matter what, to protect our earnings by being even more drastic on pricing, more drastic on product rationalization. So we'll be slightly lower on sales. But we believe we are going to be -- we're going to have very solid performance in the second half and productivity on the earning side."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Great. And then for the fourth quarter for Ag Solutions, you talked about better visibility than in the past. But just curious, what sort of gets you to the high end of the range? I mean, it's pretty wide in terms of the top end, given your guidance for A",67,"Great. And then for the fourth quarter for Ag Solutions, you talked about better visibility than in the past. But just curious, what sort of gets you to the high end of the range? I mean, it's pretty wide in terms of the top end, given your guidance for Ag Solutions from the third quarter and the low end. What sort of gets you to the top?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I would say always the same answer. When we give the mid of the range, it is under normal circumstances from a demand and weather standpoint. And those, there is always a range. You just need an infestation, you just need very strong insect pressure or ot",108,"I would say always the same answer. When we give the mid of the range, it is under normal circumstances from a demand and weather standpoint. And those, there is always a range. You just need an infestation, you just need very strong insect pressure or other pressure. And you would drive that either to the lower or either to the higher end. Today, we believe we are very comfortable with the mid of the range to see anything going up or down would be due to external events not linked to channel inventory or anything that kind, but much more to specific agricultural seasonal situation, mostly weather."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our last question comes from the line of Peter Butler with Glen Hill Investment.",15,"And our last question comes from the line of Peter Butler with Glen Hill Investment."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, early on regarding lithium, you folks had a conservative outlook on shorter term of lithium growth, but you saw good possibilities longer term. And this outlook has been proven correct. What do you see now for the longer-term growth of lithium? An",79,"Pierre, early on regarding lithium, you folks had a conservative outlook on shorter term of lithium growth, but you saw good possibilities longer term. And this outlook has been proven correct. What do you see now for the longer-term growth of lithium? And how do you -- how does your research pipeline on lithium derivatives look compared to what you're seeing from competitors and how does this change your future position on earnings and cash flow growth, et cetera?"
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Peter. Yes. So lithium, I have to say, we do have increased confidence in the future. Today, we believe this market is getting more and more solid. I have to say that we are still prudent. But the big breakthrough for us is the technology we're",291,"Thank you, Peter. Yes. So lithium, I have to say, we do have increased confidence in the future. Today, we believe this market is getting more and more solid. I have to say that we are still prudent. But the big breakthrough for us is the technology we're able to develop from a manufacturing standpoint, allowing us to add very low capital spend and decision cost of operations, ability to create 4,000 to 8,000 tons modules for lithium hydroxide instead of having to build in one shot, a 20,000 or 30,000 tons. So today, we do have an improved view and more certain view of what lithium hydroxide is doing. But on the work we've done in the last 2 years, was to develop a manufacturing process, allowing us to follow the demand growth. Which means that if the growth is not as we're expecting, we can stop 1 or 2 of these modules manufacturing and slowdown the capacity increase we have planned. If the demand becomes more aggressive, very easy for us to speed up the building of those modules. So first, your question, yes, we have increased confidence. Our strategy is very highly focused on the downstream product, where we have the highest profitability. Third, we have a safety net around demand by these manufacturing process we have in place, allowing to match the demand. Where are we on our forecast? We are taking pretty much a middle of the range. We are far in the process and predictability for the numbers I gave to you, to take the highest prediction from EV companies. So there could be upside, but you know, we are prepared also for the downside. 
And maybe I'll ask Tom to comment on the technology."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, and thanks for the question. On the technology, we've got a technology roadmap. And I'd say that with this strategy that we've undertaken on the high-value products, the biggest shift is increased collaboration and formalized collaboration with our c",85,"Yes, and thanks for the question. On the technology, we've got a technology roadmap. And I'd say that with this strategy that we've undertaken on the high-value products, the biggest shift is increased collaboration and formalized collaboration with our customers. So we do have a number of exciting opportunities that are being discussed with customers and being trialed with customers, and we're looking forward to that. It will continue to add to high-quality sales of new lithium derivatives and new applications with existing lithium derivatives."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","So as it was the last question, let me close with a couple of words before I hand the closing comments to Brian. I think we went through those 2 quarters, very highly focused on delivering what we promised to do. Everything we've done in the 2 quarters ha",188,"So as it was the last question, let me close with a couple of words before I hand the closing comments to Brian. I think we went through those 2 quarters, very highly focused on delivering what we promised to do. Everything we've done in the 2 quarters have done a few things for us. First of all, I believe from an Ag standpoint, even if the markets are not yet returning to the level of growth, this kind of market could expect to see one day. We have improved highly controlled visibility and predictability of our own business. I think from the lithium standpoint, it is a bright spot for us. We have refined our strategy. And I have to say the breakthrough we had in technology around lithium hydroxide manufacturing are an enormous win for us looking at the future. And our penetration, the business is solid. The business is highly profitable. But we also understand the challenges we have on omega-3 and it's something we'll be focusing on in the quarters to come. 
So with this, I'm going to turn the call back to Brian."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Pierre. As always, appreciate the time and the questions. I'll be available for on the call to address any further questions that you may have. So with that, thank you and have a good day.",37,"Thank you, Pierre. As always, appreciate the time and the questions. I'll be available for on the call to address any further questions that you may have. So with that, thank you and have a good day."
28606,341073936,1023278,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And ladies and gentlemen, today's conference will be available for replay after 10:00 a.m. today through September 3 at midnight. You may access the AT&T teleconference replay system at any time by dialing 1 (800) 475-6701 and entering the access code 378",72,"And ladies and gentlemen, today's conference will be available for replay after 10:00 a.m. today through September 3 at midnight. You may access the AT&T teleconference replay system at any time by dialing 1 (800) 475-6701 and entering the access code 378964. International participants may dial (320) 365-3844. That does conclude your conference for today. Thank you for your participation and for using the AT&T executive teleconference service. You may now disconnect."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the Second Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] As a reminder, today's conference is being recorded.And I would now turn the conference over to Brian Angeli, Vice Preside",50,"Good morning, and welcome to the Second Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] As a reminder, today's conference is being recorded.
And I would now turn the conference over to Brian Angeli, Vice President of Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning. Welcome to FMC Corporation's Second Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.Pier",273,"Thank you, and good morning. Welcome to FMC Corporation's Second Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.
Pierre will begin the call with a review of FMC second quarter performance and discuss the outlook for Q3 and the full year 2016. Paul will provide an overview of select financial results. The slide presentation that accompanies our results, along with our earnings release and 2016 outlook statements, are currently available on our website and the prepared remarks from today's discussion will be made available at the conclusion of the call.
As with our prior calls, Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President, FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, will join to address questions.
Before we begin, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including but not limited to, those factors identified in our earnings release and then our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based on these risks and uncertainties.
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms as well as other non-GAAP financial terms to which we may refer during today's conference call are provided on our website.
With that, I will now turn the call over to Pierre."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian, and good morning, everyone. As you can see on the first slide for the second quarter of 2016, FMC reported revenue of $810 million and adjusted operating profit of $143 million. Adjusted EPS of $0.69 was $0.01 below the second quarter of",2113,"Thank you, Brian, and good morning, everyone. As you can see on the first slide for the second quarter of 2016, FMC reported revenue of $810 million and adjusted operating profit of $143 million. Adjusted EPS of $0.69 was $0.01 below the second quarter of 2015, but above the midpoint of our guidance range.
Ag Solutions delivered another solid quarter and it continues to realize the benefits of the Cheminova acquisition. Lithium outperformed on higher sales volumes, and higher realized prices across the portfolio with lower operating cost from ongoing manufacturing excellence program.
Earnings in Health and Nutrition were below expectation as results in omega-3 were significantly weaker than anticipated. Based on our performance to date and the outlook for the back half of the year, we are increasing full year adjusted EPS guidance by $0.05 to $2.60 to $2.90 per share. I will provide more details on how that breaks down across each of the businesses shortly. But first, I will discuss second quarter results for each of our 3 segments, starting with Ag Solutions on Slide 2.
Overall, market condition and our performance in the quarter were in line with our prior expectations. We remained focused on reducing the level of FMC product inventory in the channel and on maintaining discipline on price and terms. We also took actions needed to complete the product rationalization that began in late 2014.
For the second quarter, Ag Solutions reported revenue of $515 million and segment earnings of $101 million, slightly ahead of the midpoint of our guidance range. Revenue declined 19% compared to the second quarter of 2015, largely due to lower sales volume, unfavorable weather conditions in Europe and Asia, the drawdown of channel inventory by customers in most regions and planned product rationalization all contributed to the decline in volume in the quarter.
Excluding planned product rationalization, revenue declined broadly in line with the crop protection market as a whole. Segment earnings declined 14% compared to 2015 as the impact of lower sales volumes, less favorable product mix in Asia and North America and the stronger U.S. dollar were partially offset by lower operating cost. Compared to pro forma results from Q2 last year, operating margin increased 100 basis points, reflecting pricing discipline, the elimination of sales of low-margin products due to portfolio rationalization and cost savings from the Cheminova integration.
As we move to Slide 3, I will first give a few comments on the global crop protection market then I will move on to review FMC's performance by region and discuss the outlook for Q3 and the full year. So first, the market.
Overall, conditions in the global crop protection market were as expected, little changed from Q1. In North America, soft commodity prices continue to put pressure on farm incomes resulting in more cautious buying behavior by growers and elevated inventory levels across the channel.
In Europe, unfavorable weather conditions early in the quarter, most notably in Central and Western Europe, reduced market demand, leading to lower volumes and increased channel inventory in certain countries. In Brazil, channel inventory across the market remained elevated, especially for insecticides. And while foreign exchange rates have been more stable, growers continue to be negatively impacted by a lack of credit availability.
In Asia, weather conditions were poor across most of the region resulting in weaker market demand. We believe these challenging market conditions will persist for the remainder of the year and we still forecast that the global crop protection chemical market will decline by mid- to high single-digit percent in 2016 on a U.S. dollar basis. I will now discuss FMC's performance in light of these market conditions.
First, let me address the lower-than-expected revenue for the quarter. Markets in Asia and Europe were weaker than expected, but the main driver of the lower revenue is a more successful and aggressive product rationalization.
We continue to manage the quality of our sales in order to protect margins, earnings and working capital. In North America, our strategy remained one of defending price and terms, allowing the level of FMC product inventory in the sales channel to reduce. All the data we see support our view that inventory of FMC products in the channel is declining. Reflecting the benefits of the actions we took early in the season, to reduce inventory of FMC product in the channel, sales in Q2 increased 5%. We saw strong demand for FMC's Authority brand of pre-emergent soybean herbicide and independent data show that the Authority brand has taken market share this year. We also saw grower support for the extended fungicide products we can now offer as a result of the Cheminova acquisition.
In Europe, revenue declined by 19%, driven largely by poor weather conditions and reduced volume due to the planned product rationalization as well as the impact of transitioning to a direct market access model. However, the product rationalization and move to direct market access have resulted in improved operating margins in the region.
In Latin America, revenue declined 43%, primarily as a result of steps we took to reduce the level of FMC product inventory in the sales channel in Brazil. We were encouraged by our ability to recover U.S. dollar pricing in the quarter. While not material to overall segment performance, given the seasonally lower sales volume, realized price increase in Brazil more than offset the negative impact of FX on a reported revenue.
In Asia, the combination of poor weather condition, further portfolio rationalization and a stronger U.S. dollar caused revenue to decline 22% compared to the second quarter last year. Moving on to the outlook for Ag Solutions.
Our full year segment earnings guidance remains unchanged at $380 million to $420 million. For the third quarter, we expect segment earnings of between $80 million and $90 million. At the midpoint of guidance, second half segment earnings will increase by approximately 35% compared to 2015, driven by improved performance in Brazil and Latin America and additional cost savings from the Cheminova integration. The steps we have already taken to rationalize our product portfolio and reduce the level of FMC inventory in the channel, in the sales channel, leave us well positioned as we enter the 2016, 2017 crop season in the Americas.
The relative stability of the Brazilian real over the past few months gives us increased confidence in our ability to recapture price despite tightening credit condition from growers and weak market demand as channel inventory levels decline. We expect full year segment earnings margin to be between 17% and 18%, which at the midpoint represents more than 250 basis points of improvement compared to 2015 driven by more favorable mix, improved pricing in Brazil and realization of cost savings. We remain on track to deliver the incremental cost savings target of $60 million to $70 million in 2016 and the full run rate cost saving of $140 million to $160 million by the middle of next year.
Moving on to Health and Nutrition on Slide 4. The business reported second quarter segment revenue of $195 million and segment earnings of $45 million. Revenue declined approximately 6% and earnings declined approximately 11% compared to the second quarter of 2015.
Results for the quarter were negatively impacted by worse-than-expected performance of omega-3. The headwinds we saw in omega-3 over the past year increased in the second quarter. Specifically, prices and volumes were much lower than anticipated. There is significant overcapacity in the industry, which, combined with lower demand for higher concentration products has exerted even greater pressure on prices than we saw earlier in the year. 
We have seen new entrants with business at prices that are close to cash cost of production, resulting in considerably lower volume for our products in certain key areas. We have aggressively taken costs out of this business with fixed cost falling by almost 40%. We continue to pursue new opportunities for high-end cost alteration products, but do not expect to recover these lost volumes this year and do not anticipate the change in pricing levels any time soon.
Excluding omega-3, results were in line with expectations. In nutritional ingredients, volumes in the quarter were slightly below Q2 2015, largely due to timing as orders shifted to the second half of the year. In health excipients, sales volumes increased in all key pharmaceutical markets.
Given performance to date in omega-3 and our expectations for the rest of the year, we are lowering our guidance for Health and Nutrition. We now expect full year segment earnings to be in the range of $190 million to $196 million, roughly flat with 2015, and third quarter segment earnings to be in the range of $44 million to $48 million. We continue to expect operating margins of approximately 25% for the full year helped by lower operating cost and improved production yields.
Turning next to Lithium on Slide 5.  Lithium delivered another outstanding quarter. Revenue increased 15% year-over-year to $63 million and segment earnings more than tripled to $16.5 million. Lithium's performance reflect a success of FMC strategy of converting lithium carbonate into higher value downstream specialty product supported by strong manufacturing performance, especially in Argentina in our Bessemer City Hydroxide Facility.
Higher sales volume, higher average prices in all major product categories, improved mix and lower operating costs, all contributed to deliver segment earnings above the top end of our prior guidance range and pushed segment earnings margin to over 26% in the quarter.
We expect supply/demand conditions to remain tight for the remainder of the year as previously announced capacity expansions across industry have been slow to come online. This reinforces our confidence in favorable pricing conditions through the remainder of 2016.
For the full year, we expect segment earnings to be in the range of $58 million to $66 million, an increase at the midpoint of approximately 30% compared to prior guidance and nearly 3x segment earnings in 2015. Higher prices and lower operating costs compared to last year will support operating margins in the range of 24% to 25% for the year.
We expect third quarter segment earnings to be in the range of $13 million to $17 million as the benefit of higher prices will be partially offset by seasonally lower production at our operations in Argentina. 
FMC's Lithium business is positioned to deliver significant earnings growth in 2016 and beyond. In May, we announced plans to triple our production capacity of lithium hydroxide to 30,000 metric tons by 2019 in order to meet growing demand from our customers starting with a 4,000 metric ton expansion scheduled to come online in 2017.
Last week, we announced we will accelerate that capacity expansion and we now expect 8,000 metric tons to come online by the middle of 2017. We continue to evaluate the turning or further capacity expansion and expect the entire 20,000 metric ton of additional capacity to be online by 2017. We believe, we will more than double the revenue and earnings of our Lithium business between 2016 and 2020, resulting in over 20% per year growth through the rest of this decade.
We recognize that our hydroxide investment plans require us to have cost-effective access to sufficient lithium carbonate. Our current carbonate capacity is sufficient to support the expansion in FMC's hydroxide production through at least 2018.
Beyond this, we are actively pursuing multiple tasks to ensure we are not carbonate constrained. First, we have several low capital options to debottleneck our Argentina operations, potentially adding 20% capacity. Second, we are in ongoing discussions with multiple carbonate producers. We have announced plans to add capacity in the coming years and are exploring mutually beneficial long-term supply agreement or strategic partnerships. And of course, we retained the option to add significant capacity at our operation, our existing operation in Argentina beyond the debottlenecking I just mentioned. Consequently, we are highly confident that access to lithium carbonate will not be a constrain in our ability to extend our hydroxide business in the coming years.
Before I turn the call over to Paul, I will comment briefly on the outlook for the third quarter and full year 2016 on Slide 6. As I mentioned, we are maintaining full year segment earnings for Ag Solutions and adjusting our full year earnings expectation for both Health and Nutrition and lithium. As a result, on a consolidated basis, we are increasing full year adjusted EPS guidance by $0.05 at the midpoint to $2.60 to $2.90 per share. For the third quarter, we expect adjusted EPS to be in the range of $0.53 to $0.63. 
I will now turn the call over to Paul to discuss select financial results."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Pierre. As usual, I'll start with the income statement and specifically of the tax rate. Our adjusted effective tax rate for the full year is now expected to be in the range of 24% to 25%, giving us a small benefit this quarter compared to Q2 l",611,"Thank you, Pierre. As usual, I'll start with the income statement and specifically of the tax rate. Our adjusted effective tax rate for the full year is now expected to be in the range of 24% to 25%, giving us a small benefit this quarter compared to Q2 last year.
This lowered rate is largely due to the continued change in the mix of our earnings away from high tax jurisdictions, such as the U.S., towards regions where tax rates are lower. Foreign exchange was not a major factor in our results this quarter with the stronger dollar, mainly impacting the Ag Solutions segment.
Various Asian currencies plus the Mexican peso were the drivers of the FX headwind in the quarter. The second quarter is not a period of significant activity in Brazil. And therefore, the recent strengthening of the reais had a limited impact on our financials in the quarter. However, with an FX rate in the quarter that was weaker than the same period of last year, and with the price list that largely reflect to the current spot rate, the combined effect of price and currency in Brazil was a net positive to our second quarter earnings.
Looking into the second half of the year. The recent stability in the reais-U.S. dollar exchange rate means that the assumptions regarding the future exchange rate that has underpinned our guidance is unchanged. To remind you, our guidance has assumed that we have a reais to U.S. dollar rate that is relatively stable with no major short-term swings in the FX rate, combined with a price list that largely reflects the prevailing spot exchange rate.
Sitting here today, both of those assumptions remain unchanged. And therefore, we do not expect either a positive or negative impact on our second half performance from the reais-FX rate compared to our previous guidance, provided these conditions hold.
Turning to the balance sheet and cash flow on Slide 7. We continue to make progress in increasing our cash generation while maintaining discipline on capital spending. For the first half of the year, our adjusted cash from operations was 40% higher than the first half of last year, driven primarily by stronger working capital performance.
We remain on target to meet our outlook for the full year of $450 million to $550 million of adjusted cash from operations. Net debt fell by $90 million compared to the first quarter and by over $120 million since the start of the year.
The second quarter is an important period for us in terms of cash collections in Brazil. We remain very focused on the credit capacity of our customers, particularly given the constrained access to third-party financing for Brazilian growers. This has an impact on both our ability to collect cash from customers and our willingness to continue to extend credit in the form of new sales. 
On the first point, we were pleased with our performance in collecting in Brazil. With net cash collections slightly ahead of our expectations and particularly good progress in collecting from our past due balances. As a result, we saw a meaningful reduction in our Brazil receivables balance. However, it is still significantly higher than we would like and we will remain focused on reducing our exposure in the coming quarters.
The credit tightness in Brazil has been an important factor for us for several quarters now, but our willingness to extend credit to certain segments of the market reduced. As we head into the key second half selling season in Brazil, our guidance reflects the disciplined approach to credit exposure.
And with that, I will turn the call back to Pierre."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Paul. And before I continue with my remarks, let me correct a statement I made. The 20,000 ton of additional lithium hydroxide capacity is to be online by 2019, not as I said 2017.So to continue and to conclude. I am very pleased with the ove",373,"Thank you, Paul. And before I continue with my remarks, let me correct a statement I made. The 20,000 ton of additional lithium hydroxide capacity is to be online by 2019, not as I said 2017.
So to continue and to conclude. I am very pleased with the overall execution of our strategies and improved outlook for the year. Despite ongoing challenges facing the agricultural industry, our strategy and the actions we have taken in the back end of 2015 and the first half of 2016 give us strong confidence in our performance for the remainder of the year.
We have remained focused on reducing the level of FMC product inventory in the channel, maintain discipline on price and term, aggressively manage our mix by rationalizing our product line, leading to stronger margins. This strategy, combined with a successful integration of Cheminova and the more benign FX situation in Brazil have increased the credit abilities of our business and will drive the second half performance of Ag Solutions with earnings up 35% compared to pro forma results for 2015.
We are investing in our technology roadmap in order to offer unique, value-added solutions to our customers. We see high acceptance rates for our new products launches, including our biological platform, and remain on track to introduce our new active ingredients pipeline starting in 2017.
Lithium continues to deliver strong performance altering its product mix and increasing output to meet growing market demand. FMC's focused strategy has enabled the business to take advantage of favorable market conditions to realize significant earnings growth in 2016. Our announced capacity expansion strengthens FMC's leadership position in lithium hydroxide and specialty lithium application and will deliver further growth in the years to come.
Health and Nutrition had a weaker-than-expected quarter. However, the business continues to generate high margins and return and demand across key nutritional and pharmaceutical markets will support growth over the second half of the year.
Finally, we are generating increased operating cash flow to improve our balance sheet. We are on track to increase adjusted cash from operations by approximately 40% in 2016. 
I thank you for your attention this morning. And with that, I will turn the call back to the operator for questions."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] And your first question comes from the line of Christopher Parkinson with Crdit Suisse.",16,"[Operator Instructions] And your first question comes from the line of Christopher Parkinson with Crdit Suisse."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Can you just comment a little more on your longer-term expectations for your European business, given your shift or I'd say rather evolution of your go-to-market strategy? And then also parse out your views for Northwest Europe versus CIS. And then also,",57,"Can you just comment a little more on your longer-term expectations for your European business, given your shift or I'd say rather evolution of your go-to-market strategy? And then also parse out your views for Northwest Europe versus CIS. And then also, you mentioned a product rationalization as well. Just any additional detail would be helpful."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Chris, this is Mark. Well, first of all, for Europe, obviously, we now have a very different business model with the acquisition of Cheminova. I think you're going to expect just to see, over the long haul, outperformance in the marketplace. And it kind o",170,"Chris, this is Mark. Well, first of all, for Europe, obviously, we now have a very different business model with the acquisition of Cheminova. I think you're going to expect just to see, over the long haul, outperformance in the marketplace. And it kind of fits in with your second question around the CIS in Western Europe. We obviously had a bigger exposure in Western Europe with the Cheminova acquisition, but we see a lot of opportunity in the CIS countries, other parts of Eastern Europe in terms of Poland and Hungary, Czech, Slovakia, as well as the Ukraine. Introduction of new technologies is important for us in Europe. The portfolio is strong. But with our pipeline, we have new products that will benefit, both niche crops and especially cereals, where Cheminova have exposure that FMC did not have. So if you think of the outperformance versus the market, it's really going to be cereals and the niche crops, especially in the South, and then accelerated growth in the east."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Perfect. And then just a quick follow-up. Just can you just comment a little bit more about the working capital improvement you saw there in the quarter. And then also on a go-forward basis, specifically, how do you typically evaluate growth versus credit",80,"Perfect. And then just a quick follow-up. Just can you just comment a little bit more about the working capital improvement you saw there in the quarter. And then also on a go-forward basis, specifically, how do you typically evaluate growth versus credit risk as we head into the third quarter with Brazil? And is it becoming more dependent on crop types, farm size or even region within Brazil? Just any comments on the puts and takes would be helpful."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Sure, let me touch on that. The working capital progress we made really, if you look at the cash flow improvement we had over last year in the first half of the year, you can literally pump all of that into better collections in Brazil. So we've made sign",201,"Sure, let me touch on that. The working capital progress we made really, if you look at the cash flow improvement we had over last year in the first half of the year, you can literally pump all of that into better collections in Brazil. So we've made significant progress over there. We've talked many times about the steps we're taking. I can't point to any one thing that's changed that. It's about getting some momentum behind those collection conversations. Now in terms of growth versus credit. I'm not really sure we think about it that way. We think about credit in terms of credit. We think about the ability of the customer to repay us, the stability of the customer and their access to finance.  There are natural differences by crop and by region in Brazil. And we obviously factor all of that in the way that we go-to-market. But we have the same questions that we ask and the same standards that we set regardless of region or crop, essentially, based on our confidence that we will recover the payments from our customers on the terms that we sell them to. That's the single largest factor that we consider."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, the only thing I would add, Chris is you know Brazil very well. Given where the exposure is, I would say the North, the serato regions are where it is probably the most stressed. The South with the co-ops and the distribution channel is in better sha",90,"Yes, the only thing I would add, Chris is you know Brazil very well. Given where the exposure is, I would say the North, the serato regions are where it is probably the most stressed. The South with the co-ops and the distribution channel is in better shape, and then sugarcane as well. Sugar industries have gone through a lot of challenges. But with the price of sugar today, they are in a better shape as they go forward into 2017. But it's definitely the North where the stress is."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And your next question comes from the line of Joel Jackson with BMO Capital Markets.",15,"And your next question comes from the line of Joel Jackson with BMO Capital Markets."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Just staying in Brazil. You commented that you had a good destock of your own FMC product. Are you -- can you talk about where you're seeing your competitors for their -- in the channel for inventories? I think we've seen commentary before that there had",55,"Just staying in Brazil. You commented that you had a good destock of your own FMC product. Are you -- can you talk about where you're seeing your competitors for their -- in the channel for inventories? I think we've seen commentary before that there had been over a year of products from your competitors."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you. No, we can't and we don't want to comment on competitors. It's sometimes quite difficult to understand the overall inventory in the channel. So really what's we've been doing and that's the change we started to make in the fourth quarter is tru",78,"Thank you. No, we can't and we don't want to comment on competitors. It's sometimes quite difficult to understand the overall inventory in the channel. So really what's we've been doing and that's the change we started to make in the fourth quarter is truly focusing on turning down our own inventory of product. There is product in the channel, but really to comment specifically about our competitors, that would not make sense for us to do so."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Okay. If I look at your guidance, you seem to be implying a 300 or 400 basis points improvement in Ag Solution margin in the fourth quarter. Can you talk about that, where you see the big margin pick up in Q4 and how it's going to play out?",49,"Okay. If I look at your guidance, you seem to be implying a 300 or 400 basis points improvement in Ag Solution margin in the fourth quarter. Can you talk about that, where you see the big margin pick up in Q4 and how it's going to play out?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes. Certainly, and I think this -- the comment I would make are valid for the entire second half. We are getting now into a position. If you look compared to the back end of 2015, where there is multiple area of improvement. First of all, our product mix",208,"Yes. Certainly, and I think this -- the comment I would make are valid for the entire second half. We are getting now into a position. If you look compared to the back end of 2015, where there is multiple area of improvement. First of all, our product mix is getting much stronger than what it was. We -- our actions to walk away from low margin, third party more generic products is working very well. So we are increasing the margins of our products through mix. Second of all, we have been pretty successful over the last 3 or 4 quarters in moving a price. So with a situation looking at the importance of Brazil and Latin America in Q3 and Q4 and taking into account the pricing versus FX situation, we are in a stronger position. So blend of stronger volume we're going to see in the second half of the year, a better mix because we are moving away from third-party products and the pricing FX situation will lead to, first of all, to more predictable business. We have a much better visibility going in the second half of the year than we had in a long time and with stronger margins for the business."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our next question comes from the line of Mike Harrison with Seaport Global securities.",15,"And our next question comes from the line of Mike Harrison with Seaport Global securities."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, you mentioned in the last call that Q2 or in the Lithium business was when you were expecting some seasonal production weakness there, yet you were able to deliver well ahead of your guidance. Can you talk about what drove that upside during the q",64,"Pierre, you mentioned in the last call that Q2 or in the Lithium business was when you were expecting some seasonal production weakness there, yet you were able to deliver well ahead of your guidance. Can you talk about what drove that upside during the quarter and whether there could be some potential upside as we look at your guidance for Q3 and Q4?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Certainly. I think the seasonal weakness is not only in Q2. It's in the back end of Q2 and through Q3. So we've seen part of it and we're going to keep on seeing it. It's usually due to the fact that it is winter. There is more rainy season right now in A",340,"Certainly. I think the seasonal weakness is not only in Q2. It's in the back end of Q2 and through Q3. So we've seen part of it and we're going to keep on seeing it. It's usually due to the fact that it is winter. There is more rainy season right now in Argentina, where we're operating. So it's not only a Q2 phenomenon, it's a back of Q2, early Q3. I think the visibility we have today due to our production is quite, quite correct at the earnings level. Mainly, there is multiple reasons, which have been leading to the improved earnings. First of all, the mix. We are moving more business towards our lithium hydroxide, where we've been able to operate our plants quite, quite well and where there is a healthy demand and pricing situation. Second of all, our plants have been operating also very well for carbonate production and we have been -- and we are continuing to do that for the second half, selling more products made within the company than third-party products we would resell. And then there is some volume. So if I look at the second half of the year, I think our earnings is quite in line with our expectation. I don't think there is a lot of upside. Most likely what you will see is, we decided not to change the revenue range because we are a little bit below the middle point of the range initially. Looking at the demand for the back end of the year, it's most likely going to lend us to where the higher end of the range from a revenue standpoint. But I believe, the earnings we have forecasted in lithium for Q3, Q4 are correct, unless. Unless, I'd say the only place where I could see upside, but it is not possible for us to predict that today is pricing. Pricing is always something, depending upon demand, and how capacity come on stream. So that one, we've made some assumptions, you never know."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","And then a question just on the product rationalization that you did in Ag Solutions. Is that mostly legacy FMC products or are there some Cheminova products? And is there any more to come? Just trying to get a sense of whether we could see some additiona",78,"And then a question just on the product rationalization that you did in Ag Solutions. Is that mostly legacy FMC products or are there some Cheminova products? And is there any more to come? Just trying to get a sense of whether we could see some additional pressure there. And at some point, do you hit a point where you could see some negative leverage as a result of scaling back on the number of products you're selling?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think the product rationalization is very well advanced today. I think it's a mix. It's as much from Cheminova legacy products than it is from FMC products. Both company use to resale third-party products as a service to customers. And the things you ca",189,"I think the product rationalization is very well advanced today. I think it's a mix. It's as much from Cheminova legacy products than it is from FMC products. Both company use to resale third-party products as a service to customers. And the things you can afford to do it at a given time with a very healthy market, you cannot do when the market is more tense. So it was a normal thing for us to move the way. We had very precisely defined what those products could be. I'm very pleased with the speed at which the organization responded to it. I think more than half of the shortfall in our sales today in the second quarter is coming from product rationalization, but that's pretty much where it is. So you will not see numbers going beyond what we've talked about, which was total run rate, adding of this year of $350 million, which is $100 million more than we did last year. We did $250 million last year. And this is it. There will be no further as far as we can see actions to be taken."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And your next question comes from the line of Frank Mitsch with Wells Fargo.",14,"And your next question comes from the line of Frank Mitsch with Wells Fargo."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, I was struck by the comment that the inventory levels of insecticides are rather high in Brazil. And I guess, I was thinking about Zika there. Does that offer any opportunity for you in that marketplace?",37,"Pierre, I was struck by the comment that the inventory levels of insecticides are rather high in Brazil. And I guess, I was thinking about Zika there. Does that offer any opportunity for you in that marketplace?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, Frank, this is Mark. Yes, we have seen increased sales of specific insecticides that we're providing to that vector control market. It's not huge, though. Let's put it in perspective. It's not going to move the Ag business. It's nice business to have",90,"Yes, Frank, this is Mark. Yes, we have seen increased sales of specific insecticides that we're providing to that vector control market. It's not huge, though. Let's put it in perspective. It's not going to move the Ag business. It's nice business to have. We have a leading position in Brazil. And we've seen that business grow over the last 18 months. And we expect it to continue with the way Zika is progressing through the region. But it's not going to be significant enough to really move the needle."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Interesting. I mean, as the geography of concern spreads, one would think that, that would be an opportunity. I guess, just simplistically, how would you describe your market share in that application?",32,"Interesting. I mean, as the geography of concern spreads, one would think that, that would be an opportunity. I guess, just simplistically, how would you describe your market share in that application?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","It's pretty good. Let's -- why don't we just put it in perspective. The global public health market is about $700 million, and that's within the total Ag space crop protection chemicals of over $51 billion. So really, for mosquito control, the market worl",126,"It's pretty good. Let's -- why don't we just put it in perspective. The global public health market is about $700 million, and that's within the total Ag space crop protection chemicals of over $51 billion. So really, for mosquito control, the market worldwide is about $325 million to $340 million and the U.S. is about $90 million of that. So you can get a sense of the scale of that business. In particular applications, we have a very good market share. But only with our pyrethroids, but with a product called malathion that we bought from Cheminova. So just keep it in perspective. I mean people talk about it a lot, but the U.S. market is only $90 million out of that $700 million."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Mark, I appreciate you throwing a wet blanket on that thesis. And then, lastly, Paul, you sounded more sanguined with respect to the FX impact for 2016. Do you have a size as to what you think the negative effect will be when all is said and done on the y",51,"Mark, I appreciate you throwing a wet blanket on that thesis. And then, lastly, Paul, you sounded more sanguined with respect to the FX impact for 2016. Do you have a size as to what you think the negative effect will be when all is said and done on the year?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I wish I could predict FX markets that well, Frank. I mean, I wouldn't be in this job. I'm pretty confident around that. I think the key is that we seem to have more predictability around that. You see the peso has been a surprising area for us. We didn't",132,"I wish I could predict FX markets that well, Frank. I mean, I wouldn't be in this job. I'm pretty confident around that. I think the key is that we seem to have more predictability around that. You see the peso has been a surprising area for us. We didn't -- I mean, we never see them coming. And the Brazil has been -- the reais has been some kind of a bright spot, not because of the absolute rate, but as I mentioned about the stability around the rates. And I think that's sort of the key for us as we look forward, that stability of the rates and a lack of surprise is more important to us on most of our business than the actual movement in the exchange rates."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our next question comes from line of Daniel Jester with Citibank.",12,"And our next question comes from line of Daniel Jester with Citibank."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","What kind of visibility do you have in Health and Nutrition in the second half of this year? Your guidance seems to imply an acceleration in profits, which seems seasonally maybe a little bit different than the past few years. So given sort of the comment",67,"What kind of visibility do you have in Health and Nutrition in the second half of this year? Your guidance seems to imply an acceleration in profits, which seems seasonally maybe a little bit different than the past few years. So given sort of the comments that you called out about omega-3, can you just walk us through some of the key drivers for the second half?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Certainly, I think we do have a pretty good visibility on our 3 segments today from a demand standpoint. But it is important to understand that the earnings growth, especially in the fourth quarter, is maybe more predictable because it is due to a cost si",163,"Certainly, I think we do have a pretty good visibility on our 3 segments today from a demand standpoint. But it is important to understand that the earnings growth, especially in the fourth quarter, is maybe more predictable because it is due to a cost situation. We always work our cost and decrease our cost. But the way costs flows into operations depend upon the speed at which you turn your product. And I think, we call that capitalized variance. But the main reason for the bump in earnings in the back end of the year is due to the fact that we would be operating at a lower cost than we have been operating via the quarters in previous year. That is why you will see such a jump. So it is not due to a major turn in demand for any of our products, but it's much more the benefit of prior activity we've done on operational costs and manufacturing excellence."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Okay, that's helpful. And then of this $60 million to $70 million of full year cost synergies from Cheminova, can you quantify how much of that you realized in the first half? And then maybe just holistically, beyond just cost synergies, where do you see",51,"Okay, that's helpful. And then of this $60 million to $70 million of full year cost synergies from Cheminova, can you quantify how much of that you realized in the first half? And then maybe just holistically, beyond just cost synergies, where do you see the integration process for Cheminova today?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, thanks. I think at a run rate basis, we want to close the half year on the run rate basis in the $30 million to $40 million range for the first half of the year on the Cheminova. Do you want, Mark?",43,"Yes, thanks. I think at a run rate basis, we want to close the half year on the run rate basis in the $30 million to $40 million range for the first half of the year on the Cheminova. Do you want, Mark?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","You want me to talk a little bit about the integration side. From an integration perspective, we are very much done on the commercial side, that's all in place. A lot of the functional groups are also fully integrated and operating. We have some systems t",142,"You want me to talk a little bit about the integration side. From an integration perspective, we are very much done on the commercial side, that's all in place. A lot of the functional groups are also fully integrated and operating. We have some systems that we're still working through SAP in Europe, as an example, which will be completed early in the fourth quarter. And then the long lead time item is how we bring together the different manufacturing units, the tall manufacturing units and the formulating units. We are well progressed with that. We still have some to go, but that will occur over time. And the basic need there is to make sure that we have registrations as we move products around the world. So that's the rate limiting step, but everything else is pretty much done by now."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think from the Cheminova integration, we're going to stop reporting. I mean, we'll answer any questions you guys might have. But we can almost declare success. Everything is in place to reach, as we discussed by the middle of next year, the $140 million",105,"I think from the Cheminova integration, we're going to stop reporting. I mean, we'll answer any questions you guys might have. But we can almost declare success. Everything is in place to reach, as we discussed by the middle of next year, the $140 million to $160 million run rate, the 800 to 900 positions being eliminated. So we are very much more than on track ahead of the initial schedule. And I think the lots of the remaining activities are more under impulse shop around IT, SAP, science integration. So much more back-office integration than anything during with the front end of the business."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And we do have a question from the line of Rosemarie Morbelli with Gabelli & Company.",15,"And we do have a question from the line of Rosemarie Morbelli with Gabelli & Company."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","I was wondering if you could talk about the expected lithium capacity, lithium carbonate capacity increase in 2017. Based on what you see and hear in the marketplace, is that coming on stream, a lot of it in the first half of 2017 and therefore, would hav",52,"I was wondering if you could talk about the expected lithium capacity, lithium carbonate capacity increase in 2017. Based on what you see and hear in the marketplace, is that coming on stream, a lot of it in the first half of 2017 and therefore, would have a negative impact on pricing?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Rosemarie. Yes, we're starting to see some exchange of volumes coming on even in the back half of 2016, mostly out of the new spodumene capacity that's coming online in Australia. As you know, there's also some capacity in Chile, and there has",110,"Thank you, Rosemarie. Yes, we're starting to see some exchange of volumes coming on even in the back half of 2016, mostly out of the new spodumene capacity that's coming online in Australia. As you know, there's also some capacity in Chile, and there has been capacity ramping up in Argentina, targeting back end of 2016 and early 2017. So these were the volumes that we're watching. And I characterize it, could be anywhere between 50,000 to 75,000 tons by early 2017. So as Eric commented earlier, this is where we make a pricing assumption, and we're monitoring the conditions as we interact with customers in terms of pricing expectations."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","And that particular capacity addition is going to be smaller than the demand increase, isn't it? And therefore pricing is going to come down across the board, including lithium hydroxide or you don't think so?",35,"And that particular capacity addition is going to be smaller than the demand increase, isn't it? And therefore pricing is going to come down across the board, including lithium hydroxide or you don't think so?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","No. First, yes. There will be -- we are expecting, as time goes, starting in '17 and into '18, we're expecting carbonate pricing to grew more towards normal pricing, which mean a lower pricing we are currently seeing when they will be more or they balance",126,"No. First, yes. There will be -- we are expecting, as time goes, starting in '17 and into '18, we're expecting carbonate pricing to grew more towards normal pricing, which mean a lower pricing we are currently seeing when they will be more or they balance between the carbonate demand and the supply. It will not impact the hydroxide pricing. If you look right now and if you put together all of the hydroxide capacity increase, which actually we are leading, they are very much in line with the demand increase. So from a pricing standpoint, we might not see hydroxide rising tremendously in the year to come. But I think wanted to be in a healthy pricing situation for the next 3 to 4 years."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","And just to add a little bit to that, Rosemarie. In our hydroxide business, we're targeting specific segments of that demand, where it's high quality hydroxide, where they're willing to pay for the quality we bring to the markets. So when we look at suppl",63,"And just to add a little bit to that, Rosemarie. In our hydroxide business, we're targeting specific segments of that demand, where it's high quality hydroxide, where they're willing to pay for the quality we bring to the markets. So when we look at supply/demand, we're looking even specifically at that customer mix versus one that might trade-off to carbonate or other supply."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And my second question deals with the inventory, overall inventory in the Ag sector. You said that you have lower FMC product inventories. But without talking about any specific competitors, what do you see in terms of the overall inventory channel?",59,"Okay. And my second question deals with the inventory, overall inventory in the Ag sector. You said that you have lower FMC product inventories. But without talking about any specific competitors, what do you see in terms of the overall inventory channel? Is it declining? Or is it still growing? Or more or less flat -- has it plateaued?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think from a -- as I said, I want to repeat, we're mostly focusing on our inventory. But overall, if I would have or if we would have to make an overall statement, we believe overall inventory in the channel is declining. We do not believe right now we",141,"I think from a -- as I said, I want to repeat, we're mostly focusing on our inventory. But overall, if I would have or if we would have to make an overall statement, we believe overall inventory in the channel is declining. We do not believe right now we are at a turning point from a market standpoint. But we can see we are at a place where the dialogue with the customers is changing. There is more certainty. There is more productivity. Still means that the inventory in the channel is pretty heavy. We are not yet at a situation where it's not -- but the dialogue is changing. And I believe, everybody is trying to do their bit decrease their inventory. We believe, we most likely have been most aggressive. But overall, I think the situation is improving."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our next question comes from line of Mark Connelly with CLSA.",12,"And our next question comes from line of Mark Connelly with CLSA."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Two things. Paul, you talked about the longer time line for rationalization of the manufacturing in Europe. Is that sort of a 2020 time goal in your mind? Or is there a specific target in your mind? And then the second question to Latin America again. As",106,"Two things. Paul, you talked about the longer time line for rationalization of the manufacturing in Europe. Is that sort of a 2020 time goal in your mind? Or is there a specific target in your mind? And then the second question to Latin America again. As we think about the working capital cycles in cotton and sugarcane, is your penetration in that market permanently shifting your working capital cycle in a material way? My understanding is Cheminova managed working capital much differently than you did using more receivables, for example. And I'm curious whether that has all shifted over to your way of doing things."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Well, let me address first the question on the manufacturing rationalization. Right now, we are at a place where we have a stable manufacturing network for Ag business. We are always looking at improving. But any improvement, any decision today is always",154,"Well, let me address first the question on the manufacturing rationalization. Right now, we are at a place where we have a stable manufacturing network for Ag business. We are always looking at improving. But any improvement, any decision today is always a mid- to long-term decisions because there is some product registrations, which are changing when you do a change of manufacturing. So I have to say that right now, as any company would do, we are keeping our options open. But we are in what I would call a stable manufacturing network. And we will see as time goes what are the best decisions to be taken for our business in terms of network. But today, we're not penalized by the structure we have and it's a matter of doing continuous improvement and being able to supply what will be requested by the market at the time when the market turns around."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","So you're comfortable then not being quite as asset light as you had been sort of in the medium term?",21,"So you're comfortable then not being quite as asset light as you had been sort of in the medium term?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","We are asset light. I think if you think about FMC prior to the acquisition of Cheminova, our manufacturing cost was 95% asset light. I would say today, maybe we're at 90%. We should not believe that the fact that we have a plant in India in Panoli and a",114,"We are asset light. I think if you think about FMC prior to the acquisition of Cheminova, our manufacturing cost was 95% asset light. I would say today, maybe we're at 90%. We should not believe that the fact that we have a plant in India in Panoli and a plant we have in Ronland are fundamentally changing the mix of product we shall made until manufacturers versus what is being made today. Those are big plants. But you know in the big scheme of things, the production capacity versus what we do with total network is fairly small. So it is our fundamental departure to what we used to be in the past."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Let me touch on the working capital question down there in Brazil. Sugarcane and cotton can have very, very different terms, cotton tends to be longer term, sugarcane tends to be much shorter term, although that does vary depending on the nature of the pl",253,"Let me touch on the working capital question down there in Brazil. Sugarcane and cotton can have very, very different terms, cotton tends to be longer term, sugarcane tends to be much shorter term, although that does vary depending on the nature of the planting cycles and on the financial health of the sugarcane guidance. But as a rule, as we shifted away from cotton, we'll expect to see our working capital terms come in and to what sugarcane also does the same thing. I would not though expect that you're going about to track that through our working capital balance as you look at it. It's definitely a factor that helps, but it's not so large that you're going to really see a major move in our numbers. In terms of how Cheminova approached it. Cheminova, this is to separate the 2 important differences. Cheminova did not have a different approach to working capital than anybody else in the industry. They did have a different approach to how they finance that working capital. And to be blunt, as a weak balance sheet company with very unsophisticated treasury operations, they used to use some very, very expensive local financing in Brazil, which can give the impression that they are reducing their working capital. It was appropriate for non-U.S. GAAP reporting, it was appropriate for a sub-investment grade company, it was incredibly expensive and we'll certainly factor in why their overall profitability was so low and it's certainly not something we intend to do."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And we do have a question from the line of Aleksey Yefremov with Nomura Securities.",15,"And we do have a question from the line of Aleksey Yefremov with Nomura Securities."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","What is the current competitive environment in Latin America and North America? Do you see your competitors generally being more disciplined on crop reduction prices?",25,"What is the current competitive environment in Latin America and North America? Do you see your competitors generally being more disciplined on crop reduction prices?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Well, obviously, I'm not going to talk about what competition is doing on price. I'll tell you where we are. As Pierre said earlier, we're doing everything we can to make sure we manage pricing terms across North America. And certainly in Brazil, where we",130,"Well, obviously, I'm not going to talk about what competition is doing on price. I'll tell you where we are. As Pierre said earlier, we're doing everything we can to make sure we manage pricing terms across North America. And certainly in Brazil, where we have reduced our exposure to the Brazilian market by taking out through product rationalization, significant amount of volume and revenue. But we're very focused on making sure that we maximize price, not only in terms of pricing, but across the portfolio of what we're selling. I think you're going to see all sorts of different activities as we go through the next year. But for us, it's very much around protecting the margins, protecting the value of the business and certainly, looking after working capital."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think in term of pricing, just to get back to one of the comment Paul made around the balance of FX and pricing. As you know, we tend to have a rule in Brazil, where we index price on currency. Last year, we were with a pricing running after the currenc",173,"I think in term of pricing, just to get back to one of the comment Paul made around the balance of FX and pricing. As you know, we tend to have a rule in Brazil, where we index price on currency. Last year, we were with a pricing running after the currency and trying to move up our price. This year, the same process of adjusting pricing to currency is going the other way, which mean it is not any longer us asking the customers to take higher price, but the customer asking us to lower the price more towards the currency. So needless to say that for all of us, regardless of what behavior individual companies would take, it is an easier conversation from the predictability of the pricing. And this FX situation give us a much better position to talk about pricing, more control in term of understanding pricing in the next 2 quarters. And I think, it's got to apply to every company. It is just an FX price situation."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Very helpful. And turning to Europe and crop protection. You had some revenue declines there. How much of that was your move to direct market? And was it a onetime impact or is there any way to improve that next year?",41,"Very helpful. And turning to Europe and crop protection. You had some revenue declines there. How much of that was your move to direct market? And was it a onetime impact or is there any way to improve that next year?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes. The direct market situation is a onetime impact. It is just a couple of situation, which happen all the time when you do this kind of a transfer. First of all, you work with your distribution network, which we're moving away from. Those guys have inv",173,"Yes. The direct market situation is a onetime impact. It is just a couple of situation, which happen all the time when you do this kind of a transfer. First of all, you work with your distribution network, which we're moving away from. Those guys have inventory. They have stocked -- they are selling it while you replenishing your own now warehouses to sell. So there is the period of time, where you have 2 networks, which have to roll out for a little while. And you have to give the time to your distributors to sell the product they were supposed to sell the product by contract. Second of all, you are at a stage also, where your distributors are not replenishing their inventory in advance. So by the time we get into -- this is happening at the transition now. I believe if by the time we get into European season Q1, Q2 next year, we should be in a very normalized situation and it will be stable for the future."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And we do have a question from the line of Mike Sison with KeyBanc.",14,"And we do have a question from the line of Mike Sison with KeyBanc."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Just curious that you maintained your outlook for the crop protection markets this year down mid- to high single digit. What was it down in the first half? And just trying to gauge what the expectation is for the second half in terms of demand.",45,"Just curious that you maintained your outlook for the crop protection markets this year down mid- to high single digit. What was it down in the first half? And just trying to gauge what the expectation is for the second half in terms of demand."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","So I think in the first half, the way I would look at it, Mike, is when we gave the range, we said mid-single digit to high single digit. Maybe we were thinking about more toward when we started this process, the lower end of the range, maybe 5%, 6%, 7%.",249,"So I think in the first half, the way I would look at it, Mike, is when we gave the range, we said mid-single digit to high single digit. Maybe we were thinking about more toward when we started this process, the lower end of the range, maybe 5%, 6%, 7%. We are more today on a 7%, 8% more toward the higher end of the range. And that is due, maybe less due to channel inventory than it was to specific reasons in Asia and Europe, mostly driven by weather. So for us, when we look at the market, if you remember, we were thinking about North America and Latin America in the higher end of the range, and these being helped by flattish to slightly down market in Europe and Asia. We don't see that any longer. I mean, we still see North America and Latin America on the higher end of the range, but we see Asia and Europe being down in the 5%, 6% from this year. That is why today, we are looking at maybe more the higher end of our range. For us, what we've been doing is we've been able, no matter what, to protect our earnings by being even more drastic on pricing, more drastic on product rationalization. So we'll be slightly lower on sales. But we believe we are going to be -- we're going to have very solid performance in the second half and productivity on the earning side."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Great. And then for the fourth quarter for Ag Solutions, you talked about better visibility than in the past. But just curious, what sort of gets you to the high end of the range? I mean, it's pretty wide in terms of the top end, given your guidance for A",67,"Great. And then for the fourth quarter for Ag Solutions, you talked about better visibility than in the past. But just curious, what sort of gets you to the high end of the range? I mean, it's pretty wide in terms of the top end, given your guidance for Ag Solutions from the third quarter and the low end. What sort of gets you to the top?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I would say always the same answer. When we give the mid of the range, it is under normal circumstances from a demand and weather standpoint. And those, there is always a range. You just need an infestation, you just need very strong insect pressure or ot",108,"I would say always the same answer. When we give the mid of the range, it is under normal circumstances from a demand and weather standpoint. And those, there is always a range. You just need an infestation, you just need very strong insect pressure or other pressure. And you would drive that either to the lower or either to the higher end. Today, we believe we are very comfortable with the mid of the range to see anything going up or down would be due to external events not linked to channel inventory or anything that kind, but much more to specific agricultural seasonal situation, mostly weather."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our last question comes from the line of Peter Butler with Glen Hill Investment.",15,"And our last question comes from the line of Peter Butler with Glen Hill Investment."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, early on regarding lithium, you folks had a conservative outlook on shorter term of lithium growth, but you saw good possibilities longer term. And this outlook has been proven correct. What do you see now for the longer-term growth of lithium? An",79,"Pierre, early on regarding lithium, you folks had a conservative outlook on shorter term of lithium growth, but you saw good possibilities longer term. And this outlook has been proven correct. What do you see now for the longer-term growth of lithium? And how do you -- how does your research pipeline on lithium derivatives look compared to what you're seeing from competitors and how does this change your future position on earnings and cash flow growth, et cetera?"
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Peter. Yes. So lithium, I have to say, we do have increased confidence in the future. Today, we believe this market is getting more and more solid. I have to say that we are still prudent. But the big breakthrough for us is the technology we're",291,"Thank you, Peter. Yes. So lithium, I have to say, we do have increased confidence in the future. Today, we believe this market is getting more and more solid. I have to say that we are still prudent. But the big breakthrough for us is the technology we're able to develop from a manufacturing standpoint, allowing us to add very low capital spend and efficient cost of operations, ability to create 4,000 to 8,000 tons modules for lithium hydroxide instead of having to build in one shot, a 20,000 or 30,000 tons. So today, we do have an improved view and more certain view of what lithium hydroxide is doing. But on the work we've done in the last 2 years, was to develop a manufacturing process, allowing us to follow the demand growth. Which means that if the growth is not as we're expecting, we can stop 1 or 2 of these modules manufacturing and slowdown the capacity increase we have planned. If the demand becomes more aggressive, very easy for us to speed up the building of those modules. So first, your question, yes, we have increased confidence. Our strategy is very highly focused on the downstream product, where we have the highest profitability. Third, we have a safety net around demand by these manufacturing process we have in place, allowing to match the demand. Where are we on our forecast? We are taking pretty much a middle of the range. We are far in the process and predictability for the numbers I gave to you, to take the highest prediction from EV companies. So there could be upside, but you know, we are prepared also for the downside. 
And maybe I'll ask Tom to comment on the technology."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, and thanks for the question. On the technology, we've got a technology roadmap. And I'd say that with this strategy that we've undertaken on the high-value products, the biggest shift is increased collaboration and formalized collaboration with our c",85,"Yes, and thanks for the question. On the technology, we've got a technology roadmap. And I'd say that with this strategy that we've undertaken on the high-value products, the biggest shift is increased collaboration and formalized collaboration with our customers. So we do have a number of exciting opportunities that are being discussed with customers and being trialed with customers, and we're looking forward to that. It will continue to add to high-quality sales of new lithium derivatives and new applications with existing lithium derivatives."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","So as it was the last question, let me close with a couple of words before I hand the closing comments to Brian. I think we went through those 2 quarters, very highly focused on delivering what we promised to do. Everything we've done in the 2 quarters ha",188,"So as it was the last question, let me close with a couple of words before I hand the closing comments to Brian. I think we went through those 2 quarters, very highly focused on delivering what we promised to do. Everything we've done in the 2 quarters have done a few things for us. First of all, I believe from an Ag standpoint, even if the markets are not yet returning to the level of growth, this kind of market could expect to see one day. We have improved highly controlled visibility and predictability of our own business. I think from the lithium standpoint, it is a bright spot for us. We have refined our strategy. And I have to say the breakthrough we had in technology around lithium hydroxide manufacturing are an enormous win for us looking at the future. And our penetration, the business is solid. The business is highly profitable. But we also understand the challenges we have on omega-3 and it's something we'll be focusing on in the quarters to come. 
So with this, I'm going to turn the call back to Brian."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Pierre. As always, appreciate the time and the questions. I'll be available for on the call to address any further questions that you may have. So with that, thank you and have a good day.",37,"Thank you, Pierre. As always, appreciate the time and the questions. I'll be available for on the call to address any further questions that you may have. So with that, thank you and have a good day."
28606,341073936,1023593,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And ladies and gentlemen, today's conference will be available for replay after 10:00 a.m. today through September 3 at midnight. You may access the AT&T teleconference replay system at any time by dialing 1 (800) 475-6701 and entering the access code 378",72,"And ladies and gentlemen, today's conference will be available for replay after 10:00 a.m. today through September 3 at midnight. You may access the AT&T teleconference replay system at any time by dialing 1 (800) 475-6701 and entering the access code 378964. International participants may dial (320) 365-3844. That does conclude your conference for today. Thank you for your participation and for using the AT&T executive teleconference service. You may now disconnect."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the Second Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] As a reminder, today's conference is being recorded.And I would now turn the conference over to Brian Angeli, Vice Preside",50,"Good morning, and welcome to the Second Quarter 2016 Earnings Release Conference Call for FMC Corporation. [Operator Instructions] As a reminder, today's conference is being recorded.
And I would now turn the conference over to Brian Angeli, Vice President of Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning. Welcome to FMC Corporation's Second Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.Pier",273,"Thank you, and good morning. Welcome to FMC Corporation's Second Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer.
Pierre will begin the call with a review of FMC second quarter performance and discuss the outlook for Q3 and the full year 2016. Paul will provide an overview of select financial results. The slide presentation that accompanies our results, along with our earnings release and 2016 outlook statements, are currently available on our website and the prepared remarks from today's discussion will be made available at the conclusion of the call.
As with our prior calls, Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President, FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, will join to address questions.
Before we begin, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including but not limited to, those factors identified in our earnings release and then our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based on these risks and uncertainties.
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms as well as other non-GAAP financial terms to which we may refer during today's conference call are provided on our website.
With that, I will now turn the call over to Pierre."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian, and good morning, everyone. As you can see on the first slide for the second quarter of 2016, FMC reported revenue of $810 million and adjusted operating profit of $143 million. Adjusted EPS of $0.69 was $0.01 below the second quarter of",2113,"Thank you, Brian, and good morning, everyone. As you can see on the first slide for the second quarter of 2016, FMC reported revenue of $810 million and adjusted operating profit of $143 million. Adjusted EPS of $0.69 was $0.01 below the second quarter of 2015, but above the midpoint of our guidance range.
Ag Solutions delivered another solid quarter and it continues to realize the benefits of the Cheminova acquisition. Lithium outperformed on higher sales volumes, and higher realized prices across the portfolio with lower operating cost from ongoing manufacturing excellence program.
Earnings in Health and Nutrition were below expectation as results in omega-3 were significantly weaker than anticipated. Based on our performance to date and the outlook for the back half of the year, we are increasing full year adjusted EPS guidance by $0.05 to $2.60 to $2.90 per share. I will provide more details on how that breaks down across each of the businesses shortly. But first, I will discuss second quarter results for each of our 3 segments, starting with Ag Solutions on Slide 2.
Overall, market condition and our performance in the quarter were in line with our prior expectations. We remained focused on reducing the level of FMC product inventory in the channel and on maintaining discipline on price and terms. We also took actions needed to complete the product rationalization that began in late 2014.
For the second quarter, Ag Solutions reported revenue of $515 million and segment earnings of $101 million, slightly ahead of the midpoint of our guidance range. Revenue declined 19% compared to the second quarter of 2015, largely due to lower sales volume, unfavorable weather conditions in Europe and Asia, the drawdown of channel inventory by customers in most regions and planned product rationalization all contributed to the decline in volume in the quarter.
Excluding planned product rationalization, revenue declined broadly in line with the crop protection market as a whole. Segment earnings declined 14% compared to 2015 as the impact of lower sales volumes, less favorable product mix in Asia and North America and the stronger U.S. dollar were partially offset by lower operating cost. Compared to pro forma results from Q2 last year, operating margin increased 100 basis points, reflecting pricing discipline, the elimination of sales of low-margin products due to portfolio rationalization and cost savings from the Cheminova integration.
As we move to Slide 3, I will first give a few comments on the global crop protection market then I will move on to review FMC's performance by region and discuss the outlook for Q3 and the full year. So first, the market.
Overall, conditions in the global crop protection market were as expected, little changed from Q1. In North America, soft commodity prices continue to put pressure on farm incomes resulting in more cautious buying behavior by growers and elevated inventory levels across the channel.
In Europe, unfavorable weather conditions early in the quarter, most notably in Central and Western Europe, reduced market demand, leading to lower volumes and increased channel inventory in certain countries. In Brazil, channel inventory across the market remained elevated, especially for insecticides. And while foreign exchange rates have been more stable, growers continue to be negatively impacted by a lack of credit availability.
In Asia, weather conditions were poor across most of the region resulting in weaker market demand. We believe these challenging market conditions will persist for the remainder of the year and we still forecast that the global crop protection chemical market will decline by mid- to high single-digit percent in 2016 on a U.S. dollar basis. I will now discuss FMC's performance in light of these market conditions.
First, let me address the lower-than-expected revenue for the quarter. Markets in Asia and Europe were weaker than expected, but the main driver of the lower revenue is a more successful and aggressive product rationalization.
We continue to manage the quality of our sales in order to protect margins, earnings and working capital. In North America, our strategy remained one of defending price and terms, allowing the level of FMC product inventory in the sales channel to reduce. All the data we see support our view that inventory of FMC products in the channel is declining. Reflecting the benefits of the actions we took early in the season, to reduce inventory of FMC product in the channel, sales in Q2 increased 5%. We saw strong demand for FMC's Authority brand of pre-emergent soybean herbicide and independent data show that the Authority brand has taken market share this year. We also saw grower support for the extended fungicide products we can now offer as a result of the Cheminova acquisition.
In Europe, revenue declined by 19%, driven largely by poor weather conditions and reduced volume due to the planned product rationalization as well as the impact of transitioning to a direct market access model. However, the product rationalization and move to direct market access have resulted in improved operating margins in the region.
In Latin America, revenue declined 43%, primarily as a result of steps we took to reduce the level of FMC product inventory in the sales channel in Brazil. We were encouraged by our ability to recover U.S. dollar pricing in the quarter. While not material to overall segment performance, given the seasonally lower sales volume, realized price increase in Brazil more than offset the negative impact of FX on a reported revenue.
In Asia, the combination of poor weather condition, further portfolio rationalization and a stronger U.S. dollar caused revenue to decline 22% compared to the second quarter last year. Moving on to the outlook for Ag Solutions.
Our full year segment earnings guidance remains unchanged at $380 million to $420 million. For the third quarter, we expect segment earnings of between $80 million and $90 million. At the midpoint of guidance, second half segment earnings will increase by approximately 35% compared to 2015, driven by improved performance in Brazil and Latin America and additional cost savings from the Cheminova integration. The steps we have already taken to rationalize our product portfolio and reduce the level of FMC inventory in the channel, in the sales channel, leave us well positioned as we enter the 2016, 2017 crop season in the Americas.
The relative stability of the Brazilian real over the past few months gives us increased confidence in our ability to recapture price despite tightening credit condition from growers and weak market demand as channel inventory levels decline. We expect full year segment earnings margin to be between 17% and 18%, which at the midpoint represents more than 250 basis points of improvement compared to 2015 driven by more favorable mix, improved pricing in Brazil and realization of cost savings. We remain on track to deliver the incremental cost savings target of $60 million to $70 million in 2016 and the full run rate cost saving of $140 million to $160 million by the middle of next year.
Moving on to Health and Nutrition on Slide 4. The business reported second quarter segment revenue of $195 million and segment earnings of $45 million. Revenue declined approximately 6% and earnings declined approximately 11% compared to the second quarter of 2015.
Results for the quarter were negatively impacted by worse-than-expected performance of omega-3. The headwinds we saw in omega-3 over the past year increased in the second quarter. Specifically, prices and volumes were much lower than anticipated. There is significant overcapacity in the industry, which, combined with lower demand for higher concentration products has exerted even greater pressure on prices than we saw earlier in the year. 
We have seen new entrants with business at prices that are close to cash cost of production, resulting in considerably lower volume for our products in certain key areas. We have aggressively taken costs out of this business with fixed cost falling by almost 40%. We continue to pursue new opportunities for high-end cost alteration products, but do not expect to recover these lost volumes this year and do not anticipate the change in pricing levels any time soon.
Excluding omega-3, results were in line with expectations. In nutritional ingredients, volumes in the quarter were slightly below Q2 2015, largely due to timing as orders shifted to the second half of the year. In health excipients, sales volumes increased in all key pharmaceutical markets.
Given performance to date in omega-3 and our expectations for the rest of the year, we are lowering our guidance for Health and Nutrition. We now expect full year segment earnings to be in the range of $190 million to $196 million, roughly flat with 2015, and third quarter segment earnings to be in the range of $44 million to $48 million. We continue to expect operating margins of approximately 25% for the full year helped by lower operating cost and improved production yields.
Turning next to Lithium on Slide 5.  Lithium delivered another outstanding quarter. Revenue increased 15% year-over-year to $63 million and segment earnings more than tripled to $16.5 million. Lithium's performance reflect a success of FMC strategy of converting lithium carbonate into higher value downstream specialty product supported by strong manufacturing performance, especially in Argentina in our Bessemer City Hydroxide Facility.
Higher sales volume, higher average prices in all major product categories, improved mix and lower operating costs, all contributed to deliver segment earnings above the top end of our prior guidance range and pushed segment earnings margin to over 26% in the quarter.
We expect supply/demand conditions to remain tight for the remainder of the year as previously announced capacity expansions across industry have been slow to come online. This reinforces our confidence in favorable pricing conditions through the remainder of 2016.
For the full year, we expect segment earnings to be in the range of $58 million to $66 million, an increase at the midpoint of approximately 30% compared to prior guidance and nearly 3x segment earnings in 2015. Higher prices and lower operating costs compared to last year will support operating margins in the range of 24% to 25% for the year.
We expect third quarter segment earnings to be in the range of $13 million to $17 million as the benefit of higher prices will be partially offset by seasonally lower production at our operations in Argentina. 
FMC's Lithium business is positioned to deliver significant earnings growth in 2016 and beyond. In May, we announced plans to triple our production capacity of lithium hydroxide to 30,000 metric tons by 2019 in order to meet growing demand from our customers starting with a 4,000 metric ton expansion scheduled to come online in 2017.
Last week, we announced we will accelerate that capacity expansion and we now expect 8,000 metric tons to come online by the middle of 2017. We continue to evaluate the turning or further capacity expansion and expect the entire 20,000 metric ton of additional capacity to be online by 2017. We believe, we will more than double the revenue and earnings of our Lithium business between 2016 and 2020, resulting in over 20% per year growth through the rest of this decade.
We recognize that our hydroxide investment plans require us to have cost-effective access to sufficient lithium carbonate. Our current carbonate capacity is sufficient to support the expansion in FMC's hydroxide production through at least 2018.
Beyond this, we are actively pursuing multiple tasks to ensure we are not carbonate constrained. First, we have several low capital options to debottleneck our Argentina operations, potentially adding 20% capacity. Second, we are in ongoing discussions with multiple carbonate producers. We have announced plans to add capacity in the coming years and are exploring mutually beneficial long-term supply agreement or strategic partnerships. And of course, we retained the option to add significant capacity at our operation, our existing operation in Argentina beyond the debottlenecking I just mentioned. Consequently, we are highly confident that access to lithium carbonate will not be a constrain in our ability to extend our hydroxide business in the coming years.
Before I turn the call over to Paul, I will comment briefly on the outlook for the third quarter and full year 2016 on Slide 6. As I mentioned, we are maintaining full year segment earnings for Ag Solutions and adjusting our full year earnings expectation for both Health and Nutrition and lithium. As a result, on a consolidated basis, we are increasing full year adjusted EPS guidance by $0.05 at the midpoint to $2.60 to $2.90 per share. For the third quarter, we expect adjusted EPS to be in the range of $0.53 to $0.63. 
I will now turn the call over to Paul to discuss select financial results."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Pierre. As usual, I'll start with the income statement and specifically of the tax rate. Our adjusted effective tax rate for the full year is now expected to be in the range of 24% to 25%, giving us a small benefit this quarter compared to Q2 l",611,"Thank you, Pierre. As usual, I'll start with the income statement and specifically of the tax rate. Our adjusted effective tax rate for the full year is now expected to be in the range of 24% to 25%, giving us a small benefit this quarter compared to Q2 last year.
This lowered rate is largely due to the continued change in the mix of our earnings away from high tax jurisdictions, such as the U.S., towards regions where tax rates are lower. Foreign exchange was not a major factor in our results this quarter with the stronger dollar, mainly impacting the Ag Solutions segment.
Various Asian currencies plus the Mexican peso were the drivers of the FX headwind in the quarter. The second quarter is not a period of significant activity in Brazil. And therefore, the recent strengthening of the reais had a limited impact on our financials in the quarter. However, with an FX rate in the quarter that was weaker than the same period of last year, and with the price list that largely reflect to the current spot rate, the combined effect of price and currency in Brazil was a net positive to our second quarter earnings.
Looking into the second half of the year. The recent stability in the reais-U.S. dollar exchange rate means that the assumptions regarding the future exchange rate that has underpinned our guidance is unchanged. To remind you, our guidance has assumed that we have a reais to U.S. dollar rate that is relatively stable with no major short-term swings in the FX rate, combined with a price list that largely reflects the prevailing spot exchange rate.
Sitting here today, both of those assumptions remain unchanged. And therefore, we do not expect either a positive or negative impact on our second half performance from the reais-FX rate compared to our previous guidance, provided these conditions hold.
Turning to the balance sheet and cash flow on Slide 7. We continue to make progress in increasing our cash generation while maintaining discipline on capital spending. For the first half of the year, our adjusted cash from operations was 40% higher than the first half of last year, driven primarily by stronger working capital performance.
We remain on target to meet our outlook for the full year of $450 million to $550 million of adjusted cash from operations. Net debt fell by $90 million compared to the first quarter and by over $120 million since the start of the year.
The second quarter is an important period for us in terms of cash collections in Brazil. We remain very focused on the credit capacity of our customers, particularly given the constrained access to third-party financing for Brazilian growers. This has an impact on both our ability to collect cash from customers and our willingness to continue to extend credit in the form of new sales. 
On the first point, we were pleased with our performance in collecting in Brazil. With net cash collections slightly ahead of our expectations and particularly good progress in collecting from our past due balances. As a result, we saw a meaningful reduction in our Brazil receivables balance. However, it is still significantly higher than we would like and we will remain focused on reducing our exposure in the coming quarters.
The credit tightness in Brazil has been an important factor for us for several quarters now, but our willingness to extend credit to certain segments of the market reduced. As we head into the key second half selling season in Brazil, our guidance reflects the disciplined approach to credit exposure.
And with that, I will turn the call back to Pierre."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Paul. And before I continue with my remarks, let me correct a statement I made. The 20,000 ton of additional lithium hydroxide capacity is to be online by 2019, not as I said 2017.So to continue and to conclude. I am very pleased with the ove",373,"Thank you, Paul. And before I continue with my remarks, let me correct a statement I made. The 20,000 ton of additional lithium hydroxide capacity is to be online by 2019, not as I said 2017.
So to continue and to conclude. I am very pleased with the overall execution of our strategies and improved outlook for the year. Despite ongoing challenges facing the agricultural industry, our strategy and the actions we have taken in the back end of 2015 and the first half of 2016 give us strong confidence in our performance for the remainder of the year.
We have remained focused on reducing the level of FMC product inventory in the channel, maintain discipline on price and term, aggressively manage our mix by rationalizing our product line, leading to stronger margins. This strategy, combined with a successful integration of Cheminova and the more benign FX situation in Brazil have increased the credit abilities of our business and will drive the second half performance of Ag Solutions with earnings up 35% compared to pro forma results for 2015.
We are investing in our technology roadmap in order to offer unique, value-added solutions to our customers. We see high acceptance rates for our new products launches, including our biological platform, and remain on track to introduce our new active ingredients pipeline starting in 2017.
Lithium continues to deliver strong performance altering its product mix and increasing output to meet growing market demand. FMC's focused strategy has enabled the business to take advantage of favorable market conditions to realize significant earnings growth in 2016. Our announced capacity expansion strengthens FMC's leadership position in lithium hydroxide and specialty lithium application and will deliver further growth in the years to come.
Health and Nutrition had a weaker-than-expected quarter. However, the business continues to generate high margins and return and demand across key nutritional and pharmaceutical markets will support growth over the second half of the year.
Finally, we are generating increased operating cash flow to improve our balance sheet. We are on track to increase adjusted cash from operations by approximately 40% in 2016. 
I thank you for your attention this morning. And with that, I will turn the call back to the operator for questions."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] And your first question comes from the line of Christopher Parkinson with Crdit Suisse.",16,"[Operator Instructions] And your first question comes from the line of Christopher Parkinson with Crdit Suisse."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Can you just comment a little more on your longer-term expectations for your European business, given your shift or I'd say rather evolution of your go-to-market strategy? And then also parse out your views for Northwest Europe versus CIS. And then also,",57,"Can you just comment a little more on your longer-term expectations for your European business, given your shift or I'd say rather evolution of your go-to-market strategy? And then also parse out your views for Northwest Europe versus CIS. And then also, you mentioned a product rationalization as well. Just any additional detail would be helpful."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Chris, this is Mark. Well, first of all, for Europe, obviously, we now have a very different business model with the acquisition of Cheminova. I think you're going to expect just to see, over the long haul, outperformance in the marketplace. And it kind o",170,"Chris, this is Mark. Well, first of all, for Europe, obviously, we now have a very different business model with the acquisition of Cheminova. I think you're going to expect just to see, over the long haul, outperformance in the marketplace. And it kind of fits in with your second question around the CIS in Western Europe. We obviously had a bigger exposure in Western Europe with the Cheminova acquisition, but we see a lot of opportunity in the CIS countries, other parts of Eastern Europe in terms of Poland and Hungary, Czech, Slovakia, as well as the Ukraine. Introduction of new technologies is important for us in Europe. The portfolio is strong. But with our pipeline, we have new products that will benefit, both niche crops and especially cereals, where Cheminova have exposure that FMC did not have. So if you think of the outperformance versus the market, it's really going to be cereals and the niche crops, especially in the South, and then accelerated growth in the east."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Perfect. And then just a quick follow-up. Just can you just comment a little bit more about the working capital improvement you saw there in the quarter. And then also on a go-forward basis, specifically, how do you typically evaluate growth versus credit",80,"Perfect. And then just a quick follow-up. Just can you just comment a little bit more about the working capital improvement you saw there in the quarter. And then also on a go-forward basis, specifically, how do you typically evaluate growth versus credit risk as we head into the third quarter with Brazil? And is it becoming more dependent on crop types, farm size or even region within Brazil? Just any comments on the puts and takes would be helpful."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Sure, let me touch on that. The working capital progress we made really, if you look at the cash flow improvement we had over last year in the first half of the year, you can literally pump all of that into better collections in Brazil. So we've made sign",201,"Sure, let me touch on that. The working capital progress we made really, if you look at the cash flow improvement we had over last year in the first half of the year, you can literally pump all of that into better collections in Brazil. So we've made significant progress over there. We've talked many times about the steps we're taking. I can't point to any one thing that's changed that. It's about getting some momentum behind those collection conversations. Now in terms of growth versus credit. I'm not really sure we think about it that way. We think about credit in terms of credit. We think about the ability of the customer to repay us, the stability of the customer and their access to finance.  There are natural differences by crop and by region in Brazil. And we obviously factor all of that in the way that we go-to-market. But we have the same questions that we ask and the same standards that we set regardless of region or crop, essentially, based on our confidence that we will recover the payments from our customers on the terms that we sell them to. That's the single largest factor that we consider."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, the only thing I would add, Chris is you know Brazil very well. Given where the exposure is, I would say the North, the serato regions are where it is probably the most stressed. The South with the co-ops and the distribution channel is in better sha",90,"Yes, the only thing I would add, Chris is you know Brazil very well. Given where the exposure is, I would say the North, the serato regions are where it is probably the most stressed. The South with the co-ops and the distribution channel is in better shape, and then sugarcane as well. Sugar industries have gone through a lot of challenges. But with the price of sugar today, they are in a better shape as they go forward into 2017. But it's definitely the North where the stress is."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And your next question comes from the line of Joel Jackson with BMO Capital Markets.",15,"And your next question comes from the line of Joel Jackson with BMO Capital Markets."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Just staying in Brazil. You commented that you had a good destock of your own FMC product. Are you -- can you talk about where you're seeing your competitors for their -- in the channel for inventories? I think we've seen commentary before that there had",55,"Just staying in Brazil. You commented that you had a good destock of your own FMC product. Are you -- can you talk about where you're seeing your competitors for their -- in the channel for inventories? I think we've seen commentary before that there had been over a year of products from your competitors."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you. No, we can't and we don't want to comment on competitors. It's sometimes quite difficult to understand the overall inventory in the channel. So really what's we've been doing and that's the change we started to make in the fourth quarter is tru",78,"Thank you. No, we can't and we don't want to comment on competitors. It's sometimes quite difficult to understand the overall inventory in the channel. So really what's we've been doing and that's the change we started to make in the fourth quarter is truly focusing on turning down our own inventory of product. There is product in the channel, but really to comment specifically about our competitors, that would not make sense for us to do so."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Okay. If I look at your guidance, you seem to be implying a 300 or 400 basis points improvement in Ag Solution margin in the fourth quarter. Can you talk about that, where you see the big margin pick up in Q4 and how it's going to play out?",49,"Okay. If I look at your guidance, you seem to be implying a 300 or 400 basis points improvement in Ag Solution margin in the fourth quarter. Can you talk about that, where you see the big margin pick up in Q4 and how it's going to play out?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes. Certainly, and I think this -- the comment I would make are valid for the entire second half. We are getting now into a position. If you look compared to the back end of 2015, where there is multiple area of improvement. First of all, our product mix",208,"Yes. Certainly, and I think this -- the comment I would make are valid for the entire second half. We are getting now into a position. If you look compared to the back end of 2015, where there is multiple area of improvement. First of all, our product mix is getting much stronger than what it was. We -- our actions to walk away from low margin, third party more generic products is working very well. So we are increasing the margins of our products through mix. Second of all, we have been pretty successful over the last 3 or 4 quarters in moving a price. So with a situation looking at the importance of Brazil and Latin America in Q3 and Q4 and taking into account the pricing versus FX situation, we are in a stronger position. So blend of stronger volume we're going to see in the second half of the year, a better mix because we are moving away from third-party products and the pricing FX situation will lead to, first of all, to more predictable business. We have a much better visibility going in the second half of the year than we had in a long time and with stronger margins for the business."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our next question comes from the line of Mike Harrison with Seaport Global securities.",15,"And our next question comes from the line of Mike Harrison with Seaport Global securities."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, you mentioned in the last call that Q2 or in the Lithium business was when you were expecting some seasonal production weakness there, yet you were able to deliver well ahead of your guidance. Can you talk about what drove that upside during the q",64,"Pierre, you mentioned in the last call that Q2 or in the Lithium business was when you were expecting some seasonal production weakness there, yet you were able to deliver well ahead of your guidance. Can you talk about what drove that upside during the quarter and whether there could be some potential upside as we look at your guidance for Q3 and Q4?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Certainly. I think the seasonal weakness is not only in Q2. It's in the back end of Q2 and through Q3. So we've seen part of it and we're going to keep on seeing it. It's usually due to the fact that it is winter. There is more rainy season right now in A",340,"Certainly. I think the seasonal weakness is not only in Q2. It's in the back end of Q2 and through Q3. So we've seen part of it and we're going to keep on seeing it. It's usually due to the fact that it is winter. There is more rainy season right now in Argentina, where we're operating. So it's not only a Q2 phenomenon, it's a back of Q2, early Q3. I think the visibility we have today due to our production is quite, quite correct at the earnings level. Mainly, there is multiple reasons, which have been leading to the improved earnings. First of all, the mix. We are moving more business towards our lithium hydroxide, where we've been able to operate our plants quite, quite well and where there is a healthy demand and pricing situation. Second of all, our plants have been operating also very well for carbonate production and we have been -- and we are continuing to do that for the second half, selling more products made within the company than third-party products we would resell. And then there is some volume. So if I look at the second half of the year, I think our earnings is quite in line with our expectation. I don't think there is a lot of upside. Most likely what you will see is, we decided not to change the revenue range because we are a little bit below the middle point of the range initially. Looking at the demand for the back end of the year, it's most likely going to lend us to where the higher end of the range from a revenue standpoint. But I believe, the earnings we have forecasted in lithium for Q3, Q4 are correct, unless. Unless, I'd say the only place where I could see upside, but it is not possible for us to predict that today is pricing. Pricing is always something, depending upon demand, and how capacity come on stream. So that one, we've made some assumptions, you never know."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","And then a question just on the product rationalization that you did in Ag Solutions. Is that mostly legacy FMC products or are there some Cheminova products? And is there any more to come? Just trying to get a sense of whether we could see some additiona",78,"And then a question just on the product rationalization that you did in Ag Solutions. Is that mostly legacy FMC products or are there some Cheminova products? And is there any more to come? Just trying to get a sense of whether we could see some additional pressure there. And at some point, do you hit a point where you could see some negative leverage as a result of scaling back on the number of products you're selling?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think the product rationalization is very well advanced today. I think it's a mix. It's as much from Cheminova legacy products than it is from FMC products. Both company use to resale third-party products as a service to customers. And the things you ca",189,"I think the product rationalization is very well advanced today. I think it's a mix. It's as much from Cheminova legacy products than it is from FMC products. Both company use to resale third-party products as a service to customers. And the things you can afford to do it at a given time with a very healthy market, you cannot do when the market is more tense. So it was a normal thing for us to move the way. We had very precisely defined what those products could be. I'm very pleased with the speed at which the organization responded to it. I think more than half of the shortfall in our sales today in the second quarter is coming from product rationalization, but that's pretty much where it is. So you will not see numbers going beyond what we've talked about, which was total run rate, adding of this year of $350 million, which is $100 million more than we did last year. We did $250 million last year. And this is it. There will be no further as far as we can see actions to be taken."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And your next question comes from the line of Frank Mitsch with Wells Fargo.",14,"And your next question comes from the line of Frank Mitsch with Wells Fargo."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, I was struck by the comment that the inventory levels of insecticides are rather high in Brazil. And I guess, I was thinking about Zika there. Does that offer any opportunity for you in that marketplace?",37,"Pierre, I was struck by the comment that the inventory levels of insecticides are rather high in Brazil. And I guess, I was thinking about Zika there. Does that offer any opportunity for you in that marketplace?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, Frank, this is Mark. Yes, we have seen increased sales of specific insecticides that we're providing to that vector control market. It's not huge, though. Let's put it in perspective. It's not going to move the Ag business. It's nice business to have",90,"Yes, Frank, this is Mark. Yes, we have seen increased sales of specific insecticides that we're providing to that vector control market. It's not huge, though. Let's put it in perspective. It's not going to move the Ag business. It's nice business to have. We have a leading position in Brazil. And we've seen that business grow over the last 18 months. And we expect it to continue with the way Zika is progressing through the region. But it's not going to be significant enough to really move the needle."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Interesting. I mean, as the geography of concern spreads, one would think that, that would be an opportunity. I guess, just simplistically, how would you describe your market share in that application?",32,"Interesting. I mean, as the geography of concern spreads, one would think that, that would be an opportunity. I guess, just simplistically, how would you describe your market share in that application?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","It's pretty good. Let's -- why don't we just put it in perspective. The global public health market is about $700 million, and that's within the total Ag space crop protection chemicals of over $51 billion. So really, for mosquito control, the market worl",126,"It's pretty good. Let's -- why don't we just put it in perspective. The global public health market is about $700 million, and that's within the total Ag space crop protection chemicals of over $51 billion. So really, for mosquito control, the market worldwide is about $325 million to $340 million and the U.S. is about $90 million of that. So you can get a sense of the scale of that business. In particular applications, we have a very good market share. But only with our pyrethroids, but with a product called malathion that we bought from Cheminova. So just keep it in perspective. I mean people talk about it a lot, but the U.S. market is only $90 million out of that $700 million."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Mark, I appreciate you throwing a wet blanket on that thesis. And then, lastly, Paul, you sounded more sanguined with respect to the FX impact for 2016. Do you have a size as to what you think the negative effect will be when all is said and done on the y",51,"Mark, I appreciate you throwing a wet blanket on that thesis. And then, lastly, Paul, you sounded more sanguined with respect to the FX impact for 2016. Do you have a size as to what you think the negative effect will be when all is said and done on the year?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I wish I could predict FX markets that well, Frank. I mean, I wouldn't be in this job. I'm pretty confident around that. I think the key is that we seem to have more predictability around that. You see the peso has been a surprising area for us. We didn't",132,"I wish I could predict FX markets that well, Frank. I mean, I wouldn't be in this job. I'm pretty confident around that. I think the key is that we seem to have more predictability around that. You see the peso has been a surprising area for us. We didn't -- I mean, we never see them coming. And the Brazil has been -- the reais has been some kind of a bright spot, not because of the absolute rate, but as I mentioned about the stability around the rates. And I think that's sort of the key for us as we look forward, that stability of the rates and a lack of surprise is more important to us on most of our business than the actual movement in the exchange rates."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our next question comes from line of Daniel Jester with Citibank.",12,"And our next question comes from line of Daniel Jester with Citibank."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","What kind of visibility do you have in Health and Nutrition in the second half of this year? Your guidance seems to imply an acceleration in profits, which seems seasonally maybe a little bit different than the past few years. So given sort of the comment",67,"What kind of visibility do you have in Health and Nutrition in the second half of this year? Your guidance seems to imply an acceleration in profits, which seems seasonally maybe a little bit different than the past few years. So given sort of the comments that you called out about omega-3, can you just walk us through some of the key drivers for the second half?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Certainly, I think we do have a pretty good visibility on our 3 segments today from a demand standpoint. But it is important to understand that the earnings growth, especially in the fourth quarter, is maybe more predictable because it is due to a cost si",163,"Certainly, I think we do have a pretty good visibility on our 3 segments today from a demand standpoint. But it is important to understand that the earnings growth, especially in the fourth quarter, is maybe more predictable because it is due to a cost situation. We always work our cost and decrease our cost. But the way costs flows into operations depend upon the speed at which you turn your product. And I think, we call that capitalized variance. But the main reason for the bump in earnings in the back end of the year is due to the fact that we would be operating at a lower cost than we have been operating via the quarters in previous year. That is why you will see such a jump. So it is not due to a major turn in demand for any of our products, but it's much more the benefit of prior activity we've done on operational costs and manufacturing excellence."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Okay, that's helpful. And then of this $60 million to $70 million of full year cost synergies from Cheminova, can you quantify how much of that you realized in the first half? And then maybe just holistically, beyond just cost synergies, where do you see",51,"Okay, that's helpful. And then of this $60 million to $70 million of full year cost synergies from Cheminova, can you quantify how much of that you realized in the first half? And then maybe just holistically, beyond just cost synergies, where do you see the integration process for Cheminova today?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, thanks. I think at a run rate basis, we want to close the half year on the run rate basis in the $30 million to $40 million range for the first half of the year on the Cheminova. Do you want, Mark?",43,"Yes, thanks. I think at a run rate basis, we want to close the half year on the run rate basis in the $30 million to $40 million range for the first half of the year on the Cheminova. Do you want, Mark?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","You want me to talk a little bit about the integration side. From an integration perspective, we are very much done on the commercial side, that's all in place. A lot of the functional groups are also fully integrated and operating. We have some systems t",142,"You want me to talk a little bit about the integration side. From an integration perspective, we are very much done on the commercial side, that's all in place. A lot of the functional groups are also fully integrated and operating. We have some systems that we're still working through SAP in Europe, as an example, which will be completed early in the fourth quarter. And then the long lead time item is how we bring together the different manufacturing units, the tall manufacturing units and the formulating units. We are well progressed with that. We still have some to go, but that will occur over time. And the basic need there is to make sure that we have registrations as we move products around the world. So that's the rate limiting step, but everything else is pretty much done by now."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think from the Cheminova integration, we're going to stop reporting. I mean, we'll answer any questions you guys might have. But we can almost declare success. Everything is in place to reach, as we discussed by the middle of next year, the $140 million",105,"I think from the Cheminova integration, we're going to stop reporting. I mean, we'll answer any questions you guys might have. But we can almost declare success. Everything is in place to reach, as we discussed by the middle of next year, the $140 million to $160 million run rate, the 800 to 900 positions being eliminated. So we are very much more than on track ahead of the initial schedule. And I think the lots of the remaining activities are more under impulse shop around IT, SAP, science integration. So much more back-office integration than anything during with the front end of the business."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And we do have a question from the line of Rosemarie Morbelli with Gabelli & Company.",15,"And we do have a question from the line of Rosemarie Morbelli with Gabelli & Company."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","I was wondering if you could talk about the expected lithium capacity, lithium carbonate capacity increase in 2017. Based on what you see and hear in the marketplace, is that coming on stream, a lot of it in the first half of 2017 and therefore, would hav",52,"I was wondering if you could talk about the expected lithium capacity, lithium carbonate capacity increase in 2017. Based on what you see and hear in the marketplace, is that coming on stream, a lot of it in the first half of 2017 and therefore, would have a negative impact on pricing?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Rosemarie. Yes, we're starting to see some exchange of volumes coming on even in the back half of 2016, mostly out of the new spodumene capacity that's coming online in Australia. As you know, there's also some capacity in Chile, and there has",110,"Thank you, Rosemarie. Yes, we're starting to see some exchange of volumes coming on even in the back half of 2016, mostly out of the new spodumene capacity that's coming online in Australia. As you know, there's also some capacity in Chile, and there has been capacity ramping up in Argentina, targeting back end of 2016 and early 2017. So these were the volumes that we're watching. And I characterize it, could be anywhere between 50,000 to 75,000 tons by early 2017. So as Eric commented earlier, this is where we make a pricing assumption, and we're monitoring the conditions as we interact with customers in terms of pricing expectations."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","And that particular capacity addition is going to be smaller than the demand increase, isn't it? And therefore pricing is going to come down across the board, including lithium hydroxide or you don't think so?",35,"And that particular capacity addition is going to be smaller than the demand increase, isn't it? And therefore pricing is going to come down across the board, including lithium hydroxide or you don't think so?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","No. First, yes. There will be -- we are expecting, as time goes, starting in '17 and into '18, we're expecting carbonate pricing to grew more towards normal pricing, which mean a lower pricing we are currently seeing when they will be more or they balance",126,"No. First, yes. There will be -- we are expecting, as time goes, starting in '17 and into '18, we're expecting carbonate pricing to grew more towards normal pricing, which mean a lower pricing we are currently seeing when they will be more or they balance between the carbonate demand and the supply. It will not impact the hydroxide pricing. If you look right now and if you put together all of the hydroxide capacity increase, which actually we are leading, they are very much in line with the demand increase. So from a pricing standpoint, we might not see hydroxide rising tremendously in the year to come. But I think wanted to be in a healthy pricing situation for the next 3 to 4 years."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","And just to add a little bit to that, Rosemarie. In our hydroxide business, we're targeting specific segments of that demand, where it's high quality hydroxide, where they're willing to pay for the quality we bring to the markets. So when we look at suppl",63,"And just to add a little bit to that, Rosemarie. In our hydroxide business, we're targeting specific segments of that demand, where it's high quality hydroxide, where they're willing to pay for the quality we bring to the markets. So when we look at supply/demand, we're looking even specifically at that customer mix versus one that might trade-off to carbonate or other supply."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And my second question deals with the inventory, overall inventory in the Ag sector. You said that you have lower FMC product inventories. But without talking about any specific competitors, what do you see in terms of the overall inventory channel?",59,"Okay. And my second question deals with the inventory, overall inventory in the Ag sector. You said that you have lower FMC product inventories. But without talking about any specific competitors, what do you see in terms of the overall inventory channel? Is it declining? Or is it still growing? Or more or less flat -- has it plateaued?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think from a -- as I said, I want to repeat, we're mostly focusing on our inventory. But overall, if I would have or if we would have to make an overall statement, we believe overall inventory in the channel is declining. We do not believe right now we",141,"I think from a -- as I said, I want to repeat, we're mostly focusing on our inventory. But overall, if I would have or if we would have to make an overall statement, we believe overall inventory in the channel is declining. We do not believe right now we are at a turning point from a market standpoint. But we can see we are at a place where the dialogue with the customers is changing. There is more certainty. There is more productivity. Still means that the inventory in the channel is pretty heavy. We are not yet at a situation where it's not -- but the dialogue is changing. And I believe, everybody is trying to do their bit decrease their inventory. We believe, we most likely have been most aggressive. But overall, I think the situation is improving."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our next question comes from line of Mark Connelly with CLSA.",12,"And our next question comes from line of Mark Connelly with CLSA."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Two things. Paul, you talked about the longer time line for rationalization of the manufacturing in Europe. Is that sort of a 2020 time goal in your mind? Or is there a specific target in your mind? And then the second question to Latin America again. As",106,"Two things. Paul, you talked about the longer time line for rationalization of the manufacturing in Europe. Is that sort of a 2020 time goal in your mind? Or is there a specific target in your mind? And then the second question to Latin America again. As we think about the working capital cycles in cotton and sugarcane, is your penetration in that market permanently shifting your working capital cycle in a material way? My understanding is Cheminova managed working capital much differently than you did using more receivables, for example. And I'm curious whether that has all shifted over to your way of doing things."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Well, let me address first the question on the manufacturing rationalization. Right now, we are at a place where we have a stable manufacturing network for Ag business. We are always looking at improving. But any improvement, any decision today is always",154,"Well, let me address first the question on the manufacturing rationalization. Right now, we are at a place where we have a stable manufacturing network for Ag business. We are always looking at improving. But any improvement, any decision today is always a mid- to long-term decisions because there is some product registrations, which are changing when you do a change of manufacturing. So I have to say that right now, as any company would do, we are keeping our options open. But we are in what I would call a stable manufacturing network. And we will see as time goes what are the best decisions to be taken for our business in terms of network. But today, we're not penalized by the structure we have and it's a matter of doing continuous improvement and being able to supply what will be requested by the market at the time when the market turns around."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","So you're comfortable then not being quite as asset light as you had been sort of in the medium term?",21,"So you're comfortable then not being quite as asset light as you had been sort of in the medium term?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","We are asset light. I think if you think about FMC prior to the acquisition of Cheminova, our manufacturing cost was 95% asset light. I would say today, maybe we're at 90%. We should not believe that the fact that we have a plant in India in Panoli and a",114,"We are asset light. I think if you think about FMC prior to the acquisition of Cheminova, our manufacturing cost was 95% asset light. I would say today, maybe we're at 90%. We should not believe that the fact that we have a plant in India in Panoli and a plant we have in Ronland are fundamentally changing the mix of product we shall made until manufacturers versus what is being made today. Those are big plants. But you know in the big scheme of things, the production capacity versus what we do with total network is fairly small. So it is our fundamental departure to what we used to be in the past."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Let me touch on the working capital question down there in Brazil. Sugarcane and cotton can have very, very different terms, cotton tends to be longer term, sugarcane tends to be much shorter term, although that does vary depending on the nature of the pl",253,"Let me touch on the working capital question down there in Brazil. Sugarcane and cotton can have very, very different terms, cotton tends to be longer term, sugarcane tends to be much shorter term, although that does vary depending on the nature of the planting cycles and on the financial health of the sugarcane guidance. But as a rule, as we shifted away from cotton, we'll expect to see our working capital terms come in and to what sugarcane also does the same thing. I would not though expect that you're going about to track that through our working capital balance as you look at it. It's definitely a factor that helps, but it's not so large that you're going to really see a major move in our numbers. In terms of how Cheminova approached it. Cheminova, this is to separate the 2 important differences. Cheminova did not have a different approach to working capital than anybody else in the industry. They did have a different approach to how they finance that working capital. And to be blunt, as a weak balance sheet company with very unsophisticated treasury operations, they used to use some very, very expensive local financing in Brazil, which can give the impression that they are reducing their working capital. It was appropriate for non-U.S. GAAP reporting, it was appropriate for a sub-investment grade company, it was incredibly expensive and we'll certainly factor in why their overall profitability was so low and it's certainly not something we intend to do."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And we do have a question from the line of Aleksey Yefremov with Nomura Securities.",15,"And we do have a question from the line of Aleksey Yefremov with Nomura Securities."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","What is the current competitive environment in Latin America and North America? Do you see your competitors generally being more disciplined on crop reduction prices?",25,"What is the current competitive environment in Latin America and North America? Do you see your competitors generally being more disciplined on crop reduction prices?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Well, obviously, I'm not going to talk about what competition is doing on price. I'll tell you where we are. As Pierre said earlier, we're doing everything we can to make sure we manage pricing terms across North America. And certainly in Brazil, where we",130,"Well, obviously, I'm not going to talk about what competition is doing on price. I'll tell you where we are. As Pierre said earlier, we're doing everything we can to make sure we manage pricing terms across North America. And certainly in Brazil, where we have reduced our exposure to the Brazilian market by taking out through product rationalization, significant amount of volume and revenue. But we're very focused on making sure that we maximize price, not only in terms of pricing, but across the portfolio of what we're selling. I think you're going to see all sorts of different activities as we go through the next year. But for us, it's very much around protecting the margins, protecting the value of the business and certainly, looking after working capital."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I think in term of pricing, just to get back to one of the comment Paul made around the balance of FX and pricing. As you know, we tend to have a rule in Brazil, where we index price on currency. Last year, we were with a pricing running after the currenc",173,"I think in term of pricing, just to get back to one of the comment Paul made around the balance of FX and pricing. As you know, we tend to have a rule in Brazil, where we index price on currency. Last year, we were with a pricing running after the currency and trying to move up our price. This year, the same process of adjusting pricing to currency is going the other way, which mean it is not any longer us asking the customers to take higher price, but the customer asking us to lower the price more towards the currency. So needless to say that for all of us, regardless of what behavior individual companies would take, it is an easier conversation from the predictability of the pricing. And this FX situation give us a much better position to talk about pricing, more control in term of understanding pricing in the next 2 quarters. And I think, it's got to apply to every company. It is just an FX price situation."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Very helpful. And turning to Europe and crop protection. You had some revenue declines there. How much of that was your move to direct market? And was it a onetime impact or is there any way to improve that next year?",41,"Very helpful. And turning to Europe and crop protection. You had some revenue declines there. How much of that was your move to direct market? And was it a onetime impact or is there any way to improve that next year?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes. The direct market situation is a onetime impact. It is just a couple of situation, which happen all the time when you do this kind of a transfer. First of all, you work with your distribution network, which we're moving away from. Those guys have inv",173,"Yes. The direct market situation is a onetime impact. It is just a couple of situation, which happen all the time when you do this kind of a transfer. First of all, you work with your distribution network, which we're moving away from. Those guys have inventory. They have stocked -- they are selling it while you replenishing your own now warehouses to sell. So there is the period of time, where you have 2 networks, which have to roll out for a little while. And you have to give the time to your distributors to sell the product they were supposed to sell the product by contract. Second of all, you are at a stage also, where your distributors are not replenishing their inventory in advance. So by the time we get into -- this is happening at the transition now. I believe if by the time we get into European season Q1, Q2 next year, we should be in a very normalized situation and it will be stable for the future."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And we do have a question from the line of Mike Sison with KeyBanc.",14,"And we do have a question from the line of Mike Sison with KeyBanc."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Just curious that you maintained your outlook for the crop protection markets this year down mid- to high single digit. What was it down in the first half? And just trying to gauge what the expectation is for the second half in terms of demand.",45,"Just curious that you maintained your outlook for the crop protection markets this year down mid- to high single digit. What was it down in the first half? And just trying to gauge what the expectation is for the second half in terms of demand."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","So I think in the first half, the way I would look at it, Mike, is when we gave the range, we said mid-single digit to high single digit. Maybe we were thinking about more toward when we started this process, the lower end of the range, maybe 5%, 6%, 7%.",249,"So I think in the first half, the way I would look at it, Mike, is when we gave the range, we said mid-single digit to high single digit. Maybe we were thinking about more toward when we started this process, the lower end of the range, maybe 5%, 6%, 7%. We are more today on a 7%, 8% more toward the higher end of the range. And that is due, maybe less due to channel inventory than it was to specific reasons in Asia and Europe, mostly driven by weather. So for us, when we look at the market, if you remember, we were thinking about North America and Latin America in the higher end of the range, and these being helped by flattish to slightly down market in Europe and Asia. We don't see that any longer. I mean, we still see North America and Latin America on the higher end of the range, but we see Asia and Europe being down in the 5%, 6% from this year. That is why today, we are looking at maybe more the higher end of our range. For us, what we've been doing is we've been able, no matter what, to protect our earnings by being even more drastic on pricing, more drastic on product rationalization. So we'll be slightly lower on sales. But we believe we are going to be -- we're going to have very solid performance in the second half and productivity on the earning side."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Great. And then for the fourth quarter for Ag Solutions, you talked about better visibility than in the past. But just curious, what sort of gets you to the high end of the range? I mean, it's pretty wide in terms of the top end, given your guidance for A",67,"Great. And then for the fourth quarter for Ag Solutions, you talked about better visibility than in the past. But just curious, what sort of gets you to the high end of the range? I mean, it's pretty wide in terms of the top end, given your guidance for Ag Solutions from the third quarter and the low end. What sort of gets you to the top?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","I would say always the same answer. When we give the mid of the range, it is under normal circumstances from a demand and weather standpoint. And those, there is always a range. You just need an infestation, you just need very strong insect pressure or ot",108,"I would say always the same answer. When we give the mid of the range, it is under normal circumstances from a demand and weather standpoint. And those, there is always a range. You just need an infestation, you just need very strong insect pressure or other pressure. And you would drive that either to the lower or either to the higher end. Today, we believe we are very comfortable with the mid of the range to see anything going up or down would be due to external events not linked to channel inventory or anything that kind, but much more to specific agricultural seasonal situation, mostly weather."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And our last question comes from the line of Peter Butler with Glen Hill Investment.",15,"And our last question comes from the line of Peter Butler with Glen Hill Investment."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, early on regarding lithium, you folks had a conservative outlook on shorter term of lithium growth, but you saw good possibilities longer term. And this outlook has been proven correct. What do you see now for the longer-term growth of lithium? An",79,"Pierre, early on regarding lithium, you folks had a conservative outlook on shorter term of lithium growth, but you saw good possibilities longer term. And this outlook has been proven correct. What do you see now for the longer-term growth of lithium? And how do you -- how does your research pipeline on lithium derivatives look compared to what you're seeing from competitors and how does this change your future position on earnings and cash flow growth, et cetera?"
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Peter. Yes. So lithium, I have to say, we do have increased confidence in the future. Today, we believe this market is getting more and more solid. I have to say that we are still prudent. But the big breakthrough for us is the technology we're",291,"Thank you, Peter. Yes. So lithium, I have to say, we do have increased confidence in the future. Today, we believe this market is getting more and more solid. I have to say that we are still prudent. But the big breakthrough for us is the technology we're able to develop from a manufacturing standpoint, allowing us to add very low capital spend and efficient cost of operations, ability to create 4,000 to 8,000 tons modules for lithium hydroxide instead of having to build in one shot, a 20,000 or 30,000 tons. So today, we do have an improved view and more certain view of what lithium hydroxide is doing. But on the work we've done in the last 2 years, was to develop a manufacturing process, allowing us to follow the demand growth. Which means that if the growth is not as we're expecting, we can stop 1 or 2 of these modules manufacturing and slowdown the capacity increase we have planned. If the demand becomes more aggressive, very easy for us to speed up the building of those modules. So first, your question, yes, we have increased confidence. Our strategy is very highly focused on the downstream product, where we have the highest profitability. Third, we have a safety net around demand by these manufacturing process we have in place, allowing to match the demand. Where are we on our forecast? We are taking pretty much a middle of the range. We are far in the process and predictability for the numbers I gave to you, to take the highest prediction from EV companies. So there could be upside, but you know, we are prepared also for the downside. 
And maybe I'll ask Tom to comment on the technology."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Yes, and thanks for the question. On the technology, we've got a technology roadmap. And I'd say that with this strategy that we've undertaken on the high-value products, the biggest shift is increased collaboration and formalized collaboration with our c",85,"Yes, and thanks for the question. On the technology, we've got a technology roadmap. And I'd say that with this strategy that we've undertaken on the high-value products, the biggest shift is increased collaboration and formalized collaboration with our customers. So we do have a number of exciting opportunities that are being discussed with customers and being trialed with customers, and we're looking forward to that. It will continue to add to high-quality sales of new lithium derivatives and new applications with existing lithium derivatives."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","So as it was the last question, let me close with a couple of words before I hand the closing comments to Brian. I think we went through those 2 quarters, very highly focused on delivering what we promised to do. Everything we've done in the 2 quarters ha",188,"So as it was the last question, let me close with a couple of words before I hand the closing comments to Brian. I think we went through those 2 quarters, very highly focused on delivering what we promised to do. Everything we've done in the 2 quarters have done a few things for us. First of all, I believe from an Ag standpoint, even if the markets are not yet returning to the level of growth, this kind of market could expect to see one day. We have improved highly controlled visibility and predictability of our own business. I think from the lithium standpoint, it is a bright spot for us. We have refined our strategy. And I have to say the breakthrough we had in technology around lithium hydroxide manufacturing are an enormous win for us looking at the future. And our penetration, the business is solid. The business is highly profitable. But we also understand the challenges we have on omega-3 and it's something we'll be focusing on in the quarters to come. 
So with this, I'm going to turn the call back to Brian."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Pierre. As always, appreciate the time and the questions. I'll be available for on the call to address any further questions that you may have. So with that, thank you and have a good day.",37,"Thank you, Pierre. As always, appreciate the time and the questions. I'll be available for on the call to address any further questions that you may have. So with that, thank you and have a good day."
28606,341073936,1024341,"FMC Corp., Q2 2016 Earnings Call, Aug 03, 2016",2016-08-03,"Earnings Calls","FMC Corporation","Operator","And ladies and gentlemen, today's conference will be available for replay after 10:00 a.m. today through September 3 at midnight. You may access the AT&T teleconference replay system at any time by dialing 1 (800) 475-6701 and entering the access code 378",72,"And ladies and gentlemen, today's conference will be available for replay after 10:00 a.m. today through September 3 at midnight. You may access the AT&T teleconference replay system at any time by dialing 1 (800) 475-6701 and entering the access code 378964. International participants may dial (320) 365-3844. That does conclude your conference for today. Thank you for your participation and for using the AT&T executive teleconference service. You may now disconnect."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the Third Quarter 2016 Earnings Release Conference Call for the FMC Corporation. [Operator Instructions]I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Ang",42,"Good morning, and welcome to the Third Quarter 2016 Earnings Release Conference Call for the FMC Corporation. [Operator Instructions]
I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning. Welcome to FMC Corporation's Third Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer. Pierre",270,"Thank you, and good morning. Welcome to FMC Corporation's Third Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer. Pierre will begin the call with a review of FMC's third quarter performance and discuss the outlook for Q4 and full year 2016. Paul will provide an overview of select financial results.
The slide presentation that accompanies our results, along with our earnings release and 2016 outlook statement, are available on our website, and the prepared remarks from today's discussion will be made available at the conclusion of the call.
As with our prior calls, Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President, FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, will join to address questions.
Before we begin, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including, but not limited to, those factors identified in our release and in our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based upon these risks and uncertainties.
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms as well as other non-GAAP financial terms to which we may refer during today's conference call are provided on our website.
With that, I will now turn the call over to Pierre."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian, and good morning, everyone. Q3 2016 was another strong quarter, reflecting the continued execution of our strategy. FMC reported revenue of $808 million, adjusted operating profit of $134 million and adjusted EPS of $0.67. Adjusted EPS i",1474,"Thank you, Brian, and good morning, everyone. Q3 2016 was another strong quarter, reflecting the continued execution of our strategy. FMC reported revenue of $808 million, adjusted operating profit of $134 million and adjusted EPS of $0.67. Adjusted EPS increased approximately 60% compared to the third quarter of 2015, exceeding the top end of our guidance range of $0.53 to $0.63.
Our performance for the quarter. For [indiscernible], best results of Ag Solutions and Lithium, both of which reported a significant year-over-year increase in segment earnings.
In Ag Solutions, compared to last year, we saw an improved start of the season in Latin America, especially in Brazil, a stronger performance in both Asia and North America. Lithium continued to benefit from higher prices, improved mix and lower operating costs. Third quarter segment earnings in Health and Nutrition [ph] were slightly below 2015 but in line with our expectations.
The lower tax rate in the quarter contributed approximately $0.03 to adjusted EPS. As noted in our outlook statement, and as Paul will discuss later in the call, we expect to continue to report a lower tax rate for the remainder of the year and into 2017.
Based on our performance in the third quarter and on our outlook for Q4, we are revising the range of our full-range adjusted EPS guidance to $2.76 to $2.86 per share at the mid-point. This represents an increase of $0.06 per share compared to the prior period [ph] and an increase of $0.14 compared to adjusted EPS for 2015. I will provide more detail on the outlook for Q4 shortly. But first, I will discuss third quarter results for each of our 3 segments, starting with Ag Solutions on Slide 2.
For the third quarter, Ag Solutions reported revenue of $559 million and segment earnings at the top of organic [ph] range of $90 million. Compared to the third quarter 2015, revenue declined 3% as lower sales volume in Brazil more than offset the benefit of higher prices in that country and volume growth in other regions.
Year-over-year price increases were [ph] just in Brazil, where we continue to recover pricing in U.S. dollar terms. Segment earnings increased over 50%, and margin improved 600 basis points, as higher realized [ph] prices, improved mix and favorable foreign exchange more than offset the impact of lower volumes and slightly higher costs in the quarter.
Costs were higher, principally as a result of the timing between quarters [ph] of certain expenses. For the full year, we remain on track to achieve our integration cost savings targets.
Turning to Slide 3. I will provide additional comments on Ag Solutions' regional performance and discuss the outlook for Q4, starting with Latin America.
Revenue in the region declined 18% in the quarter, driven largely by lower sales volumes in Brazil. General market weakness, ongoing product rationalization efforts and our decision to allow channel inventory levels to reduce each contributed to the decline in sales volume in Brazil. The elimination of low-margin third-party products accounted for over 50% of the volume decline in the quarter.
Revenue in the rest of Latin America was roughly flat compared to 2015. In Argentina, we continued to see increasing demand for FMC's [ph] authority herbicides. In Mexico, our focus on high-value crops is helping to offset the impact of a broader market decline.
The actions we have taken throughout the past year in Brazil enabled us to realize significant increases in U.S. dollar-based prices, improve operating margin and drive collections in the quarter. Price actions increased operating earnings in Brazil by about 30% year-over-year, which, combined with lower operating costs, reached our  [ph] operating margins to 2014 levels.
Our actions in Brazil also enabled the business to reduce accounts receivables in the country and generate cash collections of over $200 million, a significant improvement over our performance in the same quarter last year.
Moving on to Asia. Revenue in the region grew by 9% in the quarter compared to 2015, driven mainly by increased sales [ph] volume throughout the region. Improving weather conditions in Australia created strong demand for [ph] herbicide and for our fungicide portfolio. A return to a more normal monsoon season in India and Southeast Asia supported increased demand for insecticide and fungicide, with strong growth in Indonesia for rice applications.
In Europe, revenue increased 6% in the quarter. Increased sales [ph] synergies and higher volume in Eastern Europe as we expand our direct market access, coupled with strong herbicide sales in the U.K, more than offset challenging conditions in Northwest Europe.
In North America, revenue in the quarter increased 46% to 2015. We saw higher sales volumes related to new product introduction for winter and spring week and increased demand for herbicide.
Looking ahead to Q4, we expect market conditions to remain largely unchanged. We are cautiously optimistic regarding Q4 in Latin America given the start of the selling season in Brazil and strong demand for FMC product elsewhere in the region. However, we are more cautious on market conditions in North America, where we expect weak market conditions into 2016/2017 crop season.
For the fourth quarter, we expect segment earnings to be between $117 million and $137 million. At the midpoint, leasing pipe [ph] segment earnings growth of approximately 25% compared to the fourth quarter of 2015. Improved U.S. dollar pricing in Brazil and lower costs year-over-year are expected to drive a meaningful increase in segment earnings margin in the quarter from 15% in 2016 to closer to 20%. 
We are pleased with the progress made in Ag Solutions to drive margin improvements in the business. Prior to the acquisition of Cheminova, Ag Solutions consistently delivered consolidated operating margins between 20% and 25%, and we are well on our way to returning margins to that level. We are tightening our full year segment earnings guidance to $390 million to $410 million with the midpoint of our range unchanged and continue to forecast full year revenue of about $2.3 billion at the midpoint.
Turning next to Health and Nutrition on Slide 4. For the third quarter, Health and Nutrition reported revenue of $179 million and segment earnings of $45 million. Revenue declined 9% year-over-year, largely as a result of lower volume. Timing of sales to certain pharma customers in Asia and Europe and headwinds from omega-3 each contributed to the volume decline.
Segment earnings of $45 million declined 4% compared to 2015. However, operating margin improved 120 basis points to over 25% in the quarter. The negative impact of lower volumes and product mix was largely offset by lower operating costs as a result of ongoing operating excellence programs.
For the fourth quarter, we expect segment earnings of between $53 million and $57 million and for the full year forecast statement earnings to be in the range of $190 million to $194 million. At the midpoint, Q4 segment earnings are expected to increase almost 20% compared to Q4 2015. The bulk of the increase in segment earnings is due to the timing of certain favorable cost variances from prior period, which will drive segment earnings margins to between 29% and 30% in the quarter. For the full year, we expect margins of about 25% to 26%.
Moving on to Lithium on Slide 5. Lithium delivered another outstanding quarter. Revenue increased 22% to $70 million on the back of increased price and more favorable mix. Segment earnings rose to $18 million from just $2 million last year. Market conditions remained favorable, with demand increasing ahead of supply. As a result, prices across the portfolio were higher compared to the last year. These price increases, combined with most favorable sales mix, lower costs and benefit from foreign currency, drove the improvement in segment earnings and margin in the quarter.
We expect the positive momentum in Lithium to continue with fourth quarter segment earnings between $16 million and $20 million, approximately 60% higher year-over-year at the midpoint of the range. Based on Lithium's performance to date and our expectation for Q4, we are increasing full year guidance for segment earnings by $5 million at the midpoint to a range of $65 million to $69 million. Full year segment earnings margin should be about 25% compared to 10% in 2015.
Before turning the call over to Paul, I will comment briefly on the outlook for the fourth quarter and full year 2016 on Slide 6. We are tightening full year segment earnings guidance for both Ag Solutions and Health and Nutrition and increasing guidance for Lithium. Based on this segment guidance and lower tax rate, which Paul will discuss in a moment, we expect fourth quarter adjusted earnings per share to be in the range of $0.82 to $0.92 and full year adjusted EPS in the range of $2.76 to $2.86.
I will now turn the call over to Paul."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Pierre. I'll start with the tax rate and the noncontrolling interest on the income statements before I move on to the impact of currency, cash flow and the balance sheet.So first, tax. Year-to-date, our adjusted effective tax rate is around 2",721,"Thank you, Pierre. I'll start with the tax rate and the noncontrolling interest on the income statements before I move on to the impact of currency, cash flow and the balance sheet.
So first, tax. Year-to-date, our adjusted effective tax rate is around 23.5%, which is slightly lower than we initially expected. This is driven by an increase in the contribution of earnings from our foreign entities compared to prior years. And while this trend is most apparent in Ag Solutions, we're actually seeing it in all of our businesses. We expect the adjusted effective rates to be in the 23% to 24% range for the fourth quarter. And looking into 2017, we expect that rate will made for [ph] by as much as 3 percentage points, resulting in a full year adjusted effective tax rate closer to 21%. This further reduction is mainly the result of the operational integration of Cheminova, which will impact our supply chain and our earnings mix globally.
Our noncontrolling interest line continues to shrink as part of the integration of Cheminova. We've been taking advantage of opportunities to simplify the ownership structure of some of our international entities and have taken steps to consolidate ownership in places like Argentina, China and Eastern Europe. Largely as a result of these steps, we expect the noncontrolling interest line to [indiscernible] to approximately $5 million this year and remain near this level next year.
Tapping on currency. This quarter saw none of the rapid movements in major currencies that we saw last year. And as a result, FX had a far smaller impact on our results. Across all businesses and regions, currency was a tailwind to earnings, with a large favorable movement in Brazil, the biggest factor. The other major currencies towards FMC is exposed, namely the euro and RMB, had no meaningful impact on our earnings last quarter. For the year-to-date, currency has been good and [ph] neutral to earnings.
Moving on to cash flow on Slide 7. The first thing I want to point out is our increasing cash flow guidance for full year from a range of $450 million to $550 million to a range of $550 million to $600 million. The midpoint of this revised guidance reflects an increasing cash generation of almost 60% compared to 2015. Higher earnings, stronger working capital performance and tight spending discipline will all contribute to the year-over-year increase and give us confidence that the higher level of cash generation we've seen through the first 3 quarters will continue through Q4.
Underpinning our confidence in cash generation is our success in reducing our Brazil exposure. Through September, we collected over $500 million of receivables in Brazil, reducing the outstanding receivable balance by over $200 million. By the end of 2016, we expect to have collected over $700 million of outstanding receivables in Brazil alone. Equally importantly, a significant proportion of the collections are coming from those accounts that were past due at the start of the year, improving the quality of the remaining receivables balance.
Our receivables balance in Brazil, however, remains higher than we believe it should be. And we expect to continue to reduce it over the coming seasons. Based on our current visibility, we believe that we have the ability to reduce the current balance by approximately $400 million. We will deliver this reduction over the next 18 to 24 months.
Our strong cash generation has helped us reduce our net debt by over $200 million so far this year, and we expect this to fall further by year-end. Combined with higher trailing EBITDA, our adjusted net debt-to-LTM EBITDA ratio both fall into the 2.5 to 3x range as we enter 2017. We will continue to manage our debt to a level consistent with our current credit rating.
And looking into 2017, we expect our capital expenditure to remain similar to '16, at or just ahead of depreciation, leaving allowance for our planned expansions in lithium hydroxide. We will continue to seek out opportunities to invest in technologies and products for our Ag Solutions business. And at an appropriate time in 2017, we would expect to revisit our ability to engage in share repurchases while maintaining our other net debt, credit rating and investment objectives.
And with that, I will turn the call back to Pierre."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Before closing, I would like to share a few initial thoughts regarding 2017 on Slide 8. Based on what we see today, we expect the global crop protection chemical market to be about flat in 2017, creating a more stable operating environment for FMC Ag Solu",909,"Before closing, I would like to share a few initial thoughts regarding 2017 on Slide 8. Based on what we see today, we expect the global crop protection chemical market to be about flat in 2017, creating a more stable operating environment for FMC Ag Solutions.
Market demand in Europe and Asia continues to grow, and more normal weather conditions should lead to an improved demand environment in those regions next year. While it remains very early to predict the market crop protection chemical in Latin America, we are [ph] confident that we will enter 2017 with better market fundamentals that either of the previous 2 seasons.
In contrast, we expect market conditions in North America to remain challenging as we do not believe that the market-wide stalking [ph] process has run its course and that elevated levels of channel inventory, combined with low commodity prices, will dampen grower demand across the region.
In a flat market and assuming stable currencies, we believe Ag Solutions is well positioned to deliver another year of growth in segment earnings. Revenue synergy opportunities in Europe and North America, planned new product introductions and continued cost savings will more than offset cost inflation. Our preliminary view is that Ag Solutions segment earnings will grow by high single-digit percent in 2017.
In Health and Nutrition. Next year, we expect growth rate for revenue and segment earnings to return to historical levels below [ph] to mid-single-digit percent.
In Lithium, the combination of higher price, increased lithium hydroxide volume and continued cost discipline should increase segment earnings by about 40% in 2017. We expect to realize higher prices in all major downstream products next year, with the most significant increase in lithium hydroxide.
The majority of our lithium hydroxide contracts are negotiated in the fourth quarter. And based on the status of customer negotiations to date, we expect the average realized price to be significantly higher in 2017. We also expect to see a meaningful increase in the production of lithium hydroxide next year as a result of our previously announced capacity expansion. Construction of our hydroxide unit is ahead of schedule. Based on the current construction headlines, we expect production of lithium hydroxide to increase by 4,000 metric tons in 2017, with total production capacity decreasing -- increasing to 18,000 metric tons per year by the middle of next year.
Hitting [ph] the growth in demand for FMC's downstream lithium product requires access to increasing volume of lithium carbonate. Earlier this week, we announced an agreement with Nemaska Lithium to show [ph] 8,000 metric tons of lithium carbonate per year beginning in mid-2018. This agreement represents only one element of our sourcing strategy, and we are actively pursuing multiple paths to diversify our carbonate source.
In the near term, we will increase capacity at our Argentina operations by approximately 20% through [ph] low capital cost actions. We continue to evaluate long-term supply agreements and partnership with other producers of lithium carbonate, and we retain the option of expanding our carbonate production operation in Argentina in order to ensure we have a secure, reliable and cost-competitive supply of lithium carbonate.
At the corporate level, we expect costs to remain roughly flat and to continue to reduce debt. Combined with the lower tax rate for 2017, as Paul mentioned earlier, we expect to grow EPS at a faster rate than we grow operating earnings.
Consistent with prior years, we will provide more details and specific guidance for 2017 in February when we report our Q4 and full year 2016 results as we first need to see how the year ends and assess business and market conditions at that time.
To conclude, I am very pleased with our performance in the quarter and year-to-date. In volatile markets, FMC has continued to execute its strategy and deliver substantial growth in earnings. I believe we are positioned to continue this in Q4 and beyond. We continue to invest in our technology pipeline in Ag Solutions and are launching new products that bring greater value to the grower.
Last month, we announced that FMC has begun the registration process in North America of our Bixafen fungicide, 1 of the 9 active ingredients in our R&D pipeline. With our unique, high-return R&D model for active ingredient innovation and strong regional [ph] formulation capabilities, FMC is well positioned to deliver the technology and service that growers demand. We will provide additional information regarding our technology pipeline in the coming months.
Health and Nutrition continues to generate high margins and strong cash flow, and demand across our core nutrition and health market continues to grow.  We are in the process of commissioning our new MCC production facility in Thailand, which will serve the growing nutrition market in Asia. Demand for a downstream retail products continues to increase. FMC is well positioned to maintain its leading position in lithium hydroxide, butyllithium and lithium metals, and we continue to pursue multiple paths to diversify our sources of lithium carbonate to fill [ph] the expected growth in the business.
Our agreement with Nemaska is just trusted, [ph] and we look forward to announcing more action in 2017.
In closing, the actions we are taking will continue to drive performance across our businesses and position FMC to deliver increasing value to our shareholders into 2017 and beyond. I thank you for your attention this morning.
With that, I will turn the call back to the operator for questions."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] Our first question today comes from the line of Christopher Parkinson with Crdit Suisse.",16,"[Operator Instructions] Our first question today comes from the line of Christopher Parkinson with Crdit Suisse."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Your results far exceeded what your peers have been indicating for European crop protection growth, especially in 3Q. And you mentioned some things in your presentation such as direct market access across Eastern Europe and strong herbicide sales in the U",83,"Your results far exceeded what your peers have been indicating for European crop protection growth, especially in 3Q. And you mentioned some things in your presentation such as direct market access across Eastern Europe and strong herbicide sales in the UK. But can you just talk a little more about the longer-term key drivers in the market, let's say, over the next 2 years? Are we in the early innings of the Eastern European team? And what's the latest update on new registrations?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","This is Mark. You highlighted the points that we put out in the release regarding how we grew [ph] in Europe. I think for us going forward in the next few years, it's very much what we've just said in terms of direct market access. We're very pleased with",186,"This is Mark. You highlighted the points that we put out in the release regarding how we grew [ph] in Europe. I think for us going forward in the next few years, it's very much what we've just said in terms of direct market access. We're very pleased with what we see in Eastern Europe, but we're working off of a pretty small base. And we have just purchased the JV that we had in Czechoslovakia, Poland. It's important for us to expand in that area. But we shouldn't forget that France, Germany, the U.K, Spain, Italy, they're all important markets where we intend to put new products into the pipeline. We do have new products coming next year and the year after that are based upon our chromosome [ph] franchise for herbicides. So we expect to see significant growth in herbicides as we move forward. And in addition, with the acquisition of Cheminova, we've also, as we've said, expanded our fungicide portfolio. So you'll see us grow our European fungicide business substantially over the next 3 to 5 years. That's mainly the growth for us."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And Chris, remember that many of the products FMC was hitting [ph] in Europe are registered today in places like France, Italy, Spain, Portugal, Southern Europe, U.K. We were just not benefiting from a very strong sales organization as we were working wit",91,"And Chris, remember that many of the products FMC was hitting [ph] in Europe are registered today in places like France, Italy, Spain, Portugal, Southern Europe, U.K. We were just not benefiting from a very strong sales organization as we were working with a distribution network, which was mostly focused on Northern Europe. So even without adding many registration, which we will and we have new product coming, we just have the [ph] fact to increase our face-to-face presence with the market. It's going to dramatically increase our ability to grow."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Great. And just a quick follow-up. Can you just also quickly comment on where you think the insecticide inventory issues in Brazil and how that may or may not affect the market heading into 2017? And also, you've seen some recent spikes in sugar and cotto",76,"Great. And just a quick follow-up. Can you just also quickly comment on where you think the insecticide inventory issues in Brazil and how that may or may not affect the market heading into 2017? And also, you've seen some recent spikes in sugar and cotton prices. Could you just quickly comment on the conversations you're having with those customers? As I imagine, they've been better than they have been over the last couple of years."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think we are always very careful when we talk about the role of product inventory in the channel overall at the market level. But the situation in Brazil, including for insecticide, is right now feeling, I would say, more stable. As you can see, ye",166,"Yes. I think we are always very careful when we talk about the role of product inventory in the channel overall at the market level. But the situation in Brazil, including for insecticide, is right now feeling, I would say, more stable. As you can see, year-on-year numbers show a decrease in sales in addition to the progress utilization. So we believe there are actions, which are being taken for insecticide and another product to decrease the level of inventory in the channel. The discussions with growers are better. There is -- they are easier on pricing. They are easier on term, and our volumes are more predictable . So we do believe it is decreasing. We don't believe it's decreasing fast enough to create a very rubbish 2017 number. But I would say we want to be entering 2017 in a more stable situation and more flattish market than we did in the previous 2 years. Mark, do you want to comment on the sugarcane?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, sure. Chris, when you mentioned cotton and sugarcane, obviously, important crops for FMC down in Brazil. I'm more confident in sugarcane than I am in cotton. As we've talked about and Paul alluded to in terms of collections, we've been very prudent i",218,"Yes, sure. Chris, when you mentioned cotton and sugarcane, obviously, important crops for FMC down in Brazil. I'm more confident in sugarcane than I am in cotton. As we've talked about and Paul alluded to in terms of collections, we've been very prudent in our exposure to certain areas of Brazil and certain -- and crops. I would say the cotton growers have faced a very tough time in the north due to the drought. So liquidity is important for them, and we're watching that situation very carefully. Acres are expected to be flat to slightly down in Brazil as we go forward into the next season. Switching to sugarcane, you're right, sugar prices are at least double where they were last year. Ethanol prices were up in Brazil. So the fundamentals for the business is good. The one thing they are lacking right now is liquidity given all the debts they've incurred over the last few years. We're ideally positioned. We have strong market shares in insecticides and herbicides. Planting is down right now probably about 30% due to that liquidity. But I think as the business unwinds next year, I'm very confident that our sugarcane business will grow next year and be a good buffer for some of the other downsides we might see in cotton."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Just to repeat, Chris, I want to use your question to make sure that we are clear that [ph] we are continuing the our strategy. It's a different strategy, but really, we are not focused on volume at all today. I mean, what is very important for us today i",104,"Just to repeat, Chris, I want to use your question to make sure that we are clear that [ph] we are continuing the our strategy. It's a different strategy, but really, we are not focused on volume at all today. I mean, what is very important for us today is pricing our technology, why it should be priced; decreasing the level of our product in the channel; getting terms which are right; and collecting. We believe the market is such that -- this is the right strategy, which will make us much stronger when we get to a situation when the market turns around."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Our next question today comes from the line of Daniel Jester with Citi.",13,"Our next question today comes from the line of Daniel Jester with Citi."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Maybe I can just follow up on Chris' question in a different way. I think you said that low-margin product in Brazil, which you're exiting, attributed to 60% of the volume decline in the quarter. So maybe can we just talk about what's driving this 40% of",53,"Maybe I can just follow up on Chris' question in a different way. I think you said that low-margin product in Brazil, which you're exiting, attributed to 60% of the volume decline in the quarter. So maybe can we just talk about what's driving this 40% of the rest of the volume decline?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","There is 2 things which are driving the remaining 40%. First of all, we believe -- and we'll confirm that at the end of the fourth quarter, but we are believing that -- we believe that we are in a situation in Brazil where the market will still be down in",157,"There is 2 things which are driving the remaining 40%. First of all, we believe -- and we'll confirm that at the end of the fourth quarter, but we are believing that -- we believe that we are in a situation in Brazil where the market will still be down in a 10% range year-on-year for the full year. So there is a market driver. There is also the fact that we are moving away from sales, not because of rationalization but because of credit risks or term. We are very cautious in not selling for the sake of selling. We are selling when we know we can get normal terms for the region and we will be able to collect. So as I said before, volume is not the priority. So those are the 3 reasons: sales, which are fixed with good terms; market, which will decline; and product rationalization. Those are the 3 drivers."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. That's helpful. And then I think you also commented that operating margins in Brazil are sort of approaching where you were in 2014. But I think for the Ag segment as a whole, margins are still below 2014 levels. So can you comment on the other regi",62,"Okay. That's helpful. And then I think you also commented that operating margins in Brazil are sort of approaching where you were in 2014. But I think for the Ag segment as a whole, margins are still below 2014 levels. So can you comment on the other regions and where you see margin stay and how maybe they can improve into 2017?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think that if you look at when we made the acquisition of Cheminova, acquiring Cheminova was -- bring to us many benefits in terms of creating more global business, a broader fungicide portfolio, a direct access to markets in Europe and other benef",230,"Yes. I think that if you look at when we made the acquisition of Cheminova, acquiring Cheminova was -- bring to us many benefits in terms of creating more global business, a broader fungicide portfolio, a direct access to markets in Europe and other benefits, more fully the performance in -- more fully in market presence in India and Australia. But we also realized that the margins Cheminova was realizing were not at the level of what we're expecting. And we had a plan to bring those margins through cost saving, pricing and new product introduction. To the East, [ph] to recall level of FMC, and that's the road we are on. I have to say that despite the market conditions, the 1.5 years after closing on the Cheminova acquisition, we have brought back those margins to 20%, which is well -- for the fourth quarter, which is well in line even ahead of our schedule. We still have work to do. We still have remember. We still have additional costs to extract from the business from the acquisition in the next 6 to 9 months. So we still have work. But we are well on our way to margin north of 20%. It is just the integration of Cheminova, the pricing of the technology and the new product introduction, but we are well on that road map right now."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","We'll go to the line of Mike Harrison with Seaport Global.",12,"We'll go to the line of Mike Harrison with Seaport Global."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Eric, I was wondering if you could talk a little bit about the cost structure and some of the key margin drivers that you saw in Health and Nutrition this quarter. Did we see any of the variance impacts during this quarter that you mentioned you're going",54,"Eric, I was wondering if you could talk a little bit about the cost structure and some of the key margin drivers that you saw in Health and Nutrition this quarter. Did we see any of the variance impacts during this quarter that you mentioned you're going to be seeing in the fourth quarter?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Eric here. So it's a complicated question because the costs that flow through in any 1 quarter are related to a variety of factors where a lot of it is stemming from manufacturing excellence programs. So that's a sustainable component. However, as we talk",142,"Eric here. So it's a complicated question because the costs that flow through in any 1 quarter are related to a variety of factors where a lot of it is stemming from manufacturing excellence programs. So that's a sustainable component. However, as we talked about in the guidance Pierre gave for the fourth quarter, we'll see benefits stem from things such as seasonality and how we harvest seaweed, right? There are times of the year, particularly off the coast in Norway, where we get a higher-quality seaweed, we have more access to the waters because of the favorable weather, what have you, that drive one-off opportunities in costs and that -- as where variances work that close through. And it's part of the benefit we see in the fourth quarter. I want to make sure, does that answer the question you're after?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Maybe to answer a little bit more your question. If you look at previous years, it is not an abnormal situation to see -- you could see it maybe not at the same extent, but you can see it to the 2015 results, where you would see higher margin in Q4 than y",105,"Maybe to answer a little bit more your question. If you look at previous years, it is not an abnormal situation to see -- you could see it maybe not at the same extent, but you can see it to the 2015 results, where you would see higher margin in Q4 than you would see in Q3. So we realized over the year a 25% margin for the business. But we recognize that there is some seasonality to margin in this business. So there is not always a connection between a margin improvement you will see in Q4 and what you could realize in Q3."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Yes, I guess the question that I had, Eric, also had to do with the weakness in volumes during the third quarter, yet you were able to show pretty nice margin improvement. I was wondering if there was some variability around the costs or if this was struc",57,"Yes, I guess the question that I had, Eric, also had to do with the weakness in volumes during the third quarter, yet you were able to show pretty nice margin improvement. I was wondering if there was some variability around the costs or if this was structural cost takeout that was really driving the margin improvement."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, I would say it's more of the latter. The structural improvements we've made is nothing unique about what's happened sequentially from 1 quarter to the next. Volumes were lower for the reasons Pierre referenced, omega-3, as well as some timing in our",108,"Yes, I would say it's more of the latter. The structural improvements we've made is nothing unique about what's happened sequentially from 1 quarter to the next. Volumes were lower for the reasons Pierre referenced, omega-3, as well as some timing in our health business. But the cost side of that is pretty consistent. It's the structure component that gets us to a sustainable margin that's in the mid-20s, not withstanding the occasional and what we've seen in prior quarters, benefit we make it in certain quarters like the fourth quarter that are not benefit you roll forward into the first and second quarters into the following year."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","All right. Then I had a question on the Lithium business. Can you comment on what you were seeing in price activity sequentially across different products?",26,"All right. Then I had a question on the Lithium business. Can you comment on what you were seeing in price activity sequentially across different products?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, I think I'll have Tom comment more on the pricing. But right now, if you look, we had a lot of benefits from pricing on lithium carbonate up to now and maybe less of a pricing benefit of lithium hydroxide. We are now getting into the period of new co",120,"Yes, I think I'll have Tom comment more on the pricing. But right now, if you look, we had a lot of benefits from pricing on lithium carbonate up to now and maybe less of a pricing benefit of lithium hydroxide. We are now getting into the period of new contract negotiation of lithium hydroxide, which will impact mostly 2017. So directionally, what we do expect is we do expect to start to see a very significant ramp-up in lithium hydroxide pricing, which is very much in line with the negotiation we are having why we will see maybe a more stable pricing in lithium carbonate potentially lowering into 2017. Tom, you want to add some more color to that?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, just to give a little more color to that. On hydroxide, the contract negotiations are proceeding well and over the coming months, they should be all solid. We're progressing well through that. And on the carbon, as most of the folks on the market, th",112,"Yes, just to give a little more color to that. On hydroxide, the contract negotiations are proceeding well and over the coming months, they should be all solid. We're progressing well through that. And on the carbon, as most of the folks on the market, there was a little bit of softening in Q3, particularly in China. What we'll see going into next year is the smaller volume of carbonate that was locked in at lower prices similar to the hydroxide will come up. And we expect some softening on the top end. So net-net, we'll go into next year on those more opportunistic product lines kind of flat to slightly down."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And the big story, once again for us, I mean, because of the strategic focus, because of the timing of where we are in contract negotiation and increasing capacity coming up next year, the big focus for us and where you're going to see the largest contrib",53,"And the big story, once again for us, I mean, because of the strategic focus, because of the timing of where we are in contract negotiation and increasing capacity coming up next year, the big focus for us and where you're going to see the largest contributor to earnings growth is lithium hydroxide."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And next, we'll go to the line of Don Carson with Susquehanna.",12,"And next, we'll go to the line of Don Carson with Susquehanna."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This has been Richardson sitting in for Don. Just sticking with the topic of lithium. You say you're ahead of schedule with the ramps there. Can you just maybe speak to the timing of that additional tonnage?",37,"This has been Richardson sitting in for Don. Just sticking with the topic of lithium. You say you're ahead of schedule with the ramps there. Can you just maybe speak to the timing of that additional tonnage?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. What we -- we're expecting the mechanical completion of the plants. I had the pleasure actually to be there 2 weeks ago and see the plants looking good. We expect the mechanical completion of the plants in the fourth quarter this year. We're going to",136,"Yes. What we -- we're expecting the mechanical completion of the plants. I had the pleasure actually to be there 2 weeks ago and see the plants looking good. We expect the mechanical completion of the plants in the fourth quarter this year. We're going to be able to start to add product coming out of the plants in the first quarter and then we're going to start to answer the customer qualification of the products. So we believe all the commercial situation, where the product are produced by the plant, by the expansion and qualifying the customer by the middle of the year. So the 8,000 metric ton capacity we have for next year should give to us a 4,000 additional tons of product into 2017 and the full 8,000 when we get into 2018."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And I guess, slipping back to Ag and specifically, potential divestitures in your space and how you see that developing.",21,"Okay. And I guess, slipping back to Ag and specifically, potential divestitures in your space and how you see that developing."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","We are in contact with our -- with any of the companies, which are currently consolidating and were outstanding ready to participating in the purchase of any molecule -- any of this company will be divesting if they meet our portfolio. I have to say that",102,"We are in contact with our -- with any of the companies, which are currently consolidating and were outstanding ready to participating in the purchase of any molecule -- any of this company will be divesting if they meet our portfolio. I have to say that so far, we haven't seen anything which will be critical to our portfolio or any significant technology put on the market. But I think those companies are still in the -- in an early stage of the antitrust reviews. So we are standing ready, but haven't seen anything right now which has been attractive to us."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And our next question is from the line of Joel Jackson representing BMO Capital Markets.",15,"And our next question is from the line of Joel Jackson representing BMO Capital Markets."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Neil on for Joel . I mean, just following up there on the acquisitions. I mean, if you are to pursue something, can you maybe give us perhaps put some numbers around magnitude. And what would be the funding? I mean, what sort of leverage would you",55,"This is Neil on for Joel . I mean, just following up there on the acquisitions. I mean, if you are to pursue something, can you maybe give us perhaps put some numbers around magnitude. And what would be the funding? I mean, what sort of leverage would you be comfortable going back up to potentially?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I will first talk to the leverage. The size, I mean, really, I would not like to speculate here on the results of any antitrust reviews and what could be the consequences in terms of what product we sell and what would be the price. So of course, we do ou",106,"I will first talk to the leverage. The size, I mean, really, I would not like to speculate here on the results of any antitrust reviews and what could be the consequences in terms of what product we sell and what would be the price. So of course, we do our own work to be ready and try to anticipate, but that's only speculation on our part to stand ready. But it's very hard to tell and during the antitrust process in each of the region is taking place and having the companies making decisions around their portfolio. Paul, you want to talk about the leverage?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Sure. Just again, to Pierre's point, it's difficult to be particularly satisfying to you with the answer without any real specifics. But I think it's fair to say I think you've seen from our cash flow performance, we are generating a fairly good cash righ",161,"Sure. Just again, to Pierre's point, it's difficult to be particularly satisfying to you with the answer without any real specifics. But I think it's fair to say I think you've seen from our cash flow performance, we are generating a fairly good cash right now. We're deleveraging quickly. One of the characteristics, because we bought products like this frequently in the past, one of the key characteristics is that are typically very cash generative from Day 1. And so they can stand pretty decent amount of leverage from Day 1. We're also very disciplined on price. Based on everything we see, we don't see any risk to our credit rating from a cash acquisition of any of the available interesting assets that are out there right now. Again, that could change depending on what will assets come available. But we don't see any particular challenge to our balance sheet based on the opportunity that are available that we're seeing today."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","And maybe just switching to -- from a Omega-3 talked about some abating headwinds going to next year. I mean, is in the environment more competitive, equally competitive, less competitive than you were perhaps seen last quarter and going into '17?",41,"And maybe just switching to -- from a Omega-3 talked about some abating headwinds going to next year. I mean, is in the environment more competitive, equally competitive, less competitive than you were perhaps seen last quarter and going into '17?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Omega-3 is, how do we say, it is not getting worse but it is not getting better. I think it's a challenging environment. Right know, we are focusing on actions for us to leverage some of the manufacturing capacity and quality of product, especially the fa",194,"Omega-3 is, how do we say, it is not getting worse but it is not getting better. I think it's a challenging environment. Right know, we are focusing on actions for us to leverage some of the manufacturing capacity and quality of product, especially the fact that we have no way made product, which have very high quality and commend a premium to try to improve a situation. But frankly, at that stage with the oversupply, there is in this market and the number of players, the improvements you will see on omega-3 will be driven by the work we do commercially and cost twice more than us benefiting from the market. We are very -- when we've announced the numbers for expected growth for the Health and Nutrition business next year, we are very, I would say, prudent around putting into those numbers any significant improvement in the omega-3 market, which we do not see. So it is a challenge. We're addressing it. We're trying to -- we are, I would say right know, I have to admit we're more in damage control been expecting growth. But that's the situation for omega-3."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Steve Byrne with BofA.",12,"Our next question comes from the line of Steve Byrne with BofA."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Ian sitting in for Steve. Cash flow generation has been very, very good this year, and I appreciate the comments about the collections in Brazil. And looking forward to 2017, provided some luminary guidance about expecting earnings growth. Should",55,"This is Ian sitting in for Steve. Cash flow generation has been very, very good this year, and I appreciate the comments about the collections in Brazil. And looking forward to 2017, provided some luminary guidance about expecting earnings growth. Should cash from operations grow at the same level of earnings or higher or lower?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, I think you heard in my comments, we talked about probably still about $400 million of excess receivables sat on our balance sheet related to Brazil. And we've certainly expected to start to collect a significant proportion of those next year. So giv",120,"Yes, I think you heard in my comments, we talked about probably still about $400 million of excess receivables sat on our balance sheet related to Brazil. And we've certainly expected to start to collect a significant proportion of those next year. So given that, we would expect the cash flow to continue to grow really similar to how it did this year. We'll generate high EBITDA. We do not expect to have any meaningful cash outflows for CapEx over and above what we have today. And we expect to continue to decapitalize our balance sheet in Brazil. So yes, I would expect cash flow to continue to grow next year just as strong as it had been this year."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","And as a follow-up, just kind of on the broader market. What -- for Ag, specifically in Latin America, what things would you be looking for to potentially become more optimistic about a rebound in that region? I think sales are still far below prior level",56,"And as a follow-up, just kind of on the broader market. What -- for Ag, specifically in Latin America, what things would you be looking for to potentially become more optimistic about a rebound in that region? I think sales are still far below prior levels of peak. What does the industry need to see?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Well, I think for me there's a couple of things. First of all, on the macro level obviously, us, to prices start to come back were going to see expanded acres come back for but so far lot of the row crops that's one factor. Then the second factors just th",154,"Well, I think for me there's a couple of things. First of all, on the macro level obviously, us, to prices start to come back were going to see expanded acres come back for but so far lot of the row crops that's one factor. Then the second factors just the internal health of that business in the sense of where channel inventories are, past pressures, the normal seasonal-to-seasonal activity in Ag.
I think if you can get those things coming together, you're going to see someone of a rebound in the marketplace. The pass pressures obviously, nobody knows where the pass pressures are going to lie. Commodity prices are going to take some change in over yields in North America and that in America. So we've said, what we feel the market will be next year. Those will be the 2 items in Brazil, in particular, potentially Argentina that will change that picture"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I think having a stable macro political environment improved access to credit for the gross will be positive if we see that stuff happen as well.",26,"I think having a stable macro political environment improved access to credit for the gross will be positive if we see that stuff happen as well."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Our next question is from the line of Mark Connelly with CLSA.",12,"Our next question is from the line of Mark Connelly with CLSA."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, last quarter, you talked about some optimism in your outlook comments for Health and Nutrition, but not about seasonality in Q3 and Q4. What I'm wondering is do you think you have the right mix of products for what customers are looking to do with",65,"Pierre, last quarter, you talked about some optimism in your outlook comments for Health and Nutrition, but not about seasonality in Q3 and Q4. What I'm wondering is do you think you have the right mix of products for what customers are looking to do with their products over the next couple of years or do you need to tweak your portfolio leaving Omega-3 aside?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","That's a very good question. And I tell you, a difficult want to answer. I believe that we have very solid position in MCC, alginate in carrageenan. I do believe that we have the right formulation technology allowing us to meet the changing need of the ma",279,"That's a very good question. And I tell you, a difficult want to answer. I believe that we have very solid position in MCC, alginate in carrageenan. I do believe that we have the right formulation technology allowing us to meet the changing need of the market and the customers. The question for us is -- and that's the business today. If you put Omega-3 aside, we have strong market share and we are the leading supplier in the place where customers go today when they have -- they had need for new product or new technology. So I believe this is a business, which will, for the next 2, 3 years, continue to grow in the mid single-digit, as we said in the guidance, with very strong margin 25% and good cash generation. So to answer your question, I'm quite confident around that business for the next 2 to 3 years, we do have interesting new ideas based on the current product we have for new technology, for some of the changing market needs around health and other applications. The question for me is more 3 years and beyond. And really, where do we want to take that franchise? We have great product today. We have great margin and good cash generation. The first attempt to do that was omega-3. I think we didn't do a good job there. The question is, what we want the business to be, not the next 2, 3 years, but beyond that. So to answer your question. Yes, for the next 2, 3 years. Beyond that, we need a lot of work to define the midterm strategy for Health and Nutrition."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay, that's super helpful. And if I can just come back. I hate to beat on the working capital issue. But just a clarification, of the additional $400 million and everything else you're doing down there, are your credit practices in Brazil going to be mat",71,"Okay, that's super helpful. And if I can just come back. I hate to beat on the working capital issue. But just a clarification, of the additional $400 million and everything else you're doing down there, are your credit practices in Brazil going to be materially different than legacy FMC? Or is this just a matter of we've got the Cheminova cleanup and better execution well and customers in better shape?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","So the first thing I would say is when we look back the position that we find ourselves in Brazil, much of it is driven by similar comments that Pierre talked about, about changing the way we approach the business. And instead of focusing volume and volum",217,"So the first thing I would say is when we look back the position that we find ourselves in Brazil, much of it is driven by similar comments that Pierre talked about, about changing the way we approach the business. And instead of focusing volume and volume growth and share growth, focusing on getting the maximum value. An important part of that is assessing the quality of the customer and the quality of the products that we sell. We do not expect to be in a meaningfully different place in terms of terms, in terms of structure, in terms of credit that we extend to customer to either history or the rest of the market. But we will be much more and we are being much more disciplined about where we're willing to take exposure. It's really a function of multiple factors. It's a function of the movement in commodity prices. It's a function of the weaker access to credit for the growers down there in the market.  And it is, to the extent, function mobility to integrate the Cheminova portfolio and have a higher margin, more technical portfolio really across all regions and all crops. So it's more than one factor that's driving this, this move towards a stronger credit position with our customers down there."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Generally speaking, the crop chemical industries as a whole, all of its company, it is an industry, which is in Latin America and Brazil, which has been historically focused on growth and maybe a bit more open to taking risk to gain market share. And we'r",119,"Generally speaking, the crop chemical industries as a whole, all of its company, it is an industry, which is in Latin America and Brazil, which has been historically focused on growth and maybe a bit more open to taking risk to gain market share. And we're there with all of our competitors. I do think today, we might have a strategy without fundamentally changing what we've done to be more careful for the foreseeable future. I think it's important. It's working for us. And net it's allowing to collect to price. Our customers one our product. So we're going to be maybe on the lower end of the risk-taking without fundamentally changing the way we look at other receivables."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And we have a question from the line of Dmitry Silversteyn with Longbow Research.",14,"And we have a question from the line of Dmitry Silversteyn with Longbow Research."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Couple of follow-ups, if I may. First of all, with regards to your announced deal for 8,000 tons of carbonate that you're going to be getting from your new partner. Is that pretty much all of their capacity or -- and do you have the right to all of that c",58,"Couple of follow-ups, if I may. First of all, with regards to your announced deal for 8,000 tons of carbonate that you're going to be getting from your new partner. Is that pretty much all of their capacity or -- and do you have the right to all of that capacity? Or is there more behind that?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","The 8,000 tons, I think, when you say their capacity, it's not their. It's our capacity. I mean, this plant. If you talk about the expansion in China, this plant.",31,"The 8,000 tons, I think, when you say their capacity, it's not their. It's our capacity. I mean, this plant. If you talk about the expansion in China, this plant."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Nemaska.",1,"Nemaska."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Oh, in Nemaska, okay.",4,"Oh, in Nemaska, okay."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, Dmitry, this is Tom, I can take that. Nemaska's install capacity will be 28,000 tons. So it will be a meaningful part of their capacity, but it will not be meaningful to all of their capacity.",37,"Yes, Dmitry, this is Tom, I can take that. Nemaska's install capacity will be 28,000 tons. So it will be a meaningful part of their capacity, but it will not be meaningful to all of their capacity."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. I'm assuming you have some way of getting more if you need more either from these guys or from other sources as you move pass 2018, 2019?",28,"Okay. I'm assuming you have some way of getting more if you need more either from these guys or from other sources as you move pass 2018, 2019?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Well, with respect to that, as Pierre outlined in his comments, we've got a multipronged strategy where we're continually evaluating. One, how do we diversify, have security and supply low-cost supply? So we're not quite ready to announce the other pieces",61,"Well, with respect to that, as Pierre outlined in his comments, we've got a multipronged strategy where we're continually evaluating. One, how do we diversify, have security and supply low-cost supply? So we're not quite ready to announce the other pieces coming, but there'll be multiple complements that, including our own investments in our facilities as well as working with others."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I think it's important in all of these discussions, we have this Nemaska agreement. We are in current discussions with some other suppliers of carbonate for partnership. But let's not forget that there is one aspect for which we have 100% of the decision,",128,"I think it's important in all of these discussions, we have this Nemaska agreement. We are in current discussions with some other suppliers of carbonate for partnership. But let's not forget that there is one aspect for which we have 100% of the decision, it is expanding in Argentina. We can expand in Argentina. We do have the mines. We do have the capability. We have infrastructure. So it is an addition we can make. I have to admit that I'm not in the rush to make that decision because with all of the companies today investing in lithium carbonate, I believe there will be plenty of lithium carbonates for the next 2, 3, 4 years. But this is an addition we can make at any time."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay and actually kind of led into my next question Pierre. This 20% debottlenecking experience expansion that you're undertaking in Argentina. What's the timing for that to come online? Is that the back end of 2017 as well?",38,"Okay and actually kind of led into my next question Pierre. This 20% debottlenecking experience expansion that you're undertaking in Argentina. What's the timing for that to come online? Is that the back end of 2017 as well?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, this is going to start right now. I mean, we're going to see this capacity of carbonate coming in at some point during 2017, 2018. So this is undertaken right now. It is low capital and normal debottlenecking. The team has been working and we have, I",69,"Yes, this is going to start right now. I mean, we're going to see this capacity of carbonate coming in at some point during 2017, 2018. So this is undertaken right now. It is low capital and normal debottlenecking. The team has been working and we have, I think, 3 work streams, which are allowing us to get to this kind of numbers. But it's more routine capital expansion."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And Dmitry, just to give me a little bit more color that. There's multiple components of that. There are some operational efficiency changes. There are some low capital projects. There's a number of smaller projects that over the course of '17 and '18 wil",46,"And Dmitry, just to give me a little bit more color that. There's multiple components of that. There are some operational efficiency changes. There are some low capital projects. There's a number of smaller projects that over the course of '17 and '18 will add that."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","So it sounds like if I do my math right, your Argentina production will go up to about 21,000 tons. Is that about right?",24,"So it sounds like if I do my math right, your Argentina production will go up to about 21,000 tons. Is that about right?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, that's correct.",3,"Yes, that's correct."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then final question on the -- I'm sorry, on the crop protection business. And sort of your margins have been in the past, very differentiated between sort of 25% level in the first half of the year and kind of 20% level in the second half of the",153,"Okay. And then final question on the -- I'm sorry, on the crop protection business. And sort of your margins have been in the past, very differentiated between sort of 25% level in the first half of the year and kind of 20% level in the second half of the year, given where the region said to get your sales from. This year, obviously, has been distorted by everything that's going on. So it's going to be more like first half and second half be more or less even in terms of margins. As the business gets back to sort of normal execution, how do we think about 2017 margin cadence? Should we expect sort of 3 to 4-point margin difference between the first half and the second half of the year? Or is it going to be more like this year were margins are a little bit more even between the quarters?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, we're going to get into next year. And once again, it's a bit early for us to break down by quarter. We've given a directional number. But yes, the profile of the margin and the business is going to change versus historical FMC just because we have a",164,"Yes, we're going to get into next year. And once again, it's a bit early for us to break down by quarter. We've given a directional number. But yes, the profile of the margin and the business is going to change versus historical FMC just because we have a very different regional profile. I mean, remember, we are very small in Europe. We want to be much bigger in Europe where there is good marginal business. So I would say that directionally, we should have less variation in our quarterly margins than we had in the past. Now there is 2 things happening today, is there is the market situation. There is a different approach we are taking to the Latin America market and there is in the cost synergies, which are growing quarter after quarter. So that is taking us to improve margin and taking us to the 20% range. But I would say in the future, you'll have more stable margin quarter-over-quarter."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And that will come from the line of Robert Koort with Goldman Sachs.",13,"And that will come from the line of Robert Koort with Goldman Sachs."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Chris for Doug. In lithium specifically, pretty -- 40% earnings growth assumption for '17. I think you mentioned earlier kind of a low -- flat to down expectation for pricing in carbonate. Can you kind of give the other expectations that are drivi",49,"This is Chris for Doug. In lithium specifically, pretty -- 40% earnings growth assumption for '17. I think you mentioned earlier kind of a low -- flat to down expectation for pricing in carbonate. Can you kind of give the other expectations that are driving that assumption for '17?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I would say -- well, first, if you look at our business in '17, we're expecting to be, and Tom, correct me if I'm a bit off here, I would say almost 90% of our business revenues being on the specialty side, the downstream, and only 10% of the upstream, wh",187,"I would say -- well, first, if you look at our business in '17, we're expecting to be, and Tom, correct me if I'm a bit off here, I would say almost 90% of our business revenues being on the specialty side, the downstream, and only 10% of the upstream, which is carbonate and fluoride. So we're going to be even more dependent upon the price, the downstream business. We are expecting, I would say, a little benefit from carbonate chloride pricing knowing that it's only a small percentage over business and we believe this pricing is going to level off in 2017. So you would consider the 40% improvement is going to mostly come from 2 things, pricing in lithium hydroxide and volume in lithium hydroxide. You will understand that I'm going to be a bit careful on what we're expecting in terms of lithium hydroxide price increase because we are in the middle of the bench of contract negotiations. So I'll -- we will give you more detail around pricing when we get to the February earnings call because those negotiation will be behind us."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And just add a little bit more color to that. I mean, you have to realize that most of our specialty business is contracted in the prior year. So when we contracted a lot of that, it was before we saw how strong the pricing had moved across the market ove",65,"And just add a little bit more color to that. I mean, you have to realize that most of our specialty business is contracted in the prior year. So when we contracted a lot of that, it was before we saw how strong the pricing had moved across the market overall. So there's a little bit of catch-up that's happening across all the Specialty Products."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","And just on the supply agreements, the hydroxide ramp. Should we expect the additional volumes to come from new entrants like Nemaska mix? Or do you expect from existing brine or hard rock producers?",34,"And just on the supply agreements, the hydroxide ramp. Should we expect the additional volumes to come from new entrants like Nemaska mix? Or do you expect from existing brine or hard rock producers?"
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, so of course, when you look at a supply of carbonate to feed growth, you want to be certain that you have the appropriate mix of new entrants and established players. So we will not have strategy to supply carbonate into our business based only or mo",139,"Yes, so of course, when you look at a supply of carbonate to feed growth, you want to be certain that you have the appropriate mix of new entrants and established players. So we will not have strategy to supply carbonate into our business based only or mostly on new entrants in this market. Nemaska, we believe, is one of the most solid today with one of the best source of lithium. So we believe it's a fairly certain supply we're going to get from them. But we will do 2 things. One is supply from existing suppliers and not to forget that some of them already supply to us carbonate. And [indiscernible] to repeat, we can also increase our own capacity of carbonate, which is something if we decide to do it, there will be a short supply."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Well, we appreciate your time. That has all the time we have for the call today. As always, I'll be available on the call for any additional questions you may have. Thank you.",33,"Well, we appreciate your time. That has all the time we have for the call today. As always, I'll be available on the call for any additional questions you may have. Thank you."
28606,403765323,1071739,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","That concludes the FMC Corporation Third Quarter 2016 Earnings Release Conference Call. Thank you.",14,"That concludes the FMC Corporation Third Quarter 2016 Earnings Release Conference Call. Thank you."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the Third Quarter 2016 Earnings Release Conference Call for the FMC Corporation. [Operator Instructions]I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Ang",42,"Good morning, and welcome to the Third Quarter 2016 Earnings Release Conference Call for the FMC Corporation. [Operator Instructions]
I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning. Welcome to FMC Corporation's Third Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer. Pierre",270,"Thank you, and good morning. Welcome to FMC Corporation's Third Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer. Pierre will begin the call with a review of FMC's third quarter performance and discuss the outlook for Q4 and full year 2016. Paul will provide an overview of select financial results.
The slide presentation that accompanies our results, along with our earnings release and 2016 outlook statement, are available on our website, and the prepared remarks from today's discussion will be made available at the conclusion of the call.
As with our prior calls, Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President, FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, will join to address questions.
Before we begin, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including, but not limited to, those factors identified in our release and in our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based upon these risks and uncertainties.
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms as well as other non-GAAP financial terms to which we may refer during today's conference call are provided on our website.
With that, I will now turn the call over to Pierre."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian, and good morning, everyone. Q3 2016 was another strong quarter, reflecting the continued execution of our strategy. FMC reported revenue of $808 million, adjusted operating profit of $134 million and adjusted EPS of $0.67. Adjusted EPS i",1470,"Thank you, Brian, and good morning, everyone. Q3 2016 was another strong quarter, reflecting the continued execution of our strategy. FMC reported revenue of $808 million, adjusted operating profit of $134 million and adjusted EPS of $0.67. Adjusted EPS increased approximately 60% compared to the third quarter of 2015, exceeding the top end of our guidance range of $0.53 to $0.63.
Our performance for the quarter was driven largely by the results of Ag Solutions and Lithium, both of which reported a significant year-over-year increase in segment earnings.
In Ag Solutions, compared to last year, we saw an improved start of the season in Latin America, especially in Brazil, a stronger performance in both Asia and North America. Lithium continued to benefit from higher prices, improved mix and lower operating costs. Third quarter segment earnings in Health and Nutrition, there is -- were slightly below 2015 but in line with our expectation.
The lower tax rate in the quarter contributed approximately $0.03 to adjusted EPS. As noted in our outlook statement, and as Paul will discuss later in the call, we expect to continue to report a lower tax rate for the remainder of the year and into 2017.
Based on our performance in the third quarter and on our outlook for Q4, we are revising the range of our full-range adjusted EPS guidance to $2.76 to $2.86 per share. At the midpoint, this represents an increase of $0.06 per share compared to the prior period and an increase of $0.14 compared to adjusted EPS for 2015. I will provide more detail on the outlook for Q4 shortly. But first, I will discuss third quarter results for each of our 3 segments, starting with Ag Solutions on Slide 2.
For the third quarter, Ag Solutions reported revenue of $559 million and segment earnings at the top of the guidance range of $90 million. Compared to the third quarter 2015, revenue declined 3% as lower sales volume in Brazil more than offset the benefit of higher prices in that country and volume growth in other regions.
Year-over-year price increases were largest in Brazil, where we continue to recover pricing in U.S. dollar terms. Segment earnings increased over 50%, and margin improved 600 basis points, as higher realized prices, improved mix and favorable foreign exchange more than offset the impact of lower volumes and slightly higher costs in the quarter.
Costs were higher, principally as the result of the timing between quarters of certain expenses. For the full year, we remain on track to achieve our integration cost savings target.
Turning to Slide 3. I will provide additional comments on Ag Solutions' regional performance and discuss the outlook for Q4, starting with Latin America.
Revenue in the region declined 18% in the quarter, driven largely by lower sales volumes in Brazil. General market weakness, ongoing product rationalization efforts and our decision to allow channel inventory levels to reduce each contributed to the decline in sales volume in Brazil. The elimination of low-margin third-party products accounted for over 50% of the volume decline in the quarter.
Revenue in the rest of Latin America was roughly flat compared to 2015. In Argentina, we continued to see increasing demand for FMC's Authority herbicides. In Mexico, our focus on high-value crops is helping to offset the impact of a broader market decline.
The actions we have taken throughout the past year in Brazil enabled us to realize significant increases in U.S. dollar-based prices, improve operating margin and drive collections in the quarter. Price actions increased operating earnings in Brazil by about 30% year-over-year, which, combined with lower operating costs, returned operating margins to 2014 levels.
Our actions in Brazil also enabled the business to reduce accounts receivables in the country and generate cash collections of over $200 million, a significant improvement over our performance in the same quarter last year.
Moving on to Asia. Revenue in the region grew by 9% in the quarter compared to 2015, driven mainly by increased sales volume throughout the region. Improving weather conditions in Australia created strong demand for all-grade herbicide and for our fungicide portfolio. A return to a more normal monsoon season in India and Southeast Asia supported increased demand for insecticide and fungicide, with strong growth in Indonesia for rice applications.
In Europe, revenue increased 6% in the quarter. Increased sales synergies and higher volume in Eastern Europe as we expand our direct market access, coupled with strong herbicide sales in the U.K, more than offset challenging conditions in Northwest Europe.
In North America, revenue in the quarter increased 46% to 2015. We saw higher sales volumes related to new product introduction for winter and spring week and increased demand for herbicide.
Looking ahead to Q4, we expect market conditions to remain largely unchanged. We are cautiously optimistic regarding Q4 in Latin America given the start of the selling season in Brazil and strong demand for FMC product elsewhere in the region. However, we are more cautious on market conditions in North America, where we expect weak market conditions into 2016/2017 crop season.
For the fourth quarter, we expect segment earnings to be between $117 million and $137 million. At the midpoint, this implies segment earnings growth of approximately 25% compared to the fourth quarter of 2015. Improved U.S. dollar pricing in Brazil and lower costs year-over-year are expected to drive a meaningful increase in segment earnings margin in the quarter from 15% in 2016 to closer to 20%. 
We are pleased with the progress made in Ag Solutions to drive margin improvements in the business. Prior to the acquisition of Cheminova, Ag Solutions consistently delivered consolidated operating margins between 20% and 25%, and we are well on our way to returning margins to that level. We are tightening our full year segment earnings guidance to $390 million to $410 million with the midpoint of our range unchanged and continue to forecast full year revenue of about $2.3 billion at the midpoint.
Turning next to Health and Nutrition on Slide 4. For the third quarter, Health and Nutrition reported revenue of $179 million and segment earnings of $45 million. Revenue declined 9% year-over-year, largely as a result of lower volume. Timing of sales to certain pharma customers in Asia and Europe and headwinds from omega-3 each contributed to the volume decline.
Segment earnings of $45 million declined 4% compared to 2015. However, operating margin improved 120 basis points to over 25% in the quarter. The negative impact of lower volumes and product mix was largely offset by lower operating costs as a result of ongoing operating excellence programs.
For the fourth quarter, we expect segment earnings of between $53 million and $57 million and for the full year forecast segment earnings to be in the range of $190 million to $194 million. At the midpoint, Q4 segment earnings are expected to increase almost 20% compared to Q4 2015. The bulk of the increase in segment earnings is due to the timing of certain favorable cost variances from prior period, which will drive segment earnings margin to between 29% and 30% in the quarter. For the full year, we expect margin of about 25% to 26%.
Moving on to Lithium on Slide 5. Lithium delivered another outstanding quarter. Revenue increased 22% to $70 million on the back of increased price and more favorable mix. Segment earnings rose to $18 million from just $2 million last year. Market conditions remained favorable, with demand increasing ahead of supply. As a result, prices across the portfolio were higher compared to the last year. These price increases, combined with most favorable sales mix, lower costs and the benefit from foreign currency, drove the improvement in segment earnings and margin in the quarter.
We expect the positive momentum in Lithium to continue with fourth quarter segment earnings between $16 million and $20 million, approximately 60% higher year-over-year at the midpoint of the range. Based on Lithium's performance to date and our expectation for Q4, we are increasing full year guidance for segment earnings by $5 million at the midpoint to a range of $65 million to $69 million. Full year segment earnings margin should be about 25% compared to 10% in 2015.
Before turning the call over to Paul, I will comment briefly on the outlook for the fourth quarter and full year 2016 on Slide 6. We are tightening full year segment earnings guidance for both Ag Solutions and Health and Nutrition and increasing guidance for Lithium. Based on this segment guidance and the lower tax rate, which Paul will discuss in a moment, we expect fourth quarter adjusted earnings per share to be in the range of $0.82 to $0.92 and full year adjusted EPS in the range of $2.76 to $2.86.
I will now turn the call over to Paul."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Pierre. I'll start with the tax rate and the noncontrolling interest on the income statements before I move on to the impact of currency, cash flow and the balance sheet.So first, tax. Year-to-date, our adjusted effective tax rate is around 2",725,"Thank you, Pierre. I'll start with the tax rate and the noncontrolling interest on the income statements before I move on to the impact of currency, cash flow and the balance sheet.
So first, tax. Year-to-date, our adjusted effective tax rate is around 23.5%, which is slightly lower than we initially expected. This is driven by an increase in the contribution of earnings from our foreign entities compared to prior years. And while this trend is most apparent in Ag Solutions, we're actually seeing it in all of our businesses. We expect the adjusted effective rate to be in the 23% to 24% range for the fourth quarter. And looking into 2017, we expect that rate may fall by as much as 3 percentage points, resulting in a full year adjusted effective tax rate closer to 21%. This further reduction is mainly the result of the operational integration of Cheminova, which will impact our supply chain and our earnings mix globally.
Our noncontrolling interest line continues to shrink as part of the integration of Cheminova. We've been taking advantage of opportunities to simplify the ownership structure of some of our international entities and are taking -- or have taken steps to consolidate ownership in places such as Argentina, China and Eastern Europe. Largely as a result of these steps, we expect the noncontrolling interest line to fall through approximately $5 million this year and remain near this level next year.
Tapping on currency. This quarter saw none of the rapid movements in major currencies that we saw last year. And as a result, FX had a far smaller impact on our results. Across all businesses and regions, currency was a tailwind to earnings with a large favorable movement in Brazil, the biggest factor. The other major currencies for which FMC is exposed, namely the euro and RMB, had no meaningful impact on our earnings in the quarter. For the year-to-date, currency has been good and neutral to earnings.
Moving on to cash flow on Slide 7. The first thing I want to point out is our increasing cash flow guidance for full year from a range of $450 million to $550 million to a range of $550 million to $600 million. The midpoint of this revised guidance reflects an increasing cash generation of almost 60% compared to 2015. Higher earnings, stronger working capital performance and tight spending discipline will all contribute to the year-over-year increase and give us confidence that the higher level of cash generation we've seen through the first 3 quarters will continue through Q4.
Underpinning our confidence in cash generation is our success in reducing our Brazil exposure. Through September, we collected over $500 million of receivables in Brazil, reducing the outstanding receivable balance by over $200 million. By the end of 2016, we expect to have collected over $700 million of outstanding receivables in Brazil alone. Equally importantly, a significant proportion of the collections are coming from those accounts that were past due at the start of the year, improving the quality of the remaining receivables balance.
Our receivables balance in Brazil, however, remains higher than we believe it should be. And we expect to continue to reduce it over the coming seasons. Based on our current visibility, we believe that we have the ability to reduce the current balance by approximately $400 million. We will deliver this reduction over the next 18 to 24 months.
Our strong cash generation has helped us reduce our net debt by over $200 million so far this year, and we expect this to fall further by year-end. Combined with higher trailing EBITDA, our adjusted net debt-to-LTM EBITDA ratio will fall into the 2.5 to 3x range as we enter 2017. We will continue to manage our debt to a level consistent with our current credit rating.
And looking into 2017, we expect our capital expenditure to remain similar to '16, at or just ahead of depreciation, leaving allowance for our planned expansions in lithium hydroxide. We will continue to seek out opportunities to invest in technologies and products for our Ag Solutions business. And at an appropriate time in 2017, we would expect to revisit our ability to engage in share repurchases while maintaining our other net debt, credit rating and investment objectives.
And with that, I will turn the call back to Pierre."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Before closing, I would like to share a few initial thoughts regarding 2017 on Slide 8. Based on what we see today, we expect the global crop protection chemical market to be about flat in 2017, creating a more stable operating environment for FMC Ag Solu",902,"Before closing, I would like to share a few initial thoughts regarding 2017 on Slide 8. Based on what we see today, we expect the global crop protection chemical market to be about flat in 2017, creating a more stable operating environment for FMC Ag Solutions.
Market demand in Europe and Asia continues to grow, and more normal weather conditions should lead to an improved demand environment in those regions next year. While it remains very early to predict the market crop protection chemical in Latin America, we are quietly confident that we will enter 2017 with better market fundamentals than either of the previous 2 seasons.
In contrast, we expect market conditions in North America to remain challenging as we do not believe that the market-wide destocking process has run its course and that elevated levels of channel inventory, combined with low commodity prices, will dampen grower demand across the region.
In a flat market and assuming stable currencies, we believe Ag Solutions is well positioned to deliver another year of growth in segment earnings. Revenue synergy opportunities in Europe and North America, planned new product introductions and continued cost savings will more than offset cost inflation. Our preliminary view is that Ag Solutions segment earnings will grow by high single-digit percent in 2017.
In Health and Nutrition. Next year, we expect growth rate for revenue and segment earnings to return to historical levels of low to mid-single-digit percent.
In Lithium, the combination of higher price, increased lithium hydroxide volume and continued cost discipline should increase segment earnings by about 40% in 2017. We expect to realize higher prices in all major downstream products next year, with the most significant increase in lithium hydroxide.
The majority of our lithium hydroxide contracts are negotiated in the fourth quarter. And based on the status of customer negotiations to date, we expect the average realized price to be significantly higher in 2017. We also expect to see a meaningful increase in the production of lithium hydroxide next year as a result of our previously announced capacity expansion. Construction of our hydroxide unit is ahead of schedule. Based on the current construction headlines, we expect production of lithium hydroxide to increase by 4,000 metric tons in 2017, with total production capacity decreasing -- increasing to 18,000 metric tons per year by the middle of next year.
Hitting the growth in demand for FMC's downstream lithium product requires access to increasing volume of lithium carbonate. Earlier this week, we announced an agreement with Nemaska Lithium to show us 8,000 metric tons of lithium carbonate per year beginning in mid-2018. This agreement represents only one element of the sourcing strategy, and we are actively pursuing multiple path to diversify our carbonate source.
In the near term, we will increase capacity at our Argentina operations by approximately 20% through low-capital cost actions. We continue to evaluate long-term supply agreements and partnerships with other producers of lithium carbonate, and we retain the option of expanding our carbonate production operation in Argentina in order to ensure we have a secure, reliable and cost-competitive supply of lithium carbonate.
At the corporate level, we expect costs to remain roughly flat and to continue to reduce debt. Combined with the lower tax rate for 2017, as Paul mentioned earlier, we expect to grow EPS at a faster rate than we grow operating earnings.
Consistent with prior years, we will provide more details and specific guidance for 2017 in February when we report our Q4 and full year 2016 results as we first need to see how the year ends and assess business and market conditions at that time.
To conclude, I am very pleased with our performance in the quarter and year-to-date. In volatile markets, FMC has continued to execute its strategy and deliver substantial growth in earnings. I believe we are positioned to continue this in Q4 and beyond. We continue to invest in our technology pipeline in Ag Solutions and are launching new products that bring greater value to the grower.
Last month, we announced that FMC has begun the registration process in North America of our Bixafen fungicide, 1 of the 9 active ingredients in our R&D pipeline. With our unique, high-return R&D model for active ingredient innovation and strong regional formulation capabilities, FMC is well positioned to deliver the technology and service that growers demand. We will provide additional information regarding our technology pipeline in the coming months.
Health and Nutrition continues to generate high margins and strong cash flow, and demand across our core nutrition and health market continues to grow.  We are in the process of commissioning our new MCC production facility in Thailand, which will serve the growing nutrition market in Asia. Demand for our downstream retail products continues to increase. FMC is well positioned to maintain its leading position in lithium hydroxide, butyllithium and lithium metals, and we continue to pursue multiple path to diversify our sources of lithium carbonate to feed the expected growth in the business. Our agreement with Nemaska is just trusted, and we look forward to announcing more action in 2017.
In closing, the actions we are taking will continue to drive performance across our businesses and position FMC to deliver increasing value to our shareholders into 2017 and beyond. I thank you for your attention this morning.
With that, I will turn the call back to the operator for questions."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] Our first question today comes from the line of Christopher Parkinson with Crdit Suisse.",16,"[Operator Instructions] Our first question today comes from the line of Christopher Parkinson with Crdit Suisse."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Your results far exceeded what your peers have been indicating for European crop protection growth, especially in 3Q. And you mentioned some things in your presentation such as direct market access across Eastern Europe and strong herbicide sales in the U",83,"Your results far exceeded what your peers have been indicating for European crop protection growth, especially in 3Q. And you mentioned some things in your presentation such as direct market access across Eastern Europe and strong herbicide sales in the UK. But can you just talk a little more about the longer-term key drivers in the market, let's say, over the next 2 years? Are we in the early innings of the Eastern European team? And what's the latest update on new registrations?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","This is Mark. You highlighted the points that we put out in the release regarding how we grew in Europe. I think for us going forward in the next few years, it's very much what we've just said in terms of direct market access. We're very pleased with what",184,"This is Mark. You highlighted the points that we put out in the release regarding how we grew in Europe. I think for us going forward in the next few years, it's very much what we've just said in terms of direct market access. We're very pleased with what we see in Eastern Europe, but we're working off of a pretty small base. And we have just purchased the JV that we had in Czechoslovakia, Poland. It's important for us to expand in that area. But we shouldn't forget that France, Germany, the U.K, Spain, Italy, they're all important markets where we intend to put new products into the pipeline. We do have new products coming next year and the year after that are based upon our clomazone franchise for herbicides. So we expect to see significant growth in herbicides as we move forward. And in addition, with the acquisition of Cheminova, we've also, as we've said, expanded our fungicide portfolio. So you'll see us grow our European fungicide business substantially over the next 3 to 5 years. That's mainly the growth for us."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And Chris, remember that many of the products FMC was hitting in Europe are registered today in places like France, Italy, Spain, Portugal, Southern Europe, U.K. We were just not benefiting from a very strong sales organization as we were working with a d",88,"And Chris, remember that many of the products FMC was hitting in Europe are registered today in places like France, Italy, Spain, Portugal, Southern Europe, U.K. We were just not benefiting from a very strong sales organization as we were working with a distribution network, which was mostly focused on Northern Europe. So even without adding many registration, which we will and we have new product coming, with just the fact to increase our face-to-face presence with the market is going to dramatically increase our ability to grow."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Great. And just a quick follow-up. Can you just also quickly comment on where you think the insecticide inventory issues in Brazil and how that may or may not affect the market heading into 2017? And also, you've seen some recent spikes in sugar and cotto",75,"Great. And just a quick follow-up. Can you just also quickly comment on where you think the insecticide inventory issues in Brazil and how that may or may not affect the market heading into 2017? And also, you've seen some recent spikes in sugar and cotton prices. Could you just quickly comment on the conversations you're having with those customers? As I imagine, they've been better than they have over the last couple of years."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think we are always very careful when we talk about the role of product inventory in the channel overall at the market level. But the situation in Brazil, including for insecticide, is right now feeling, I would say, more stable. As you can see, ye",166,"Yes. I think we are always very careful when we talk about the role of product inventory in the channel overall at the market level. But the situation in Brazil, including for insecticide, is right now feeling, I would say, more stable. As you can see, year-on-year numbers show a decrease in sales in addition to the progress utilization. So we believe there are actions which are being taken for insecticide and other product to decrease the level of inventory in the channel. The discussions with growers are better. There is -- they are easier on pricing. They are easier on term, and our volumes are more predictable . So we do believe it is decreasing. We don't believe it's decreasing fast enough to create a very rubbish 2017 number. But I would say we want to be entering 2017 in a more stable situation and more flattish market than we did in the previous 2 years. Mark, do you want to comment on the sugarcane?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, sure. Chris, when you mentioned cotton and sugarcane, obviously, important crops for FMC down in Brazil. I'm more confident in sugarcane than I am in cotton. As we've talked about and Paul alluded to in terms of collections, we've been very prudent i",217,"Yes, sure. Chris, when you mentioned cotton and sugarcane, obviously, important crops for FMC down in Brazil. I'm more confident in sugarcane than I am in cotton. As we've talked about and Paul alluded to in terms of collections, we've been very prudent in our exposure to certain areas of Brazil and, certainly, in crops. I would say the cotton growers have faced a very tough time in the north due to the drought. So liquidity is important for them, and we're watching that situation very carefully. Acres are expected to be flat to slightly down in Brazil as we go forward into the next season. Switching to sugarcane, you're right, sugar prices are at least double where they were last year. Ethanol prices were up in Brazil. So the fundamentals for the business is good. The one thing they are lacking right now is liquidity given all the debts they've incurred over the last few years. We're ideally positioned. We have strong market shares in insecticides and herbicides. Planting is down right now, probably about 30% due to that liquidity. But I think as the business unwinds next year, I'm very confident that our sugarcane business will grow next year and be a good buffer for some of the other downsides we might see in cotton."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Just to repeat, Chris, I want to use your question to make sure that we are clear, but we are continuing with the strategy. It's a different strategy, but really, we are not focused on volume at all today. I mean, what is very important for us today is pr",103,"Just to repeat, Chris, I want to use your question to make sure that we are clear, but we are continuing with the strategy. It's a different strategy, but really, we are not focused on volume at all today. I mean, what is very important for us today is pricing our technology, where it should be priced; decreasing the level of our product in the channel; getting terms which are right; and collecting. We believe the market is such that -- this is the right strategy, which will make us much stronger when we get to a situation where the market turns around."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Our next question today comes from the line of Daniel Jester with Citi.",13,"Our next question today comes from the line of Daniel Jester with Citi."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Maybe I can just follow up on Chris' question in a different way. I think you said that low-margin product in Brazil, which you're exiting, attributed to 60% of the volume decline in the quarter. So maybe can we just talk about what's driving this 40% of",53,"Maybe I can just follow up on Chris' question in a different way. I think you said that low-margin product in Brazil, which you're exiting, attributed to 60% of the volume decline in the quarter. So maybe can we just talk about what's driving this 40% of the rest of the volume decline?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","There is 2 things which are driving the remaining 40%. First of all, we believe -- and we'll confirm that at the end of the fourth quarter, but we are believing that -- we believe that we are in a situation in Brazil where the market will still be down in",157,"There is 2 things which are driving the remaining 40%. First of all, we believe -- and we'll confirm that at the end of the fourth quarter, but we are believing that -- we believe that we are in a situation in Brazil where the market will still be down in a 10% range year-on-year for the full year. So there is a market driver. There is also the fact that we are moving away from sales, not because of rationalization but because of credit risks or term. We are very cautious in not selling for the sake of selling. We are selling when we know we can get normal terms for the region and we will be able to collect. So as I said before, volume is not the priority. So those are the 3 reasons: sales, which are fixed with good terms; market, which will decline; and product rationalization. Those are the 3 drivers."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. That's helpful. And then I think you also commented that operating margins in Brazil are sort of approaching where you were in 2014. But I think for the Ag segment as a whole, margins are still below 2014 levels. So can you comment on the other regi",62,"Okay. That's helpful. And then I think you also commented that operating margins in Brazil are sort of approaching where you were in 2014. But I think for the Ag segment as a whole, margins are still below 2014 levels. So can you comment on the other regions and where you see margins stay and how maybe they can improve into 2017?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think that if you look at when we made the acquisition of Cheminova, acquiring Cheminova was -- bring to us many benefits in terms of creating more global business, a broader fungicide portfolio, a direct access to markets in Europe and other benef",228,"Yes. I think that if you look at when we made the acquisition of Cheminova, acquiring Cheminova was -- bring to us many benefits in terms of creating more global business, a broader fungicide portfolio, a direct access to markets in Europe and other benefits, more fully the performance in -- more fully in market presence in India and Australia. But we also realized that the margins Cheminova was realizing were not at the level of what we're expecting. And we had a plan to bring those margins through cost saving, pricing and new product introduction to the east to recall level of FMC. And that's the road we are on. I have to say that despite the market conditions, 1.5 years after closing on the Cheminova acquisition, we have brought back those margins to 20%, which is well -- for the fourth quarter, which is well in line, even ahead of our schedule. We still have work to do. We still have remember. We still have additional costs to extract from the business from the acquisition in the next 6 to 9 months. So we still have work. But we are well on our way to margin north of 20%. It is just the integration of Cheminova, the pricing of the technology and the new product introduction, but we are well on that road map right now."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","We'll go to the line of Mike Harrison with Seaport Global.",12,"We'll go to the line of Mike Harrison with Seaport Global."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Eric, I was wondering if you could talk a little bit about the cost structure and some of the key margin drivers that you saw in Health and Nutrition this quarter. Did we see any of the variance impacts during this quarter that you mentioned you're going",54,"Eric, I was wondering if you could talk a little bit about the cost structure and some of the key margin drivers that you saw in Health and Nutrition this quarter. Did we see any of the variance impacts during this quarter that you mentioned you're going to be seeing in the fourth quarter?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Eric here. So it's a complicated question because the costs that flow through in any 1 quarter are related to a variety of factors where a lot of it is stemming from manufacturing excellence programs. So that's a sustainable component. However, as we talk",143,"Eric here. So it's a complicated question because the costs that flow through in any 1 quarter are related to a variety of factors where a lot of it is stemming from manufacturing excellence programs. So that's a sustainable component. However, as we talked about in the guidance Pierre gave for the fourth quarter, we'll see benefits stem from things such as seasonality and how we harvest seaweed, right? There are times of the year, particularly off the coast in Norway, where we get a higher-quality seaweed, we have more access to the waters because of the favorable weather, what have you, that drive one-off opportunities in costs, and that -- and where our variances work, that flows through. And it's part of the benefit we see in the fourth quarter. I want to make sure, does that answer the question you're after?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Mike, maybe to answer a little bit more your question, if you look at previous years, it is not an abnormal situation to see -- you could see it maybe not at the same extent, but you can see it to the 2015 results, where you would see higher margin in Q4",106,"Mike, maybe to answer a little bit more your question, if you look at previous years, it is not an abnormal situation to see -- you could see it maybe not at the same extent, but you can see it to the 2015 results, where you would see higher margin in Q4 than you would see in Q3. So we realized over the year a 25% margin for the business. But we recognize that there is some seasonality to margin in this business. So there is not always a connection between a margin improvement you will see in Q4 and what you could realize in Q3."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Yes. I guess the question that I had, Eric, also had to do with the weakness in volumes during the third quarter, yet you were able to show pretty nice margin improvement. I was wondering if there was some variability around the costs or if this was struc",57,"Yes. I guess the question that I had, Eric, also had to do with the weakness in volumes during the third quarter, yet you were able to show pretty nice margin improvement. I was wondering if there was some variability around the costs or if this was structural cost takeout that was really driving the margin improvement."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, I would say it's more of the latter. The structural improvements we've made is nothing unique about what's happened sequentially from 1 quarter to the next. Volumes were lower for the reasons Pierre referenced, omega-3, as well as some timing in our",107,"Yes, I would say it's more of the latter. The structural improvements we've made is nothing unique about what's happened sequentially from 1 quarter to the next. Volumes were lower for the reasons Pierre referenced, omega-3, as well as some timing in our health business. But the cost side of that is pretty consistent. It's a structural component that gets us to a sustainable margin that's in the mid-20s, notwithstanding the occasional, and what we've seen in prior quarters, benefit we can make in certain quarters like the fourth quarter that are not benefits you roll forward into the first or second quarters of the following year."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","All right. Then I had a question on the Lithium business. Can you comment on what you were seeing in price activity sequentially across different products?",26,"All right. Then I had a question on the Lithium business. Can you comment on what you were seeing in price activity sequentially across different products?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think I'll have Tom commenting more on the pricing. But right now, if you look, we had a lot of benefits from pricing on lithium carbonate up to now and maybe less of a pricing benefit of lithium hydroxide. We are now getting into the period of new",120,"Yes. I think I'll have Tom commenting more on the pricing. But right now, if you look, we had a lot of benefits from pricing on lithium carbonate up to now and maybe less of a pricing benefit of lithium hydroxide. We are now getting into the period of new contract negotiation of lithium hydroxide, which will impact mostly 2017. So directionally, what we do expect is we do expect to start to see a very significant ramp-up in lithium hydroxide pricing, which is very much in line with the negotiation we are having, while we will see maybe a more stable pricing in lithium carbonate potentially lowering into 2017. Tom, you want to add some more color to that?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. Just to give a little more color to that, on hydroxide, the contract negotiations are proceeding well, and over the coming months, they should be all solid. We're progressing well through those. And on the carbonate, as most of the folks on the marke",112,"Yes. Just to give a little more color to that, on hydroxide, the contract negotiations are proceeding well, and over the coming months, they should be all solid. We're progressing well through those. And on the carbonate, as most of the folks on the market, there was a little bit of softening in Q3, particularly in China. What we'll see going into next year is the smaller volume of carbonate that was locked in at lower prices similar to the hydroxide will come up. And we expect some softening on the top end. So net-net, we'll go into next year on those more opportunistic product lines kind of flat to slightly down."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And the big story, once again, for us, I mean, because of the strategic focus, because of the timing of where we are in contract negotiation and increasing capacity coming up next year, the big focus for us and where you're going to see the largest contri",53,"And the big story, once again, for us, I mean, because of the strategic focus, because of the timing of where we are in contract negotiation and increasing capacity coming up next year, the big focus for us and where you're going to see the largest contributor to earnings growth is lithium hydroxide."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And next, we'll go to the line of Don Carson with Susquehanna.",12,"And next, we'll go to the line of Don Carson with Susquehanna."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Ben Richardson sitting in for Don. Just sticking on -- with the topic of lithium. You say you're ahead of schedule with the ramps there. Can you just maybe speak to the timing of that additional tonnage?",39,"This is Ben Richardson sitting in for Don. Just sticking on -- with the topic of lithium. You say you're ahead of schedule with the ramps there. Can you just maybe speak to the timing of that additional tonnage?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. What we -- we're expecting the mechanical completion of the plants. I had the pleasure actually to be there 2 weeks ago and see the plants looking really good. We expect the mechanical completion of the plants in the fourth quarter this year. We're g",139,"Yes. What we -- we're expecting the mechanical completion of the plants. I had the pleasure actually to be there 2 weeks ago and see the plants looking really good. We expect the mechanical completion of the plants in the fourth quarter this year. We're going to be able to start to add products coming out of the plants in the first quarter, and then we're going to start to answer the customer qualification of the products. So we believe we'll be in a commercial situation where the products are produced by the plant, by the expansion and qualifying the customer by the middle of the year. So the 8,000 metric ton capacity we have for next year should give to us a 4,000 additional tons of products into 2017 and the full 8,000 when we get into 2018."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And I guess slipping back to Ag and, specifically, potential divestitures in your space and how you see that developing.",21,"Okay. And I guess slipping back to Ag and, specifically, potential divestitures in your space and how you see that developing."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","We are in contact with our -- with any of the companies which are currently consolidating, and we are standing ready to participating in the purchase of any molecule -- any of this company would be divesting if they meet our portfolio. I have to say that",103,"We are in contact with our -- with any of the companies which are currently consolidating, and we are standing ready to participating in the purchase of any molecule -- any of this company would be divesting if they meet our portfolio. I have to say that so far, we haven't seen anything which will be critical to our portfolio or any significant technology put on the market. But I think those companies are still in the -- in an early stage of the antitrust reviews. So we are standing ready but haven't seen anything right now which has been attractive to us."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And our next question is from the line of Joel Jackson representing BMO Capital Markets.",15,"And our next question is from the line of Joel Jackson representing BMO Capital Markets."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Milan on for Joel. I mean, just following up there on the acquisitions. I mean, if you are to pursue something, can you maybe give us -- perhaps put some numbers around magnitude? And what would be the funding? I mean, what sort of leverage would",56,"This is Milan on for Joel. I mean, just following up there on the acquisitions. I mean, if you are to pursue something, can you maybe give us -- perhaps put some numbers around magnitude? And what would be the funding? I mean, what sort of leverage would you be comfortable going back up to potentially?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I'll first talk to the leverage. The size -- I mean, really, I would not like to speculate here on the results of any antitrust reviews and what could be the consequences in terms of what product would be for sale and what would be the price. So of course",108,"I'll first talk to the leverage. The size -- I mean, really, I would not like to speculate here on the results of any antitrust reviews and what could be the consequences in terms of what product would be for sale and what would be the price. So of course, we do our own work to be ready and try to anticipate, but that's only speculation in our part to stand ready. But it's very hard to tell until the antitrust process in each of the region is taking place and having the companies making decisions around their portfolio. Paul, you want to talk about the leverage?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Sure. Just again, to Pierre's point, it's difficult to be particularly satisfying to you with the answer without any real specifics. But I think it's fair to say, I think you've seen from my cash flow performance, we are generating a fairly good cash righ",164,"Sure. Just again, to Pierre's point, it's difficult to be particularly satisfying to you with the answer without any real specifics. But I think it's fair to say, I think you've seen from my cash flow performance, we are generating a fairly good cash right now. We're deleveraging quickly. One of the characteristics -- because we bought products like this frequently in the past, one of the key characteristics is that they are typically very cash generative from day 1. And so they can stand a pretty decent amount of leverage from day 1. We also are very disciplined on price. Based on everything we see, we don't see any risk to our credit rating from a cash acquisition of any of the available interesting assets that are out there right now. Again, that could change depending on what assets come available. But we don't see any particular challenge to our balance sheet based on the opportunities that are available that we see today."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","And maybe just switching to omega-3, you talked about some abating headwinds going into next year. I mean, is the environment more competitive, equally competitive, less competitive than you were perhaps seeing last quarter and going into '17?",39,"And maybe just switching to omega-3, you talked about some abating headwinds going into next year. I mean, is the environment more competitive, equally competitive, less competitive than you were perhaps seeing last quarter and going into '17?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Omega-3 is a -- how do we say, it is not getting worse, but it is not getting better. I think it's a challenging environment. Right now, we are focusing on actions for us to leverage some of the manufacturing capacity and quality of product, especially th",202,"Omega-3 is a -- how do we say, it is not getting worse, but it is not getting better. I think it's a challenging environment. Right now, we are focusing on actions for us to leverage some of the manufacturing capacity and quality of product, especially the fact that we have no way made product, which have very high quality and commend a premium, to try to improve a situation. But frankly, at that stage, with the oversupply there is in this market and the number of players, the improvements you will see on omega-3 will be driven by the work we do commercially and cost-wise more than us benefiting from the market. We are very -- when we've -- when we announced the numbers for expected growth for the Health and Nutrition business next year, we are very, I would say, prudent around putting into those numbers any significant improvement in the omega-3 market, which we do not see. So it is a challenge. We're addressing it. We are trying to -- we are in -- I would say, right now, I have to admit we are more in damage control than expecting growth. But that's the situation for omega-3."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Steve Byrne with BofA.",12,"Our next question comes from the line of Steve Byrne with BofA."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Ian sitting in for Steve. Cash flow generation has been very, very good this year, and I appreciate the comments about some of the collections in Brazil. And looking forward to 2017, provided some preliminary guidance about expecting earnings grow",57,"This is Ian sitting in for Steve. Cash flow generation has been very, very good this year, and I appreciate the comments about some of the collections in Brazil. And looking forward to 2017, provided some preliminary guidance about expecting earnings growth. Should cash from operations grow at the same level of earnings or higher or lower?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think you heard in my comments, we talked about probably still about $400 million of excess receivables sat on our balance sheet related to Brazil. And we'd certainly expect to start to collect a significant proportion of those next year. So given",123,"Yes. I think you heard in my comments, we talked about probably still about $400 million of excess receivables sat on our balance sheet related to Brazil. And we'd certainly expect to start to collect a significant proportion of those next year. So given that, we would expect the cash flow to continue to grow really similar like to what -- how it did this year. We'll generate high EBITDA. We do not expect to have any meaningful cash outflows for CapEx over and above what we have today. And we expect to continue to decapitalize our balance sheet in Brazil. So yes, I would expect cash flow to continue to grow next year just as strong as it had been this year."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","And as a follow-up, just kind of on the broader market. What -- for Ag, specifically in Latin America, what things would you be looking for to potentially become more optimistic about a rebound in that region? I think sales are still far below prior level",56,"And as a follow-up, just kind of on the broader market. What -- for Ag, specifically in Latin America, what things would you be looking for to potentially become more optimistic about a rebound in that region? I think sales are still far below prior levels of peak. What does the industry need to see?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Well, I think for me, there's a couple of things. First of all, on the macro level, obviously, if commodity prices start to come back, we're going to see expanded acres down in Brazil for a lot of the raw crops. That's one factor. Then the second factor i",154,"Well, I think for me, there's a couple of things. First of all, on the macro level, obviously, if commodity prices start to come back, we're going to see expanded acres down in Brazil for a lot of the raw crops. That's one factor. Then the second factor is just the internal health of that business in the sense of where channel inventories are, pest pressures, the normal seasonal-to-seasonal activity in Ag. I think if you can get those things coming together, you're going to see somewhat of a rebound in the marketplace. The pest pressures, obviously, nobody knows where the pest pressures are going to lie. Commodity prices are going to take some change in over yields in North America and Latin America. So we've said what we feel the market will be next year. Those will be the 2 items, in Brazil, in particular; and potentially, Argentina that would change that picture."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","The one thing I'd just add to that, I think having a stable macro political environment and improved access to credit for the growers will be a positive if we see that start to happen as well.",38,"The one thing I'd just add to that, I think having a stable macro political environment and improved access to credit for the growers will be a positive if we see that start to happen as well."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Our next question is from the line of Mark Connelly with CLSA.",12,"Our next question is from the line of Mark Connelly with CLSA."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, last quarter, you talked about some optimism in your outlook comments for Health and Nutrition but not about seasonality in Q3 and Q4. What I'm wondering is, do you think you have the right mix of products for what customers are looking to do with",65,"Pierre, last quarter, you talked about some optimism in your outlook comments for Health and Nutrition but not about seasonality in Q3 and Q4. What I'm wondering is, do you think you have the right mix of products for what customers are looking to do with their products over the next couple of years? Or do you need to tweak your portfolio leaving Omega-3 aside?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","That's a very good question. And I'd tell you, it's a difficult one to answer. I believe that we have a very solid position in MCC, alginate and carrageenan. I do believe that we have the right formulation technology allowing us to meet the changing need",278,"That's a very good question. And I'd tell you, it's a difficult one to answer. I believe that we have a very solid position in MCC, alginate and carrageenan. I do believe that we have the right formulation technology allowing us to meet the changing need of the market and the customers. The question for us is -- and that's a business. Today, if you put omega-3 aside, we have strong market share, and we are the leading supplier in the place where our customers go today when they have need for new product or new technology. So I believe this is a business which will, for the next 2, 3 years, continue to grow in the mid-single-digit, as we said in the guidance, with very strong margin, 25%, and good cash generation. So to answer your question, I'm quite confident around that business for the next 2 to 3 years. We do have interesting new ideas based on the current product we have for new technology, for some of the changing market needs around health and other applications. The question for me is more 3 years and beyond. And really, where do we want to take that franchise? We have great product today. We have great margin and good cash generation. The first attempt to do that was omega-3. I think we didn't do a good job there. The question is what we want the business to be, not in next 2, 3 years but beyond that. So to answer your question, yes, for the next 2, 3 years. Beyond that, we need a lot of work to define the midterm strategy for Health and Nutrition."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. That's super helpful. And if I could just come back, I hate to beat on the working capital issue. But just a clarification, of the additional $400 million and everything else you're doing down there, are your credit practices in Brazil going to be m",71,"Okay. That's super helpful. And if I could just come back, I hate to beat on the working capital issue. But just a clarification, of the additional $400 million and everything else you're doing down there, are your credit practices in Brazil going to be materially different than legacy FMC? Or is this just a matter of we've got the Cheminova cleanup and better execution, well, and customers in better shape?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","So the first thing I would say, though, is when we look back at the position that we find ourselves in, in Brazil, much of it is driven by similar comments that Pierre talked about, about changing the way we approach the business. And instead of focusing",224,"So the first thing I would say, though, is when we look back at the position that we find ourselves in, in Brazil, much of it is driven by similar comments that Pierre talked about, about changing the way we approach the business. And instead of focusing on volume and volume growth and share growth, focusing on getting the maximum value. An important part of that is assessing the quality of the customer and the quality of the products that we sell. We do not expect to be in a meaningfully different place in terms of terms, in terms of structure, in terms of credit that we extend to customers, to either history or the rest of the market. But we will be much more and we are being much more disciplined about where we're willing to take exposure. It's really a function of multiple factors. It's a function of the movement in commodity prices. It's a function of the weaker access to credit for the growers down there in the market. And it is, to an extent, a function of our ability to integrate the Cheminova portfolio and have a higher margin, more technical portfolio really across all regions and all crops. So it's more than one factor that's driving this, this move towards a stronger credit position with our customers down there."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I think, generally speaking, the crop chemical industry as a whole, first, and all of our peer company, it is an industry which is in Latin America and Brazil, which has been historically focused on growth and maybe a bit more open to taking risk to gain",125,"I think, generally speaking, the crop chemical industry as a whole, first, and all of our peer company, it is an industry which is in Latin America and Brazil, which has been historically focused on growth and maybe a bit more open to taking risk to gain market share. And we are there with all of our competitors. I do think today, we might have a strategy without fundamentally changing what we've done to be more careful for the foreseeable future. I think it's important. It's working for us. And it's allowing to collect, to price. Our customers want our product. So we're going to be maybe on the lower end of the risk taking without fundamentally changing the way we look at other receivables."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And we have a question from the line of Dmitry Silversteyn with Longbow Research.",14,"And we have a question from the line of Dmitry Silversteyn with Longbow Research."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","A couple of follow-ups, if I may. First of all, with regards to your announced deal for 8,000 tons of carbonate that you're going to be getting from your new partner, is that pretty much all of their capacity or -- and you do have the right to all of that",59,"A couple of follow-ups, if I may. First of all, with regards to your announced deal for 8,000 tons of carbonate that you're going to be getting from your new partner, is that pretty much all of their capacity or -- and you do have the right to all of that capacity? Or is there more behind that?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","The 8,000 tons is -- I think when you say their capacity, it's not their -- it's our capacity, I mean, this plant. If you talk about the expansion in China, this plant...",34,"The 8,000 tons is -- I think when you say their capacity, it's not their -- it's our capacity, I mean, this plant. If you talk about the expansion in China, this plant..."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","In Nemaska.",2,"In Nemaska."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Oh, in Nemaska, okay.",4,"Oh, in Nemaska, okay."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, Dmitry, this is Tom. I can take that. Nemaska's installed capacity will be 28,000 tons. So it will be a meaningful part of their capacity, but it will not be meaningful for all of their capacity.",37,"Yes, Dmitry, this is Tom. I can take that. Nemaska's installed capacity will be 28,000 tons. So it will be a meaningful part of their capacity, but it will not be meaningful for all of their capacity."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And I'm assuming you have some way of getting more if you need more either from these guys or from other sources as you move past 2018, 2019.",29,"Okay. And I'm assuming you have some way of getting more if you need more either from these guys or from other sources as you move past 2018, 2019."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Well, with respect to that, as Pierre outlined in his comments, we've got a multipronged strategy where we're continually evaluating, one, how do we diversify, have security of supply, low-cost supply. So we're not quite ready to announce the other pieces",62,"Well, with respect to that, as Pierre outlined in his comments, we've got a multipronged strategy where we're continually evaluating, one, how do we diversify, have security of supply, low-cost supply. So we're not quite ready to announce the other pieces coming, but there'll be multiple components to that, including our own investments in our facilities as well as working with others."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I think it's important in all of these discussions, we have this Nemaska agreement. We are in current discussions with some other suppliers of carbonate for partnership. But let's not forget that there is one aspect for which we have 100% of the decision,",129,"I think it's important in all of these discussions, we have this Nemaska agreement. We are in current discussions with some other suppliers of carbonate for partnership. But let's not forget that there is one aspect for which we have 100% of the decision, it is expanding in Argentina. We can expand in Argentina. We do have the mines. We do have the capability. We have the infrastructure. So it is a decision we can make. I have to admit that I'm not in the rush to make that decision because with all of the companies today investing in lithium carbonate, I believe there will be plenty of lithium carbonates for the next 2, 3, 4 years. But this is a decision we can make at any time."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And you actually kind of led into my next question, Pierre. This 20% debottlenecking expansion that you're undertaking in Argentina, what's the timing for that to come online? Is that a back end of 2017 as well?",38,"Okay. And you actually kind of led into my next question, Pierre. This 20% debottlenecking expansion that you're undertaking in Argentina, what's the timing for that to come online? Is that a back end of 2017 as well?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. This is going to start right now. I mean, we're going to see this capacity of carbonate coming in at some point during 2017, 2018. So this is undertaken right now. It is low capital and normal debottlenecking. The team has been working, and we have,",71,"Yes. This is going to start right now. I mean, we're going to see this capacity of carbonate coming in at some point during 2017, 2018. So this is undertaken right now. It is low capital and normal debottlenecking. The team has been working, and we have, I think, 3 work streams, which are allowing us to get to this kind of numbers. But it's more routine capital expansion, I mean."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. And Dmitry, just to give you a little more color on that. There's multiple components to that. So there are some operational efficiency changes. There are some low-capital projects. There's a number of small projects that over the course of '17 and '",48,"Yes. And Dmitry, just to give you a little more color on that. There's multiple components to that. So there are some operational efficiency changes. There are some low-capital projects. There's a number of small projects that over the course of '17 and '18 will add to that."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","So it sounds like your -- if I do my math right, your Argentinian production will go up to about 21,000 tons. Is that about right?",26,"So it sounds like your -- if I do my math right, your Argentinian production will go up to about 21,000 tons. Is that about right?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, that's correct.",3,"Yes, that's correct."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then final question on the crop protection business and sort of -- your margins have been, in the past, very differentiated between sort of 25% level in the first half of the year and kind of 20% level in the second half of the year, given where",150,"Okay. And then final question on the crop protection business and sort of -- your margins have been, in the past, very differentiated between sort of 25% level in the first half of the year and kind of 20% level in the second half of the year, given where the regions that you get your sales from. This year, obviously, has been distorted by everything that's going on. So it's going to be more like first half and second half be more or less even in terms of margins. As the business gets back to sort of normal execution, how do we think about 2017 margin cadence? Should we expect sort of a 3- to 4-point margin difference between the first half and the second half of the year? Or is it going to be more like this year where margins are a little bit more even between the quarters?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. We're going to get into next year. And once again, it's a bit early for us to break down by quarter. We've given a directional number. But yes, the profile of the margins and the business is going to change versus historical FMC just because we have",161,"Yes. We're going to get into next year. And once again, it's a bit early for us to break down by quarter. We've given a directional number. But yes, the profile of the margins and the business is going to change versus historical FMC just because we have a very different regional profile. I mean, remember, we are very small in Europe. We want to be much bigger in Europe where there is good marginal business. So I would say that directionally, we should have less variation in our quarterly margins than we had in the past. Now there is 2 things happening today is there is the market situation. There is a different approach we are taking to the Latin America market, and there is the cost synergies, which are growing quarter-after-quarter. So that is taking us to improved margin and taking us to the 20% range. But I would say, in the future, you'll have more stable margin quarter-over-quarter."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","We have time for one more question today, and that will come from the line of Robert Koort with Goldman Sachs.",21,"We have time for one more question today, and that will come from the line of Robert Koort with Goldman Sachs."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Chris Evans on for Bob. In Lithium, specifically, pretty -- 40% earnings growth assumption for '17. I think you mentioned earlier kind of a low -- flat to down expectation for pricing in carbonate. Can you kind of give the other expectations that",51,"This is Chris Evans on for Bob. In Lithium, specifically, pretty -- 40% earnings growth assumption for '17. I think you mentioned earlier kind of a low -- flat to down expectation for pricing in carbonate. Can you kind of give the other expectations that are driving that assumption for '17?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I would say -- well, first, if you look at our business in '17, we're expecting to be -- and Tom, correct me if I'm a bit off here, but I would say almost 90% of our business revenues being on the specialty side, the downstream, and only 10% on the upstre",188,"I would say -- well, first, if you look at our business in '17, we're expecting to be -- and Tom, correct me if I'm a bit off here, but I would say almost 90% of our business revenues being on the specialty side, the downstream, and only 10% on the upstream, which is carbonate and fluoride. So we're going to be even more dependent upon the price, the downstream business. We are expecting, I would say, little benefit from carbonate chloride pricing knowing that it's only a small percentage of our business, and we believe this pricing is going to level off in 2017. So you would consider the 40% improvement is going to mostly come from 2 things, pricing in lithium hydroxide and volume in lithium hydroxide. You will understand that I'm going to be a bit careful on what expecting in terms of lithium hydroxide price increase because we are in the middle of the bench of contract negotiations. So I'll -- we will give you more detail around pricing when we get to the February earnings call because those negotiations will be behind us."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And just to add a little bit more color to that. I mean, you have to realize that most of our specialty business is contracted in the prior year. So when we contracted a lot of that, it was before we saw how strong the pricing had moved across the market",67,"And just to add a little bit more color to that. I mean, you have to realize that most of our specialty business is contracted in the prior year. So when we contracted a lot of that, it was before we saw how strong the pricing had moved across the market overall. So there's a little bit of catch-up that's happening across all of the specialty products."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","And just on the supply agreements to feed your hydroxide ramp. Should we expect the additional volumes to come from new entrants like Nemaska? Or do you expect from existing brine or hard rock producers?",35,"And just on the supply agreements to feed your hydroxide ramp. Should we expect the additional volumes to come from new entrants like Nemaska? Or do you expect from existing brine or hard rock producers?"
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. So of course, when you look at a supply of carbonate to feed growth, you want to be certain that you have the appropriate mix of new entrants and established players. So we will not -- having a strategy to supply carbonate into our business based onl",142,"Yes. So of course, when you look at a supply of carbonate to feed growth, you want to be certain that you have the appropriate mix of new entrants and established players. So we will not -- having a strategy to supply carbonate into our business based only or mostly on new entrants in this market. Nemaska, we believe, is one of the most solid today with one of the best source of lithium. So we believe it's a fairly certain supply we're going to get from them. But we will do 2 things. One is supply from existing suppliers, and not to forget that some of them are already supplying to us carbonate. And [indiscernible] to repeat, we can also increase our own capacity of carbonate, which is something if we decide to do it, there will be a short supply."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Well, we appreciate your time. That's all the time we have for the call today. As always, I'll be available on the call for any additional questions you may have. Thank you.",32,"Well, we appreciate your time. That's all the time we have for the call today. As always, I'll be available on the call for any additional questions you may have. Thank you."
28606,403765323,1072124,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","That concludes the FMC Corporation Third Quarter 2016 Earnings Release Conference Call. Thank you.",14,"That concludes the FMC Corporation Third Quarter 2016 Earnings Release Conference Call. Thank you."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the Third Quarter 2016 Earnings Release Conference Call for the FMC Corporation. [Operator Instructions]I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Ang",42,"Good morning, and welcome to the Third Quarter 2016 Earnings Release Conference Call for the FMC Corporation. [Operator Instructions]
I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning. Welcome to FMC Corporation's Third Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer. Pierre",270,"Thank you, and good morning. Welcome to FMC Corporation's Third Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer. Pierre will begin the call with a review of FMC's third quarter performance and discuss the outlook for Q4 and full year 2016. Paul will provide an overview of select financial results.
The slide presentation that accompanies our results, along with our earnings release and 2016 outlook statement, are available on our website, and the prepared remarks from today's discussion will be made available at the conclusion of the call.
As with our prior calls, Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President, FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, will join to address questions.
Before we begin, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including, but not limited to, those factors identified in our release and in our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based upon these risks and uncertainties.
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms as well as other non-GAAP financial terms to which we may refer during today's conference call are provided on our website.
With that, I will now turn the call over to Pierre."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian, and good morning, everyone. Q3 2016 was another strong quarter, reflecting the continued execution of our strategy. FMC reported revenue of $808 million, adjusted operating profit of $134 million and adjusted EPS of $0.67. Adjusted EPS i",1470,"Thank you, Brian, and good morning, everyone. Q3 2016 was another strong quarter, reflecting the continued execution of our strategy. FMC reported revenue of $808 million, adjusted operating profit of $134 million and adjusted EPS of $0.67. Adjusted EPS increased approximately 60% compared to the third quarter of 2015, exceeding the top end of our guidance range of $0.53 to $0.63.
Our performance for the quarter was driven largely by the results of Ag Solutions and Lithium, both of which reported a significant year-over-year increase in segment earnings.
In Ag Solutions, compared to last year, we saw an improved start of the season in Latin America, especially in Brazil, a stronger performance in both Asia and North America. Lithium continued to benefit from higher prices, improved mix and lower operating costs. Third quarter segment earnings in Health and Nutrition varied -- were slightly below 2015 but in line with our expectations.
The lower tax rate in the quarter contributed approximately $0.03 to adjusted EPS. As noted in our outlook statement, and as Paul will discuss later in the call, we expect to continue to report a lower tax rate for the remainder of the year and into 2017.
Based on our performance in the third quarter and on our outlook for Q4, we are revising the range of our full-range adjusted EPS guidance to $2.76 to $2.86 per share. At the midpoint, this represents an increase of $0.06 per share compared to the prior period and an increase of $0.14 compared to adjusted EPS for 2015. I will provide more detail on the outlook for Q4 shortly. But first, I will discuss third quarter results for each of our 3 segments, starting with Ag Solutions on Slide 2.
For the third quarter, Ag Solutions reported revenue of $559 million and segment earnings at the top of our guidance range of $90 million. Compared to the third quarter 2015, revenue declined 3%, as lower sales volume in Brazil more than offset the benefit of higher prices in that country and volume growth in other regions.
Year-over-year price increases were largest in Brazil, where we continue to recover pricing in U.S. dollar terms. Segment earnings increased over 50%, and margin improved 600 basis points, as higher realized prices, improved mix and favorable foreign exchange more than offset the impact of lower volumes and slightly higher costs in the quarter.
Costs were higher, principally as the result of the timing between quarters of certain expenses. For the full year, we remain on track to achieve our integration cost savings target.
Turning to Slide 3. I will provide additional comments on Ag Solutions' regional performance and discuss the outlook for Q4, starting with Latin America.
Revenue in the region declined 18% in the quarter, driven largely by lower sales volumes in Brazil. General market weakness, ongoing product rationalization efforts and our decision to allow channel inventory levels to reduce each contributed to the decline in sales volume in Brazil. The elimination of low-margin third-party products accounted for over 50% of the volume decline in the quarter.
Revenue in the rest of Latin America was roughly flat compared to 2015. In Argentina, we continued to see increasing demand for FMC's Authority herbicides. In Mexico, our focus on high-value crops is helping to offset the impact of a broader market decline.
The actions we have taken throughout the past year in Brazil enabled us to realize significant increases in U.S. dollar-based prices, improve operating margin and drive collections in the quarter. Price actions increased operating earnings in Brazil by about 30% year-over-year, which, combined with lower operating costs, returned operating margins to 2014 levels.
Our actions in Brazil also enabled the business to reduce accounts receivables in the country and generate cash collections of over $200 million, a significant improvement over our performance in the same quarter last year.
Moving on to Asia. Revenue in the region grew by 9% in the quarter compared to 2015, driven mainly by increased sales volume throughout the region. Improving weather conditions in Australia created strong demand for all-grade herbicide and for our fungicide portfolio. A return to a more normal monsoon season in India and Southeast Asia supported increased demand for insecticide and fungicide, with strong growth in Indonesia for rice applications.
In Europe, revenue increased 6% in the quarter. Increased sales synergies and higher volume in Eastern Europe as we expand our direct market access, coupled with strong herbicide sales in the U.K., more than offset challenging conditions in Northwest Europe.
In North America, revenue in the quarter increased 46% to 2015. We saw higher sales volumes related to new product introductions for winter and spring wheat and increased demand for herbicide.
Looking ahead to Q4, we expect market conditions to remain largely unchanged. We are cautiously optimistic regarding Q4 in Latin America given the start of the selling season in Brazil and strong demand for FMC product elsewhere in the region. However, we are more cautious on market conditions in North America, where we expect weak market conditions into 2016/2017 crop season.
For the fourth quarter, we expect segment earnings to be between $117 million and $137 million. At the midpoint, this implies segment earnings growth of approximately 25% compared to the fourth quarter of 2015. Improved U.S. dollar pricing in Brazil and lower costs year-over-year are expected to drive a meaningful increase in segment earnings margin in the quarter from 15% in 2016 to closer to 20%. 
We are pleased with the progress made in Ag Solutions to drive margin improvements in the business. Prior to the acquisition of Cheminova, Ag Solutions consistently delivered consolidated operating margins between 20% and 25%, and we are well on our way to returning margins to that level. We are tightening our full year segment earnings guidance to $390 million to $410 million, with the midpoint of our range unchanged, and continue to forecast full year revenue of about $2.3 billion at the midpoint.
Turning next to Health and Nutrition on Slide 4. For the third quarter, Health and Nutrition reported revenue of $179 million and segment earnings of $45 million. Revenue declined 9% year-over-year, largely as a result of lower volume. Timing of sales to certain pharma customers in Asia and Europe and headwinds from omega-3 each contributed to the volume declines.
Segment earnings of $45 million declined 4% compared to 2015. However, operating margin improved 120 basis points to over 25% in the quarter. The negative impact of lower volumes and product mix was largely offset by lower operating costs as a result of ongoing operating excellence programs.
For the fourth quarter, we expect segment earnings of between $53 million and $57 million and for the full year forecast segment earnings to be in the range of $190 million to $194 million. At the midpoint, Q4 segment earnings are expected to increase almost 20% compared to Q4 2015. The bulk of the increase in segment earnings is due to the timing of certain favorable cost variances from prior period, which will drive segment earnings margin to between 29% and 30% in the quarter. For the full year, we expect margins of about 25% to 26%.
Moving on to Lithium on Slide 5. Lithium delivered another outstanding quarter. Revenue increased 22% to $70 million on the back of increased price and more favorable mix. Segment earnings rose to $18 million from just $2 million last year. Market conditions remained favorable, with demand increasing ahead of supply. As a result, prices across the portfolio were higher compared to the last year. These price increases, combined with the most favorable sales mix, lower costs and the benefit from foreign currency, drove the improvement in segment earnings and margin in the quarter.
We expect the positive momentum in Lithium to continue, with fourth quarter segment earnings between $16 million and $20 million, approximately 60% higher year-over-year at the midpoint of the range. Based on Lithium's performance to date and our expectation for Q4, we are increasing full year guidance for segment earnings by $5 million at the midpoint to a range of $65 million to $69 million. Full year segment earnings margin should be about 25% compared to 10% in 2015.
Before turning the call over to Paul, I will comment briefly on the outlook for the fourth quarter and full year 2016 on Slide 6. We are tightening full year segment earnings guidance for both Ag Solutions and Health and Nutrition and increasing guidance for Lithium. Based on this segment's guidance and the lower tax rate, which Paul will discuss in a moment, we expect fourth quarter adjusted earnings per share to be in the range of $0.82 to $0.92 and full year adjusted EPS in the range of $2.76 to $2.86.
I will now turn the call over to Paul."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Pierre. I'll start with the tax rate and the noncontrolling interest on the income statements before I move on to the impact of currency, cash flow and the balance sheet.So first, tax. Year-to-date, our adjusted effective tax rate is around 2",724,"Thank you, Pierre. I'll start with the tax rate and the noncontrolling interest on the income statements before I move on to the impact of currency, cash flow and the balance sheet.
So first, tax. Year-to-date, our adjusted effective tax rate is around 23.5%, which is slightly lower than we initially expected. This is driven by an increase in the contribution of earnings from our foreign entities compared to prior years. And while this trend is most apparent in Ag Solutions, we're actually seeing it in all of our businesses. We expect the adjusted effective rate to be in the 23% to 24% range for the fourth quarter. And looking into 2017, we expect that rate may fall by as much as 3 percentage points, resulting in a full year adjusted effective tax rate closer to 21%. This further reduction is mainly the result of the operational integration of Cheminova, which will impact our supply chain and our earnings mix globally.
Our noncontrolling interest line continues to shrink as part of the integration of Cheminova. We've been taking advantage of opportunities to simplify the ownership structure of some of our international entities and are taking or have taken steps to consolidate ownership in places such as Argentina, China and Eastern Europe. Largely as a result of these steps, we expect the noncontrolling interest line to fall to approximately $5 million this year and remain near this level next year.
Talking on currency. This quarter saw none of the rapid movements in major currencies that we saw last year. And as a result, FX had a far smaller impact on our results. Across all businesses and regions, currency was a tailwind to earnings, with a large favorable movement in Brazil the biggest factor. The other major currencies for which FMC is exposed, namely the euro and RMB, had no meaningful impact on our earnings in the quarter. For the year-to-date, currency has been good and neutral to earnings.
Moving on to cash flow on Slide 7. The first thing I want to point out is our increasing cash flow guidance for full year from a range of $450 million to $550 million to a range of $550 million to $600 million. The midpoint of this revised guidance reflects an increasing cash generation of almost 60% compared to 2015. Higher earnings, stronger working capital performance and tight spending discipline were all contributors to the year-over-year increase and give us confidence that the higher level of cash generation we've seen through the first 3 quarters will continue through Q4.
Underpinning our confidence in cash generation is our success in reducing our Brazil exposure. Through September, we collected over $500 million of receivables in Brazil, reducing the outstanding receivable balance by over $200 million. By the end of 2016, we expect to have collected over $700 million of outstanding receivables in Brazil alone. Equally importantly, a significant proportion of the collections are coming from those accounts that were past due at the start of the year, improving the quality of the remaining receivables balance.
Our receivables balance in Brazil, however, remains higher than we believe it should be. And we expect to continue to reduce it over the coming seasons. Based on our current visibility, we believe that we have the ability to reduce the current balance by approximately $400 million. We will deliver this reduction over the next 18 to 24 months.
Our strong cash generation has helped us reduce our net debt by over $200 million so far this year, and we expect this to fall further by year-end. Combined with higher trailing EBITDA, our adjusted net debt-to-LTM EBITDA ratio will fall into the 2.5 to 3x range as we enter 2017. We will continue to manage our debt to a level consistent with our current credit rating.
And looking into 2017, we expect our capital expenditure to remain similar to '16, at or just ahead of depreciation, leaving allowance for our planned expansions in lithium hydroxide. We will continue to seek out opportunities to invest in technologies and products for our Ag Solutions business. And at an appropriate time in 2017, we would expect to revisit our ability to engage in share repurchases while maintaining our other net debt, credit rating and investment objectives.
And with that, I will turn the call back to Pierre."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Before closing, I would like to share a few initial thoughts regarding 2017 on Slide 8. Based on what we see today, we expect the global crop protection chemical market to be about flat in 2017, creating a more stable operating environment for FMC Ag Solu",901,"Before closing, I would like to share a few initial thoughts regarding 2017 on Slide 8. Based on what we see today, we expect the global crop protection chemical market to be about flat in 2017, creating a more stable operating environment for FMC Ag Solutions.
Market demand in Europe and Asia continues to grow, and more normal weather conditions should lead to an improved demand environment in those regions next year. While it remains very early to predict the market crop protection chemical in Latin America, we are quietly confident that we will enter 2017 with better market fundamentals than either of the previous 2 seasons.
In contrast, we expect market conditions in North America to remain challenging as we do not believe that the market-wide destocking process has run its course and that elevated levels of channel inventory, combined with low commodity prices, will dampen grower demand across the region.
In a flat market and assuming stable currencies, we believe Ag Solutions is well positioned to deliver another year of growth in segment earnings. Revenue synergy opportunities in Europe and North America, planned new product introductions and continued cost savings will more than offset cost inflation. Our preliminary view is that Ag Solutions' segment earnings will grow by high single-digit percent in 2017.
In Health and Nutrition. Next year, we expect growth rate for revenue and segment earnings to return to historical levels of low to mid-single-digit percent.
In Lithium, the combination of higher price, increased lithium hydroxide volume and continued cost discipline should increase segment earnings by about 40% in 2017. We expect to realize higher prices in all major downstream products next year, with the most significant increase in lithium hydroxide.
The majority of our lithium hydroxide contracts are negotiated in the fourth quarter. And based on the status of customer negotiations to date, we expect the average realized price to be significantly higher in 2017. We also expect to see a meaningful increase in the production of lithium hydroxide next year as a result of our previously announced capacity expansion. Construction of our hydroxide unit is ahead of schedule. Based on the current construction headlines, we expect production of lithium hydroxide to increase by 4,000 metric tons in 2017, with total production capacity decreasing -- increasing to 18,000 metric tons per year by the middle of next year.
Hitting the growth in demand for FMC's downstream lithium product requires access to increasing volume of lithium carbonate. Earlier this week, we announced an agreement with Nemaska Lithium to source 8,000 metric tons of lithium carbonate per year beginning in mid-2018. This agreement represents only one element of the sourcing strategy, and we are actively pursuing multiple path to diversify our carbonate source.
In the near term, we will increase capacity at our Argentina operations by approximately 20% through low-capital cost actions. We continue to evaluate long-term supply agreements and partnerships with other producers of lithium carbonate, and we retain the option of expanding our carbonate production operation in Argentina in order to ensure we have a secure, reliable and cost-competitive supply of lithium carbonate.
At the corporate level, we expect costs to remain roughly flat and to continue to reduce debt. Combined with the lower tax rate for 2017, as Paul mentioned earlier, we expect to grow EPS at a faster rate than we grow operating earnings.
Consistent with prior years, we will provide more details and specific guidance for 2017 in February when we report our Q4 and full year 2016 results as we first need to see how the year ends and assess business and market conditions at that time.
To conclude, I am very pleased with our performance in the quarter and year-to-date. In volatile markets, FMC has continued to execute its strategy and deliver substantial growth in earnings. I believe we are positioned to continue this in Q4 and beyond. We continue to invest in our technology pipeline in Ag Solutions and are launching new products that bring greater value to the grower.
Last month, we announced that FMC has begun the registration process in North America of our Bixafen fungicide, 1 of the 9 active ingredients in our R&D pipeline. With our unique, high-return R&D model for active ingredient innovation and strong regional formulation capabilities, FMC is well positioned to deliver the technology and service that growers demand. We will provide additional information regarding our technology pipeline in the coming months.
Health and Nutrition continues to generate high margins and strong cash flow, and demand across our core nutrition and health market continues to grow.  We are in the process of commissioning our new MCC production facility in Thailand, which will serve the growing nutrition market in Asia. Demand for our downstream lithium products continues to increase. FMC is well positioned to maintain its leading position in lithium hydroxide, butyllithium and lithium metals, and we continue to pursue multiple paths to diversify our sources of lithium carbonate to feed the expected growth in the business. Our agreement with Nemaska is just trusted, and we look forward to announcing more actions in 2017.
In closing, the actions we are taking will continue to drive performance across our businesses and position FMC to deliver increasing value to our shareholders into 2017 and beyond. I thank you for your attention this morning.
With that, I will turn the call back to the operator for questions."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] Our first question today comes from the line of Christopher Parkinson with Crdit Suisse.",16,"[Operator Instructions] Our first question today comes from the line of Christopher Parkinson with Crdit Suisse."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Your results far exceeded what your peers have been indicating for European crop protection growth, especially in 3Q. And you mentioned some things in your presentation such as direct market access across Eastern Europe and strong herbicide sales in the U",83,"Your results far exceeded what your peers have been indicating for European crop protection growth, especially in 3Q. And you mentioned some things in your presentation such as direct market access across Eastern Europe and strong herbicide sales in the U.K. But can you just talk a little more about the longer-term key drivers in the market, let's say, over the next 2 years? Are we in the early innings of the Eastern European theme? And what's the latest update on new registrations?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Chris, this is Mark. You highlighted the points that we put out in the release regarding how we grew in Europe. I think for us going forward in the next few years, it's very much what we've just said in terms of direct market access. We're very pleased wi",185,"Chris, this is Mark. You highlighted the points that we put out in the release regarding how we grew in Europe. I think for us going forward in the next few years, it's very much what we've just said in terms of direct market access. We're very pleased with what we see in Eastern Europe, but we're working off of a pretty small base. And we have just purchased the JV that we had in Czechoslovakia, Poland. It's important for us to expand in that area. But we shouldn't forget that France, Germany, the U.K., Spain, Italy, they're all important markets where we intend to put new products into the pipeline. We do have new products coming next year and the year after that are based upon our clomazone franchise for herbicides. So we expect to see significant growth in herbicides as we move forward. And in addition, with the acquisition of Cheminova, we've also, as we've said, expanded our fungicide portfolio. So you'll see us grow our European fungicide business substantially over the next 3 to 5 years. That's mainly the growth for us."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And, Chris, remember that many of the products FMC was selling in Europe are registered today in places like France, Italy, Spain, Portugal, Southern Europe, U.K. We were just not benefiting from a very strong sales organization as we were working with a",89,"And, Chris, remember that many of the products FMC was selling in Europe are registered today in places like France, Italy, Spain, Portugal, Southern Europe, U.K. We were just not benefiting from a very strong sales organization as we were working with a distribution network, which was mostly focused on Northern Europe. So even without adding many registrations, which we will and we have new product coming, we just have, in fact, to increase our face-to-face presence with the market is going to dramatically increase our ability to grow."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Great. And just a quick follow-up. Can you just also quickly comment on where you think the insecticide inventory issue in Brazil and how that may or may not affect the market heading into 2017? And also, you've seen some recent spikes in sugar and cotton",75,"Great. And just a quick follow-up. Can you just also quickly comment on where you think the insecticide inventory issue in Brazil and how that may or may not affect the market heading into 2017? And also, you've seen some recent spikes in sugar and cotton prices. Could you just quickly comment on the conversations you're having with those customers? As I imagine, they've been better than they have over the last couple of years."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think we are always very careful when we talk about the role of product inventory in the channel overall at the market level. But the situation in Brazil, including for insecticide, is right now feeling, I would say, more stable. As you can see, ye",165,"Yes. I think we are always very careful when we talk about the role of product inventory in the channel overall at the market level. But the situation in Brazil, including for insecticide, is right now feeling, I would say, more stable. As you can see, year-on-year numbers show a decrease in sales in addition to the progress utilization. So we believe there are actions which are being taken for insecticides and other product to decrease the level of inventory in the channel. The discussions with growers are better. There is -- they are easier on pricing. They are easier on term, and our volumes are more predictable. So we do believe it is decreasing. We don't believe it's decreasing fast enough to create a very robust 2017 number. But I would say we want to be entering 2017 in a more stable situation and more flattish market than we did in the previous 2 years. Mark, do you want to comment on the sugarcane?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, sure. Chris, when you mentioned cotton and sugarcane, obviously, important crops for FMC down in Brazil. I'm more confident in sugarcane than I am in cotton. As we've talked about and Paul alluded to in terms of collections, we've been very prudent i",217,"Yes, sure. Chris, when you mentioned cotton and sugarcane, obviously, important crops for FMC down in Brazil. I'm more confident in sugarcane than I am in cotton. As we've talked about and Paul alluded to in terms of collections, we've been very prudent in our exposure to certain areas of Brazil and, certainly, in crops. I would say the cotton growers have faced a very tough time in the north due to the drought. So liquidity is important for them, and we're watching that situation very carefully. Acres are expected to be flat to slightly down in Brazil as we go forward into the next season. Switching to sugarcane, you're right, sugar prices are at least double where they were last year. Ethanol prices were up in Brazil. So the fundamentals for the business is good. The one thing they are lacking right now is liquidity, given all the debts they've incurred over the last few years. We're ideally positioned. We have strong market shares in insecticides and herbicides. Planting is down right now, probably about 30% due to that liquidity. But I think as the business unwinds next year, I'm very confident that our sugarcane business will grow next year and be a good buffer for some of the other downsides we might see in cotton."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Just to repeat, Chris, I want to use your question to make sure that we are clear, but we are continuing with the strategy. It's a different strategy, but really, we are not focused on volume at all today. I mean, what is very important for us today is pr",103,"Just to repeat, Chris, I want to use your question to make sure that we are clear, but we are continuing with the strategy. It's a different strategy, but really, we are not focused on volume at all today. I mean, what is very important for us today is pricing our technology, where it should be priced; decreasing the level of our products in the channel; getting terms which are right; and collecting. We believe the market is such that -- this is the right strategy, which will make us much stronger when we get to a situation where the market turns around."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Our next question today comes from the line of Daniel Jester with Citi.",13,"Our next question today comes from the line of Daniel Jester with Citi."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Maybe I can just follow up on Chris' question in a different way. I think you said that low-margin product in Brazil, which you're exiting, attributed to 60% of the volume decline in the quarter. So maybe can we just talk about what's driving this 40% of",53,"Maybe I can just follow up on Chris' question in a different way. I think you said that low-margin product in Brazil, which you're exiting, attributed to 60% of the volume decline in the quarter. So maybe can we just talk about what's driving this 40% of the rest of the volume decline?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","There is 2 things which are driving the remaining 40%. First of all, we believe -- and we'll confirm that at the end of the fourth quarter, but we are believing that -- we believe that we are in a situation in Brazil where the market will still be down in",157,"There is 2 things which are driving the remaining 40%. First of all, we believe -- and we'll confirm that at the end of the fourth quarter, but we are believing that -- we believe that we are in a situation in Brazil where the market will still be down in the 10% range year-on-year for the full year. So there is a market driver. There is also the fact that we are moving away from sales, not because of rationalization but because of credit risks or term. We are very cautious in not selling for the sake of selling. We are selling when we know we can get normal terms for the region and we will be able to collect. So as I said before, volume is not the priority. So those are the 3 reasons: sales, which are fixed with good terms; market, which will decline; and product rationalization. Those are the 3 drivers."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. That's helpful. And then I think you also commented that operating margins in Brazil are sort of approaching where you were in 2014. But I think for the Ag segment as a whole, margins are still below 2014 levels. So can you comment on the other regi",62,"Okay. That's helpful. And then I think you also commented that operating margins in Brazil are sort of approaching where you were in 2014. But I think for the Ag segment as a whole, margins are still below 2014 levels. So can you comment on the other regions and where you see margins stay and how maybe they can improve into 2017?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think that if you look at when we made the acquisition of Cheminova, acquiring Cheminova would bring to us many benefits in terms of creating more global business, a broader fungicide portfolio, a direct access to markets in Europe and other benefi",228,"Yes. I think that if you look at when we made the acquisition of Cheminova, acquiring Cheminova would bring to us many benefits in terms of creating more global business, a broader fungicide portfolio, a direct access to markets in Europe and other benefits, more fully the performance in -- more fully in market presence in India and Australia. But we also realized that the margins Cheminova was realizing were not at the level of what we're expecting. And we had a plan to bring those margins through cost saving, pricing and new product introduction due to at least the recall level of FMC. And that's the road we are on. I have to say that despite the market conditions, 1.5 years after closing on the Cheminova acquisition, we have brought back those margins to 20%, which is well -- for the fourth quarter, which is well in line, even ahead, of our schedule. We still have work to do. We still have remember. We still have additional costs to extract from the business from the acquisition in the next 6 to 9 months. So we still have work. But we are well on our way to margin north of 20%. It is just the integration of Cheminova, the pricing of the technology and the new product introduction, but we are well on that road map right now."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","We'll go to the line of Mike Harrison with Seaport Global.",12,"We'll go to the line of Mike Harrison with Seaport Global."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Eric, I was wondering if you could talk a little bit about the cost structure and some of the key margin drivers that you saw in Health and Nutrition this quarter. Did we see any of the variance impacts during this quarter that you mentioned you're going",54,"Eric, I was wondering if you could talk a little bit about the cost structure and some of the key margin drivers that you saw in Health and Nutrition this quarter. Did we see any of the variance impacts during this quarter that you mentioned you're going to be seeing in the fourth quarter?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Eric here. So it's a complicated question because the costs that flow through in any 1 quarter are related to a variety of factors, where a lot of it is stemming from manufacturing excellence programs, same-store so that's a sustainable component. However",144,"Eric here. So it's a complicated question because the costs that flow through in any 1 quarter are related to a variety of factors, where a lot of it is stemming from manufacturing excellence programs, same-store so that's a sustainable component. However, as we talked about in the guidance Pierre gave for the fourth quarter, we'll see benefits stem from things such as seasonality and how we harvest seaweed, right? There are times of the year, particularly off the coast of Norway, where we get a higher-quality seaweed, we have more access to the waters because of the favorable weather, what have you, that drive one-off opportunities in costs, and that -- and where our variances work, that flows through. And it's part of the benefit we see in the fourth quarter. I want to make sure, does that answer the question you're after?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Mike, maybe to answer a little bit more your question, if you look at previous years, it is not an abnormal situation to see -- you could see it maybe not at the same extent, but you can see it to the 2015 results, where you would see higher margin in Q4",106,"Mike, maybe to answer a little bit more your question, if you look at previous years, it is not an abnormal situation to see -- you could see it maybe not at the same extent, but you can see it to the 2015 results, where you would see higher margin in Q4 than you would see in Q3. So we realized over the year a 25% margin for the business. But we recognize that there is some seasonality to margin in this business. So there is not always a connection between a margin improvement you will see in Q4 and what you could realize in Q3."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Yes. I guess the question that I had, Eric, also had to do with the weakness in volumes during the third quarter, yet you were able to show pretty nice margin improvement. I was wondering if there was some variability around the costs or if this was struc",57,"Yes. I guess the question that I had, Eric, also had to do with the weakness in volumes during the third quarter, yet you were able to show pretty nice margin improvement. I was wondering if there was some variability around the costs or if this was structural cost takeout that was really driving the margin improvement."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, I would say it's more of the latter. The structural improvements we've made is nothing unique about what's happened sequentially from 1 quarter to the next. Volumes were lower for the reasons Pierre referenced, omega-3, as well as some timing in our",107,"Yes, I would say it's more of the latter. The structural improvements we've made is nothing unique about what's happened sequentially from 1 quarter to the next. Volumes were lower for the reasons Pierre referenced, omega-3, as well as some timing in our health business. But the cost side of that is pretty consistent. It's a structural component that gets us to a sustainable margin that's in the mid-20s, notwithstanding the occasional, and what we've seen in prior quarters, benefit we can make in certain quarters like the fourth quarter that are not benefits you roll forward into the first or second quarters of the following year."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","All right. Then I had a question on the Lithium business. Can you comment on what you were seeing in price activity sequentially across different products?",26,"All right. Then I had a question on the Lithium business. Can you comment on what you were seeing in price activity sequentially across different products?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think I'll have Tom commenting more on the pricing. But right now, if you look, we had a lot of benefits from pricing on lithium carbonate up to now and maybe less of a pricing benefit of lithium hydroxide. We are now getting into the period of new",120,"Yes. I think I'll have Tom commenting more on the pricing. But right now, if you look, we had a lot of benefits from pricing on lithium carbonate up to now and maybe less of a pricing benefit of lithium hydroxide. We are now getting into the period of new contract negotiations of lithium hydroxide, which will impact mostly 2017. So directionally, what we do expect is we do expect to start to see a very significant ramp-up in lithium hydroxide pricing, which is very much in line with the negotiation we are having, while we will see maybe a more stable pricing in lithium carbonate potentially lowering into 2017. Tom, you want to add some more color to that?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. Just to give a little more color to that, on hydroxide, the contract negotiations are proceeding well, and over the coming month, they should be all solid. We're progressing well through those. And on the carbonate, as most of the folks saw in the ma",113,"Yes. Just to give a little more color to that, on hydroxide, the contract negotiations are proceeding well, and over the coming month, they should be all solid. We're progressing well through those. And on the carbonate, as most of the folks saw in the market, there was a little bit of softening in Q3, particularly in China. What we'll see going into next year is the smaller volume of carbonate that was locked in at lower prices similar to the hydroxide will come up. And we expect some softening on the top end. So net-net, we'll go into next year on those more opportunistic product lines kind of flat to slightly down."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And the big story, once again, for us, I mean, because of the strategic focus, because of the timing of where we are in contract negotiations and increasing capacity coming up next year, the big focus for us and where you're going to see the largest contr",53,"And the big story, once again, for us, I mean, because of the strategic focus, because of the timing of where we are in contract negotiations and increasing capacity coming up next year, the big focus for us and where you're going to see the largest contributor to earnings growth is lithium hydroxide."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And next, we'll go to the line of Don Carson with Susquehanna.",12,"And next, we'll go to the line of Don Carson with Susquehanna."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Ben Richardson sitting in for Don. Just sticking on -- with the topic of lithium. You say you're ahead of schedule with the ramp there. Can you just maybe speak to the timing of that additional tonnage?",39,"This is Ben Richardson sitting in for Don. Just sticking on -- with the topic of lithium. You say you're ahead of schedule with the ramp there. Can you just maybe speak to the timing of that additional tonnage?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. What we -- we're expecting the mechanical completion of the plants. I had the pleasure actually to be there 2 weeks ago and see the plants looking really good. We expect the mechanical completion of the plants in the fourth quarter this year. We're g",139,"Yes. What we -- we're expecting the mechanical completion of the plants. I had the pleasure actually to be there 2 weeks ago and see the plants looking really good. We expect the mechanical completion of the plants in the fourth quarter this year. We're going to be able to start to add products coming out of the plants in the first quarter, and then we're going to start to enter the customer qualifications of the products. So we believe we'll be in a commercial situation where the products are produced by the plant, by the expansion and qualifying the customer by the middle of the year. So the 8,000 metric ton capacity we have for next year should give to us a 4,000 additional tons of products into 2017 and the full 8,000 when we get into 2018."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And I guess, though, slipping back to Ag and, specifically, potential divestitures in your space and how you see that developing.",22,"Okay. And I guess, though, slipping back to Ag and, specifically, potential divestitures in your space and how you see that developing."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","We are in contact with our -- with any of the companies which are currently consolidating, and we are standing ready to participating in the purchase of any molecule -- any of this company would be divesting if they meet our portfolio. I have to say that",103,"We are in contact with our -- with any of the companies which are currently consolidating, and we are standing ready to participating in the purchase of any molecule -- any of this company would be divesting if they meet our portfolio. I have to say that so far, we haven't seen anything which would be critical to our portfolio or any significant technology put on the market. But I think those companies are still in the -- in an early stage of the antitrust reviews. So we are standing ready but haven't seen anything right now which has been attractive to us."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And our next question is from the line of Joel Jackson representing BMO Capital Markets.",15,"And our next question is from the line of Joel Jackson representing BMO Capital Markets."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Milan on for Joel. I mean, just following up there on the acquisitions. I mean, if you are to pursue something, can you maybe give us -- perhaps put some numbers around magnitude? And what would be the funding? I mean, what sort of leverage would",56,"This is Milan on for Joel. I mean, just following up there on the acquisitions. I mean, if you are to pursue something, can you maybe give us -- perhaps put some numbers around magnitude? And what would be the funding? I mean, what sort of leverage would you be comfortable going back up to potentially?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I'll first talk to the leverage. The size -- I mean, really, I would not like to speculate here on the results of any antitrust reviews and what could be the consequences in terms of what product would be for sale and what would be the price. So of course",108,"I'll first talk to the leverage. The size -- I mean, really, I would not like to speculate here on the results of any antitrust reviews and what could be the consequences in terms of what product would be for sale and what would be the price. So of course, we do our own work to be ready and try to anticipate, but that's only speculation on our part to stand ready. But it's very hard to tell until the antitrust process in each of the regions is taking place and having the companies making decisions around their portfolio. Paul, you want to talk about the leverage?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Sure. Just again, to Pierre's point, it's difficult to be particularly satisfying to you with the answer without any real specifics. But I think it's fair to say, I think you've seen from my cash flow performance, we are generating a fairly good cash righ",165,"Sure. Just again, to Pierre's point, it's difficult to be particularly satisfying to you with the answer without any real specifics. But I think it's fair to say, I think you've seen from my cash flow performance, we are generating a fairly good cash right now. We're deleveraging quickly. One of the characteristics -- because we bought products like this frequently in the past, one of the key characteristics is that they are typically very cash generative from day 1. And so they can stand a pretty decent amount of leverage from day 1. We also are very disciplined on price. Based on everything we can see, we don't see any risk to our credit rating from a cash acquisition of any of the available interesting assets that are out there right now. Again, that could change depending on what assets come available. But we don't see any particular challenge to our balance sheet based on the opportunities that are available that we see today."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","And maybe just switching to omega-3, you talked about some abating headwinds going into next year. I mean, is the environment more competitive, equally competitive, less competitive than you were perhaps seeing last quarter and going into '17?",39,"And maybe just switching to omega-3, you talked about some abating headwinds going into next year. I mean, is the environment more competitive, equally competitive, less competitive than you were perhaps seeing last quarter and going into '17?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Omega-3 is a -- how do we say, it is not getting worse, but it is not getting better. I think it's a challenging environment. Right now, we are focusing on actions for us to leverage some of the manufacturing capability and quality of product, especially",202,"Omega-3 is a -- how do we say, it is not getting worse, but it is not getting better. I think it's a challenging environment. Right now, we are focusing on actions for us to leverage some of the manufacturing capability and quality of product, especially the fact that we have no way made product which have very high quality and commend a premium, to try to improve a situation. But frankly, at that stage, with the oversupply there is in this market and the number of players, the improvements you will see on omega-3 will be driven by the work we do commercially and cost-wise more than us benefiting from the market. We are very -- when we've -- when we announced the numbers for expected growth for the Health and Nutrition business next year, we are very, I would say, prudent around putting into those numbers any significant improvement in the omega-3 market, which we do not see. So it is a challenge. We're addressing it. We are trying to -- we are in -- I would say, right now, I have to admit we are more in damage control than expecting growth. But that's the situation for omega-3."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Steve Byrne with BofA.",12,"Our next question comes from the line of Steve Byrne with BofA."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Ian sitting in for Steve. Cash flow generation has been very, very good this year, and I appreciate the comments about some of the collections in Brazil. And looking forward to 2017, provided some preliminary guidance about expecting earnings grow",57,"This is Ian sitting in for Steve. Cash flow generation has been very, very good this year, and I appreciate the comments about some of the collections in Brazil. And looking forward to 2017, provided some preliminary guidance about expecting earnings growth, should cash from operations grow at the same level of earnings or higher or lower?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think you heard in my comments, we talked about probably still about $400 million of excess receivables sitting on our balance sheet related to Brazil. And we'd certainly expect to start to collect a significant proportion of those next year. So gi",123,"Yes. I think you heard in my comments, we talked about probably still about $400 million of excess receivables sitting on our balance sheet related to Brazil. And we'd certainly expect to start to collect a significant proportion of those next year. So given that, we would expect the cash flow to continue to grow really similar like to what -- how it did this year. We'll generate high EBITDA. We do not expect to have any meaningful cash outflows for CapEx over and above what we have today. And we expect to continue to decapitalize our balance sheet in Brazil. So yes, I would expect cash flow to continue to grow next year just as strong as it had been this year."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","And as a follow-up, just kind of on the broader market. What -- for Ag, specifically in Latin America, what things would you be looking for to potentially become more optimistic about a rebound in that region? I think sales are still far below prior level",56,"And as a follow-up, just kind of on the broader market. What -- for Ag, specifically in Latin America, what things would you be looking for to potentially become more optimistic about a rebound in that region? I think sales are still far below prior levels of peak. What does the industry need to see?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Well, I think for me, there's a couple of things. First of all, on the macro level, obviously, if commodity prices start to come back, we're going to see expanded acres down in Brazil for a lot of the row crops. That's one factor. Then the second factor i",154,"Well, I think for me, there's a couple of things. First of all, on the macro level, obviously, if commodity prices start to come back, we're going to see expanded acres down in Brazil for a lot of the row crops. That's one factor. Then the second factor is just the internal health of that business in the sense of where channel inventories are, pest pressures, the normal seasonal-to-seasonal activity in Ag. I think if you can get those things coming together, you're going to see somewhat of a rebound in the marketplace. The pest pressures, obviously, nobody knows where the pest pressures are going to lie. Commodity prices are going to take some change in overall yields in North America and Latin America. So we said what we feel the market will be next year. Those will be the 2 items, in Brazil, in particular; and potentially, Argentina that would change that picture."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","The one thing I'd just add to that, I think having a stable macro political environment and improved access to credit for the growers will be a positive if we see that start to happen as well.",38,"The one thing I'd just add to that, I think having a stable macro political environment and improved access to credit for the growers will be a positive if we see that start to happen as well."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Our next question is from the line of Mark Connelly with CLSA.",12,"Our next question is from the line of Mark Connelly with CLSA."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, last quarter, you talked about some optimism in your outlook comments for Health and Nutrition but not about seasonality in Q3 and Q4. What I'm wondering is, do you think you have the right mix of products for what customers are looking to do with",65,"Pierre, last quarter, you talked about some optimism in your outlook comments for Health and Nutrition but not about seasonality in Q3 and Q4. What I'm wondering is, do you think you have the right mix of products for what customers are looking to do with their products over the next couple of years? Or do you need to tweak your portfolio, leaving Omega-3 aside?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","That's a very good question. And I'd tell you, it's a difficult one to answer. I believe that we have a very solid position in MCC, alginate and carrageenan. I do believe that we have the right formulation technology allowing us to meet the changing need",279,"That's a very good question. And I'd tell you, it's a difficult one to answer. I believe that we have a very solid position in MCC, alginate and carrageenan. I do believe that we have the right formulation technology allowing us to meet the changing need of the market and the customers. The question for us is -- and that's a business. Today, if you put omega-3 aside, we have strong market share, and we are the leading supplier in the place where our customers go today when they have the need for new product or new technology. So I believe this is a business which will for the next 2, 3 years continue to grow in the mid-single-digit, as we said in the guidance, with very strong margin, 25%, and good cash generation. So to answer your question, I'm quite confident around that business for the next 2 to 3 years. We do have interesting new ideas based on the current product we have for new technology, for some of the changing market needs around health and other applications. The question for me is more 3 years and beyond. And really, where do we want to take that franchise? We have great product today. We have great margin and good cash generation. The first attempt to do that was omega-3. I think we didn't do a good job there. The question is what we want the business to be, not in next 2, 3 years but beyond that. So to answer your question, yes, for the next 2, 3 years. Beyond that, we need a lot of work to define the midterm strategy for Health and Nutrition."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. That's super helpful. And if I could just come back, I hate to beat on the working capital issue, but just a clarification. Of the additional $400 million and everything else you're doing down there, are your credit practices in Brazil going to be m",71,"Okay. That's super helpful. And if I could just come back, I hate to beat on the working capital issue, but just a clarification. Of the additional $400 million and everything else you're doing down there, are your credit practices in Brazil going to be materially different than legacy FMC? Or is this just a matter of we've got the Cheminova cleanup and better execution, well, and customers in better shape?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","So the first thing I would say, though, is when we look back at the position that we find ourselves in, in Brazil, much of it is driven by similar comments that Pierre talked about, about changing the way we approach the business. And instead of focusing",224,"So the first thing I would say, though, is when we look back at the position that we find ourselves in, in Brazil, much of it is driven by similar comments that Pierre talked about, about changing the way we approach the business. And instead of focusing on volume and volume growth and share growth, focusing on getting the maximum value. An important part of that is assessing the quality of the customer and the quality of the products that we sell. We do not expect to be in a meaningfully different place in terms of terms, in terms of structure, in terms of credit that we extend to customers, to either history or the rest of the market. But we will be much more and we are being much more disciplined about where we're willing to take exposure. It's really a function of multiple factors. It's a function of the movement in commodity prices. It's a function of the weaker access to credit for the growers down there in the market. And it is, to an extent, a function of our ability to integrate the Cheminova portfolio and have a higher margin, more technical portfolio really across all regions and all crops. So it's more than one factor that's driving this, this move towards a stronger credit position with our customers down there."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I think, generally speaking, the crop chemical industry as a whole, first, and all of our peer companies, it is an industry which is in Latin America and Brazil, which has been historically focused on growth and maybe a bit more open to taking risk to gai",125,"I think, generally speaking, the crop chemical industry as a whole, first, and all of our peer companies, it is an industry which is in Latin America and Brazil, which has been historically focused on growth and maybe a bit more open to taking risk to gain market share. And we are there with all of our competitors. I do think today, we might have a strategy without fundamentally changing what we've done to be more careful for the foreseeable future. I think it's important. It's working for us. And it's allowing to collect, to price. Our customers want our product. So we're going to be maybe on the lower end of the risk taking without fundamentally changing the way we look at other receivables."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And we have a question from the line of Dmitry Silversteyn with Longbow Research.",14,"And we have a question from the line of Dmitry Silversteyn with Longbow Research."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","A couple of follow-ups, if I may. First of all, with regards to your announced deal for 8,000 tons of carbonate that you're going to be getting from your new partner, is that pretty much all of their capacity or -- and you do have the right to all of that",59,"A couple of follow-ups, if I may. First of all, with regards to your announced deal for 8,000 tons of carbonate that you're going to be getting from your new partner, is that pretty much all of their capacity or -- and you do have the right to all of that capacity? Or is there more behind that?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","The 8,000 tons is -- when you say their capacity, it's not their -- it's our capacity, I mean, this plant. If you talk about the expansion in China, this plant...",32,"The 8,000 tons is -- when you say their capacity, it's not their -- it's our capacity, I mean, this plant. If you talk about the expansion in China, this plant..."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","In Nemaska.",2,"In Nemaska."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Oh, in Nemaska, okay.",4,"Oh, in Nemaska, okay."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, Dmitry, this is Tom. I can take that. Nemaska's installed capacity will be 28,000 tons. So it will be a meaningful part of their capacity, but it will not by any means be all of their capacity.",38,"Yes, Dmitry, this is Tom. I can take that. Nemaska's installed capacity will be 28,000 tons. So it will be a meaningful part of their capacity, but it will not by any means be all of their capacity."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And I'm assuming you have some way of getting more if you need more either from these guys or from other sources as you move past 2018, 2019.",29,"Okay. And I'm assuming you have some way of getting more if you need more either from these guys or from other sources as you move past 2018, 2019."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Well, with respect to that, as Pierre outlined in his comments, we've got a multipronged strategy where we're continually evaluating, one, how do we diversify, have security of supply, low-cost supply. So we're not quite ready to announce the other pieces",62,"Well, with respect to that, as Pierre outlined in his comments, we've got a multipronged strategy where we're continually evaluating, one, how do we diversify, have security of supply, low-cost supply. So we're not quite ready to announce the other pieces coming, but there'll be multiple components to that, including our own investments in our facilities as well as working with others."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I think it's important in all of these discussions, we have this Nemaska agreement. We are in current discussions with some other suppliers of carbonate for partnership. But let's not forget that there is one aspect for which we have 100% of the decision,",129,"I think it's important in all of these discussions, we have this Nemaska agreement. We are in current discussions with some other suppliers of carbonate for partnership. But let's not forget that there is one aspect for which we have 100% of the decision, it is expanding in Argentina. We can expand in Argentina. We do have the mines. We do have the capability. We have the infrastructure. So it is a decision we can make. I have to admit that I'm not in a rush to make that decision because with all of the companies today investing in lithium carbonate, I believe there will be plenty of lithium carbonates for the next 2, 3, 4 years. But this is a decision we can make at any time."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And you actually kind of led into my next question, Pierre. This 20% debottlenecking expansion that you're undertaking in Argentina, what's the timing for that to come online? Is that a back end of 2017 as well?",38,"Okay. And you actually kind of led into my next question, Pierre. This 20% debottlenecking expansion that you're undertaking in Argentina, what's the timing for that to come online? Is that a back end of 2017 as well?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. This is going to start right now. I mean, we're going to see this capacity of carbonate coming in at some point during 2017, 2018. So this is undertaken right now. It is low capital and normal debottlenecking. The team has been working, and we have,",71,"Yes. This is going to start right now. I mean, we're going to see this capacity of carbonate coming in at some point during 2017, 2018. So this is undertaken right now. It is low capital and normal debottlenecking. The team has been working, and we have, I think, 3 work streams, which are allowing us to get to these kind of numbers. But it's more routine capital expansion, I mean."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. And, Dmitry, just to give you a little more color on that. There's multiple components to that. So there are some operational efficiency changes. There are some low-capital projects. There's a number of small projects that over the course of '17 and",48,"Yes. And, Dmitry, just to give you a little more color on that. There's multiple components to that. So there are some operational efficiency changes. There are some low-capital projects. There's a number of small projects that over the course of '17 and '18 will add to that."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","So it sounds like your -- if I do my math right, your Argentinian production will go up to about 21,000 tons. Is that about right?",26,"So it sounds like your -- if I do my math right, your Argentinian production will go up to about 21,000 tons. Is that about right?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, that's correct.",3,"Yes, that's correct."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then final question on the crop protection business and sort of -- your margins have been, in the past, very differentiated between a sort of 25% level in the first half of the year and kind of a 20% level in the second half of the year, given w",153,"Okay. And then final question on the crop protection business and sort of -- your margins have been, in the past, very differentiated between a sort of 25% level in the first half of the year and kind of a 20% level in the second half of the year, given where the regions that you get your sales from. This year, obviously, has been distorted by everything that's going on. So it's going to be more like first half and second half will be more or less even in terms of margins. As the business gets back to sort of normal execution, how do we think about 2017 margin cadence? Should we expect sort of a 3- to 4-point margin difference between the first half and the second half of the year? Or is it going to be more like this year, where margins are a little bit more even between the quarters?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. We're going to get into it next year. And once again, it's a bit early for us to break down by quarter. We've given a directional number. But yes, the profile of the margins and the business is going to change versus historical FMC just because we ha",162,"Yes. We're going to get into it next year. And once again, it's a bit early for us to break down by quarter. We've given a directional number. But yes, the profile of the margins and the business is going to change versus historical FMC just because we have a very different regional profile. I mean, remember, we are very small in Europe. We want to be much bigger in Europe where there is good marginal business. So I would say that directionally, we should have less variation in our quarterly margins than we had in the past. Now there is 2 things happening today is, there is the market situation. There is a different approach we are taking to the Latin America market, and there is the cost synergies, which are growing quarter-after-quarter. So that is taking us to improved margin and taking us to the 20% range. But I would say, in the future, you'll have more stable margin quarter-over-quarter."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","We have time for one more question today, and that will come from the line of Robert Koort with Goldman Sachs.",21,"We have time for one more question today, and that will come from the line of Robert Koort with Goldman Sachs."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Chris Evans on for Bob. In Lithium, specifically, pretty -- 40% earnings growth assumption for '17. I think you mentioned earlier kind of a low -- flat to down expectation for pricing in carbonate. Can you kind of give the other expectations that",51,"This is Chris Evans on for Bob. In Lithium, specifically, pretty -- 40% earnings growth assumption for '17. I think you mentioned earlier kind of a low -- flat to down expectation for pricing in carbonate. Can you kind of give the other expectations that are driving that assumption for '17?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I would say -- well, first, if you look at our business in '17, we're expecting to be -- and Tom, correct me if I'm a bit off here, but I would say almost 90% of our business revenues being on the specialty side, the downstream, and only 10% on the upstre",189,"I would say -- well, first, if you look at our business in '17, we're expecting to be -- and Tom, correct me if I'm a bit off here, but I would say almost 90% of our business revenues being on the specialty side, the downstream, and only 10% on the upstream, which is carbonate and fluoride. So we're going to be even more dependent upon the price, the downstream business. We are expecting, I would say, little benefit from carbonate chloride pricing knowing that it's only a small percentage of our business, and we believe this pricing is going to level off in 2017. So you would consider the 40% improvement is going to mostly come from 2 things, pricing in lithium hydroxide and volume in lithium hydroxide. You will understand that I'm going to be a bit careful on what I'm expecting in terms of lithium hydroxide price increase because we are in the middle of the bunch of contract negotiations. So I'll -- we will give you more detail around pricing when we get to the February earnings call, because those negotiations will be behind us."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And just to add a little bit more color to that. I mean, you have to realize that most of our specialty business is contracted in the prior year. So when we contracted a lot of that, it was before we saw how strong the pricing had moved across the market",67,"And just to add a little bit more color to that. I mean, you have to realize that most of our specialty business is contracted in the prior year. So when we contracted a lot of that, it was before we saw how strong the pricing had moved across the market overall. So there's a little bit of catch-up that's happening across all of the specialty products."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","And just on the supply agreements to feed your hydroxide ramp, should we expect the additional volumes to come from new entrants like Nemaska? Or do you expect from existing brine or hard rock producers?",35,"And just on the supply agreements to feed your hydroxide ramp, should we expect the additional volumes to come from new entrants like Nemaska? Or do you expect from existing brine or hard rock producers?"
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. So of course, when you look at a supply of carbonate to feed growth, you want to be certain that you have the appropriate mix of new entrants and established players. So we will not -- having a strategy to supply carbonate into our business based onl",144,"Yes. So of course, when you look at a supply of carbonate to feed growth, you want to be certain that you have the appropriate mix of new entrants and established players. So we will not -- having a strategy to supply carbonate into our business based only or mostly on new entrants in this market. Nemaska, we believe, is one of the most solid today, with one of the best sources of lithium. So we believe it's a fairly certain supply we're going to get from them. But we will do 2 things. One is supply from existing suppliers, and not to forget that some of them are already supplying to us carbonate. And a similar goal, to repeat, we can also increase our own capacity of carbonate, which is something if we decide to do it, there will be a short supply."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Well, we appreciate your time. That's all the time we have for the call today. As always, I'll be available on the call for any additional questions you may have. Thank you.",32,"Well, we appreciate your time. That's all the time we have for the call today. As always, I'll be available on the call for any additional questions you may have. Thank you."
28606,403765323,1072490,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","That concludes the FMC Corporation Third Quarter 2016 Earnings Release Conference Call. Thank you.",14,"That concludes the FMC Corporation Third Quarter 2016 Earnings Release Conference Call. Thank you."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Good morning, and welcome to the Third Quarter 2016 Earnings Release Conference Call for the FMC Corporation. [Operator Instructions]I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Ang",42,"Good morning, and welcome to the Third Quarter 2016 Earnings Release Conference Call for the FMC Corporation. [Operator Instructions]
I will now turn the conference over to Mr. Brian Angeli, Vice President, Investor Relations for FMC Corporation. Mr. Angeli, you may begin."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Thank you, and good morning. Welcome to FMC Corporation's Third Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer. Pierre",270,"Thank you, and good morning. Welcome to FMC Corporation's Third Quarter 2016 Earnings Call. Joining me today is Pierre Brondeau, President, Chief Executive Officer and Chairman; and Paul Graves, Executive Vice President and Chief Financial Officer. Pierre will begin the call with a review of FMC's third quarter performance and discuss the outlook for Q4 and full year 2016. Paul will provide an overview of select financial results.
The slide presentation that accompanies our results, along with our earnings release and 2016 outlook statement, are available on our website, and the prepared remarks from today's discussion will be made available at the conclusion of the call.
As with our prior calls, Mark Douglas, President, FMC Agricultural Solutions; Eric Norris, President, FMC Health and Nutrition; and Tom Schneberger, Vice President and Global Business Director, FMC Lithium, will join to address questions.
Before we begin, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including, but not limited to, those factors identified in our release and in our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based upon these risks and uncertainties.
Today's discussion will focus on adjusted earnings for all income statement and EPS references and pro forma revenue and segment earnings for FMC Agricultural Solutions. A reconciliation and definition of these terms as well as other non-GAAP financial terms to which we may refer during today's conference call are provided on our website.
With that, I will now turn the call over to Pierre."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Brian, and good morning, everyone. Q3 2016 was another strong quarter, reflecting the continued execution of our strategy. FMC reported revenue of $808 million, adjusted operating profit of $134 million and adjusted EPS of $0.67. Adjusted EPS i",1470,"Thank you, Brian, and good morning, everyone. Q3 2016 was another strong quarter, reflecting the continued execution of our strategy. FMC reported revenue of $808 million, adjusted operating profit of $134 million and adjusted EPS of $0.67. Adjusted EPS increased approximately 60% compared to the third quarter of 2015, exceeding the top end of our guidance range of $0.53 to $0.63.
Our performance for the quarter was driven largely by the results of Ag Solutions and Lithium, both of which reported a significant year-over-year increase in segment earnings.
In Ag Solutions, compared to last year, we saw an improved start of the season in Latin America, especially in Brazil, a stronger performance in both Asia and North America. Lithium continued to benefit from higher prices, improved mix and lower operating costs. Third quarter segment earnings in Health and Nutrition varied -- were slightly below 2015 but in line with our expectations.
The lower tax rate in the quarter contributed approximately $0.03 to adjusted EPS. As noted in our outlook statement, and as Paul will discuss later in the call, we expect to continue to report a lower tax rate for the remainder of the year and into 2017.
Based on our performance in the third quarter and on our outlook for Q4, we are revising the range of our full-range adjusted EPS guidance to $2.76 to $2.86 per share. At the midpoint, this represents an increase of $0.06 per share compared to the prior period and an increase of $0.14 compared to adjusted EPS for 2015. I will provide more detail on the outlook for Q4 shortly. But first, I will discuss third quarter results for each of our 3 segments, starting with Ag Solutions on Slide 2.
For the third quarter, Ag Solutions reported revenue of $559 million and segment earnings at the top of our guidance range of $90 million. Compared to the third quarter 2015, revenue declined 3%, as lower sales volume in Brazil more than offset the benefit of higher prices in that country and volume growth in other regions.
Year-over-year price increases were largest in Brazil, where we continue to recover pricing in U.S. dollar terms. Segment earnings increased over 50%, and margin improved 600 basis points, as higher realized prices, improved mix and favorable foreign exchange more than offset the impact of lower volumes and slightly higher costs in the quarter.
Costs were higher, principally as the result of the timing between quarters of certain expenses. For the full year, we remain on track to achieve our integration cost savings target.
Turning to Slide 3. I will provide additional comments on Ag Solutions' regional performance and discuss the outlook for Q4, starting with Latin America.
Revenue in the region declined 18% in the quarter, driven largely by lower sales volumes in Brazil. General market weakness, ongoing product rationalization efforts and our decision to allow channel inventory levels to reduce each contributed to the decline in sales volume in Brazil. The elimination of low-margin third-party products accounted for over 50% of the volume decline in the quarter.
Revenue in the rest of Latin America was roughly flat compared to 2015. In Argentina, we continued to see increasing demand for FMC's Authority herbicides. In Mexico, our focus on high-value crops is helping to offset the impact of a broader market decline.
The actions we have taken throughout the past year in Brazil enabled us to realize significant increases in U.S. dollar-based prices, improve operating margin and drive collections in the quarter. Price actions increased operating earnings in Brazil by about 30% year-over-year, which, combined with lower operating costs, returned operating margins to 2014 levels.
Our actions in Brazil also enabled the business to reduce accounts receivables in the country and generate cash collections of over $200 million, a significant improvement over our performance in the same quarter last year.
Moving on to Asia. Revenue in the region grew by 9% in the quarter compared to 2015, driven mainly by increased sales volume throughout the region. Improving weather conditions in Australia created strong demand for all-grade herbicide and for our fungicide portfolio. A return to a more normal monsoon season in India and Southeast Asia supported increased demand for insecticide and fungicide, with strong growth in Indonesia for rice applications.
In Europe, revenue increased 6% in the quarter. Increased sales synergies and higher volume in Eastern Europe as we expand our direct market access, coupled with strong herbicide sales in the U.K., more than offset challenging conditions in Northwest Europe.
In North America, revenue in the quarter increased 46% to 2015. We saw higher sales volumes related to new product introductions for winter and spring wheat and increased demand for herbicide.
Looking ahead to Q4, we expect market conditions to remain largely unchanged. We are cautiously optimistic regarding Q4 in Latin America given the start of the selling season in Brazil and strong demand for FMC product elsewhere in the region. However, we are more cautious on market conditions in North America, where we expect weak market conditions into 2016/2017 crop season.
For the fourth quarter, we expect segment earnings to be between $117 million and $137 million. At the midpoint, this implies segment earnings growth of approximately 25% compared to the fourth quarter of 2015. Improved U.S. dollar pricing in Brazil and lower costs year-over-year are expected to drive a meaningful increase in segment earnings margin in the quarter from 15% in 2016 to closer to 20%. 
We are pleased with the progress made in Ag Solutions to drive margin improvements in the business. Prior to the acquisition of Cheminova, Ag Solutions consistently delivered consolidated operating margins between 20% and 25%, and we are well on our way to returning margins to that level. We are tightening our full year segment earnings guidance to $390 million to $410 million, with the midpoint of our range unchanged, and continue to forecast full year revenue of about $2.3 billion at the midpoint.
Turning next to Health and Nutrition on Slide 4. For the third quarter, Health and Nutrition reported revenue of $179 million and segment earnings of $45 million. Revenue declined 9% year-over-year, largely as a result of lower volume. Timing of sales to certain pharma customers in Asia and Europe and headwinds from omega-3 each contributed to the volume declines.
Segment earnings of $45 million declined 4% compared to 2015. However, operating margin improved 120 basis points to over 25% in the quarter. The negative impact of lower volumes and product mix was largely offset by lower operating costs as a result of ongoing operating excellence programs.
For the fourth quarter, we expect segment earnings of between $53 million and $57 million and for the full year forecast segment earnings to be in the range of $190 million to $194 million. At the midpoint, Q4 segment earnings are expected to increase almost 20% compared to Q4 2015. The bulk of the increase in segment earnings is due to the timing of certain favorable cost variances from prior period, which will drive segment earnings margin to between 29% and 30% in the quarter. For the full year, we expect margins of about 25% to 26%.
Moving on to Lithium on Slide 5. Lithium delivered another outstanding quarter. Revenue increased 22% to $70 million on the back of increased price and more favorable mix. Segment earnings rose to $18 million from just $2 million last year. Market conditions remained favorable, with demand increasing ahead of supply. As a result, prices across the portfolio were higher compared to the last year. These price increases, combined with the most favorable sales mix, lower costs and the benefit from foreign currency, drove the improvement in segment earnings and margin in the quarter.
We expect the positive momentum in Lithium to continue, with fourth quarter segment earnings between $16 million and $20 million, approximately 60% higher year-over-year at the midpoint of the range. Based on Lithium's performance to date and our expectation for Q4, we are increasing full year guidance for segment earnings by $5 million at the midpoint to a range of $65 million to $69 million. Full year segment earnings margin should be about 25% compared to 10% in 2015.
Before turning the call over to Paul, I will comment briefly on the outlook for the fourth quarter and full year 2016 on Slide 6. We are tightening full year segment earnings guidance for both Ag Solutions and Health and Nutrition and increasing guidance for Lithium. Based on this segment's guidance and the lower tax rate, which Paul will discuss in a moment, we expect fourth quarter adjusted earnings per share to be in the range of $0.82 to $0.92 and full year adjusted EPS in the range of $2.76 to $2.86.
I will now turn the call over to Paul."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Thank you, Pierre. I'll start with the tax rate and the noncontrolling interest on the income statements before I move on to the impact of currency, cash flow and the balance sheet.So first, tax. Year-to-date, our adjusted effective tax rate is around 2",724,"Thank you, Pierre. I'll start with the tax rate and the noncontrolling interest on the income statements before I move on to the impact of currency, cash flow and the balance sheet.
So first, tax. Year-to-date, our adjusted effective tax rate is around 23.5%, which is slightly lower than we initially expected. This is driven by an increase in the contribution of earnings from our foreign entities compared to prior years. And while this trend is most apparent in Ag Solutions, we're actually seeing it in all of our businesses. We expect the adjusted effective rate to be in the 23% to 24% range for the fourth quarter. And looking into 2017, we expect that rate may fall by as much as 3 percentage points, resulting in a full year adjusted effective tax rate closer to 21%. This further reduction is mainly the result of the operational integration of Cheminova, which will impact our supply chain and our earnings mix globally.
Our noncontrolling interest line continues to shrink as part of the integration of Cheminova. We've been taking advantage of opportunities to simplify the ownership structure of some of our international entities and are taking or have taken steps to consolidate ownership in places such as Argentina, China and Eastern Europe. Largely as a result of these steps, we expect the noncontrolling interest line to fall to approximately $5 million this year and remain near this level next year.
Talking on currency. This quarter saw none of the rapid movements in major currencies that we saw last year. And as a result, FX had a far smaller impact on our results. Across all businesses and regions, currency was a tailwind to earnings, with a large favorable movement in Brazil the biggest factor. The other major currencies for which FMC is exposed, namely the euro and RMB, had no meaningful impact on our earnings in the quarter. For the year-to-date, currency has been good and neutral to earnings.
Moving on to cash flow on Slide 7. The first thing I want to point out is our increasing cash flow guidance for full year from a range of $450 million to $550 million to a range of $550 million to $600 million. The midpoint of this revised guidance reflects an increasing cash generation of almost 60% compared to 2015. Higher earnings, stronger working capital performance and tight spending discipline were all contributors to the year-over-year increase and give us confidence that the higher level of cash generation we've seen through the first 3 quarters will continue through Q4.
Underpinning our confidence in cash generation is our success in reducing our Brazil exposure. Through September, we collected over $500 million of receivables in Brazil, reducing the outstanding receivable balance by over $200 million. By the end of 2016, we expect to have collected over $700 million of outstanding receivables in Brazil alone. Equally importantly, a significant proportion of the collections are coming from those accounts that were past due at the start of the year, improving the quality of the remaining receivables balance.
Our receivables balance in Brazil, however, remains higher than we believe it should be. And we expect to continue to reduce it over the coming seasons. Based on our current visibility, we believe that we have the ability to reduce the current balance by approximately $400 million. We will deliver this reduction over the next 18 to 24 months.
Our strong cash generation has helped us reduce our net debt by over $200 million so far this year, and we expect this to fall further by year-end. Combined with higher trailing EBITDA, our adjusted net debt-to-LTM EBITDA ratio will fall into the 2.5 to 3x range as we enter 2017. We will continue to manage our debt to a level consistent with our current credit rating.
And looking into 2017, we expect our capital expenditure to remain similar to '16, at or just ahead of depreciation, leaving allowance for our planned expansions in lithium hydroxide. We will continue to seek out opportunities to invest in technologies and products for our Ag Solutions business. And at an appropriate time in 2017, we would expect to revisit our ability to engage in share repurchases while maintaining our other net debt, credit rating and investment objectives.
And with that, I will turn the call back to Pierre."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Before closing, I would like to share a few initial thoughts regarding 2017 on Slide 8. Based on what we see today, we expect the global crop protection chemical market to be about flat in 2017, creating a more stable operating environment for FMC Ag Solu",901,"Before closing, I would like to share a few initial thoughts regarding 2017 on Slide 8. Based on what we see today, we expect the global crop protection chemical market to be about flat in 2017, creating a more stable operating environment for FMC Ag Solutions.
Market demand in Europe and Asia continues to grow, and more normal weather conditions should lead to an improved demand environment in those regions next year. While it remains very early to predict the market crop protection chemical in Latin America, we are quietly confident that we will enter 2017 with better market fundamentals than either of the previous 2 seasons.
In contrast, we expect market conditions in North America to remain challenging as we do not believe that the market-wide destocking process has run its course and that elevated levels of channel inventory, combined with low commodity prices, will dampen grower demand across the region.
In a flat market and assuming stable currencies, we believe Ag Solutions is well positioned to deliver another year of growth in segment earnings. Revenue synergy opportunities in Europe and North America, planned new product introductions and continued cost savings will more than offset cost inflation. Our preliminary view is that Ag Solutions' segment earnings will grow by high single-digit percent in 2017.
In Health and Nutrition. Next year, we expect growth rate for revenue and segment earnings to return to historical levels of low to mid-single-digit percent.
In Lithium, the combination of higher price, increased lithium hydroxide volume and continued cost discipline should increase segment earnings by about 40% in 2017. We expect to realize higher prices in all major downstream products next year, with the most significant increase in lithium hydroxide.
The majority of our lithium hydroxide contracts are negotiated in the fourth quarter. And based on the status of customer negotiations to date, we expect the average realized price to be significantly higher in 2017. We also expect to see a meaningful increase in the production of lithium hydroxide next year as a result of our previously announced capacity expansion. Construction of our hydroxide unit is ahead of schedule. Based on the current construction headlines, we expect production of lithium hydroxide to increase by 4,000 metric tons in 2017, with total production capacity decreasing -- increasing to 18,000 metric tons per year by the middle of next year.
Hitting the growth in demand for FMC's downstream lithium product requires access to increasing volume of lithium carbonate. Earlier this week, we announced an agreement with Nemaska Lithium to source 8,000 metric tons of lithium carbonate per year beginning in mid-2018. This agreement represents only one element of the sourcing strategy, and we are actively pursuing multiple path to diversify our carbonate source.
In the near term, we will increase capacity at our Argentina operations by approximately 20% through low-capital cost actions. We continue to evaluate long-term supply agreements and partnerships with other producers of lithium carbonate, and we retain the option of expanding our carbonate production operation in Argentina in order to ensure we have a secure, reliable and cost-competitive supply of lithium carbonate.
At the corporate level, we expect costs to remain roughly flat and to continue to reduce debt. Combined with the lower tax rate for 2017, as Paul mentioned earlier, we expect to grow EPS at a faster rate than we grow operating earnings.
Consistent with prior years, we will provide more details and specific guidance for 2017 in February when we report our Q4 and full year 2016 results as we first need to see how the year ends and assess business and market conditions at that time.
To conclude, I am very pleased with our performance in the quarter and year-to-date. In volatile markets, FMC has continued to execute its strategy and deliver substantial growth in earnings. I believe we are positioned to continue this in Q4 and beyond. We continue to invest in our technology pipeline in Ag Solutions and are launching new products that bring greater value to the grower.
Last month, we announced that FMC has begun the registration process in North America of our Bixafen fungicide, 1 of the 9 active ingredients in our R&D pipeline. With our unique, high-return R&D model for active ingredient innovation and strong regional formulation capabilities, FMC is well positioned to deliver the technology and service that growers demand. We will provide additional information regarding our technology pipeline in the coming months.
Health and Nutrition continues to generate high margins and strong cash flow, and demand across our core nutrition and health market continues to grow.  We are in the process of commissioning our new MCC production facility in Thailand, which will serve the growing nutrition market in Asia. Demand for our downstream lithium products continues to increase. FMC is well positioned to maintain its leading position in lithium hydroxide, butyllithium and lithium metals, and we continue to pursue multiple paths to diversify our sources of lithium carbonate to feed the expected growth in the business. Our agreement with Nemaska is just trusted, and we look forward to announcing more actions in 2017.
In closing, the actions we are taking will continue to drive performance across our businesses and position FMC to deliver increasing value to our shareholders into 2017 and beyond. I thank you for your attention this morning.
With that, I will turn the call back to the operator for questions."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","[Operator Instructions] Our first question today comes from the line of Christopher Parkinson with Crdit Suisse.",16,"[Operator Instructions] Our first question today comes from the line of Christopher Parkinson with Crdit Suisse."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Your results far exceeded what your peers have been indicating for European crop protection growth, especially in 3Q. And you mentioned some things in your presentation such as direct market access across Eastern Europe and strong herbicide sales in the U",83,"Your results far exceeded what your peers have been indicating for European crop protection growth, especially in 3Q. And you mentioned some things in your presentation such as direct market access across Eastern Europe and strong herbicide sales in the U.K. But can you just talk a little more about the longer-term key drivers in the market, let's say, over the next 2 years? Are we in the early innings of the Eastern European theme? And what's the latest update on new registrations?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Chris, this is Mark. You highlighted the points that we put out in the release regarding how we grew in Europe. I think for us going forward in the next few years, it's very much what we've just said in terms of direct market access. We're very pleased wi",185,"Chris, this is Mark. You highlighted the points that we put out in the release regarding how we grew in Europe. I think for us going forward in the next few years, it's very much what we've just said in terms of direct market access. We're very pleased with what we see in Eastern Europe, but we're working off of a pretty small base. And we have just purchased the JV that we had in Czechoslovakia, Poland. It's important for us to expand in that area. But we shouldn't forget that France, Germany, the U.K., Spain, Italy, they're all important markets where we intend to put new products into the pipeline. We do have new products coming next year and the year after that are based upon our clomazone franchise for herbicides. So we expect to see significant growth in herbicides as we move forward. And in addition, with the acquisition of Cheminova, we've also, as we've said, expanded our fungicide portfolio. So you'll see us grow our European fungicide business substantially over the next 3 to 5 years. That's mainly the growth for us."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And, Chris, remember that many of the products FMC was selling in Europe are registered today in places like France, Italy, Spain, Portugal, Southern Europe, U.K. We were just not benefiting from a very strong sales organization as we were working with a",89,"And, Chris, remember that many of the products FMC was selling in Europe are registered today in places like France, Italy, Spain, Portugal, Southern Europe, U.K. We were just not benefiting from a very strong sales organization as we were working with a distribution network, which was mostly focused on Northern Europe. So even without adding many registrations, which we will and we have new product coming, we just have, in fact, to increase our face-to-face presence with the market is going to dramatically increase our ability to grow."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Great. And just a quick follow-up. Can you just also quickly comment on where you think the insecticide inventory issue in Brazil and how that may or may not affect the market heading into 2017? And also, you've seen some recent spikes in sugar and cotton",75,"Great. And just a quick follow-up. Can you just also quickly comment on where you think the insecticide inventory issue in Brazil and how that may or may not affect the market heading into 2017? And also, you've seen some recent spikes in sugar and cotton prices. Could you just quickly comment on the conversations you're having with those customers? As I imagine, they've been better than they have over the last couple of years."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think we are always very careful when we talk about the role of product inventory in the channel overall at the market level. But the situation in Brazil, including for insecticide, is right now feeling, I would say, more stable. As you can see, ye",165,"Yes. I think we are always very careful when we talk about the role of product inventory in the channel overall at the market level. But the situation in Brazil, including for insecticide, is right now feeling, I would say, more stable. As you can see, year-on-year numbers show a decrease in sales in addition to the progress utilization. So we believe there are actions which are being taken for insecticides and other product to decrease the level of inventory in the channel. The discussions with growers are better. There is -- they are easier on pricing. They are easier on term, and our volumes are more predictable. So we do believe it is decreasing. We don't believe it's decreasing fast enough to create a very robust 2017 number. But I would say we want to be entering 2017 in a more stable situation and more flattish market than we did in the previous 2 years. Mark, do you want to comment on the sugarcane?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, sure. Chris, when you mentioned cotton and sugarcane, obviously, important crops for FMC down in Brazil. I'm more confident in sugarcane than I am in cotton. As we've talked about and Paul alluded to in terms of collections, we've been very prudent i",217,"Yes, sure. Chris, when you mentioned cotton and sugarcane, obviously, important crops for FMC down in Brazil. I'm more confident in sugarcane than I am in cotton. As we've talked about and Paul alluded to in terms of collections, we've been very prudent in our exposure to certain areas of Brazil and, certainly, in crops. I would say the cotton growers have faced a very tough time in the north due to the drought. So liquidity is important for them, and we're watching that situation very carefully. Acres are expected to be flat to slightly down in Brazil as we go forward into the next season. Switching to sugarcane, you're right, sugar prices are at least double where they were last year. Ethanol prices were up in Brazil. So the fundamentals for the business is good. The one thing they are lacking right now is liquidity, given all the debts they've incurred over the last few years. We're ideally positioned. We have strong market shares in insecticides and herbicides. Planting is down right now, probably about 30% due to that liquidity. But I think as the business unwinds next year, I'm very confident that our sugarcane business will grow next year and be a good buffer for some of the other downsides we might see in cotton."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Just to repeat, Chris, I want to use your question to make sure that we are clear, but we are continuing with the strategy. It's a different strategy, but really, we are not focused on volume at all today. I mean, what is very important for us today is pr",103,"Just to repeat, Chris, I want to use your question to make sure that we are clear, but we are continuing with the strategy. It's a different strategy, but really, we are not focused on volume at all today. I mean, what is very important for us today is pricing our technology, where it should be priced; decreasing the level of our products in the channel; getting terms which are right; and collecting. We believe the market is such that -- this is the right strategy, which will make us much stronger when we get to a situation where the market turns around."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Our next question today comes from the line of Daniel Jester with Citi.",13,"Our next question today comes from the line of Daniel Jester with Citi."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Maybe I can just follow up on Chris' question in a different way. I think you said that low-margin product in Brazil, which you're exiting, attributed to 60% of the volume decline in the quarter. So maybe can we just talk about what's driving this 40% of",53,"Maybe I can just follow up on Chris' question in a different way. I think you said that low-margin product in Brazil, which you're exiting, attributed to 60% of the volume decline in the quarter. So maybe can we just talk about what's driving this 40% of the rest of the volume decline?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","There is 2 things which are driving the remaining 40%. First of all, we believe -- and we'll confirm that at the end of the fourth quarter, but we are believing that -- we believe that we are in a situation in Brazil where the market will still be down in",157,"There is 2 things which are driving the remaining 40%. First of all, we believe -- and we'll confirm that at the end of the fourth quarter, but we are believing that -- we believe that we are in a situation in Brazil where the market will still be down in the 10% range year-on-year for the full year. So there is a market driver. There is also the fact that we are moving away from sales, not because of rationalization but because of credit risks or term. We are very cautious in not selling for the sake of selling. We are selling when we know we can get normal terms for the region and we will be able to collect. So as I said before, volume is not the priority. So those are the 3 reasons: sales, which are fixed with good terms; market, which will decline; and product rationalization. Those are the 3 drivers."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. That's helpful. And then I think you also commented that operating margins in Brazil are sort of approaching where you were in 2014. But I think for the Ag segment as a whole, margins are still below 2014 levels. So can you comment on the other regi",62,"Okay. That's helpful. And then I think you also commented that operating margins in Brazil are sort of approaching where you were in 2014. But I think for the Ag segment as a whole, margins are still below 2014 levels. So can you comment on the other regions and where you see margins stay and how maybe they can improve into 2017?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think that if you look at when we made the acquisition of Cheminova, acquiring Cheminova would bring to us many benefits in terms of creating more global business, a broader fungicide portfolio, a direct access to markets in Europe and other benefi",228,"Yes. I think that if you look at when we made the acquisition of Cheminova, acquiring Cheminova would bring to us many benefits in terms of creating more global business, a broader fungicide portfolio, a direct access to markets in Europe and other benefits, more fully the performance in -- more fully in market presence in India and Australia. But we also realized that the margins Cheminova was realizing were not at the level of what we're expecting. And we had a plan to bring those margins through cost saving, pricing and new product introduction due to at least the recall level of FMC. And that's the road we are on. I have to say that despite the market conditions, 1.5 years after closing on the Cheminova acquisition, we have brought back those margins to 20%, which is well -- for the fourth quarter, which is well in line, even ahead, of our schedule. We still have work to do. We still have remember. We still have additional costs to extract from the business from the acquisition in the next 6 to 9 months. So we still have work. But we are well on our way to margin north of 20%. It is just the integration of Cheminova, the pricing of the technology and the new product introduction, but we are well on that road map right now."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","We'll go to the line of Mike Harrison with Seaport Global.",12,"We'll go to the line of Mike Harrison with Seaport Global."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Eric, I was wondering if you could talk a little bit about the cost structure and some of the key margin drivers that you saw in Health and Nutrition this quarter. Did we see any of the variance impacts during this quarter that you mentioned you're going",54,"Eric, I was wondering if you could talk a little bit about the cost structure and some of the key margin drivers that you saw in Health and Nutrition this quarter. Did we see any of the variance impacts during this quarter that you mentioned you're going to be seeing in the fourth quarter?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Eric here. So it's a complicated question because the costs that flow through in any 1 quarter are related to a variety of factors, where a lot of it is stemming from manufacturing excellence programs, same-store so that's a sustainable component. However",144,"Eric here. So it's a complicated question because the costs that flow through in any 1 quarter are related to a variety of factors, where a lot of it is stemming from manufacturing excellence programs, same-store so that's a sustainable component. However, as we talked about in the guidance Pierre gave for the fourth quarter, we'll see benefits stem from things such as seasonality and how we harvest seaweed, right? There are times of the year, particularly off the coast of Norway, where we get a higher-quality seaweed, we have more access to the waters because of the favorable weather, what have you, that drive one-off opportunities in costs, and that -- and where our variances work, that flows through. And it's part of the benefit we see in the fourth quarter. I want to make sure, does that answer the question you're after?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Mike, maybe to answer a little bit more your question, if you look at previous years, it is not an abnormal situation to see -- you could see it maybe not at the same extent, but you can see it to the 2015 results, where you would see higher margin in Q4",106,"Mike, maybe to answer a little bit more your question, if you look at previous years, it is not an abnormal situation to see -- you could see it maybe not at the same extent, but you can see it to the 2015 results, where you would see higher margin in Q4 than you would see in Q3. So we realized over the year a 25% margin for the business. But we recognize that there is some seasonality to margin in this business. So there is not always a connection between a margin improvement you will see in Q4 and what you could realize in Q3."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Yes. I guess the question that I had, Eric, also had to do with the weakness in volumes during the third quarter, yet you were able to show pretty nice margin improvement. I was wondering if there was some variability around the costs or if this was struc",57,"Yes. I guess the question that I had, Eric, also had to do with the weakness in volumes during the third quarter, yet you were able to show pretty nice margin improvement. I was wondering if there was some variability around the costs or if this was structural cost takeout that was really driving the margin improvement."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, I would say it's more of the latter. The structural improvements we've made is nothing unique about what's happened sequentially from 1 quarter to the next. Volumes were lower for the reasons Pierre referenced, omega-3, as well as some timing in our",107,"Yes, I would say it's more of the latter. The structural improvements we've made is nothing unique about what's happened sequentially from 1 quarter to the next. Volumes were lower for the reasons Pierre referenced, omega-3, as well as some timing in our health business. But the cost side of that is pretty consistent. It's a structural component that gets us to a sustainable margin that's in the mid-20s, notwithstanding the occasional, and what we've seen in prior quarters, benefit we can make in certain quarters like the fourth quarter that are not benefits you roll forward into the first or second quarters of the following year."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","All right. Then I had a question on the Lithium business. Can you comment on what you were seeing in price activity sequentially across different products?",26,"All right. Then I had a question on the Lithium business. Can you comment on what you were seeing in price activity sequentially across different products?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think I'll have Tom commenting more on the pricing. But right now, if you look, we had a lot of benefits from pricing on lithium carbonate up to now and maybe less of a pricing benefit of lithium hydroxide. We are now getting into the period of new",120,"Yes. I think I'll have Tom commenting more on the pricing. But right now, if you look, we had a lot of benefits from pricing on lithium carbonate up to now and maybe less of a pricing benefit of lithium hydroxide. We are now getting into the period of new contract negotiations of lithium hydroxide, which will impact mostly 2017. So directionally, what we do expect is we do expect to start to see a very significant ramp-up in lithium hydroxide pricing, which is very much in line with the negotiation we are having, while we will see maybe a more stable pricing in lithium carbonate potentially lowering into 2017. Tom, you want to add some more color to that?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. Just to give a little more color to that, on hydroxide, the contract negotiations are proceeding well, and over the coming month, they should be all solid. We're progressing well through those. And on the carbonate, as most of the folks saw in the ma",113,"Yes. Just to give a little more color to that, on hydroxide, the contract negotiations are proceeding well, and over the coming month, they should be all solid. We're progressing well through those. And on the carbonate, as most of the folks saw in the market, there was a little bit of softening in Q3, particularly in China. What we'll see going into next year is the smaller volume of carbonate that was locked in at lower prices similar to the hydroxide will come up. And we expect some softening on the top end. So net-net, we'll go into next year on those more opportunistic product lines kind of flat to slightly down."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And the big story, once again, for us, I mean, because of the strategic focus, because of the timing of where we are in contract negotiations and increasing capacity coming up next year, the big focus for us and where you're going to see the largest contr",53,"And the big story, once again, for us, I mean, because of the strategic focus, because of the timing of where we are in contract negotiations and increasing capacity coming up next year, the big focus for us and where you're going to see the largest contributor to earnings growth is lithium hydroxide."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And next, we'll go to the line of Don Carson with Susquehanna.",12,"And next, we'll go to the line of Don Carson with Susquehanna."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Ben Richardson sitting in for Don. Just sticking on -- with the topic of lithium. You say you're ahead of schedule with the ramp there. Can you just maybe speak to the timing of that additional tonnage?",39,"This is Ben Richardson sitting in for Don. Just sticking on -- with the topic of lithium. You say you're ahead of schedule with the ramp there. Can you just maybe speak to the timing of that additional tonnage?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. What we -- we're expecting the mechanical completion of the plants. I had the pleasure actually to be there 2 weeks ago and see the plants looking really good. We expect the mechanical completion of the plants in the fourth quarter this year. We're g",139,"Yes. What we -- we're expecting the mechanical completion of the plants. I had the pleasure actually to be there 2 weeks ago and see the plants looking really good. We expect the mechanical completion of the plants in the fourth quarter this year. We're going to be able to start to add products coming out of the plants in the first quarter, and then we're going to start to enter the customer qualifications of the products. So we believe we'll be in a commercial situation where the products are produced by the plant, by the expansion and qualifying the customer by the middle of the year. So the 8,000 metric ton capacity we have for next year should give to us a 4,000 additional tons of products into 2017 and the full 8,000 when we get into 2018."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And I guess, though, slipping back to Ag and, specifically, potential divestitures in your space and how you see that developing.",22,"Okay. And I guess, though, slipping back to Ag and, specifically, potential divestitures in your space and how you see that developing."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","We are in contact with our -- with any of the companies which are currently consolidating, and we are standing ready to participating in the purchase of any molecule -- any of this company would be divesting if they meet our portfolio. I have to say that",103,"We are in contact with our -- with any of the companies which are currently consolidating, and we are standing ready to participating in the purchase of any molecule -- any of this company would be divesting if they meet our portfolio. I have to say that so far, we haven't seen anything which would be critical to our portfolio or any significant technology put on the market. But I think those companies are still in the -- in an early stage of the antitrust reviews. So we are standing ready but haven't seen anything right now which has been attractive to us."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And our next question is from the line of Joel Jackson representing BMO Capital Markets.",15,"And our next question is from the line of Joel Jackson representing BMO Capital Markets."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Milan on for Joel. I mean, just following up there on the acquisitions. I mean, if you are to pursue something, can you maybe give us -- perhaps put some numbers around magnitude? And what would be the funding? I mean, what sort of leverage would",56,"This is Milan on for Joel. I mean, just following up there on the acquisitions. I mean, if you are to pursue something, can you maybe give us -- perhaps put some numbers around magnitude? And what would be the funding? I mean, what sort of leverage would you be comfortable going back up to potentially?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I'll first talk to the leverage. The size -- I mean, really, I would not like to speculate here on the results of any antitrust reviews and what could be the consequences in terms of what product would be for sale and what would be the price. So of course",108,"I'll first talk to the leverage. The size -- I mean, really, I would not like to speculate here on the results of any antitrust reviews and what could be the consequences in terms of what product would be for sale and what would be the price. So of course, we do our own work to be ready and try to anticipate, but that's only speculation on our part to stand ready. But it's very hard to tell until the antitrust process in each of the regions is taking place and having the companies making decisions around their portfolio. Paul, you want to talk about the leverage?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Sure. Just again, to Pierre's point, it's difficult to be particularly satisfying to you with the answer without any real specifics. But I think it's fair to say, I think you've seen from my cash flow performance, we are generating a fairly good cash righ",165,"Sure. Just again, to Pierre's point, it's difficult to be particularly satisfying to you with the answer without any real specifics. But I think it's fair to say, I think you've seen from my cash flow performance, we are generating a fairly good cash right now. We're deleveraging quickly. One of the characteristics -- because we bought products like this frequently in the past, one of the key characteristics is that they are typically very cash generative from day 1. And so they can stand a pretty decent amount of leverage from day 1. We also are very disciplined on price. Based on everything we can see, we don't see any risk to our credit rating from a cash acquisition of any of the available interesting assets that are out there right now. Again, that could change depending on what assets come available. But we don't see any particular challenge to our balance sheet based on the opportunities that are available that we see today."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","And maybe just switching to omega-3, you talked about some abating headwinds going into next year. I mean, is the environment more competitive, equally competitive, less competitive than you were perhaps seeing last quarter and going into '17?",39,"And maybe just switching to omega-3, you talked about some abating headwinds going into next year. I mean, is the environment more competitive, equally competitive, less competitive than you were perhaps seeing last quarter and going into '17?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Omega-3 is a -- how do we say, it is not getting worse, but it is not getting better. I think it's a challenging environment. Right now, we are focusing on actions for us to leverage some of the manufacturing capability and quality of product, especially",202,"Omega-3 is a -- how do we say, it is not getting worse, but it is not getting better. I think it's a challenging environment. Right now, we are focusing on actions for us to leverage some of the manufacturing capability and quality of product, especially the fact that we have no way made product which have very high quality and commend a premium, to try to improve a situation. But frankly, at that stage, with the oversupply there is in this market and the number of players, the improvements you will see on omega-3 will be driven by the work we do commercially and cost-wise more than us benefiting from the market. We are very -- when we've -- when we announced the numbers for expected growth for the Health and Nutrition business next year, we are very, I would say, prudent around putting into those numbers any significant improvement in the omega-3 market, which we do not see. So it is a challenge. We're addressing it. We are trying to -- we are in -- I would say, right now, I have to admit we are more in damage control than expecting growth. But that's the situation for omega-3."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Our next question comes from the line of Steve Byrne with BofA.",12,"Our next question comes from the line of Steve Byrne with BofA."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Ian sitting in for Steve. Cash flow generation has been very, very good this year, and I appreciate the comments about some of the collections in Brazil. And looking forward to 2017, provided some preliminary guidance about expecting earnings grow",57,"This is Ian sitting in for Steve. Cash flow generation has been very, very good this year, and I appreciate the comments about some of the collections in Brazil. And looking forward to 2017, provided some preliminary guidance about expecting earnings growth, should cash from operations grow at the same level of earnings or higher or lower?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. I think you heard in my comments, we talked about probably still about $400 million of excess receivables sitting on our balance sheet related to Brazil. And we'd certainly expect to start to collect a significant proportion of those next year. So gi",123,"Yes. I think you heard in my comments, we talked about probably still about $400 million of excess receivables sitting on our balance sheet related to Brazil. And we'd certainly expect to start to collect a significant proportion of those next year. So given that, we would expect the cash flow to continue to grow really similar like to what -- how it did this year. We'll generate high EBITDA. We do not expect to have any meaningful cash outflows for CapEx over and above what we have today. And we expect to continue to decapitalize our balance sheet in Brazil. So yes, I would expect cash flow to continue to grow next year just as strong as it had been this year."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","And as a follow-up, just kind of on the broader market. What -- for Ag, specifically in Latin America, what things would you be looking for to potentially become more optimistic about a rebound in that region? I think sales are still far below prior level",56,"And as a follow-up, just kind of on the broader market. What -- for Ag, specifically in Latin America, what things would you be looking for to potentially become more optimistic about a rebound in that region? I think sales are still far below prior levels of peak. What does the industry need to see?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Well, I think for me, there's a couple of things. First of all, on the macro level, obviously, if commodity prices start to come back, we're going to see expanded acres down in Brazil for a lot of the row crops. That's one factor. Then the second factor i",154,"Well, I think for me, there's a couple of things. First of all, on the macro level, obviously, if commodity prices start to come back, we're going to see expanded acres down in Brazil for a lot of the row crops. That's one factor. Then the second factor is just the internal health of that business in the sense of where channel inventories are, pest pressures, the normal seasonal-to-seasonal activity in Ag. I think if you can get those things coming together, you're going to see somewhat of a rebound in the marketplace. The pest pressures, obviously, nobody knows where the pest pressures are going to lie. Commodity prices are going to take some change in overall yields in North America and Latin America. So we said what we feel the market will be next year. Those will be the 2 items, in Brazil, in particular; and potentially, Argentina that would change that picture."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","The one thing I'd just add to that, I think having a stable macro political environment and improved access to credit for the growers will be a positive if we see that start to happen as well.",38,"The one thing I'd just add to that, I think having a stable macro political environment and improved access to credit for the growers will be a positive if we see that start to happen as well."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","Our next question is from the line of Mark Connelly with CLSA.",12,"Our next question is from the line of Mark Connelly with CLSA."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Pierre, last quarter, you talked about some optimism in your outlook comments for Health and Nutrition but not about seasonality in Q3 and Q4. What I'm wondering is, do you think you have the right mix of products for what customers are looking to do with",65,"Pierre, last quarter, you talked about some optimism in your outlook comments for Health and Nutrition but not about seasonality in Q3 and Q4. What I'm wondering is, do you think you have the right mix of products for what customers are looking to do with their products over the next couple of years? Or do you need to tweak your portfolio, leaving Omega-3 aside?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","That's a very good question. And I'd tell you, it's a difficult one to answer. I believe that we have a very solid position in MCC, alginate and carrageenan. I do believe that we have the right formulation technology allowing us to meet the changing need",279,"That's a very good question. And I'd tell you, it's a difficult one to answer. I believe that we have a very solid position in MCC, alginate and carrageenan. I do believe that we have the right formulation technology allowing us to meet the changing need of the market and the customers. The question for us is -- and that's a business. Today, if you put omega-3 aside, we have strong market share, and we are the leading supplier in the place where our customers go today when they have the need for new product or new technology. So I believe this is a business which will for the next 2, 3 years continue to grow in the mid-single-digit, as we said in the guidance, with very strong margin, 25%, and good cash generation. So to answer your question, I'm quite confident around that business for the next 2 to 3 years. We do have interesting new ideas based on the current product we have for new technology, for some of the changing market needs around health and other applications. The question for me is more 3 years and beyond. And really, where do we want to take that franchise? We have great product today. We have great margin and good cash generation. The first attempt to do that was omega-3. I think we didn't do a good job there. The question is what we want the business to be, not in next 2, 3 years but beyond that. So to answer your question, yes, for the next 2, 3 years. Beyond that, we need a lot of work to define the midterm strategy for Health and Nutrition."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. That's super helpful. And if I could just come back, I hate to beat on the working capital issue, but just a clarification. Of the additional $400 million and everything else you're doing down there, are your credit practices in Brazil going to be m",71,"Okay. That's super helpful. And if I could just come back, I hate to beat on the working capital issue, but just a clarification. Of the additional $400 million and everything else you're doing down there, are your credit practices in Brazil going to be materially different than legacy FMC? Or is this just a matter of we've got the Cheminova cleanup and better execution, well, and customers in better shape?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","So the first thing I would say, though, is when we look back at the position that we find ourselves in, in Brazil, much of it is driven by similar comments that Pierre talked about, about changing the way we approach the business. And instead of focusing",224,"So the first thing I would say, though, is when we look back at the position that we find ourselves in, in Brazil, much of it is driven by similar comments that Pierre talked about, about changing the way we approach the business. And instead of focusing on volume and volume growth and share growth, focusing on getting the maximum value. An important part of that is assessing the quality of the customer and the quality of the products that we sell. We do not expect to be in a meaningfully different place in terms of terms, in terms of structure, in terms of credit that we extend to customers, to either history or the rest of the market. But we will be much more and we are being much more disciplined about where we're willing to take exposure. It's really a function of multiple factors. It's a function of the movement in commodity prices. It's a function of the weaker access to credit for the growers down there in the market. And it is, to an extent, a function of our ability to integrate the Cheminova portfolio and have a higher margin, more technical portfolio really across all regions and all crops. So it's more than one factor that's driving this, this move towards a stronger credit position with our customers down there."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I think, generally speaking, the crop chemical industry as a whole, first, and all of our peer companies, it is an industry which is in Latin America and Brazil, which has been historically focused on growth and maybe a bit more open to taking risk to gai",125,"I think, generally speaking, the crop chemical industry as a whole, first, and all of our peer companies, it is an industry which is in Latin America and Brazil, which has been historically focused on growth and maybe a bit more open to taking risk to gain market share. And we are there with all of our competitors. I do think today, we might have a strategy without fundamentally changing what we've done to be more careful for the foreseeable future. I think it's important. It's working for us. And it's allowing to collect, to price. Our customers want our product. So we're going to be maybe on the lower end of the risk taking without fundamentally changing the way we look at other receivables."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","And we have a question from the line of Dmitry Silversteyn with Longbow Research.",14,"And we have a question from the line of Dmitry Silversteyn with Longbow Research."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","A couple of follow-ups, if I may. First of all, with regards to your announced deal for 8,000 tons of carbonate that you're going to be getting from your new partner, is that pretty much all of their capacity or -- and you do have the right to all of that",59,"A couple of follow-ups, if I may. First of all, with regards to your announced deal for 8,000 tons of carbonate that you're going to be getting from your new partner, is that pretty much all of their capacity or -- and you do have the right to all of that capacity? Or is there more behind that?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","The 8,000 tons is -- when you say their capacity, it's not their -- it's our capacity, I mean, this plant. If you talk about the expansion in China, this plant...",32,"The 8,000 tons is -- when you say their capacity, it's not their -- it's our capacity, I mean, this plant. If you talk about the expansion in China, this plant..."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","In Nemaska.",2,"In Nemaska."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Oh, in Nemaska, okay.",4,"Oh, in Nemaska, okay."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, Dmitry, this is Tom. I can take that. Nemaska's installed capacity will be 28,000 tons. So it will be a meaningful part of their capacity, but it will not by any means be all of their capacity.",38,"Yes, Dmitry, this is Tom. I can take that. Nemaska's installed capacity will be 28,000 tons. So it will be a meaningful part of their capacity, but it will not by any means be all of their capacity."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And I'm assuming you have some way of getting more if you need more either from these guys or from other sources as you move past 2018, 2019.",29,"Okay. And I'm assuming you have some way of getting more if you need more either from these guys or from other sources as you move past 2018, 2019."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Well, with respect to that, as Pierre outlined in his comments, we've got a multipronged strategy where we're continually evaluating, one, how do we diversify, have security of supply, low-cost supply. So we're not quite ready to announce the other pieces",62,"Well, with respect to that, as Pierre outlined in his comments, we've got a multipronged strategy where we're continually evaluating, one, how do we diversify, have security of supply, low-cost supply. So we're not quite ready to announce the other pieces coming, but there'll be multiple components to that, including our own investments in our facilities as well as working with others."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I think it's important in all of these discussions, we have this Nemaska agreement. We are in current discussions with some other suppliers of carbonate for partnership. But let's not forget that there is one aspect for which we have 100% of the decision,",129,"I think it's important in all of these discussions, we have this Nemaska agreement. We are in current discussions with some other suppliers of carbonate for partnership. But let's not forget that there is one aspect for which we have 100% of the decision, it is expanding in Argentina. We can expand in Argentina. We do have the mines. We do have the capability. We have the infrastructure. So it is a decision we can make. I have to admit that I'm not in a rush to make that decision because with all of the companies today investing in lithium carbonate, I believe there will be plenty of lithium carbonates for the next 2, 3, 4 years. But this is a decision we can make at any time."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And you actually kind of led into my next question, Pierre. This 20% debottlenecking expansion that you're undertaking in Argentina, what's the timing for that to come online? Is that a back end of 2017 as well?",38,"Okay. And you actually kind of led into my next question, Pierre. This 20% debottlenecking expansion that you're undertaking in Argentina, what's the timing for that to come online? Is that a back end of 2017 as well?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. This is going to start right now. I mean, we're going to see this capacity of carbonate coming in at some point during 2017, 2018. So this is undertaken right now. It is low capital and normal debottlenecking. The team has been working, and we have,",71,"Yes. This is going to start right now. I mean, we're going to see this capacity of carbonate coming in at some point during 2017, 2018. So this is undertaken right now. It is low capital and normal debottlenecking. The team has been working, and we have, I think, 3 work streams, which are allowing us to get to these kind of numbers. But it's more routine capital expansion, I mean."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. And, Dmitry, just to give you a little more color on that. There's multiple components to that. So there are some operational efficiency changes. There are some low-capital projects. There's a number of small projects that over the course of '17 and",48,"Yes. And, Dmitry, just to give you a little more color on that. There's multiple components to that. So there are some operational efficiency changes. There are some low-capital projects. There's a number of small projects that over the course of '17 and '18 will add to that."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","So it sounds like your -- if I do my math right, your Argentinian production will go up to about 21,000 tons. Is that about right?",26,"So it sounds like your -- if I do my math right, your Argentinian production will go up to about 21,000 tons. Is that about right?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes, that's correct.",3,"Yes, that's correct."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","Okay. And then final question on the crop protection business and sort of -- your margins have been, in the past, very differentiated between a sort of 25% level in the first half of the year and kind of a 20% level in the second half of the year, given w",153,"Okay. And then final question on the crop protection business and sort of -- your margins have been, in the past, very differentiated between a sort of 25% level in the first half of the year and kind of a 20% level in the second half of the year, given where the regions that you get your sales from. This year, obviously, has been distorted by everything that's going on. So it's going to be more like first half and second half will be more or less even in terms of margins. As the business gets back to sort of normal execution, how do we think about 2017 margin cadence? Should we expect sort of a 3- to 4-point margin difference between the first half and the second half of the year? Or is it going to be more like this year, where margins are a little bit more even between the quarters?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. We're going to get into it next year. And once again, it's a bit early for us to break down by quarter. We've given a directional number. But yes, the profile of the margins and the business is going to change versus historical FMC just because we ha",162,"Yes. We're going to get into it next year. And once again, it's a bit early for us to break down by quarter. We've given a directional number. But yes, the profile of the margins and the business is going to change versus historical FMC just because we have a very different regional profile. I mean, remember, we are very small in Europe. We want to be much bigger in Europe where there is good marginal business. So I would say that directionally, we should have less variation in our quarterly margins than we had in the past. Now there is 2 things happening today is, there is the market situation. There is a different approach we are taking to the Latin America market, and there is the cost synergies, which are growing quarter-after-quarter. So that is taking us to improved margin and taking us to the 20% range. But I would say, in the future, you'll have more stable margin quarter-over-quarter."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","We have time for one more question today, and that will come from the line of Robert Koort with Goldman Sachs.",21,"We have time for one more question today, and that will come from the line of Robert Koort with Goldman Sachs."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","This is Chris Evans on for Bob. In Lithium, specifically, pretty -- 40% earnings growth assumption for '17. I think you mentioned earlier kind of a low -- flat to down expectation for pricing in carbonate. Can you kind of give the other expectations that",51,"This is Chris Evans on for Bob. In Lithium, specifically, pretty -- 40% earnings growth assumption for '17. I think you mentioned earlier kind of a low -- flat to down expectation for pricing in carbonate. Can you kind of give the other expectations that are driving that assumption for '17?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","I would say -- well, first, if you look at our business in '17, we're expecting to be -- and Tom, correct me if I'm a bit off here, but I would say almost 90% of our business revenues being on the specialty side, the downstream, and only 10% on the upstre",189,"I would say -- well, first, if you look at our business in '17, we're expecting to be -- and Tom, correct me if I'm a bit off here, but I would say almost 90% of our business revenues being on the specialty side, the downstream, and only 10% on the upstream, which is carbonate and fluoride. So we're going to be even more dependent upon the price, the downstream business. We are expecting, I would say, little benefit from carbonate chloride pricing knowing that it's only a small percentage of our business, and we believe this pricing is going to level off in 2017. So you would consider the 40% improvement is going to mostly come from 2 things, pricing in lithium hydroxide and volume in lithium hydroxide. You will understand that I'm going to be a bit careful on what I'm expecting in terms of lithium hydroxide price increase because we are in the middle of the bunch of contract negotiations. So I'll -- we will give you more detail around pricing when we get to the February earnings call, because those negotiations will be behind us."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","And just to add a little bit more color to that. I mean, you have to realize that most of our specialty business is contracted in the prior year. So when we contracted a lot of that, it was before we saw how strong the pricing had moved across the market",67,"And just to add a little bit more color to that. I mean, you have to realize that most of our specialty business is contracted in the prior year. So when we contracted a lot of that, it was before we saw how strong the pricing had moved across the market overall. So there's a little bit of catch-up that's happening across all of the specialty products."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Analysts","And just on the supply agreements to feed your hydroxide ramp, should we expect the additional volumes to come from new entrants like Nemaska? Or do you expect from existing brine or hard rock producers?",35,"And just on the supply agreements to feed your hydroxide ramp, should we expect the additional volumes to come from new entrants like Nemaska? Or do you expect from existing brine or hard rock producers?"
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Yes. So of course, when you look at a supply of carbonate to feed growth, you want to be certain that you have the appropriate mix of new entrants and established players. So we will not -- having a strategy to supply carbonate into our business based onl",144,"Yes. So of course, when you look at a supply of carbonate to feed growth, you want to be certain that you have the appropriate mix of new entrants and established players. So we will not -- having a strategy to supply carbonate into our business based only or mostly on new entrants in this market. Nemaska, we believe, is one of the most solid today, with one of the best sources of lithium. So we believe it's a fairly certain supply we're going to get from them. But we will do 2 things. One is supply from existing suppliers, and not to forget that some of them are already supplying to us carbonate. And a similar goal, to repeat, we can also increase our own capacity of carbonate, which is something if we decide to do it, there will be a short supply."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Executives","Well, we appreciate your time. That's all the time we have for the call today. As always, I'll be available on the call for any additional questions you may have. Thank you.",32,"Well, we appreciate your time. That's all the time we have for the call today. As always, I'll be available on the call for any additional questions you may have. Thank you."
28606,403765323,1073560,"FMC Corp., Q3 2016 Earnings Call, Nov 03, 2016",2016-11-03,"Earnings Calls","FMC Corporation","Operator","That concludes the FMC Corporation Third Quarter 2016 Earnings Release Conference Call. Thank you.",14,"That concludes the FMC Corporation Third Quarter 2016 Earnings Release Conference Call. Thank you."
